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It is a well-documented and a historical fact that human beings have ingested certain substances in 
order to change their perceptions of reality for centuries, if not millennia (RSA, 2007; Nutt, 2015; 
Bancroft, 2009, ch.2; Bennet & Holloway, 2010, ch.2). However, it was not until the beginning of 
the twentieth century that a serious effort was made to outlaw certain drugs for use other than 
medical, through international and national conventions and frameworks. The regulation of certain 
drugs has resulted in a policy framework to manage the governance of drug policy interventions, 
and it is the development of this framework, and participation of drug consumers (policy 




Using interpretive policy analysis as an overarching research design, the thesis explores and 
critiques the development of the concept of ‘problem drug use’, and seeks to unpick this concept 
using Carol Bacchis ‘What’s the Problem Represented to Be’ (WPR) approach (Bacchi, 2009). In 
doing so it highlights the master narratives framing both drug use, and drug user participation 
within policy development, in Scotland. Furthermore, as a result of using the WPR approach to 
analyse the data, a new critical theory entitled critical drug theory (CDT) is developed. This theory 
sits alongside other critical theories such as critical race theory, by focussing on the narratives of 




The narratives surrounding drug use define the process by which the participation of stakeholders 
is incorporated into policy making. More specifically, the narratives of drug harm and the 
medico/legal structures which surround problematic drug use mean that participation is focused 
on a small section of the drug using population, namely problematic drug users. This focus is, in 
part, a result of systemic narratives that have been used to justify policies and practices which 
disproportionately affect those whose ethnicity, social class, gender, religious, ideological and 
political viewpoints do not fit into the dominant narrative.  
 
Critical drug theory is grounded in critical thought with the underlying premise that the 
foundations of drug policy, national and international, are based on ideological reasoning that is 
often used to suppress and silence those who seek to challenge the status quo. Subjecting policies 
to critique and critical evaluation, such as research into the impact drug laws have on individuals 
and society (as opposed to the impact drug use has), should be advocated, along with public 
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This thesis is dedicated to Kenny Simpson. 
“I never judge anybody on how they are presented, everybody’s got their stories to tell, I just don’t 
think there is acknowledgment of that. I think there needs to be more of a caring agenda and common 






Obituary written by myself for Kenny Simpson for SDPC website: 
 
Kenny Simpson worked for the police most of his life, latterly as a civilian running the Statement 
of Opinion Unit for Police Scotland. He was a champion for sensible drug policy and increasing 
dialogue and trust between the different institutions and communities responsible for drug policy 
in Scotland. He represented the middle ground – not pro legalisation but keen to see reform in 
order to improve the lives of problematic substance users in Scotland. I knew Kenny for a short 
time, but what I did know of him I enjoyed immensely. Kenny was a participant of the Scottish 
Drug Policy Conversations since its inception, and always provided a balanced, thoughtful but 
passionate voice on a range of drug policy issues. I recently interviewed him for my research on 
narratives within Scottish drug policy communities. Kenny was passionate about leaving a legacy 
and making sure there was an institutional memory about the changes in drug policy. “You know 
one day I’ll drop off the radar, I’ll probably go and do something drug related somewhere, but 
you know who becomes the go to person?” 
 
In recent years Kenny was involved in many different groups and often spoke at debates on drug 
policy. He was not an advocate of legalisation but only because he thought it hid the real issue 
which is opiate abuse:  
 
“But see the whole legalisation issue for me, that’s a backburner. For me there’s wider 
issues than legalising it. You’re never going to legalise heroin ever, and heroin’s the issue. 
And I’ve said that to Mike (from SDPC), I’m fed up with the Police looking at other things 
when we’ve got people dying. And if we don’t try and go public and raise that agenda, you 
know it’s like the elephant in the room, for Scottish Government, for Police Scotland, for 
addiction services, for NHS, all these people are dying and it’s like [whistles] nobody 
bothers. It’s just another heroin user. It’s like ‘aye there was 4 heroin deaths this morning, 
aye well what else is new’. I think that’s a tragedy. You know, if there were 4 fatal road 
accidents every day, and that’s a strap line that the media have picked up: there are more 
drug deaths than there are fatal road accidents’. You know, if there was 4 fatal road 
accidents every day you’d have police initiatives, you’d have traffic department out there 
and they’d be on the telly…” 
 
And fundamentally this is why he continued to be involved in the police and other groups 
dedicated to drug policy issues: he wanted dialogue and sensible drug policies which actually 
address the tragedy of drug deaths and doesn’t shy away from looking at radical options. He was 
pragmatic and a copper through and through, always ready with words of wisdom and 
encouragement. I – and many others- will miss the chats, his advice and down to earth common 
sense approach to life, and my heart breaks for his close friends and family. Gone far too soon, I 





engagement amongst those in the drug policy world and beyond. Rest in Peace you kind and 




I started this PhD journey in 2014. During that time I moved house 3 times, raised two children 
from 1 and 2.5 years old to almost 7 and 8.5 years old, and recovered from a life threatening lung 
infection which saw me hospitalised for a month. It is safe to say that without certain people in my 
life, this PhD would never have come to fruition.  
 
So firstly I would like to thank my partner, William Molleson, who, despite our ups and downs, 
supported me tirelessly through this process. My children, Lewis and Elliot, who put up with 
mummy needing to leave home for several days at time to ‘write my book’, and who witnessed 
my occasional melt-downs at the pressure this, and other life circumstances put on me. A huge 
thank you to my mum, Barbara Bryan, who provided childcare, emotional and financial support, 
and an unending stream of love and admiration for what I was doing. She also gave me the skills 
I needed to navigate life, which served me well including during the PhD. My gratitude also goes 
to my dad, Neil Ross, and his partner Mitsie, who also provided endless childcare, support and 
encouragement throughout this process, especially when I was seriously ill.  
 
Another family, my partners, must be thanked too. Sue Nuttgens, my partners’ mother has been 
amazing throughout the last 6 years. She also helped out with childcare, financial support and 
emotional support when it all got too much, and Will’s dad, John Molleson, who constantly 
encouraged me to continue, and provided financial support to help me get this final push done 
without the stress of a full-time job. My gratitude.  
 
A major emotional support has been my close friendship group, who have provided spaces for me 
to stay, space for me to moan/chatter about the stress of doing the PhD, and in some cases provided 
childcare and financial support to help me cover difficult periods. So Chandra Mather, thank you 
for being my star sister, who I can turn to no matter what, and who has seen me grow from a wee 
girl wanting a family and a ‘real’ job, to a professional woman. To Jannica Honey, my partner in 
crime and friend since my early clubbing days, the deep love and honest support I receive is 
invaluable. To Aisha Khan, and Olivia Furness, two of my oldest friends from school, who also 
partied hard with me in my twenties, and have been part of my journey. And finally to Jem le 
Lievre, my best pal who I stayed with lots and discussed the deeper aspects of philosophy and 
conscious altering, always good chats. To you all I say a huge thank you.  
 
Then there are the academic supports without which I would not be here. Firstly my supervisors 
Oliver Escobar and Angus Bancroft. I was concerned at the beginning to the PhD that I may have 





However, I feel I had the best, most inspiring and supportive supervisors I could ever have hoped 
for. I used to go for meetings with my supervisors and come out feeling like a newly chipped 
diamond. I feel like they were able to understand what I was trying to explain, and chipped away 
at the rough outside to reveal the shining core inside. Their constant support, frequent contact, and 
insightful and gentle nudging’s in the right direction, allowed me to grow as a researcher and an 
academic. I cannot thank you enough.  
 
I also must thank some additional staff. Richard Freeman from the Academy of Government, who, 
despite my slightly radical ideas, took me on, supported the SDPC and facilitated many of the 
sessions. I didn’t always find it easy to work with him, but I know he valued what I was doing, 
and his support gave me the platform which enabled the development of SDPC. Thank you. I also 
want to thank John Sturrock, of Core Solutions, who despite commanding a good salary for 
mediation work, agreed to facilitate several sessions ad hoc, and our development as a group was 
better for it. Thank you. I would also like to thank the IT team at the University of Edinburgh. It 
may seem silly, but without them I would have struggled with many of the programmes, broken 
computers, weird IT issues and general IT knowledge. It has been amazing to be part of an 
organisation that I can take my IT issues to immediately and have them fixed! I will miss that.  
 
And finally I wish to thank Leonel Cardoso (Kalkito). Leo was my first adult partner, true love, 
and a ‘chaotic and hedonistic drug user’. He introduced me to worlds I would never have accessed 
had it not been for his heroin dependency and extreme drug use. Despite us separating we stayed 
in touch until he died 6 years later at the age of 35, of Hepatitis B resulting in multiple organ 
failure. Yet it is in his memory that I took on drugs policy. His life and his death are what spurred 
me to action, believing that he would still be alive today if it were not for the current drug policy 
agenda. His family over the years have been incredibly supportive of my journey and I wish to 
thank them: Leonel Cardoso Snr, Ricardo and Maria Graca Soeiro. So, to our wee gypsy, rest in 















Reflections of a Drug User: Coming Out and Coming Here 
 
“It was a driech and drizzly November afternoon and the clouds hung heavy over Edinburgh 
Castle. As I trudged the dreary streets the weather reflected my mood: grey, despondent and heavy 
with tears. I was 20 years old, a hardened clubber with 5 years of partying under my belt, but I 
had just discovered the man I loved, and had agreed to marry, was a heroin addict. I knew nothing 
about heroin addiction. My illegal drugs of choice at that age were amphetamines, magic 
mushrooms, cannabis, and above all, ecstasy (MDMA). 
 
I started taking illegal drugs early. By the age of 13 I had tried my first joint and was a regular 
tobacco smoker and cider drinker. By 15 I was taking amphetamine with the punks and getting 
into techno music. My initiation into ecstasy happened on New Years eve 1995/96. I had made 
sure I had a gram of base speed (pure amphetamine) for the evening, and my friends and I found 
an afterparty at an abandoned house in the center of Edinburgh. However, when it got time to get 
stuck into the speed I found to my horror that I had lost it. Not to worry said a friendly host, we 
have pills called California Sunrises (ecstasy), ever tried them? I had not, but true to my inquisitive 
and risk taking personality I was keen to. From there I spent the next 8 years indulging in different 
mind expanding substances, with periods of what some would term ‘problematic use’ interspersed. 
It was during this time that I met and fell in love with a Portuguese man called Kalkito. We partied 
hard and loved hard, but 1 year into the relationship it transpired that Kalkito had been a heroin 
addict since he was 14, and he had come to Scotland to get away from his addiction. Unfortunately 
it did not work, and this is how, at the age of 20, I found myself wandering the streets of Edinburgh 










As I trudged up Cockburn Street having left the local 
council offices after a disheartening conversation with a 
council officer on the help available to heroin users, I 
looked up and saw a sign. A big glowing sign saying 
‘Crew 2000 Take Drugs Seriously’. Seriously? I thought 
as I stared at the sign. Behind the sign the windows 
showed a warm glowing shop, and people who looked 
like me hanging out near the back, making me feel safe. 
I stepped into the shop searching for support, and came 
out the shop having signed up to volunteering for them 
on a monthly basis, and the rest is history, as they say. 
Crew 2000 frontage. Photo by Crew2000 






The reason I tell this story is that the help I found led to where I am now, writing this PhD, 
engaging in policy formation, advice and activism. My understanding of reality has been shaped 
and formed by my interaction with drug-using communities, and the drugs themselves. And it is 
Crew 2000 who set me on the path of drug policy, a path that has combined both personal and 
professional engagement with multiple and disparate illegal drug-using communities. 
  
Crew 2000 is a drug harm reduction charity set up in 1992 by a group of ravers. As the rave 
scene matured there was an increasing number of different drugs, music and venues to choose 
from. With this came an increase in production and use of ecstasy in particular, and multiple 
batches from multiple sources meant multiple variations and no real knowledge how to take them 
safely. As one interview participant involved in drug policing at the time told me, the largest 
amount he had ever come across up until the mid ‘90’s was 100 tablets. By the end of the ‘90’s 
they were getting busts up to 10’s/100’s of thousands of tablets. Crew 2000 was set up by ravers 
for ravers, or anyone who used psychoactive drugs. They provided, and still provide, harm 
reduction advice at music festivals, clubs, pubs and through their drop-in shop on Cockburn Street 
in Edinburgh. At the time I joined it was still very much run by ravers/clubbers, and we were peers 
to those we were helping. Our chill out tents at festivals were havens for those who had over 
indulged, or indulged the wrong thing! Off shift the volunteers partied like our peers, which gave 
us a credence within the scenes that all other harm reduction agencies (such as there were) did not 
have. Peer to peer, with a motto of ‘some do some don’t, some will some won’t’, we shared our 
harm reduction advice with love.  
 
For the next 5 years I worked as a peer volunteer at Crew 2000, and from my voluntary 
experience I moved into paid employment in the support sector. I continued clubbing but my drug 
using patterns changed. I moved from weekly indulgence to monthly indulgence, although I 
continued to smoke cannabis daily, and still did until very recently. Through my involvement in 
the support sector I began working with heavy opiate and alcohol users, many homeless or at risk 
of homelessness. I had personal experience of the pain heroin addiction can wreak on families and 
loved ones: I separated from my partner in my early 20’s because I was unable to provide the 
support he needed. He died several years later from multiple organ failure resulting from extreme 
intoxication and hepatitis B and C infections.  
 
However, apart from my ex-partner, although my peer group were still using drugs regularly, 
I saw that their use was different in many aspects to those I worked with. Those who accessed the 
services were using drugs in order to intoxicate themselves beyond comprehension. Many, if not 
all, had deep trauma from childhood or later years, and the drugs were a way of medicating against 
this psychological pain. My peer group on the other hand, were mainly using drugs in order to 
enhance the experience of social gatherings. The more involved I became the more I wondered 





ways that drugs were being used by people, and understood that the reasons for use are complex 
and varied. I also witnessed the destruction of friends lives when they interacted with the criminal 
justice system. The following story is about an old friend of mine, yet it is not unique, and I have 
met several families and individuals who have suffered a similar fate.  
 
“In 2001 a good friend of mine was jailed for 6 years having been found guilty of intent to 
supply ecstasy and cannabis. James (not his real name) had been dealing cannabis for 
years, always to friends and always in small amounts. Through his cannabis contact he was 
able to get ecstasy pills, and as a result he started buying large batches of pills to supply 
his friendship group. For some reason, it was never cleared up but we think he may have 
been grassed (told on) by an informer, his flat was busted on the same day he had picked 
up his 9 bar (bar of cannabis weighing 9 ounces) and 250 ecstasy tablets. He was sentenced 
to 6 years and would get out in 3 with good behaviour. When he went into prison he was a 
young, good looking man whose only drug vice was using cannabis and ecstasy. When he 
came out he was a haggard, despondent heroin addict. The trauma he experienced in prison 
never left him. I was unable to reconnect with him as a friend because our lives had drifted 
far apart, and the last time I saw him several years ago he had lost all his teeth, was still 
using heroin, and had serious mental health issues.” 
 
It is these, and numerous other little stories that pepper this thesis, that help shine a light on 
how my reality is shaped by these experiences. Everyone has these similar vignettes, especially 
within the broader Scottish drug and alcohol scenes, and they combine to make narratives that 
guide how we view the world, how we interpret our experiences, and for this research how we 
form opinions on drug use and drug policy responses. Importantly, it is the meaning we attach to 
our experiences that guide how we react, but meaning is subjective, and one of the hurdles in 
developing policy responses that encompass such a myriad of different experiences - and meanings 
- is finding common meanings through the elicitation and exploration of shared narratives. 
 
A Word on Language 
 
 Throughout this thesis there are terms that I use which are subject to much debate. It is 
important therefore that I outline some of these terms, in order to clarify how I use them.  
 
 The first word is ‘problem’. This word is used constantly, in both the drug policy 
community and the thesis. In both it is used to describe the focus of drug policy and drug user 
themselves, by using the terms ‘problem drug/substance use’ and ‘problematic drug/substance 
user’. The concept of a ‘problem’ or ‘problematic’ is extremely vague, and dependent on individual 
constructions on what these terms actually mean: one person’s problem is another person’s 
paradise! Carol Bacchi (2009, 2015, 2016, 2018) has interrogated this problem paradigm and I use 





However, in doing so I must also address my own use of the term ‘problem’. For example, Bacchi 
states that:  
 
‘…in the WPR approach, governments do not react to problems that are presumed to be 
self-evident. Rather, they are seen to be involved in the creation or production of 
“problems” as particular sorts of problems, with particular parameters, causes, effects, 
and remedies. There is no suggestion of manipulation in this proposition; rather, it is a 
description of the way in which policies do their work…’ (Bacchi, 2018, 5). 
 
Bacchi suggests shifting the focus to problematisations within policies, that is, the focus on 
a particular ‘problem’ reveals what is implicit in the construction of that ‘problem’. Bacchi pulls 
heavily on Foucault’s genealogical archaeology (Foucault, 1986; Bacchi, 2018) and his emphasis 
on examining the forms of problematisations within studied phenomena.  
 
While elements of this thesis explores the problematisation’ within policies, another aspect 
is the use of the term ‘problem drug use’, and ‘problematic drug users’ to describe the kinds of 
drug use and users that is the focus of much of drug policy. There is no universal definition of 
what constitutes ‘problem drug use’ (Chatwin, 2018, 137-138), however institutions and countries 
have tended to define it as harms stemming from injecting drug use. For example, The UN Office 
of Drugs and Crime (UNDOC) state that: “While there is no established definition of problem drug 
users, they are usually defined by countries as those that regularly use illicit substances and can 
be considered dependent, and those who inject drugs” (UNODC, World Drug Report, 2011).  The 
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) defines it as “Injecting 
drug use or long duration/regular use of opioids, cocaine and or amphetamines” (EMCDDA, 
European Drug Report 2017). The Scottish Government develop this definition a bit further to 
define ‘problem drug users’ as: “a category of people who will be experiencing or causing social, 
psychological, physical, medical or legal problems because of their drug use. They are likely to 
be in touch with drug treatment services, although many will not” (Scottish Government, 2008, 
12). They initially state that the focus is on opioid and benzodiazepine use (Ibid, 1), but the 
definition leaves the possibility of other non-injecting or opioid based use to be considered 
‘problem drug use’. This concept forms a core aspect of the critique in this thesis, and I explore 
and build on this in chapters 4 to 6. It should be recognised however that the term ‘problem’ is not 
value neutral, and wherever possible I shall highlight how this impacts the research or knowledge 
contributions of the thesis.  
 
The other term is ‘knowledge’. In this chapter I have explored how meaning is developed 
using narratives and stories, and how an individual’s background knowledge and experience 
influences the way in which they view reality. Furthermore I have set out that I look to use the 
concept of subjugated knowledge as described by Foucault, when using both my own experience, 





particularly in policy, encompasses a vast array of different viewpoints (c.f. Radaelli, 1995; 
Freemand & Sturdy, 2014). What constitute knowledge is therefore difficult to pin down, although 
generally speaking it is ‘taken to include information, ideas and arguments, as well as well-tested 
beliefs, and should encompass law as well as professional and academic knowledge’ (Freem and 
& Sturdy, 2014, 3; Radaelli, 1995, 161). For the purpose of this thesis I use the term to describe 
both experiential knowledge (information and understanding gained from personal experience) 
and the wider concept of how knowledge is generated.  
 
A further note is needed in regards the concept of harm reduction. Drug harm reduction is 
the use of initiatives such as needles exchanges, advise on taking drugs safely, drug checking, drug 
consumption rooms, and other initiatives that seek predominantly to reduce the harm from taking 
drugs. As a policy tool it has been in use in Scotland from around the mid 1980’s, although it came 
to prominence at the end of the 1980’s and early 1990’s in response to concerns around the spread 
of HIV through injecting drug use, and the increase in psychoactive drug use at raves and outdoor 
festivals. Although a major part of drug policy in Scotland, it receives very little attention in this 
thesis, and the main reason for this is it did not show up often in the data. I have therefore spent 
very little time exploring or critiquing this concept except where it appears in the data, for example 
during the 1990’s rave scene in chapter 5.  
 
A final important explanation is needed of what I mean by ‘drug policy communities’. 
Throughout this thesis I refer to the drug policy community, and communities. I use both the 
singular and plural, which may be confusing but speaks to the wide range of actors involved in 
drug policy in Scotland. For clarity, when I use the term ‘community’ I am referring to the fairly 
small pot of policy actors in Scotland who are directly involved in the policy making process. 
When I use the term ‘communities’ I am referring to the small group of practitioners, but also the 
wider stakeholder groups that cannot be merged into one ‘community’ because they represent 









Preparing the Ground 
 
In part 1 of the thesis I set out the political and policy backdrop of the research, and explore 
the literature surrounding narratives, dialogue and policy in order to highlight the research gap 
addressed by this thesis. Chapter 1 starts us off by setting the historical context of drug policy, and 
the political and policy developments in the UK. The focus of this chapter is the structural 
framework that governs drug policy, in order to set the scene for the research. Furthermore, it 
begins to address a core theme in the thesis: that the development of the harm paradigm 
surrounding drug use has meant a focus on a health based policy that seeks the recovery of 
‘problem drug users. This focus on health silences those drug consumers that do not fit within the 
‘problem/harm’ paradigm. By shifting focus away from criminal justice interventions, yet still 
relying on them to support policy, a section of the drug using population fails to be represented in 
the national strategy. Chapter 2 then explores the concept of narrative in social research, and how 
narrative analysis can help to provide deeper understanding of complex policy ‘problems’. In 
doing so it highlights the research gap: how participation is carried out, and meaningfully 
experienced by different policy stakeholders. Chapter 3 is the methods chapters and sets out 
methodological framework, including the data collected, the different analytical frameworks I use 
and the process of writing up. My methodology combines multiple different strategies, and in this 
chapter I set out and clarify how and why I use this approach. An important aspect of the analytical 
structure is the use of Carol Bacchi’s ‘What’s the Problem Represented to Be’ approach (WPR 
approach, explained in chapter 3). This analytical framework inspired the structure of the thesis, 
where each chapter explores 1-3 of the analytical questions in order to develop the case for what 
the ‘problem’ (drugs) is represented to be in Scottish policy formation. As a result the focus of the 
thesis is both the master and counter narratives within Scottish drug policy, as well as the 
representation of the problem.  
 
Part 2 of the thesis encompasses chapters 4-6 and begins to explore the data by developing a 
historical genealogy of drug policy development in Scotland entitled Historical Legacies. Chapter 
4 takes us through the 1980’s, entitled the heroin years, and develops the argument that the increase 
of heroin use, combined with the HIV/AIDs epidemic set the tone for a harm based drug policy 
focussed on certain communities and certain kinds of drug use. It uses a narrative storytelling 
structure utilising interview data and documentary analysis to show how the ‘harm paradigm’ 
emerged from this period. Chapter 5 looks at the time period from 1990-2008 and is a partially 





drug using communities at the time to highlight how this kind of drug use has been silenced, or 
side-lined, by policy makers, in addition to showing how developments at a UK level result in 
narrowing of the focus to ‘problem drug use’. Finally chapter 6 uses interview data and 
documentary analysis to show how Scotland developed the recovery agenda in the early part of 
the 21st century, and how this impacts on the narratives surrounding drug use and policy formation 
going forward. 
 
Part 3 of the thesis forms the contributions to the field of knowledge and encompasses chapters 
7-9. Chapter 7 takes the data I collected from participant observation with three stakeholder 
groups, and analyses this engagement using the WPR approach, and narrative analysis. From this 
a typology of stakeholders is identified, and used as a structure for the policy stories set out in 
chapter 9. Chapter 8 sets out the theoretical development that this thesis contributes to – critical 
drug theory (CDT). CDT is an extension of critical theory, and takes inspiration from critical race 
theory, particularly the use of narrative and storytelling in challenging oppressive and 
discriminative practice and policy. The last chapter in this part is chapter 9. This chapter develops 
this focus on storytelling by setting out a series of fictional narratives that explore the both the 
historical development of drug policy, and the typology of stakeholder engagement. The aim of 
this chapter is to show how powerful fictionalised stories can be in creating alternative narratives 
that speak to range of concerns, and may provide the certainty policy makers need in order to enact 
drug policy reform.  
 
Finally, chapter 10 concludes the thesis by bringing the findings together in narrative format, 









Setting the Scene: Politics and Policy 
 
History and Context of Drug Policy in the UK  
 
 It is a well-documented and a historical fact that human beings have ingested certain 
substances in order to change their perceptions of reality for centuries, if not millennia (RSA, 2007; 
Nutt, 2015; Bancroft, 2009, ch.2; Bennet & Holloway, 2010, ch.2). However, it was not until the 
beginning of the twentieth century that serious efforts were made to outlaw certain drugs for use 
other than medical, through international and national conventions and frameworks. 
 
 One of the reasons for the increased regulation and criminalisation of drug use over the 
past 100 years is the proliferation of many different types of available drugs, for medical and non-
medical use, together with the concern by some in the medical profession about the health risks 
associated with drug use, especially with dependent opiate use at the turn of the twentieth century 
(Duster, 1970). At the time of the Pharmacy Act 1868, which was designed to regulate the supply 
of morphine and opiates (South, 2002), drug use appears to have been restricted to alcohol, 
tobacco, opium (and its derivatives), hashish and cocaine. These substances were taken by many 
different social groups and use of these substances was not considered particularly harmful, 
immoral or unusually deviant (Duster, 1970; South, 2002); many of them could be found in 
household supplies such as cold remedies or Coca Cola.  
 
 During the first decade of the twentieth century there were sporadic attempts to regulate 
and control the supply of opium, such as the Opium Conference in 1909 and Shanghai Conference 
in 1911, instigated by the USA. The USA had increasingly come under pressure from religious 
factions and traders concerned about the effect of the opium trade between Britain, China and 
India; traders felt American trade was being undermined, and religious factions were concerned 
about the effect of opium addiction on the Chinese and at home. However, the first major move to 
have a serious effect on the supply of drugs was the Hague Convention of 1912. The Convention 
tried to establish an international agreement on the restriction of opium to medical use only, and 
the imposition of criminal sanctions on those found doing otherwise. However, due to the outbreak 
of war in 1914 it was not taken up by every country; but was later incorporated into the Treaty of 
Versailles in 1919 under article 295 (South, 2002).1 
 
                                                          
1 Parts of this section were taken from my Criminology Dissertation ‘The Criminalisation of Recreational Drug 
Users: Questions of Risk and Morality. This was submitted to the University of Edinburgh in 2008 in partial 





 The USA was one country which met their obligation promptly, and this was done via the 
Harrison Narcotics Act of 1914. It is argued that the result of this Act was to criminalise whole 
sections of society (Duster, 1970), because although it outlawed doctors from giving out opiate 
derivatives for non medical purposes the Supreme Court ruling in Webb v US (1919) held that 
maintaining an addiction did not constitute a medical purpose (Duster, 1970). The result was the 
eventual alienation of people who had become ‘legitimately’ addicted to opiates and now found 
their addiction was criminalised and outlawed. Many of these addicts were Chinese immigrants 
and it has been suggested that the opiate laws, in Britain at least, were a result of moral panics over 
“oriental conspiracies” (South, 2002; Hari, 2015). This alienation and criminalisation of certain 
social groups throughout society due to increased drug laws has since been a common feature of 
what is now known as ‘the war on drugs’ (Hari, 2015; Manderson, 2005).  
 
 Britain fulfilled its treaty obligations in 1914 with the Defence of the Realm Act, and the 
provisions were further legislated on with the passing of the Dangerous Drugs Act 1920. This latter 
Act not only outlawed the sale of opium, but included tinctures of cannabis and cocaine and its 
derivatives. It is speculated that the addition of cocaine to the list was in response to stories of 
‘crazed’ soldiers during World War 1 (Transform, 2008; RSA, 2007). In 1926 the ‘Rolleston 
Committee’, set up by Sir Humphry Rolleston, recommended that addiction be treated as a disease 
and therefore should be regulated by doctors stating that addiction is a “problem to be solved not 
a sin to be punished” (RSA, 2007). This declaration shows us that drug use was not considered to 
be a moral or criminal issue but rather a medical and social issue that could only be tackled by 
medical and social solutions. This became known as the ‘British position’ and was not altered until 
the 1960s when it came under increasing pressure to conform to an international regulatory 
position (Stimson, 1987). 
 
 From the 1920s to the mid-1960s Britain was relatively unaffected by the hysteria and 
moral panic surrounding cannabis and heroin use that had gripped America, driven by the Federal 
Bureau of Narcotics and the now infamous Harry Anslinger (South, 2002; Hari, 2015; Babor et al, 
2018). There appears to have been a more gradual and pragmatic approach during this time, 
although the criminalisation of cannabis and the new crime of possession in an amendment to the 
Dangerous Drugs Act 1920 in 1928 may have been a result of inflated views of the prevalence of 
its use and harm (Transform, 2008). The only developments of importance until the mid-1960s 
was the creation of the Home Office Drugs Branch in 1934 and the Brain Report in 1961 which 
upheld the findings of the Rolleston Committee and favoured the status quo regarding drug 
prescription and criminalisation. 
 
 However, this comfortable ‘British position’ was about to change with the influence of the 
United Nations Single Convention on Narcotic Drugs 1961, the 1971 Convention on Psychotropic 
Substances and a later addition of the 1988 UN Convention against Illicit Traffic in Narcotic Drugs 





conventions and protocols agreed by the UN bodies. The UN Convention therefore marked the 
end of domestic control over drug regulation and policy, and by the mid 1970s most major 
countries had implemented drugs legislation following what is known as the ABC classification 
system, with A being the most punitive classification and each drug placed within the system 
"according to the accepted dangers and harmfulness in light of current knowledge" (House of 
Commons Science and Technology Committee, 2006:a).  
 
 For decades it has been the conventional wisdom that under these Conventions flexibility 
in drug control measures was not possible. However, in recent years have been a swathe of 
countries and US states which have challenged the underpinnings of the UN treaties. The 
Netherlands initiated this challenge with the de facto decriminalisation of cannabis, and the spread 
of cannabis café culture during the 70s and 80s. In 2001 Portugal changed its laws in order to focus 
resources on health-based measures by decriminalising possession of controlled drugs. 
Switzerland has for several decades been a pioneer of harm reduction among injecting drug users, 
Czechnia has decriminalised personal possession and home cultivation of cannabis up to 10 grams, 
Lichtenstein is proposing regulating cannabis, and several eastern European countries have 
personal possession and medical use of cannabis decriminalised. South American countries such 
as Uruguay have legalised the coca leaf and cannabis, Mexico’s Supreme Court has declared the 
illegality of cannabis to be unconstitutional, and many other South American countries have 
decriminalised personal and/or medical use of cannabis. Canada legalised the commercial sale of 
cannabis in 2018, the US has seen 33 states decriminalise the sale and production of cannabis for 
medical use, and the legalisation of cannabis for recreational use in 11 of the states. This prompted 
the US State Department to issue a press release in 2014 declaring: 
 
  “Things have changed since 1961. We must have enough flexibility to allow us to 
incorporate those changes into our policies … to tolerate different national drug policies, 
to accept the fact that some countries will have very strict drug approaches; other countries 
will legalize entire categories of drugs” (William Brownfield, Assistant Secretary of State, 
Bureau of International Narcotics and Law Enforcement Affairs, Reuters, 2014).  
 
This challenge to the dominance of the UN treaty obligations has prompted worldwide 
debate on the future of global drug policy.  
 
Political and Policy Background: Who Makes the Policy?  
 
 Formation and implementation of drugs policy in the UK is three tiered; international, 










 As mentioned, the international drug control regime is governed by the 3 UN Conventions 
on narcotic and psychotropic substances, which regulate manufacturing, trade, possession and 
restrictions to illicit drugs. The most important convention is the 1961 protocol, amended by the 
1972 protocol, which states first and foremost that the aim of the Convention is to maintain the 
health and wellbeing of humanity by restricting and eliminating access to controlled substances, 
unless for medical purposes, and to recognise the role society has in preventing drug abuse. This, 
they felt, was best done through criminal measures aimed at drug producers, traders and users, in 
combination with social measures to address underlying issues. The United Nations Office on 
Drugs and Crime (UNODC), oversees the implementation of these conventions, however the main 
debating body which is responsible for reviewing and overseeing the scheduling of prohibited 
drugs is the Commission on Narcotic Drugs (CND). The CND receives recommendations from 
the Expert Committee on Drug Dependence (ECDD), a department of the World Health 
Organisation (WHO) who are responsible for evaluating the medical and abuse potential of all 
psychoactive substances. While the UN consists of 193 member states only 53 of these countries 
have representation on the CND meaning that many member states do not get an opportunity to 
contribute to international debates on drug policy and control. Furthermore 90% of the UNODC’s 
funding consists of voluntary contributions from member states, making it “particularly 
responsive to those member states that finance it (UNU report, 2015). While the CND is the 
primary debating forum within UNODC, the International Narcotics Control Board (INCB) is the 
final body responsible for interpreting the Conventions. Made up of 13 independent experts, this 
Board has responsibility for monitoring and ensuring compliance with the Conventions, as well as 
providing nominal support to help states implement their treaty obligations.  
 
 Although the international drug control structures have been in place for over 50 years, it 
was not until 1990 that member states met to reaffirm a commitment to the conventions and agreed 
to issue a ‘Political Declaration and Programme of Action’ (UN, 1990). This was in response to 
the growing number of illicit drug users and an increase in drug related crime and harm resulting 
from the manufacturing, importation and selling of drugs, in particular the spread of blood borne 
viruses such as HIV (Human Immunodeficiency Virus) (ibid: 5). Although the declaration 
recognised the links between health and drug use, why illicit drug use was on the increase (such 
as the loss of communities resulting from deindustrialisation in many Western countries, or the 
levels of poverty) was not addressed. The declaration agreed to strengthen the controls on the use 
and trafficking of narcotic drugs and resolved to “protect mankind from the scourge of drug abuse 
and the illicit trafficking in narcotic and psychotropic substances (ibid: 6).  
 
 The next meeting in 1998 was the ‘General Assembly’ at its twentieth special session on 
the world drug ‘problem’. Member states agreed to adopt a Political Declaration and Plan of Action 





report biennially to the commission and meet again in 2009 to assess the Plan of Action. Crucially 
the tone of the Declaration recognised the importance of harm reduction and the role community 
plays in reducing drug related harm (UN, 1998).  
 
 In the 2009 Declaration an interesting twist developed. In the opening statement of the 
Declaration the United Nations Under-Secretary-General and Executive Director of the United 
Nations Office on Drugs and Crime, Mr. Antonio Maria Costa spoke of the need to find a balance 
between the criminalisation of drug users and the legalisation of drugs (UN, 2009:3). This was 
only one aspect of note however, and overall drug policy reformists were disappointed (IDPC, 
2009). The thrust of the Declaration focused on supply and demand reduction through criminal 
sanctions while at the same time increasing the provisions of harm reduction, support and 
prevention for people dependent on drugs. In contrast to the previous Declarations this one focused 
in-depth on what nation states and the international community should focus their attention on. It 
was planned that the next meeting would be a Special Assembly in 2019 in which all the targets 
and agreements set out in 2009 could be assessed and reaffirmed. However, in response to growing 
frustrations and increasing ‘flexibility’ in the reading of the treaty obligations by various member 
states, Mexico, Columbia and Guatemala successfully campaigned for the 2019 session to be 
brought forward to 2016. Furthermore, in order to widen participation beyond the limitations of 
CND they convinced member states of the need to hold a General Assembly Special Session on 
Drugs, allowing for wider participation and increased deliberation than would otherwise have 
happened.  
 
 The importance of widening participation cannot be understated. For the first time in the 
history of international drug control policy the concept of civic engagement had been incorporated 
into the decision making process. While still limited to the democratic mechanism of 
representation (as opposed to other democratic engagement tools such as 
collaboration/participation of stakeholders) and the limits of governments to engage with their 
publics in international politics, there were significant contributions from non-governmental 
organisations ranging from the Global Commission on Drug Policy to the Swedish Youth 
Temperance Movement. Furthermore, the Civil Society Task Force, supported by the UN and set 
up by the Vienna NGO Committee on Drugs (VNGOC) and the New York NGO Committee on 
Drugs (NYNGOC), initially gauged the involvement on civil society in drugs policy around the 
world with a view to providing avenues of representation at the 2016 United Nations General 
Assembly (UNGASS) and beyond. The reason for this engagement was the growing 
acknowledgement that many countries and individuals wanted to see a change in the international 
treaties to allow a relaxation in drugs law, especially around cannabis.  
 
The need for deliberative dialogue was highlighted in a report published by the UN 
University, who gathered stakeholder opinions throughout 2015 in the lead up to UNGASS 2016. 





be looked at as a springboard from which conversation and deliberation will flow from, up to and 
beyond the Political Declaration and Plan of Action in 2019:  
 
“[t]he global drug policy conversation between UNGASS 2016 and the renewal of the UN 
Political Declaration and Plan of Action should not aim to create a one-size-fits-all policy 
discourse to replace the ‘War on Drugs’, but rather be based on national-level flexibility 
coupled with agreed global principles – or, as we put it earlier, principled pluralism” 
(UNU, 2015:29). 
 
 States were encouraged to actively engage their publics in order to understand and highlight 
localised research and solutions to drug harm, regulation and control, in addition to creating a 
global conversation guided by three principles: 1) protection of human rights; 2) promotion of 
human development; and 3) guidance by the best available scientific evidence. This focus on 
deliberative process echoes the focus of the research. An important driver of the research was the 
desire to explore broader engagement methods using deliberative processes such as respectful 
dialogue, and creating safe spaces for deliberation, so that broader civic engagement could take 
place. Unfortunately UNGASS 2016 did not produce the policy reform many were looking for, 
including any meaningful deliberative engagement with wider public, and reiterated the 
commitment of the previous three conventions. The only ray of hope for reformists was the change 
in language to focus on drug abuse as opposed to eradicating all drug use.  
 
 In the international context the European Union has a limited impact on national drugs 
policy as all member states are UN signatories and therefore constrained by the UN Conventions. 
However, the EU has issued several ‘Decisions’ which strengthen the current UN Conventions, of 
note: the 2004 Framework Decision on penalties for trafficking, (Council for the European Union, 
2004) which sets out minimum criteria for drug trafficking offences, and the 2005 Council 




 UK drugs policy is governed by the Misuse of Drugs Act 1971 (MDA) which was enacted 
in order to fulfil the 3 UN treaty obligations mentioned above. In addition, there is: the Misuse of 
Drugs Regulations 2001 which set outs the schedule of each drug; the Medicines Act 1968, which 
regulates the manufacture and supply of medicines; the Drug Trafficking Act 1994, which makes 
it an offence to sell items associated with the preparation and use of controlled drugs; the Crime 
and Disorder Act 1998, which implements Drug Treatment and Testing Orders for those convicted 
of drug offences; the Drugs Act 2005, which among other things made fresh magic mushrooms a 
class A drug; and the Psychoactive Substances Act 2016, which criminalises the sale and import, 






 Controlled drugs are placed in a classification system, with A being the most harmful, and 
C being the least harmful. Measurements of harm and recommendation to the government on 
classification is taken from the Advisory Council on the Misuse of Drugs (ACMD). However the 
ACMD’s advisory role is becoming increasingly at odds with government decisions on the 
classification of psychoactive substances (Stevens, 2018). The main leaders in policy are the Home 
Office and the Department of Health, under the banner of Drug Misuse and Dependence. These 
departments produce policy reports on commentary, evaluation and implementation of UK policy.  
 
 This research is focused on narratives within Scottish drug policy formation, and 
participation of stakeholders within the policy making process. It will therefore focus specifically 
on the workings of the devolved Parliament, looking only at national or international policy when 
it intersects with devolved policy, for example with criminal sanctions. 
 
Devolved: The Scottish Position  
 
 In 1998 the Scotland Act devolved many aspects of political and legislative competence to 
the newly formed Scottish Parliament. However, while Scotland has always retained a separate 
criminal justice system (Act of the Union 1707, article 57), the criminal laws contained within the 
MDA were not devolved. The MDA is therefore a reserved matter under Schedule 5 B1 of The 
Scotland Act 1998. There has not been any formal justification as to why the MDA was reserved; 
it can only be assumed, by tacit understanding of the debates surrounding devolution, that the 
reserving of these powers was in order to maintain uniformity in sentencing and classification 
throughout the UK, and to make sure Scotland could not deviate from UN treaty obligations. The 
only change to this reservation is from Section 19 of the Scotland Act 2012 which devolved power 
to grant licenses for the prescription of opiates and cocaine to the Scottish Ministers, and the recent 
changes in cannabis legislation to allow all Specialist Consultants to prescribe cannabis 
(prescription rules being a devolved matter).  
 
 Interpretation of the MDA, where possible, is devolved to the Scottish Parliament, and 
Scotland’s current drug policy is set out in the document ‘The Road to Recovery' (2008), and the 
2018 refresh of this strategy ‘Rights, Respect and Recovery’. These documents set out strategic 
actions designed to promote recovery and reduce the impact of drug use through improving the 
life chances of those most likely to develop ‘problematic drug use’. In 2008 the Scottish Drugs 
Strategy Delivery Commission (DSDC) was set up to replace the Scottish Advisory Committee on 
Drug Misuse in order to help “the Scottish Government deliver a drugs policy that is fit for the 
21st century for all the people of Scotland.” (Scottish Government Press Release, 2009). The 
DSDC was dissolved in November 2014 and was replaced by the Partnership for Action in Drugs 






 Because my exploration of participation in Scottish drug policy takes place from 2014-
2018, and the focus is on the engagement I participated in, as opposed to the various policy 
governance shifts taking place, the following sections set out the shifting landscape in more detail.  
 
Scottish Drug Policy Governance: Shifting Landscapes – 2012 to 2018 
 
 The term ‘governance’ is used to describe “the processes and mechanisms by which policy 
is directed, controlled and held to account (Hughes et al, 2010; UKDPC, 2012, 8). Furthermore, 
they recommended that: “There is a need to develop and test the use of deliberative methods for 
engaging with the public around the complexities of the evidence base and the goals and options 
for drug policy.” (UKDPC, 2012, 4). This thesis focuses on participation within drug policy, as 
one aspect of good drug policy governance, and in particular I created and used a deliberative 
forum (The Scottish Drug Policy Conversations, discussed in chapter 3) to explore whether 
deliberative methods can increase meaningful engagement within participatory processes. The 
term ‘participatory processes’ encapsulates an array of participation tools being tried out in order 
to increase involvement in democratic decision making. The reason for this is that “when policies 
are worked out for rather than with a politically excluded constituency, they are unlikely to engage 
all relevant concerns” (Phillips, 1995-quoted in Smith 2009, 7: emphasis in the original).  
 
 Returning to Scotland, in 2012 there was media and political debate regarding drug related 
deaths stemming from the 2011 statistics which saw 584 such deaths. This prompted wider 
discussion on whether the current strategy of harm reduction as promoted by the 2008 Road to 
Recovery (including methadone treatment and needle exchanges) was in fact maintaining peoples 
drug use rather than stopping it (DSDC, 2013). In response to this pressure the DSDC were asked 
to conduct an inquiry into opioid replacement therapy provision in Scotland and their report in 
2013 made twelve recommendations. One of the main findings that was picked up by the Scottish 
Government was the lack of “effective information systems and relevant research into problems 
drug use and recovery” (Scottish Government, 2015:2). The publication of this report arguably 
signalled the death knell for the DSDC: following the report the DSDC was disbanded and a 
steering group was set up to explore how these recommendations could be taken forward. In 2015 
they published the ‘National Framework for Problem Drug Use and Recovery’. What followed 
was complete overhaul of the Scottish drug policy advisory structure. 
 
 The first aspect was the creation of an Executive Committee to oversee policy formation 
entitled Partnership for Action on Drugs in Scotland (PADS). The aim of the committee was to 
“provide the necessary leadership in order to continue to tackle problem alcohol and drug use in 
Scotland” (PADS, 2016). The Executive Committee was chaired by the Minister for Public Health 
and Sport, and had several permanent members and several ad hoc members. Underneath this there 






1. Reducing Harm and Drug-Related Deaths 
2. Improving the Quality of Services 
3. Building Recovery Centred Communities and Reducing Stigma 
4. Lived Experience – to provide an executive advisory link between the policy formation 
and drug users/ex-users 
5. Education - met irregularly 
 
 Alongside this, the government drug policy department was moved from the Justice 
Department to the Health Department and its name changed from the Drug Policy Unit to the 
Substance Misuse Unit (SMU). This change signalled a re-focusing of policy from (illicit) drug 
use to broader substance use including alcohol, and focused attention on the mis-use of substances 
as a health issue, as opposed to general drug use as a criminal issue. In doing so it effectively 
ignored the criminal sanctions imposed upon drug consumers in order to focus on the perceived 
‘problematic’ drug consumers, predominantly injecting heroin users. This shall be explored in 
more detail in the chapter 4. A second outcome of this document was the commitment to broaden 
the advisory landscape:  
 
“With a focus on a collaborative way of working between Government, sponsored 
organisations, academics, ADPs and drug services, the priorities identified within this 
document will inform the new groups making up the advisory landscape, articulate a clear 
direction of travel for those working in the drugs field and directly influence Government 
policy” (Scottish Government, 2015: 10). 
 
 In order to articulate this commitment, the SMU were encouraged to engage with 
stakeholder groups. Representatives from the SMU attended our conversations and I was in regular 
contact with civil servants about engagement activities. In addition to this, the Scottish 
Government committed £80,000 for 3 years to establish a research network, the Drugs Research 
Network for Scotland (DRNS), with the aim of creating networks between the different 
stakeholder communities and identifying gaps in research and funding.  
 
 In August 2017, the Scottish Government released the drug related death (DRD) statistics 
for 2016 (NRS, 2017) to much anticipation. Close attention had been paid to England, Wales and 
Northern Ireland's release several weeks previously, with significant increases across the board. 
At the same time the UK Government released their updated drug strategy (Home Office, 2017) 
which, it was argued, “promises enhanced monitoring of the prevalence of substances controlled 
by the Misuse of Drugs Act 1971, but offers no real prospect of reducing the harms associated 
with their use” (Winstock et al, 2017, 1). In light of the publicity surrounding the English and 
Welsh DRD statistics the Scottish Government were prepped. Many people working within the 
drug policy arena, such as those who were part of my sample group, and colleagues on the Drug 





provide the window of opportunity needed to create advised policy reform. There had been some 
promising moves over the past couple of years, particularly in regards to stakeholder engagement 
and implementation of effective yet controversial initiatives (discussed in chapter 7). Despite this, 
there was frustration by many at the pace of change and the large cuts to drug treatment services 
that had also taken place over the last two years (Hamilton & Stevens, 2017). So it was with this 
in mind that the Scottish Government pre-empted the DRDs release, and consequences, by 
announcing a refresh of their drug policy strategy document ‘The Road to Recovery 2008’, at a 
conference hosted by the Scottish Drug Forum entitled ‘Drug Policy through a Health Lens’ (SDF, 
2017a).  
 
 Drug policy communities in Scotland welcomed this announcement (SDF, 2017a; SDPC 
notes), and critical responses to the DRD statistics - which saw an increase of 23%, from 706 in 
2015 to 868 in 2016 (NRS, 2016) - were tempered by the possibility of innovative policy shifts 
resulting from the proposed refresh. Despite this there was commentary from key policy actors 
including executive committee members of the PADS group (McCauley, Robertson & Parkes, 
2017) and participants of the SDPC (SDPC, 2017a), reflecting the frustration, and in many 
instances cynicism, by policy stakeholders at the timing of the refresh and the fear that it may be 
more rhetoric than reality. As one interviewee noted:  
 
“[t}hey are doing [this] because they have to, it’s the drugs deaths which have risen to 
such a great height that they’ve been pushed to do it, they’ve been brought squealing to 
actually address it because the reality is what they have tried, and put their faith in in the 
past has not been working” (Senior Drug Advisor). 
 
Yet another comment came from members of the Scottish Government’s Advisory 
Committee PADS, who, in a joint article wrote:  
 
“The prevention of DRDs in Scotland requires an immediate and radical harm reduction 
led response, developed in collaboration with people who use drugs. Evidence-based 
solutions are available, but it is absolutely crucial that they receive support from all 
sections of Scottish society in order to destigmatise drug use and encourage people to seek 
help. The tragedy of Scotland’s spiralling deaths from drug use is everyone’s problem. The 
time for brave leadership and concerted action is now” (McCaulay, Robertson and Parkes, 
2017). 
 
 In the new structure it was interesting to note the lack of a committee dealing with the 
enforcement/justice aspect to health, despite the ability of Police Scotland and the Crown Office 
to set policy that directly impacts drug users. For example, at the same time as the Scottish 
Government were implementing the new policy framework, Police Scotland were in the process 





those caught were processed through the Crown Prosecution Service (CPS). However, the majority 
of cases were either discharged or ‘no further action was taken’ (SDPC, 2016). According to the 
police representatives who attended the SDPC session on this cannabis policy (SDPC, 2016), a 
decision between the Lord Advocate, the CPS and Police Scotland was made to stop prosecutions 
of small amounts of cannabis (the initial proposal was all class B and C drugs) and instead issue 
Recorded Police Warnings. Interestingly the SMU were not consulted on this policy shift, at least 
not formally. This highlights an important finding that will be discussed further in the thesis- that 
policy decisions are often made without formal or meaningful consultations with stakeholders, and 
there appears to be no direct link between criminal justice responses and health responses to drug 
issues.  
 
 There is however, an indirect link via the focus on reducing health inequalities. In 2017 the 
Scottish Government set up a Health and Justice Collaboration Board (Scottish Government, 
2017), that seeks to link health and community justice responses. While the overarching focus is 
on the need to reduce inequality in order to improve the wellbeing and life chances of individuals 
(NHS Health Scotland, 2017a, 2017b; Scottish Government, 2017a) there is specific focus on the 
impact of drug and alcohol use as risk factors in offending (NHS Health Scotland, 2017b, p.25). 
A stated vision of the Board is: “We will work with others to improve health and wellbeing in 
justice settings, focusing on mental health and substance use” (Scottish Government, 2017a, 3).  
The response is to increase collaboration between the different institutions responsible for 
wellbeing such as local authorities and service providers: “[to] ensure the development of 
integrated care pathways for people within justice services and information sharing to ensure they 
receive continuity of alcohol support and treatment in both custody and the community” (NHS 
Health Scotland, 2017a, p.26).  
 
 The important point here is that despite there being collaboration between justice and 
health, the focus is on health intervention within the custodial setting, as opposed to solutions that 
remove drug use from the justice setting. The implications of this are far reaching when one 
considers the aim of drug policy (contested), and highlights a growing tension within drug policy 
between public health responses and criminal justice responses. Furthermore, this focus on health 
highlights the issue that this thesis explores: the silencing of those drug consumers that do not fit 
within the ‘problem’ definition paradigm – recovery of ‘problematic drug users’. As you will see, 
this speaks to a core finding in the research: that by shifting focus away from criminal justice 
interventions, yet still relying on them to support policy interventions, a section of the drug using 
population fails to be represented in the national strategy.  
  
 Throughout 2017 and 2018 there were initiatives to broaden engagement, and how this 
manifested from a participant’s point of view is explored in this thesis. In 2018 the Scottish 
Government published an updated drug strategy called Rights, Respect and Recovery (2018), 





response to yet another increase in drug related deaths (27% increase in 1 year, from 934 deaths 
in 2017 to 1187 deaths in 2018), the advisory structure was unofficially disbanded and a new 
‘Drugs Deaths Taskforce’ (Scottish Government, 2019) was set up. I say unofficially because there 
was no official disbanding of the committee, and no official announcement. Yet those of us 
involved in the committee (I was the user representative for the harms group) were not invited to 
any more meetings, and the chairs were instructed that there would be no more meetings. Indeed, 
one of my interview participants, who was also the chair of the harms committee and had been a 
government advisor for over 40 years, was completely removed from the government advisory 
structure. While I do not comment in depth on developments beyond the data collection period of 
2015-18, it sets the scene and shows how the governance of drug policy in Scotland has been 
constantly changing, and, arguably, lacks structure or leadership, something which became evident 
as I engaged with the different policy groups.  
 
On the other hand, the different changes to the governance structure is indicative of a 
government grappling with the re-focussing of drugs policy from justice to health. This move is in 
line with calls to establish evidence based drug policy, with most evidence pointing towards more 
public health engagement and community based solutions as opposed to criminal justice sanctions 
(UKDPC, 2012; Scottish Government, 2018).  
 
Issues with the Formation of Drug Policy Evidence and the use of ‘Experts’ 
 
In the last 20 years there has been a move towards ‘evidence based policy’ that seeks to 
utilise research evidence in the development of policy (Bennett & Holloway 2010). Evidence 
based policy often fits well with morally driven policy, such as drug policy, as it utilises rational 
‘scientific’ approaches to the analysis of evidence in order to justify policy decisions (Stevens, 
2011; Ritter, 2015). It attempts to bridge the gap between knowledge production and policy 
making however, there is little research into the effectiveness it has in bridging this gap (Smith, 
2013, ch.3; Lancaster, 2014; Ritter, 2015; Moore et al, 2011). There is also criticism that evidence 
based policy fails to react to the changing pace of the policy process; evidence of effectiveness 
may be slow to be translated into policy practice, by which time new evidence has emerged 
(Lancaster & Ritter, 2013; Ritter, 2015). In response to this criticism, policy makers have taken to 
using the term ‘evidence informed policy’ (Head, 2008). This term reflects the fact that policy is 
made of multiple inputs, one of them being systemically reviewed evidence, and the understanding 
that  ‘[a]s in other policy spheres, drugs policy is shaped by a number of competing influences 
including politics, ideologies, values, the media, perceived public opinion and pragmatic 
constraints such as funding’ (Duke and Thom, 2014, 970). It is therefore not possible to have a 
policy based entirely on research evidence, however, what political, ideological and value based 
ideas are incorporated into the development of policy are a matter of debate (Stevens, 2009; Head, 






While there has generally been an increase in the use of evidence in drug policy making, 
or at the very least a commitment (c.f. Scottish Government, 2018), there has been less attention 
paid to the role of the researchers in producing such evidence. Given that researchers play such an 
important role in the dissemination of knowledge within drug policy it is imperative that the 
“assumptions and worldview” of the researchers are looked at (Ritter, 2015, 183). The way in 
which a ‘problem’ is identified and understood will influence the way it is researched, and which 
options and solutions will be suggested. The definition of the ‘problem’ defines the scope of the 
solutions. The research design itself can define the ‘problem’ by selecting the questions, the 
outcome measurements and the data analysis techniques, which then creates a ‘body of 
knowledge’. This knowledge is then assumed to exist outwith the research process yet is in fact a 
result of the techniques used, and the paradigm from which the researcher is working: the policy 
solutions will match the problem definition (Ritter, 2015). I shall be exploring this in more depth 
in chapters 8 and 9, but for now the following chapter will further develop the discussion on the 
role of the researcher in developing evidence, and how ones world view impacts the way in which 









Setting the Scene: Narrative and Meaning in Policy 
 
Background Knowledge and the ‘Situated Knower’ 
 
As discussed in the previous chapter, there is a complex relationship between the concept 
of knowledge, and the concept of evidence. It is for this reason that explorations of how we as 
individuals develop knowledge, and how life experience impacts this knowledge, is important. 
Traditional Cartesian models of scientific inquiry follow the belief that knowledge exists outwith 
the knower - the atomistic model of knowing. However, phenomenological and non-positivist 
approaches tend to incorporate some understanding that knowledge cannot be separated from the 
knower. For example, feminist epistemological approaches have developed the concept of situated 
knowers (Haraway, 1988) - that there are some experiences which cannot be known by others, 
because the structure of society and the systemic differences between genders results in 
experiences that cannot be accessed by the other gender. This concept can be expanded to social 
position and other systemic differences in society (Fricker, 2015). Feminists, in general, argue that 
these categories (in particular gender) are relevant as long as society is structured along the lines 
that differentiate between gender and social class (Grasswick, 2018; Harding; 1991). Broadly 
speaking the acknowledgment of where the knower is in space and time will impact the research 
development and findings (Hartsock, 1983; Harding, 1986; Grasswick, 2018).  
  
This concept of situated knowing links strongly with the concept of ‘background 
understanding’ that is important in both philosophical discussions on understanding (Hegel, in 
Houlgate 2013; Gadamer, 2003; Wagenaar, 2015, ch.7) and interpretive research (Yanow, 2000; 
Schwartz-Shea and Yanow, 2012, ch.2; Wagenaar, 2015, ch.7). Ordinary understanding involves 
much more than just seeing, or knowing. It is a sensory experience that involves “intentions, 
feelings, expectations, perceptions, memories and embodiments” (Wagenaar, 2015, 197). It is a 
process that is often involuntary, participative and interactive – when we are confronted with a 
situation that requires an understanding there are processes at work that rely on background 
knowledge which is virtually unknowable to us – even with constant self-reflection. Philosophical 
hermeneutics (the basis on which interpretive research is built) however comes from the standpoint 
that: “understanding is not a separate activity, to be switched off when we need it; it is life itself, 
simultaneously emerging from life and always answerable to its challenges and demands” 
(Wagenaar, 2015, 199).  
 
The setting [context] is important as it is the background to our actions and understanding. 
When we act we cannot grasp the full implications of our actions, the hidden meanings that may 
be portrayed, or the consequences of our actions. Background understanding is described by 





cultural impressions, norms, and desires, ultimately can be described as the unconscious mind 
(Taylor, 2002; Wagenaar, 2015; Grondin, 2003). Background understanding is activated when we 
interact through our practices (actions), making us engaged agents capable of interpreting our 
environment and interactions. This form of understanding comes to the fore when we work on it, 
improve it to fit the situation, and then retreats to the background again.  
 
Situated knowledge has come under criticism however, in particular from Carol Bacchi, 
whose ‘problem’ analysis approach I use throughout the thesis (Bacchi, 2009). Bacchi highlights 
the difference between situated knowledge as set out by Haraway and others, and subjugated 
knowledge, as set out by Foucault. The issue Bacchi sees is that situated knowledge makes the 
claim to be representing a ‘better’ form of knowledge, by putting the experience of the ‘knower’ 
at the fore. However, this presents us with a problem. If all knowledge is situated (the claim that 
knowledge is a result of the socially situated position of the individual), how is it possible to have 
a “preferred” knowledge. It presents us with a recursive issue: if everyone’s knowledge is situated, 
how is it possible to ever know ‘the truth’.  
 
A way of addressing this is to make it clear that there is no claim to a final truth: knowledge 
is intersubjective - truth is a temporary agreement in an ongoing conversation – and the exploration 
of a topic is about developing understanding and meaning around that topic. This Habermasian 
notion of truth as subjective is a key underpinning of the thesis, hence the use of narratives. It also 
speaks to Foucault’s subjugated knowledge. This form of knowledge is not about the content 
(truth) but the way in which knowledge becomes the common sense taken for granted kind of 
knowledge, and how certain groups are discredited from being able to participate in that knowledge 
development. Foucault’s knowledge is therefore about the relations of power, rather than the 
pursuit of the truth.  
 
“Subjugated knowledge’s”, in Foucault, include forms of “erudite” knowledges and 
“disqualified” knowledges. “Erudite” knowledge’s consist of “blocks of historical 
knowledges that were present in the functional and systematic ensembles, but which were 
masked”. The role of critique is “to reveal their existence by using, obviously enough, the 
tools of scholarship… The analytic task is to bring all these knowledges to the fore, to 
contribute to an “insurrection of knowledge’s” in order to challenge “the centralising 
powers linked to the institution and functioning of an organised scientific discourse” 
(Foucault 1980: 84). To “emancipate” “subjugated knowledges” from “subjection” 
renders them “capable of opposition and of struggle” and of being used “tactically” 
(Bacchi, 2018). 
 
This concept of knowledge was extremely important for my research. I initially grappled 
with the idea of knowledge as a concept, having had so many different experiences that did not 





slate. I held deeply ingrained ideas about what drug policy should look like, the kinds of 
stakeholders involved, and way in which we should be involved. Furthermore I came to this 
research as an active drug user, with decades of drug using experience. My involvement in so 
called deviant groups (ravers, clubbers, drug using communities) has meant that my knowledge of 
these communities differs significantly from those who do not have this experience, and arguably 
falls within the remit of subjugated knowledge. This meant that my understanding of what 
‘problem drug use’ and other terms such as ‘drug harm’ present in the policy world, held meaning 
for me, and this meaning was attached to stories and experiences I had developed over the years. 
Often my meanings conflicted with official meanings, resulting in competing ideas of how a term 
should be used, and ultimately what the ‘truth’ was. My knowledge of the drugs themselves, and 
the issues surrounding drug using communities, was from both a ‘user’ perspective and a 
‘professional’ perspective, yet did not fit in with the narratives being put forward by institutions. 
For example, in drug policy the term ‘drug user’ was used to describe a section of the drug using 
population who use ‘problematically’. I challenged this term constantly because I, and others, felt 
that it hid the real meaning behind it, and masked the fact that the majority of drug users are not 
‘problem’ users. Indeed the term ‘problem drug user’ is one that shall be explored and critiqued 
throughout this thesis. The reason I use subjugated knowledge is to alter the accepted 
understanding of how evidence is produced and valued in drug policy. In doing so I aim to produce 
counter and meta narratives as a solution to what is both an empirical and epistemological 
challenge.  
 
Narrative Habitus  
 
A recent development in narrative is the concept of narrative habitus, first proposed by 
Frank (2010) as a way of describing an ‘inner library of stories’ (52-53) that one intuitively reaches 
for when trying to make sense of the world. Fleetwood however develops this idea to make it more 
relevant to criminological analysis. In her 2016 article she makes the compelling case for linking 
Bourdieu’s concept of habitus with narrative.  
 
The overall gist of the argument shows that Bourdieu’s development of agency is 
complimentary to narrative. It has been critiqued that Bourdieu’s work focuses too heavily on the 
‘field’ (the external social world we all share and live in) and habitus (the collection of life 
events/culture/perceptions etc that shape an individual and how they relate to the world), and pays 
less attention to individual agency (the creative, spontaneous element). However, Fleetwood 
argues that this is not the case, and that his theoretical writings show there is a flexibility within 
his concepts that take into account the dynamic between agency, habitus and field. He connects 
“objective structures with their subjective representations” (Fleetwood, 2016, 181).  
 
Bourdieu was predominantly concerned with how language is used as a form of class 





Fleetwood develops the concept of narrative habitus by using Bourdieu’s theory of social practice 
to support this theoretical development:  
 
“The notion of a narrative habitus can be summed up as follows. In the same way that 
Bourdieu understands the habitus as the internalisation of one’s position in the field, the 
narrative habitus is the internalisation of the narrative doxa (common sense) pertaining to 
the field, including vocabulary, narrative formats, tropes, discursive formats and subject 
positions etc. Creativity is possible within the limits prescribed by the habitus. The 
narrative habitus structures individuals’ narratives and narrative identity. It sustains and 
motivates action in two ways: narratives may be habitual, as ongoing rationalisations for 
behaviours, or evaluations may take place through narrative. Finally, narrative doxa 
(common sense – or master narratives) pertaining to fields structure how stories are 
received, including notions of truth” (Fleetwood, 2016, 181). 
 
Habitus here is the internalisation of one’s experience in life, and similarly the doxa of that 
position is internalised. People are predisposed to certain narratives because of the doxa 
surrounding that field. The doxa is developed because of habitus: people are preconditioned to 
view certain stories/narratives as ‘common sense’ resulting from knowledge developed from their 
life experience. Narrative habitus therefore is the collection of narratives that guide an individual’s 
perception and action, the stories they tell themselves and are told that help them make sense of 
their environment. Bourdieu was more focussed on ways of knowing that did not involve discourse 
– “schemes are able to pass directly from practice to practice without moving through discourse” 
(Bourdieu, 1990, 74). However, Fleetwood convincingly argues that it is a small jump from habitus 
(our understanding of the field based on practice) to narrative habitus (understanding of the field 
based on discursive communication).  
 
Narrative habitus is therefore the recognition that narrative allows the individual to create 
their own reality through discourse, but that this discourse is constrained by the habitus –the 
environment one finds oneself in. Narratives interact with habitus by helping one make sense of 
experience – habitus is the vast background knowledge we have from our internalised structure, 
narrative is that which guides what new experiences (and narratives) we engage with. In this way 
narrative habitus links closely with the concept of the situated knower and background knowledge 
discussed above, and provides a framework by which situated knowledge can become shared 
structural realities. The way that multiple perspectives are often presented is through dialogue 
between actors: “Only by presenting ‘multiple perspectives that correspond to the multiplicity of 
co-existing and sometimes directly competing, points of view’, can we see the full picture” 








Positionality: To talk about me or to not talk about me, that is the question 
 
Taking the concept of situated knowledge further, a way of incorporating this into research 
is through the use of positionality and auto-ethnography. Auto-ethnography has been described as 
“an autobiographical genre of writing and research that displays multiple layers of consciousness, 
connecting the personal to the cultural” (Ellis & Bochner, 2000, 739). However, for me the 
question was, why include anything more than a snippet here and there, or a bit of a chapter on my 
thoughts about the process etc? Why document the journey I have taken as I worked through the 
process of learning, personally and professionally? 
 
The answer is that stories have audiences, and they guide the stories too. Genres are written 
with an audience in mind; stories aimed at children, crime thrillers for those who enjoy suspense, 
reports are written for people who need the information, and policy briefs are written so that they 
can be easily fed into a policy process. This is a thesis, and as such my audience is you. I believe 
that my journey of discovery is of sufficient interest in that it plays a major role in how I conducted 
my research, and the understandings I came to. Furthermore, while there is an increasing interest 
into why participatory processes should be part of drug policy formation, there is little research 
into how it is actually carried out. By peppering the research with my own stories relevant to the 
topic, you will see how my thinking evolved, what ideas resonated with my own experience, and 
how these influenced the decisions I took in coming to conclusions. Furthermore, my experience 
in the drugs community, both as a drug consumer, drug worker and policy advisor means that I 
bring to this study a personal and professional understanding of the narratives present in each 
community, and the challenges in creating pathways for stakeholder participation.  
 
Another important reason for using aspects of auto-ethnography in this thesis is my desire 
to develop empathy and compassion by creating common stories that we can all relate to and 
understand. As Frank (1996, 158) writes, “storying the “I” is about “thinking with stories” by 
joining with these stories and allowing one’s own thoughts to adopt the story’s inherent logic of 
caution, its temporality and its narrative tensions”. Furthermore, as we shall see, a major aspect 
of the research was the exploration of the silences in drug policy, and these silences are around 
drug use for pleasure and intoxication. As mentioned I have spent many years involved in drug 
using communities, and the use of auto-ethnography helps to shine a light on this ignored and 
silenced community.  
 
Yet this approach also presented challenges in regards to my own positionality within the 
research, for as Ettorre highlights: “[w]e transform our personal stories into political realities by 
revealing power inequalities inherent in human relationships as well as the complex cultures of 
emotions embedded in these unequal relationships.” (2017, 357). My role as researcher, drug user 
participant and policy advisor, meant that I was at times part of this power imbalance. By being 





I was part of the institutional structure, while at other times I was at the part of the stakeholders 
who were at the sharp end of these unequal relationships. This exposed me to potential harms, for 
as Blakeman (2007) points out:  
 
“[t]he double-edged side of reflexivity (disclosure through positionality) is that, through 
disclosure, researchers are open to challenge about research ethics, but unless the hidden 
ethnography is made more transparent a more realistic account of fieldwork will not be 
forthcoming” (701). 
 
I explore this in the conclusion, however I mention it here because as a result of these 
reflections I sought to use my knowledge of the language of power to redress the unequal 
relationship inherent in institutional processes such as policy development, and I develop this 
throughout the thesis. This ties in with the concept of subjugated knowledge as discussed above. 
By using my position within the subjugated community, I was able to highlight and “emancipate 
the subjugated knowledges” (Foucault 1980: 84) by giving them a voice: through the participation 
group I set up (set out in the next chapter); by bringing them to the policy groups I was involved 
in; and in this thesis.  
 
Using Dialogical Meaning to Create Meaningful Dialogue 
 
Dialogue became an important tool in my research, and here I explain what I mean by 
dialogue, and how it can be a powerful tool in creating conditions of trust and meaning. Dialogical 
meaning is a focus of interpretive research, with a starting point that meaning is a result of our 
everyday experiences, some of which fall outwith our capacity to fully understand (Wagenaar, 
2015, ch.8). Meaning emerges through dialogue between actors and the world. In discursive and 
hermeneutic analysis, meaning is seen as an object of research (Fay, 1996, 146; Wagenaar, 2015, 
ch.8), with the researcher setting out to ‘uncover’ what the meaning is to the actors in the research. 
In contrast, because meaning emerges through dialogue between the researcher and actors/objects 
of research, there is no ‘uncovering’ of meaning, but rather the emergence of meaning that can 
only be articulated by the interpreter, and is dependent on the life experience of that interpreter 
(Wagenaar, 2015, ch.8). Furthermore this meaning takes place in ‘emergent time’: 
[U]nderstanding arises from a situation of engagement, that it is shaped by a particular 
perspective that we cannot transcend, and that it takes the form of a “conversation’ with the object 
of meaning”. (Wagenaar, 2015, 196). Dialogical meaning therefore does not attempt to ‘uncover’ 
the truth in the way hermeneutic and discursive meaning, or any form of scientific research, 
attempts to do. Instead it looks at broadening understandings, and individual horizons through 
conversations with the object (person, document etc):  “In the dialogical conception of meaning, on 
the other hand, meaning emerges only in relation to the interpreter. As a consequence meanings change 







In this way the use of dialogical meaning compliments the use of subjugated knowledge as 
outlined above, by not attempting to get to the truth, but to explore what ‘truth’ means to ourselves 
and others. 
 
Dialogical Meaning and Expanding Horizons 
 
Horizons is a term coined by Gadamer (1976) and is important in understanding dialogical 
meaning. Think of standing on a hill and looking towards the horizon. Then imagine that the hill 
suddenly gets half a mile taller, with you standing on it. Your horizon will have shifted and 
landscape that was once beyond that horizon will now be visible. We all operate within our own 
horizons, but the key here is that horizons can shift, expand and contract and intermingle with 
other horizons. Think of the hill and imagine several other hills with people on them. As they rise 
up to your level they are able to perceive what you perceive, and vice versa. As understanding 
takes place through dialogue, our horizons shift – we can feel this when we have those moments 
of insight, when you feel you mind expand as a result of information that changes the very 
foundation of your concept of reality. Here I reflect on one of my early experiences: 
 
“My first memory of an expanding horizon comes from when I was about 5 years old. I 
cannot remember the exact context in which it expanded, on reflection it may have been to 
do with getting the bus. We used to get the bus to Tollcross in Edinburgh, about 2 miles 
from my home. The journey of the bus, for a 5 year old, followed a certain path, and in my 
mind that was the boundary of my reality, Tollcross. Other places existed within that 
boundary such as the playpark, my school, the local church, the roundabout. One day I had 
the realisation that the world was larger than this 2 mile radius, that it took in the whole of 
Edinburgh city, and beyond. The physical feeling of this understanding was so strong that 
I had an existential moment that has stayed with me to this day. My world, my horizon, 
expanded to include all those things that I could not see immediately, but were out there in 
the same way Tollcross was out there, and accessible in the same way Tollcross was 
accessible by bus.”  
 
While this example may highlight the personal growth and developmental horizon 
expansion that my 5 year old self experienced, it sums up the experience of expanding 
consciousness that can accompany dialogical processes in other worlds such as policy. In less 
profound ways, dialogue creates these expanding horizons by encouraging understanding between 
actors. This deeper understanding can shift the boundary of the individual’s reality, opening up 
aspects of themselves and the world around them that had previously been hidden from view. The 
concept of ‘horizon’ is used in this context by Gadamer, and Wagenaar, to show that “we are 
always part of the situation we are trying to understand…we live and understand in emergent 
time” (Wagenaar, 2015, 203). Meaning exists within us, as opposed to ‘out there’. Our meanings 





experience, but we can build bridges between perspectives (and therefore expand our horizons) by 
engaging in dialogue with other perspectives. The concept of horizons contradicts the idea of an 
autonomous, independent subjectivity, as well as a detached objective observer. It encompasses 
the idea that we are constantly being “thrown into the world” (Wagenaar, 2015, 205). By a fusion 
of horizons our understanding is constantly shifting and emerging, never static, particularly if you 
are acting as an engaged agent (taking on board all these concepts and reflecting on you own 
process using dialogue): “Understanding therefore, is better described as ‘coming-to-an-
understanding’: ongoing, provisional, fallible, always open to revision” (Wagenaar, 2015, 206). 
 
Because dialogical meaning involves cultivating a mindset that is comfortable, or least 
aware, that one will never have full control over our objects of study, or have full access to the 
reality we are taking part in, there needs to be some ethical considerations. Firstly, this process 
involves self-reflection, and this is not always easy. In order to comprehend the above we need to 
accept that we are not fully transparent to ourselves, or willing to open up to others. This requires 
an element of vulnerability and trust. In order to create a fusion of horizons, particularly in dialogue 
between people, you need to be willing to change your assumptions, have them challenged. Not 
everyone is able to do this, and I found this particularly hard to begin with. 
 
Secondly, coming to an understanding requires that the parties involved are willing to 
“function together” (Taylor, 2002, 128). In order to do that there needs to be mutual respect and 
openness. Having mutual respect and openness requires one to feel that the other has something to 
teach them, that they can learn from their perspective. Part of my research methods involved 
interviews, and an example of this ‘functioning together’ can be seen when I started to analyse my 
interview transcript data. On the one hand I felt required to interpret the interview data and create 
new understanding based on it, on the other hand I was strongly committed to the concept of 
respectful dialogue, and avoiding interpretation based on my own prejudices and beliefs. I 
overcame this dilemma slowly by understanding that the researcher can add without imposing, and 
by incorporating stories into my findings that allowed me to present chunks of data that retained 
the perspective of my interviewees. By incorporating dialogical meaning into my analysis I 
overcame the desire to ‘uncover’ a truth, instead focussing on how I perceived the interaction, and 
the meaning that emerged from it. At the risk of over-quoting Wagenaar, it is this quote that 
underpins my approach perfectly:  
 
“Dialogical meaning is, thus, a human condition, an awareness of the open-ended, fallible, 
and shared nature of our understanding of the world, and of our tentative, never finished 
attempts at elucidating and overcoming the indissoluble partiality of our position in the 
world. In dialogical meaning understanding is intimately tied to action. It emerges from 
the patterned activities we engage in when we grapple with concrete situations that present 
themselves to us as in need of being resolved. Meaning emerges from our interaction with 






Meaning, therefore, is created throughout the research process and understanding emerges 
from immersing yourself in the process. Importantly dialogical meaning is developed through 
dialogue between actors. A way of creating dialogue is through stories, and these stories can help 
us understand larger narratives that provide the master, and counter meanings to individuals and 
groups within society. By cultivating a dialogical approach to meaning, meaningful dialogue is 
possible.  
 
Exploring the Role of Narrative in Research  
 
Social science is concerned with meaning making, and recent developments have seen 
narrative analysis as an important way of understanding meanings (Fischer, 2003). Narrative study 
stems from anthropology and the study of narratives in religious texts such as the Bible and the 
Talmud (Czarniawska, 2004; Douglas, 2007) and moved to folklore and mythology with the 
publication of Vladimir Propps’ Morphology of the Folktale in 1928. This instigated a swathe of 
contemporary research in the linguistic and literary disciplines where the structure and content of 
stories were subjected to much analysis and discussion (Czarniawska, 2005; Wagenaar, 2012; see 
further Roland Barthes and Mikhail Bakhtim). The use of narrative research and analysis began to 
spread out from the earlier disciplines around the 1960s with the publication of Labov and 
Waletszky’s essay ‘Narrative Analysis: oral versions of personal experience’ (1967), and historian 
Hayden Whites’ book on the historical imagination (1973). Narrative research in the broader social 
sciences took off in the early 1980s in response to a number of factors including: the increase of 
women in these areas (Griffiths and McLeod, 2008) andthe recognition that narrative plays a key 
role in the way we communicate (Orr, 1996), make sense of organisational life (Weik, 1995) and 
organize political life (Schram & Neisser, 1997; Roe, 1994). 
 
 Narratives are a way to communicate with each other using stories, giving us an 
understanding of not just individual lives but the cultural narrative or community narrative 
(Bruner, 1991; Gee 1986; Mischler 1985; Reissman 1993): “The power of narrative is not so much 
that it is about life but that it interacts in life.” (Daiute, 2014, 2). Having said that, there is no 
single definition of what constitutes a narrative or story in social science, however, there are 
foundations and convergences that most narrative analysts, or those writing about it, appear to 
agree on (laid out below). 
 
 Generally speaking narrative and stories are used interchangeably within social research, 
however I found this approach messy, and at times confusing, so took inspiration from Feldman 
et al (2004) and Wagenaar (2012) and chose to distinguish (as much as possible) narratives from 
stories. In this research narrative is the overarching themes that emerge from the stories, and will 
be presented as the master narratives and counter narratives. Stories are individual ‘subsets’ of the 





the overarching narratives, allowing for numerous, and at times competing stories to be 
incorporated (Czarniawska, 2014). Yet, while a distinction helps to clarify, there are often times 
when the two definitions overlap. 
  
The classical structure of a story is Aristotelian: a beginning, middle and end, with a plot that 
involves the “reversal of the hero’s fate” (Wagenaar, 2012, 201). It has also been argued that a 
story must have a sequence of events (Labov and Waletzky, 1967), while others argue that it is the 
consequences of stories that make them relevant (Young, 1987; Czarniawska, 2004) or functions 
(Wagenaar, 2000; Forester, 1999). A further twist to the tale, and one that takes Aristotelian 
development further, is the mythologist Joseph Campbell's elaboration of ‘the hero’s journey’ in 
his book ‘The hero with the thousand faces’ (2008). In this development the story not only has a 
beginning, middle and end, with a plot, a sequence of events and a function, but it also sees the 
hero overcoming adversity in three distinct phases, ending with a reversal of the hero’s fate by 
moving him onto the next level of consciousness (marriage, wealth, happiness etc.).  
 
 The template provided by sociolinguist William Labov tweaks the Aristotelian structure. 
In this the story starts with an abstract (introduction) that sets the genre and the style. It then 
orientates the reader by setting out the time, place and key characters. The story then develops a 
complicating action which requires the characters to react, and this is then resolved and evaluated 
by exploring what happened, was it done well, etc. Finally a coda ends the story and, if the story 
takes place within a conversational setting, this is the signal for other speakers to come in. Labov 
felt that this template needed to exist in order for narratives to be considered ‘fully formed’ (Frank, 
2015, p.10).  
 
 According to Charles Tilly (2006) stories differ from ‘technical accounts’ in that they rely 
on imagination and are character driven. Stories can be wide ranging, all forms of communication 
can be in story form, as long as they follow a sequential order and have some elements of 
connection. Time is therefore another important component of the structure of a story, yet it is not 
necessarily linear but temporal, and often cyclical, as explored below (Bhaktin, 2002; Ricoeur, 
2002). A story therefore consists of elements such as plot, characters, beginning/middle and ending 
which signal to the reader they are engaging in a story. The bedtime test as Frank (2015) describes 
it is helpful: if your child asks for a story they will not be happy with some complex rendering of 
an action, they need a beginning, a middle which usually involves some kind of suspense or 
challenge that needs to be overcome, and a ending, or resolution (Frank, 2015). Stories therefore 
speak to the child in us, the point in time when logic, reason and structure were only beginning to 
be formed.  
 
 Stories are ultimately subjective because they are about the individual experience, but often 
they reach out to a larger audiences by tapping into universal themes that touch every reader. 





understanding…[they] are meant to be provisional and temporary. And also interactive and 
dialogical.” (Wagenaar, 2012, 212). We use stories to explain why events happen, how we got 
where we were and why we acted in a certain way. Importantly we use stories to convince, give 
advice and persuade others of our point of view.  
 
 Because stories can be open ended, and are constantly updated in light of new information, 
they provide a way to reflect how reality is experienced, as opposed to how it is theorized 
(Wagenaar, 2012, ch.8; Bruner, 1992). The content of a story signals to the reader how the narrator 
constructs their reality, and shows the taken for granted underlying normative judgments about 
how reality is, and should, be perceived (Bruner, 1992). By using multiple stories to explore 
underlying normative judgments about the reality of a situation, event or policy, it is possible to 
see where those stories converge (and therefore speak to a unified belief) and where they counter 
(and therefore highlight contested normative judgments).  
 
 Further, stories have emotional impact and therefore: “A good story makes us care about 
its subject…historical storytelling helps keep us morally engaged with the world by showing us 
how to care about it and its origins in way that had not been done before” (Cronon, 1992, 1375-
5). Where we place characters, the emphasis we have on certain characters, and the lack of certain 
characters all point to the ‘realm of moral concerns’ (Wagenaar, 2012,p. 213). “Characters in 
stories are moral constructions that indicate our beliefs about how people fit into society” (Bruner, 
1986, 39). This was particularly evident in my participants stories - the stories relating to drug use, 
or responses to drug use and resulting harms, were often spoken using language which highlighted 
the participants feelings of anger or betrayal at the lack of concern by the institutions, the wider 
public or politicians. While not always explicit, the stories showed a deep undercurrent of 
compassion and concern for the wellbeing of individuals and society. For example, the following 
story is about one of my interview participants first contact with a heroin user. The participant is 
a G.P., and will be introduced in the methods chapter, but here I use this vignette to show how the 
stigma towards drug users can be embedded within institutional settings:  
 
“But I do remember when I was a junior doctor, the first time I really ever came across a 
recreational drug user, or whatever you call it, was a girl who is in the ward, a young, very 
young attractive redheaded girl who had asthma, and she had a bad asthma attack, or 
maybe she had pneumonia I can’t remember. Anyway she had a chest problem, it was a 
chest clinic, and she was in overnight, and then she told me she was using heroin, you know 
I said what’s all this injection site stuff, and I was again thinking, why would a pretty girl 
like that use drugs, you know. And again I was totally naïve and totally sort of, you know, 
she was perfectly clever nice bonnie girl, and I said to her you know you’ve got to stop, and 
what can we do to help. I spoke to the consultant and he said oh for Christ sake get her out 
of the ward, get her out, you know. And I said but you know she’s ill, she’s needing some 





heroin and she pushed off and I never saw her again. And I thought well that’s a pretty 
feeble approach you know from the medical profession, so I spoke to some of my colleagues 
in psychiatry and they said oh you know, we don’t do treatment, and they had a methadone 
clinic but, I never heard from her again” (Senior Drug Advisor). 
  
 A simple reading of this story highlights the empathy the narrator has towards the heroin 
user. Terms such as ‘very young attractive redhead girl’, and ‘perfectly clever nice bonnie girl’, 
show his need to describe her in what he considers a good light (although a deeper reading would 
analyse the use of the arguably patronizing and patriarchal based descriptions), cementing his 
belief that his profession were not treating her appropriately. The way he recalls the response of 
his colleagues also highlights the contempt he felt was directed to heroin users, and in his words 
the ‘feeble approach’ they had. This vignette is used to demonstrate on a surface level how the 
content of stories, and the emphasis put on characters, can point to the moral concerns of the 
narrator. As Wagenaar (2012) states: “Our concern with a character when we listen to a story 
always points to a concern with the larger issues at hand, usually a breach of or threat to the 
accepted order of obligation and responsibilities. To the moral order in other words.” (p.213). 
Equally the concern with a character by the narrator often points to a concern about a broader 
breach of obligation or responsibility, as demonstrated above.  
 
 This moral concern is evident in what Deborah Stone describes as ‘policy stories’. In her 
book, The Policy Paradox (2002) she discusses two broad narratives that are prevalent in policy: 
“the story of decline” (it was once good but now it is bad, and only going to get worse if we don’t 
do something about it); and “the story of helplessness and control” (it was out of our control but 
now we have found a way to bring it into our control) (Stone, 2002, ch.6).  
 
 The decline story is present throughout drugs policy, and most obvious in the story of rising 
drug deaths. Part two of the thesis charts this story, but briefly the story goes ‘drug deaths are 
rising, we need to do something about it, we have a new initiative/tag line/bit of money, we are 
now in control’. This leads onto the second story, control. The underlying theme in the control 
story is the move from fate to control over destiny. Variants include conspiracy - where those who 
have control are misusing it to the detriment of the broader populace, and blame the victim story 
(Stone, 2002, p. 144). In the latter variant the victim is painted as the perpetrator of their own 
downfall, and this is evident in the overarching narrative surrounding ‘problem drug users’. 
‘Problem drug users’ are often seen as people lacking the commitment or will to stop using drugs: 
“what all these stories of control have in common is their assertion that there is choice” (Stone, 
2002, p.144). The story goes ‘we will provide individuals with the means to take control over their 
lives and they will be responsible’. The two often interweave together. First it is the story of 







Stories in Policy: The Personal is Political  
 
 Policy stories are often referred to as policy narratives (Roe, 1994; Stone, 2002), yet for 
clarity I have attempted to separate the two. Policy stories are the stories told by individuals when 
describing or relating an action. Policy narratives on the other hand are the overarching narratives 
that encompass the multiple individual stories to make a larger, broader master narrative. For 
example, the story of decline described above can be related to an individual’s story (she was once 
good but now she has an addiction) as well as a broader narrative about drug users (they were once 
good but now they have an addiction). These overarching narratives are used to underwrite and 
stabilize policy decisions on topics which have uncertainty, complexity and disagreement at their 
core (Roe, 1994, ch.2). However, these policy narratives often reveal deep power inequalities 
embedded within personal responses to policy. As Ettore comments: ‘[w]e transform our personal 
stories into political realities by revealing power inequalities inherent in human relationships as 
well as the complex cultures of emotions embedded in these unequal relationships’ (2017, 2). 
 
 Importantly, policy narratives are often intractable and impervious to empirical evidence 
because they contain stories which resonate with the narrator, or constituent, as Roberts (2016) 
explains: ‘Policy narratives possess significant institutional characteristics in so far as they 
constrain political actors ‘thoughts and actions’ by limiting the possible ways of viewing that 
issue’ (84). In the face of critique they become more embedded because, while critique is essential, 
it creates uncertainty and instability, two things that policy makers loathe (Roe, 1994, ch.2; Stone, 
2002). Because stories provide such an important role in representing human action and problem 
solving, countering a policy narrative cannot merely critique the story, it needs to provide a new, 
better story that competently challenges and replaces the original narrative (Wagenaar, 2015, ch.8; 
Roe, 1984, 40 for similar vein of thought). This counter narrative needs to be as effective as the 
master narrative and follow similar plot lines for it to usurp the master narrative. 
 
 When competing narratives are difficult to read, or do not have a coherent structure to them 
and are a series of critiques, policy makers will fall on ambiguity and harden the master narrative 
line, because this provides security and strength to an issue which is complex and full of risk (Roe, 
1993; Stone, 2002). It is argued therefore that policy analysts should focus on the structure of the 
narratives, both master and counter, and explore the similarities and differences in order to craft 
an alternative story that deals with the uncertainty and risk inherent in all complex policymaking 
(Roe, 1994, ch.2). Using personal stories to highlight policy narratives (both master and counter) 
allows the researcher to craft meta narratives that speak to both the policy making community, and 
the wider stakeholder community.  
 
One of the challenges in identifying counter narratives is distinguishing between counter 
narratives and critiques. Policy narratives are stories that are used to underwrite and stabilize policy 





Stone, 2002). Critique can be used to counter master narratives but they are not stories because, 
while they may have a plot with characters, often closely aligned to the critiqued policy, they take 
the policy point by point and argue it down but never offer any solution. In short they don’t have 
an ending, and therefore tell us what we should be against, but don’t provide an answer for what 
we should be for (Roe, 1994), or ‘what is’ (Fischer, 2003). This is not always the case in drugs 
policy: many critical drug scholars critique drug policy and point to other frameworks such as 
decriminalisation or legalisation. However, where they often fall down is the lack of a simpler, 
coherent story that can compete with the master narrative that ‘drugs are bad, that’s why they are 
illegal’.  
 
Further, the master narrative often concerns risk, and the story is highlighting the risk of 
something and how it can be managed. Where counter narratives can fail is in not taking account 
of the risk inherent in the story, or by highlighting their own risk but not providing a strong 
narrative to counter it. The perception of risk and how to manage it is crucial to policy decisions, 
and by extension policy stories (Roe, 1994). For example, as this research will show, with drugs 
policy it is the risk of harm posed by ‘problematic drug use’ that underwrites the responses to it.  
 
‘From a narrative analytical viewpoint, the more asymmetries between narratives in 
difficult policy issues, the greater the uncertainty and risk associated with those issues. The 
potential for uncertainty or risk increases when one of more of the competing narratives is 
not really a conventional story at all but rather a critique. At best, critiques leave 
unaddressed the palpable need of government officials and politicians to have a storyline 
when faced by what they do not know, or cannot otherwise analyse and justify. At worst, 
critiques serve only to intensify the ambiguities of an issues’ (Roe, 1994, pp.74). 
 
However, while Roe is correct in stating that critiques can have a destabilizing effect, in some 
policy ‘problems’ that is the intended outcome (Fischer, 2003). Further, critiques are a form 
argument, and arguments underpin most policy initiatives (Stone, 1998; Majone, 1989; Fischer, 
2003). Critiques focused on a local/national ‘problem’ may be part of a larger international or 
global narrative, or argument, which may provide certainty and strong counter narratives, but in 
the context of micro debates serve only as critiques (Fischer, 2003). Roe’s analysis does not 
adequately account for the wider structural and global influence, nor does it account for the 
dialectal and narrative quality of policy debates (Fischer, 2003, ch,8). Critique is essential to 
challenge dominant practices however, therefore ways to critique, while also providing alternatives 
that do not destabilise, are important.  
 
Narrative Interventions  
 
A way of critiquing that can also be transformational is the concept of narrative 





situation/individual/group or action. Narrative interventions can be used to impose a particular 
narrative on a marginalised group in order to make it conform and ‘[t]hus, narrative interventions 
can, in Bourdieu’s terms, do ‘symbolic violence’ through the imposition of dominant discourses 
onto marginalised populations.’ (Fleetwood, 2016, 187). Further, Fleetwood gives examples of 
research on how alcohol drinkers have incorporated the bad side effects of drinking too much into 
their own ‘hilarious’ stories, suggesting that public health campaigns that highlight these negative 
effects may not work. Similarly, my masters’ research into the effectiveness of Scotland’s public 
health campaign on cocaine found that elements of the message increased a desire to try the drug 
(Ross, 2014).  
 
However, Fleetwood (2016) discusses the role of narrative interventions in changing the 
harmful discourse, as opposed to the perceived harmful person, which has relevancy for drugs 
policy, and in particular this thesis. By challenging the narrative that exists, whether it is the use 
of language or collection of stories to describe a person/event/action, and replacing that 
language/story with a different one that does not marginalise or harm the group, there is a 
possibility of critiquing the policy and providing an alternative narrative that changes the framing 
but does not destabilise the framework.  
 
The Research Gap and the Research Design 
 
Although drugs policy, national and international, is a well-researched area, there is very 
little research into drug policy communities as defined in this chapter, and no previous studies 
which fitted the context. While there is research into drug policy formation in Australia (Ritter, 
2009; Bacchi, 2018; Lancaster et al , 2018), the UK (Stevens, 2011; MacGregor et al, 2014; Nutt, 
2010) and at a European level (O’Gorman et al., 2014; van Amsterdam et al., 2015), these studies 
focus on how policy is formulated top down: problem, statement, consultation, legislation and 
implementation. Research has highlighted the problem of translating policy research into policy 
formation (Ritter, 2009), explored the construction of drug policy ‘problems’ (Bacchi, 2012; 
Lancaster, 2014; Stevens, 2019) as well as more nuanced assessments of how drugs policy is 
constructed using harm indexes (van Amsterdam and van den Brink, 2010; Carhart-Harris and 
Nutt, 2013; Rogeberg et al., 2018). However, to date there has only been one study which looks at 
the narratives underpinning drug policy formation in the UK, and this is focused on a small group 
of policy makers in a UK Government policy department examining the role these narratives play 
in the use of evidence (Stevens, 2011).  
 
My research however seeks to go beyond the formation of policy at the top level and find 
the underlying narratives which guide Scottish drug policy, and those involved in the policy 
process. It uses Carol Bacchis analytical tool ‘What’s the Problem Represented to Be’ (WPR) 
approach to explore the problematisation of drug use and users, and to develop a critical analysis 





expansive understanding of narrative in social research, by explicitly combining multiple 
narratives and stories to create new meta narratives that show ways in which policy can be 
implemented as equitably as possible. It explores how Scottish drug policy can be best understood 
as emerging from the policy community in Scotland: that personal stories and collective journeys 
have resulted in a policy landscape that is focused on the health of its citizens, as opposed to an 
ideological stance (Stevens, 2011).  
 
In order to encompass the different methods and analytical tools used in the research I used 
Interpretive Policy Analysis (IPA) as an overarching researching design. IPA is a research 
paradigm which combines interpretive approaches to social sciences and public policy analysis 
(Wagenaar, 2015; Yanow, 2000; Colebatch, 2002). It grew out of the interpretive movement in 
social policy and allows for multiple approaches to the research design, methods and analysis 
(Yanow, 2000; Schwartz-Shea and Yanow, 2012; Wagenaar, 2015).  
 
Interpretive research is founded on the philosophical approach of hermeneutics and 
phenomenology (Bevir, 2000; Wagenaar, 2015; Blaikie, 1993). Phenomenology is a philosophical 
approach which argues that human consciousness exists because of perceptions, and these 
perceptions appear to us as phenomena (Yanow, 2000; Wagenaar, 2015). Philosophical 
hermeneutics is a development of classical hermeneutics; a theory for interpretation, specifically 
biblical texts, in order to develop understanding and meaning. Philosophical hermeneutics has a 
long history of development (Gadamer, 1960; Safranski, 1999; Wagenaar, 2015, ch.4) which I will 
not explore here. For the purpose of setting out my research design, it is the role of the hermeneutic 
circle in illuminating the whole by exploring the individual parts that I am interested in (Schwartz-
Shea and Yannow, 2012; Gadamer, 1976). The hermeneutic circle describes a way of developing 
understanding and meaning by expressing “the idea that there is no fixed starting point for inquiry: 
the process of sense making begins wherever the individual ‘is’ in her understanding at that 
moment, with whatever grasp of things she has at that time” (Schwartz-Shea and Yanow, 2012, 
30).  
I structured my data collection starting from the principle that I had prior knowledge 
resulting from my involvement in the field (Perigrine Schwartz-Shea, 2012; Wagenaar, 2015). 
However, I intuitively turned the hermeneutic circle into spiral, as I could not relate to the closed 
circuit of the circle. I saw the process of transformation as a continuing spiral of knowledge 
formation, and was pleased when I came across Cerwonka and Malkki (2007), who describe the 
process of research as “more spiral in nature than linear and cumulative”(12). Similarly, 
Schwarts-Shea and Yanow state “the resulting research style is better conceived of as a spiral than 
a circle” (2012, 31). In the context of my evolving understanding of meaning, the hermeneutic 
spiral presented a visual representation of the way in which my mind gathered information, and 









From this I worked from the basis that there were phenomena to be explored by following 
the hermeneutic circle (or spiral) of re-evaluating my research questions as I conducted my data 
collection and analysis. Importantly I was following the hermeneutic approach of seeking to 
understand motives, meanings and perceptions (individual subjectivities) in order to find a 
common whole (Yanow, 2002; Gadamer. 1976). The idea was that through this I would be able to 
explore why some evidence is used and some not, using the biographical data generated by my 
interviews with policy makers. However, by constructing my initial research question around 
puzzles that I had identified, with the help of my prior knowledge and literature on the subject, it 
became evident that I had limited my focus to an area which I felt was important, but which my 
data had begun to show me was only part of the picture. This is an important process in interpretive 
research, and helped to reformulate my research questions, and hone the focus of data collection 
going forward. As the research progressed, I incorporated dialogic meaning into my data collection 
and analysis.  
 
One of the challenges I had using IPA was that the policy world I studied is so broad that 
it encompasses multiple actors, multiple communities and a variety of potential objects of study. 
While the focus of IPA is on policy worlds (as opposed to policies in and of themselves), I was 
initially overwhelmed by the vastness of the community. This led to a research design which at 
times felt messy and unstructured, yet the iterative process which arose from the messiness helped 





to hone the focus of the research, and highlighted shared meanings and narratives which would 
not have been evident had I chosen a more top down structured thematic approach. One way I did 
this was to tighten the focus of the ‘drug policy community’. I chose to focus it down to immediate 
actors, people who are/were involved in working in the drug policy field, or the wider academic, 
professional, activist arena.  
 
There were three important aspects to my research which led me to conduct my research 





As demonstrated above I was, and am, deeply involved in drug using and drug policy 
communities in Scotland, and any design needed to reflect that. Context in this case is described 
as knowledge and experience gained as a result of previous immersion in the field, and can also 
be described as ‘local knowledge’ (Yanow, 2000), background knowledge (Wagernaar, 2015) and 
situated knowledge (Haraway, 2006; Fricker, 2013; Grasswick, 2018), although the latter two 
encompass more than just immersion in a particular field. 
 
2. Research Methods 
 
At the same time as starting my PhD I was also in the process of setting up a conversation 
group with drug policy stakeholders, with a view to creating dialogue between different drug 
policy communities. The rationale behind this was the desire from many quarters to start talking, 
and doing drugs policy differently. This, combined with the opportunity to access important 
stakeholders for interviews, my immersion in the wider drug policy community, and the recent 
change in Scottish drug policy resulting in events highlighting the Scottish Governments narrative, 
meant that I wanted to encompass a variety of data collection methods. IPA, with its flexibility in 
methods, and focus on getting an in depth understanding by utilising multiple methods (Schawartz-
She & Yannow, 2012; Yannow, 2000) seemed a very good fit.  
 
3. Transformational Aims and Outcomes 
 
One of the most important aspects of my research was my desire to produce 
transformational outcomes through the use of dialogue and shared stories. When I started the 
research I was concerned with this stance because I had yet to fully explore the role of critical 
studies, IPA and WPR Approach. However, it was the following quote which made me understand 
that my approach to policy analysis was best suited within the IPA discipline, and in particular the 





“[t]he task of the analyst is to create a situation of “collaborative dialogue” (Innes and 
Booher, 2003, 2010) in which the stories of the contending parties become gradually more 
complex and inclusive to create a joint platform for action” (Wagenaar, 2015, 221).  
 
Using dialogue as a transformational tool became a fundamental aspect of the research and 
built on existing developments in this discipline (Way et al, 2015; Barge, 2002; Wagenaar 2015). 
IPA allowed me to incorporate the stories and narratives that emerged from my data and transform 




Research Question 1 
 
‘What are the master and counter narratives within Scottish drug policy communities?’ 
 
By using narrative to highlight the impact specific knowledge and histories have on policy 
formation and why certain individuals become involved in this area, it was hypothesised that there 
are two competing narratives informed by the history of public health and criminal justice 
interventions around drug use in Scotland, originating in the HIV crisis of the 1980s. This means 
that the formal focus on harm reduction and recovery in drug policy disguises fundamental 
disagreements about criminal justice and drug treatment practice. Question 1 was designed to 
explore this hypothesis and highlight whether there are shared narratives which will enable these 
communities to work towards an understanding of different concepts of drug related harm, and 
solutions stemming from this. 
 
Research Question 2 
 
‘What are the challenges in engaging different epistemic communities in a participatory policy 
process?’ 
 
A further research question was on the participatory aspect of the research. Initially this 
question was seeking to explore why stakeholders such as drug consumers were not being 
consulted or engaged in drug policy development. This has changed due to the Scottish 
Government making a commitment to engage drug consumers (and a broader range of 
stakeholders) in drug policy deliberation. However, the question remains pertinent, with focus on 
how meaningful that engagement is, thereby highlighting the challenges in participation.  
 






‘What is critical drug theory, and how can it help us understand drug policy formation in 
Scotland?’ 
 
Finally, as a result of using grounded theory to initially analyse my data, and the WPR 
approach to critically analyse in more depth, I developed the beginning of a theoretical framework 
I call ‘critical drug theory’ (CDT). CDT is a development of critical theory, in particular critical 
race theory (CRT), that argues drug policy reflects a certain world view, and by extension 
discriminates against those who challenge this world view. CRT uses a counter narrative to 
challenge dominant discriminatory narratives, and I developed the narrative arm of CDT as a result 
of hearing and experiencing these counter narratives throughout my data collection. The question 
for this thesis is, can this theoretical development help us understand the barriers to wider 




This research grew out of my perception of personal troubles that transform into public 
‘problems’. It starts with myself, the researcher, experiencing and seeing the personal impact that 
the drug laws have had on myself, and my community. While it may ‘only’ be my perception that 
these troubles have been caused or exacerbated by the drug policy framework, it nevertheless 
represented my, and many others, reality and therefore needed to be explored. What was surprising 
about listening to the public narratives (in the form of the data I collected) was that many of my 
own concerns and private troubles were reflected and co-created by the participants - from 
interviewee and observational data - many of whom I did not expect to share the same reality with. 
By having shared experiences with the research participants, I was more able to fully understand 
their construction of the ‘problem’. The following chapter sets out the methods I used to explore 






There are Methods to this Madness 
 
“Methods purport to function like instructions. That, after all, is their whole idea. They tell 
you how to go about doing research. But here we run into a huge paradox. The instruction 
is meant to set the novice on the proper path, yet he only grasps what the method is about 
after he has found and walked the path himself. The paradox is that instructions are not 
beginnings, but rather the endpoints of a long process of socialization in which instructions 
are not much use because the novice doesn’t have the body of experience to interpret them 
properly” (Wagenaar, 2015). 
 
This, in a nutshell, was my process. In way it is like learning how to cook. I spent several 
years as a chef, but before I did I was often impressed at how some people just ‘knew’ what to add 
to a meal to make it taste good. When you are cooking you follow the recipe, and if you have never 
cooked before you follow it blindly, with a view to replicating the recipe as closely as possible. 
Once you are confident in cooking you start to add a little bit here, a little bit there, and the 
instructions act as guidance, as opposed to a strict rule. I spent a large portion of the PhD following 
the different instructions surrounding all the various methods I came across throughout the process, 
yet it was not until I had nearly completed the thesis that I began to truly understand what I had 
used, how I had used it, and how it enhanced (or tainted) the ‘flavour’ of the data. However, I 
would add that this socialization path is essential and should not be viewed as daunting. Through 
my grappling with different methodological concepts, methods, theories and frameworks, I began 
to see the wood from the trees, and understand which processes fitted both the research topic, and 
my own research style.  
 
As demonstrated above, I did not come to this topic with a clean slate. While arguably no 
one comes to a research topic with an empty mind (Charmaz, 2006; Wagernaar, 2015), my 
background knowledge and presuppositions conspicuously steered the direction I was going. The 
challenge was how to design and conduct my research while taking into account this knowledge, 
incorporating it into the process yet not allowing it foreclose the possibility of discovery through 
the research. I overcame this challenge by using interpretive policy analysis (IPA), as described 
above, which allows for the incorporation of background/local knowledge and utilises a range of 
methods, and by having a deeply reflexive component to the thesis, thereby integrating my 
background knowledge and experience into the overall research design.  
 
This chapter is divided into 2 sections. Section 1 will document how I generated the data. 
In order to explore this community in detail I chose to use multiple methods, partly as a pragmatic 
response to the different communities I sought to explore (policy makers, policy advisors, drug 





IPA. This multiple method approach is helpful when conducting grounded theory as it allows for 
multiple sites of selection, and builds flexibility into the design which allows for testing emergent 
questions in different contexts (Charmaz, 2004, Ch,2). My choice of methods was also influenced 
by the context in which I found myself and the availability of my participants. For example, I used 
purposive sampling (Ritchie et al, 2014, ch.5) to set the parameters for my interview participants, 
and accessed them through the networks and relationships I was cultivating as a result of the 
participant observation I was conducting (Ritchie et al, 2014, ch.5). Section 1 will therefore tease 
out an order from the intertwined data generation processes, and show how I managed to gather 
in-depth rich data on my community of study. 
 
Section 2 will set out how I analysed the data using grounded theory, narrative analysis 
(Charmaz, 2004, Czarniawska, 2004, Daiute, 2014) and the WPR Approach (Bacchi, 2009). I 
started my analysis using grounded theory and closely followed the steps outlined by Glaser and 
Strauss (1967) and developed by Charmaz (2004) of close coding, thematic development and 
theoretical sampling. The analysis and data generation were iterative, and following this process I 
began to develop the framework of a new theory: critical drug theory. Theoretical development is 
one of the main outcomes of grounded theory approaches (Charmaz, 2004, ch.6) yet there is a 
danger of getting lost in the creation of grand theories in order to distract oneself from the messy 
business of data analysis (Wagenaar, 2015, ch.8). In this section I demonstrate how I came to 
construct this theoretical framework, and how it then helped me understand my data better, provide 
the structure needed to conduct narrative value analysis (Daiute, 2014) and uncover master 
narratives within my data. Furthermore, I introduce the WPR Approach and show how I used this 
to structure and analyse the narrative content of the data, present it in the following chapters.  
Diagram 2 sets the methodological framework, and Diagram 3 visualizes the process of data 














In order to explore the current and competing narratives within Scottish drug policy 
communities I utilized a range of methods to ‘access’ a broad sample of data (Yanow, 2000, 
Daiute, 2014, ch.2). The core data for interpretive policy analyses are interviews, observation and 
document analysis (Yanow, 2000, ch.2; Wagenaar, 2015, ch.9) but, as Yanow (2000, 27) states: 
 
 “The “data” of interpretive analysis is the words, symbolic objects, and acts of policy-
relevant actors along with policy text, plus the meaning these artefacts have for them…[i]n 
this sense, then, we might more properly speak of accessing the local knowledge that the 
analyst needs to make sense of a policy situation. 
 
I therefore sought to ‘access’ as much policy relevant data and context in order to create a 
deeper understanding of the narratives at play. Policy relevant data was determined by my research 
questions, in particular data that highlighted narratives and participation within the community 
such as observing at meetings, observing and taking part in stakeholder engagements, informal 
conversation between myself and stakeholders, official documents and interviews.  
 
My data was a mix of naturally occurring and generated data (Richie et al, 2014, ch.3). 
Naturally occurring data refers to data such as documents, conversations, internet and other data 
which I came across (Ritchie et al, 2014, ch.3). Generated data is that which is generated by the 
researcher such as interviews, focus groups, and to some observational data (Ritchie et al, 2014, 
ch.3). The distinction between these two forms of data is not always clear cut, as will be explored 
below (Silverman, 2004; Ritchie et al, 2014, ch.3). The bulk of my findings came from my 





interviews, and the development of critical drug theory arose from the iterative process laid out in 
grounded theory analysis (Charmaz, 2004). As stated by Wagenaar (2015) “deep qualitative 
interviewing and the systematic analysis of interview data are the core business of interpretive 
policy analysis” (251), and gathering rich data through interviewing (explained below) provides 
the researcher with in-depth understanding of the topic (Lofland & Lofland, 1995).  
 
Document Analysis  
 
Document analysis is usually the first form of data collection that an IPA practitioner starts 
with in order to provide an initial overview and understanding of the field (Yanow, 2000). This is 
not the literature review but rather documents which are produced by the policy community which 
shed light on what narratives are being used. They can be used to develop interview questions 
(Yanow, 2000) and can highlight gaps or discrepancies between observed or interview data, and 
the documents (Charmaz, 2004, ch.2). For example, the confusion around what a ‘problematic 
drug user‘actually is was initially highlighted to me in the strategy document, The Road to 
Recovery (2008). There is a lack of clarity whether a ‘problematic drug user’ is an opiate and 
benzodiazepine user, or a user of any drug who experience social medical, legal and familial issues 
resulting from drug use. This prompted me to explore this confusion in my interviews and 
observation.  
 
I conducted selective document analysis primarily to highlight institutional narratives and 
responses. I have focused my attention on documents produced by the Scottish Government, 
because much of the institutional responses to drug policy stem from this source. In particular the 
following four documents are of importance to understanding the current policy narratives of the 
Scottish Government. I have included a non-exhaustive list of documents produced by Scottish 
administrations over the last 30 years in the appendix.  
 
1. The Road to Recovery 2008 - Scotland’s cross party drug strategy, due to be revised in 
the next year or so (speculative time date from policy actors within the government) 
2. Right, Respect and Recovery (2018) - Scotland’s most recent drug strategy document 
that builds on the Road to Recovery 
3. Research for Recovery 2010 - evidence to support The Road to Recovery 
4. The Scottish Framework for Problem Drug Use and Recovery 2015 - sets out the new 
advisory landscape set up by the Scottish Government in 2016 
 
These are the core documents which the Scottish Government work from and use to support 
the current narrative. In addition to these specific documents I have analysed reports published by 
Public Health Information for Scotland2 which is the new government body responsible for drugs 
                                                          





research. I have also used the websites and associated documents of Police Scotland3, NHS Health 
Scotland4, Scottish Drugs Forum5 and the Scottish Recovery Consortium6. The rationale for 
including the latter two is these organizations are the principle recipients of government funding 




As Rossman and Rallis (2003) state “in-depth interviewing is the hallmark of qualitative 
research” (180), and the purpose of these interviews in IPA is to “obtain rich, detailed material 
that can be used in qualitative grounded-theory-type analysis (Wagenaar, 2015, 252). I had 
originally intended to conduct a large sample of interviews (40-50) with a range of actors that had 
been identified as suitable respondents. However, after conducting the first interviews I realized 
that the research questions would be better answered by longer in-depth interviews. As Michael 
Erben (1998:5) argues: 
 
 “What the size of such an interview sample is should be dictated by the purpose for which 
the research is being carried out. The exact size of any sample in qualitative research 
cannot be ascertained through quantitative methods. It is for this reason that it is all the 
more important that the consciously chosen sample must correspond to the overall aims of 
the study.” 
 
I therefore chose to limit my sample to 12 participants, in the desire to carry out in-depth 
narrative based interviews as opposed to a larger sample. This provided enough data that 
overarching themes and narratives were identifiable, while also providing data that was rich in 
detail (Ritchie; 2014). Further, using grounded theory from the start I was able to tailor my final 
interviews to provide an element of theoretical sampling (testing the theoretical construct that has 
emerged from the grounded analysis) (Glaser and Strauss, 1967; Ritchie, 2014). 
 
Sampling: Community and Criteria 
 
As Howard Becker points out ‘[s]ampling is a major problem for any kind of research. We 
can't study every case of whatever we're interested in, nor should we want to’ (1998: 67), and this 
set the tone for my own sampling decisions. In order to define the sampling parameters within the 
broad definition of ‘the Scottish drug policy community’ I used a form of purposive sampling 
(Patton, 2002), also known as criterion sampling (LeCompte & Preissle, 1993). Purposive 
sampling is the process of selecting participants based on pre-determined criterion in order to 
ensure that there is broad coverage of the topic being studied (Ritchie et al, 2014, ch.5). A further 
                                                          
3 www.scotland.police.uk  
4 www.healthscotland.scot/health-topics/drugs  
5 www.sdf.org.uk  





refinement of this form of sampling is critical or typical case sampling (Ritchie et al, 2014, ch.5; 
Creswell, 2013; Patton, 2002). This form of purposive sampling is particularly suited to my 
research topic because participants were chosen on the basis that they have access to knowledge 
particular to the research topic. For this research the phenomenon being studied is the drug 
‘problem’ in relation to policy development and participation, therefore I needed to sample 
generationally (people who were there at the time and now) in addition to people who had 
experience of both the policy development, and drug use or drug ‘problems’. I chose to define drug 
policy formation on 2 levels; level 1 meant that respondents had been directly involved in creating 
policy (through government or an advisory committee attached to the government), and level 2 
meant that the respondent had been involved in either an advisory capacity as an independent 
(academic or 3rd sector organization) or had been involved in the implementation of the policy 
(through a national or local agency). Drug use was not overtly sampled for, however I knew that 
several of the respondents had experience, and therefore knew that I was including this element 
when I chose to interview them. This restricted my potential respondents to those who had an in 
depth understanding of Scottish drug policy, and provided coverage of a range of levels within the 
policy process, as well as experience of drug use.  
 
Access to participants was facilitated by my existing engagement with the Scottish drug 
policy community and my convening of The Scottish Drug Policy Conversations (SDPC - more 
below). The SDPC provided the networks and the opportunity to build relationships so that when 
it came time to request interviews from key policy stakeholders, I had a relationship based on trust 
with many of them.  
 
A potential issue with this sampling technique is that certain narratives will be overlooked. 
For example, I only had one interviewee who argued that policy should focus more on criminal 
justice sanctions, although this narrative represents a large section of the Scottish public. This can 
result from the focus being narrowly defined to a small group of people active in the drug policy 
world, and can result in the exclusion of non-traditional policy voices, namely drug consumers. 
However, Scotland is a small country and policy makers/advisors are generally accessible to 
researchers and those within the academic community. With my background, or situated 
knowledge of this world (as demonstrated in the previous chapters) I was able to identify key 
actors who would be able to elucidate the current narratives at different levels of the policy process. 
Yes, certain voices were left out; in particular those who did not engage with the SDPC, third 
sector organisations who work with drug consumers, those whose specific focus would have been 
drug consumption, and direct interviews with civil servants (although I made several requests for 
interviews). Yet it is not possible to have complete coverage of such a vast topic (see further 
Becker, 1998, ch.3): my research was looking to explore broad narratives surrounding drug policy, 






On the other hand, I approached my research with the understanding that the distinction 
between drug consumers and drug policy actors is false. By approaching it in this way, I created 
the space for policy actors to be honest about their current or past drug use. Not only did I have 
participants who had or were currently using drugs, but also a range of drug using experiences, 
from what could be termed ‘problematic’ to ‘recreational’, thereby covering a range of 
experiences. Below is a table setting out the name and details of those I interviewed. I ascribed 
each interviewee a number which will be referred to when quoting. There was varying levels of 
anonymity consent so some interviewees are only ascribed a number and a general description of 
their profession.  
 
Details Interview name  
Policy Officer for a third sector organisation focussed on drugs. Senior Policy 
Officer 
Addiction psychiatrist and Scottish Government advisor from 1998-2015. Drug Policy 
Advisor  




Senior civil servant at the Scottish Government. Senior Civil 
Servant 
Minister for the Scottish Parliament from 2007-2014. Ex Scottish 
Minister #1 
Retired Police Officer working for Police Scotland and the Serious 
Organised Crime Association. Now deceased 
Retired Police 
Officer 
CEO of a third sector recovery based charity. CEO of Drug 
Charity 
Long history of local government involvement, part of the original Alcohol 
and Drug Partnership development, instrumental in the development of 








GP and senior advisor to the Scottish Government for over 30 years. Chair 
of various sub committees. Since retired. 
Senior Drug 
Advisor 
MSP 1998-2007.  Ex Scottish 
Minister #2  
 
Ethical Considerations  
 
Before I recruited interview participants I applied, and was granted, ethical approval from 
the School of Social and Political Science at the University of Edinburgh. While I did not plan to 





there were questions regarding drug use that may have brought up traumatic memories, in addition 
to disclosure of current or previous criminal activity. As it was there were two interviews which 
resulted in the participant disclosing traumatic past experiences, however the participants did not 
appear to find this experience difficult, although I cannot know for certain whether this is the case, 
and it served to provide context to their broader life story. In addition, several participants 
disclosed previous or current criminal activity (drug use), with one asking that their disclosure be 
completely anonymous. This caused slight difficulty given the small sample number, however I 
circumvented this by having all quotes completely anonymised, and participants were happy with 
this.  
 
In regards to confidential storage of personal data, I recorded the interviews on a digital 
recorder and stored the recordings on my password protected computer. Once I had transcribed the 
audio I destroyed the recordings. 
 
Gaining Informed Consent 
 
I recruited most of my participants by asking them in person whether they would be willing 
to be interviewed, and I followed this up with email communication to arrange a suitable date and 
place. The remaining participants were recruited via email due to distance and not having the 
opportunity to meet face to face. All my interviewees were given a participant information sheet 
(see appendix A) which informed them of the nature and scope of the interview and research, and 
were asked to sign a consent form which specified various levels of anonymity (see appendix B), 
an ‘opt-in’ approach (Ritchie et al, 2014, ch.5). 
 
All of my participants agreed to allow full disclosure of name, position, age and gender, 
apart from one who felt her current position did not need to be known as the interview was based 
on her role as manager for the Scottish Government Drug Policy Unit, a position she no longer 
held, and another who did not want their name disclosed. Incorporating these requests into the data 
opened up the ethical consideration of representation. When one set of respondents wish to remain 
anonymous, it follows that those who are not anonymous have their voices heard more clearly. 
This can be an issue if we are anonymising groups that traditionally have little representation such 
as drug consumers, however in this research those who requested anonymity were in positions of 
power. Representation is therefore not so clear cut, but the desire to remain anonymous when 
talking about sensitive issues such as drug use, or the workings of government, highlights the 
challenges in creating open and transparent spaces that can break down boundaries and reduce 




All of my interviews were semi-structured and used open-ended questions. The first seven 





emerging themes from field work, observation and 
document analysis, resulted in the emergence of the 
theoretical framework of critical drug theory (CDT). 
The next five interviews were similarly structured but 
additional questions were asked in order to test the 
emerging theory (Glaser & Strauss, 1964; Charmaz, 
2012).  
I was interested in participants’ life stories, 
partly as a way of immersing ourselves into a 
conversation, and partly because I had a hunch that 
background experience of drug use impacted the 
narrative individuals later used when talking about drug 
policy. I therefore conducted the interview as a 
conversation, with the participant leading by telling me 
where they were from, where they grew up, and first 
experience of drug use (personal or through family and 
friends). Interestingly the opening question ‘so tell me 
bit about yourself, where you were born, where you 
grew up’, elicited a surprised response from many of the 
participants, for example ‘early life? Wow…how 
unexpected! (Interview#3). It appeared that because of 
the topic and the relationship I had built with many of 
them, they were expecting to talk about the process of 
policy making and politics, as opposed to who they were 
and where they came from. Opening the interview this 
way settled the participants into the rhythm of the 
interview, and helped bolster an atmosphere of trust by 
engaging with their personal story.  
 
Although I had created my interview guide, I 
found there were five questions that steered the direction 
of the interview:  
1. Tell me a bit about your early life. Where 
were you born, where did you grow up?  
2. When was the first time you came across 
drug use? 
3. How did you become involved in the drugs field? 
4. How would you describe drug users? 
5. How would you describe drug related harm? 
 
With my interviews, I feel that I 
created that relaxed space most of 
the time, indeed I feel potentially I 
was too relaxed and informal, 
allowing the interviewees to guide 
the topic, as opposed to me asking 
lots of inquiring questions. Often I 
would pick up on a topic or 
something they had said, and at the 
right moment I would take them 
back to it. But listening to my 
interviews as I transcribed them 
there are often moments which I 
wished I had probed a bit deeper, or 
gone a bit further, as this would 
have given me insights that I would 
not be able to get outwith that 
setting. For example, conversations 
on certain individuals/policy and 
how they interact with them may 
have flowed freely after one hour of 
sitting talking and laughing and 
building a rapport, but it is not the 
kind of thing I can email for a follow 
up, as they would not be so 
forthcoming, remembering that 
the information is being use to 
scrutinise and analyse that topic. 







With these five questions I was able to move through their lives, dipping in and out of 
certain parts of their narrative, and building a broad picture of the individual, as well as the policy 
realm they inhabit(ed) (Rossman and Rallis, 2003, ch.7). As with most of my methods I engaged 
with the interview process using dialogic techniques, creating a conversation with my participant 
in which both of us developed a deeper understanding of the topic being discussed (Rossman and 
Rallis, 2003, ch.7; Way et al, 2015). What resulted was a “transform[ation of] information into 
shared experience” (Denzin, 2001, p. 24). An example of this can be seen in the following extract:  
 
 Ex Scottish Minister #2 I don’t like the term problematic drug user, because who 
defines what the problem is, I don’t like the paternalism that that it implies I suppose. But 
without question, again quite a common sensical way, you know you see people that, you 
know, just in a bad way… 
 Me: I like the term chaotic drug user, because that kind of describes a reaction which 
encompasses a wee bit more of the kind of people that we’re talking about, which is 
somebody who is unable to sustain you know that sort of normal lifestyle so to speak… 
 Ex Scottish Minister #2: yeah it’s interesting that you kind of put that in front of me, 
you’ve prompted me… I’ve never thought about it that way before but, again you’re right, 
I suppose [long pause] I’m much more concerned I suppose about where people aren’t able 
to manage their lives, than where they are. 
 
Many of the questions I planned to ask were addressed by the participant before I had a 
chance to ask them, and the natural rhythm of the interview brought out the themes and ideas that 
were beginning to emerge in my data as the process gathered pace.  
 
The Rhythm of the Interview: Monitoring the Quality 
 
One of the hardest aspects for me as an interviewer was monitoring the quality of the 
interview and making sure that I came out of the interview with in-depth data to take forward. 
Because I had developed a prior relationship with most participants they were aware of my 
opinions on the topic, and we had already established a rapport. As Way et al (2015) discuss, 
dialogue can be used as a transformative tool, not only eliciting knowledge from the participant, 
but also creating the conditions for the researcher and the participant to explore their similarities 
and differences in a respectful and thoughtful manner (Way et al, 2015; Barge 2002). This was 
evident in much of our interaction, with either myself or my participant mulling over points and 
reflecting on points. Cunliffe (2003) encourages this form of collaborative meaning making 
between researcher and participant because it allows us to ‘question the distinctions we make 
between what is fact or fiction, the nature of knowledge and ultimately our purpose and practice 






Yet, as Wagenaar points out “a research interview is not a conversation with a friend” 
(2015, 253), and there is a balance to be struck between creating the conditions for transformational 




I decided to transcribe my interviews verbatim in order collect all the data in the interview 
(Charmaz, 2006) and allow for surprise (Wagenaar, 2015, ch.9). One of the most surprising 
outcomes however was the insights I gained regarding my interviewing style, and the way in which 
we interacted with each other during the interview. I noticed that at the beginning of the interview 
I listened to the participant with very little interruption except for clarification points and to guide 
them back to the original question. However, as it got more in depth I found myself interrupting 
sometimes in order to put an idea across (a big no no according to Wagenaar, 2015, 257), or narrate 
a story which was pertinent to what they were discussing. While this may have helped to create 
the condition for transformational dialogue, there was a danger that I was steering the tone of the 
interview to suit my interpretation (Wagenaar, 2015, ch.9; Ritchie et al, 2015, ch.7). Interrupting 
the flow of the conversation can prevent the participants from reflecting further on the topic (Way 
et al, 2015). In my early interviews there were occasions where my participant came back to the 
topic stating, “as I was going to say…”  
 
However, using the iterative process I started transcribing immediately and was able to 
pick up on these issues to adjust my technique moving forward (Charmaz, 2006, ch.2, Schwartz-
Shea and Yanow, 2012, ch.2). 
 
During the transcription process I decided that while I would disclose who I interviewed 
and use full names and positions, at times I would anonymise the answers. I discovered during the 
transcription process that many of my interviewees had relaxed during the interview to such an 
extent they disclosed stories about themselves and others they may not have originally intended 
to. There were several ‘off the record’ comments, and indeed, when I informed participants that I 
planned to anonymize parts of the transcripts several were relieved, knowing they had disclosed 
more than they had intended to. In the end I have not used anecdotes or stories that I felt the 
participants would not have felt comfortable with. Ethically and morally this feels the right thing 
to do.  
 
Continuing the Communication 
 
Because my relationship with my respondents went beyond the interview space I was able 
to create ongoing communication with them, and to contact them for any clarification or 
elaboration on areas covered in the interview. Many of the respondents were also part of the SDPC, 





field notes from the SDPC sessions. Although I offered to send the completed transcripts for them 
to read over, no one wanted them, with one participant expressing relief that I had not sent it as he 
was afraid of reading his responses.  
 
However, one of the issues of using so called ‘elites’ - or rather those with very busy lives 
and willing to give you an hour of your time and no more - is that because the research question is 
open, I found there were questions I wished I had asked but I was unable to return for a second 
reading, so to speak. For example: one of my first interviewees is a well known ex-politician and 
professional, and when I conducted the interview I was still using the format of biographical 
interviewing in order to understand where participants came from, and asking about their 
experience of Scottish politics and drugs policy. However, my last interview highlighted the role 
this participant had played in the Royal Society of Arts report ‘Drugs: facing facts (2007), and I 
would have loved to have gone back and asked for a bit more detail on the reception of the report 
and how it worked with the release of The Road to Recovery. This is not possible anymore because 
the participant was appointed to a high level policing job, and was unwilling to discuss any further 
involvement.  
 
Participant Observation and Action Research – Blurring the Lines 
 
An important data collection source was the policy group I helped to set up called the 
Scottish Drug Policy Conversations (SDPC). The following section explores how I approached 
this source, and the difficulty I had in clarifying the type of collection method. 
 
Participant Observation  
 
Observation is a central method in qualitative research, initially used as an anthropological 
tool, but now incorporated into many disciplines including sociology (Ritchie et al, 2014, ch. 9). 
Observation as an ethnographic tool involves observing the group, community, organization, 
meeting, and taking detailed field notes with which to analyse (Ritchie et al, 2014). There are 
various continuums first outlined by Gold (1958) ranging from complete participation to complete 
observer; the extent to which the researcher participates will depend on the aims of the study, and 
the conditions available to them (Ritchie el al, 2014; Schwartz-Shea & Yanow, 2012; Cohen et al, 
2011).  
 
For example, in 2008 Alex Stevens conducted participant observation in a drug policy unit 
of the UK Government (Stevens, 2011). Initially he had been seconded to work as an adviser to 
the unit for 6 months, and he saw the opportunity this represented to study the way in which 
evidence influenced policy. Realising that knowledge of his research would impact his findings he 
applied, and was granted, ethical clearance to conduct covert observation (complete observation). 





daily basis were not. The result was a study which explored the competing narratives within the 
UK policy unit, and uncovered policy decisions which may not have been observable had the staff 
known he was conducting research. On the other end of the spectrum, Taylor et al (2004) 
conducted observation of injecting drug users in Scotland in order to better understand the route 
of transmission between injecting drug users. The researcher themselves however were not 
participants, they used video recordings of participants injecting drugs and analysed the recordings 
(Tayler et al, 2004). Observation therefore spans complete immersion in the field of study to 
external observation of the object of study. Use of observational data in this research ranged from 
complete immersion in the field to more passive participant observation of meetings, as explored 
below.  
 
The Case of the Scottish Drugs Policy Conversations (SDPC) 
 
In 2014 Scotland held a referendum on Scottish independence, which was not successful. 
However, the impact of the referendum inspired greater discussions on more powers for the 
Scottish Government, and in some drug policy communities the possibility of having more control 
over our own drugs policy. Myself and several other academics independently submitted proposals 
to the Smith Commission on devolution of the powers held under the Misuse of Drugs Act 1971. 
While nothing came of our submissions, myself and Mike McCarron (a long term public health 
and 3rd sector professional within the drugs field) developed the concept of the Scottish Drugs 
Policy Conversations, with a view to create a multi-civic led network to explore options for change 
in Scotland (see www.sdpc.org.uk). The development of SDPC is set out in the Appendix 2, 
including a breakdown of the different conversations held. More details of the conversation are 
explored in chapter 7.  
 
The first conversation took place on the 25th June 2015 at the Academy of Government, and 
we have since held 14 sessions, with 2 more to be held in 2020.  The initial meeting highlighted 
several important points that are recurring narratives within the drug policy debate.  
 
“Overall most people have been open and excited about the prospect of being involved in 
a movement that may change the way in which drug policy is debated and talked about. 
There has been much conversation about why we are here, concerns that we have over 
current policy, representation of stakeholders and other issues detailed below” (SDPC 
notes, 28th June 2019). 
 
Methodological and Ethical Challenges: My Role Within the SDPC 
 
When I chose the SDPC as an object of study I believed I would be engaging in participant 
observation: that I would be participating within the SDPC and using this position to observe and 





therefore my role within it had not yet been established. The complication arose as a result of my 
role within SDPC, and the move from behind the scenes convener and participant, to convener, 
facilitator, administrator and participant. Is it possible to call this participant observation when I 
am instrumental in creating the event, and setting the agenda for the meetings, in addition to 
steering the conversations within the space? Indeed I have not so much immersed myself in the 
community I am studying, I have created the community. It is possible that SDPC could have 
provided the opportunity to conduct action research. Although the development of the SDPC was 
spurred on by the commitment set out in my awarding of the Principle Career Development 
Scholarship, I did not foresee the SDPC becoming a space for action research because I lacked 
confidence in my ability as a facilitator and researcher, understandable given my limited 
experience in the field. As the research developed I began to understand my role within SDPC and 
the broader research process, reflecting a deepening understanding of the role reflection and 
deliberation play in creating meaningful spaces for dialogue and transformation. While there were 
intense life changes taking part outwith the PhD setting which added to my development, the 
process was initiated by an incident which took place on a course I attended. As part of the process 
of changing from activist to researcher and initiator of dialogue I went on a course on public 
engagement. It was a 2 day course designed to give you some skills in how to design and carry out 
different public engagement activities. As part of the group exercises, we took it in turns to 
facilitate and participate in an activity. It is perhaps most useful to read the reflections of this 
incident recorded at the time. 
 
Reflections on day one 
 
“This day mainly focused on dialogue and creating spaces for dialogue, active listening 
and group participation in facilitation methods.  
It was fascinating because I learned an immense amount about my lack of self-awareness 
when it comes to group interactions and dominating the conversation. Previously I had felt 
that I was good at being able to give space to those who wanted to talk but at the same time 
allow for those who are happy not to talk so much.  
In the facilitation group I became embroiled in a confrontational exchange with one of the 
participants who appeared, to me, to become fixated with this idea of getting everyone to 
input. Initially I was put on the back foot by him because he made a snarky comment about 
my style of facilitation which raised my hackles and made me lose confidence in my ability. 
He focused on the fact that not everyone was inputting, whereas my thoughts were that as 
long as the space was available, it was not appropriate to push everyone to contribute. 
If I had practiced dialogic techniques, I could have stepped back from his comment and 
looked underneath it. As it was, it meant that when he started pointing out that people were 
not getting a say, we entered into a kind of sparring of words. But I had no idea that this is 
what was being perceived by everyone else, and while I thought he was the protagonist it 





Anyway, in the debrief it came out and it really shook me to the core, not least because it is 
something that Willy talks about regarding my ability to communicate, how I am sometimes 
completely unable to practice self-awareness. Very interesting and makes me realise that I 
am not quite ready to become a facilitator.  
Another outcome was the self-sabotaging techniques I appear to use such as flippant jokes 
or self-depreciation which have served me well in many group contexts but now just come 
across as unprofessional. I am learning how to don different hats and this will take time.  
Need to develop the ability to ACTIVELY LISTEN” (Field notes from How to Design Public 
Engagement Conversations. 1st March 2016). 
 
The result of this interaction opened up an aspect of myself which previously had been 
covered. It touched not only the way in which I dealt with professional and educational 
interactions, but also my personal relationships. I began an ongoing journey into the impact that 
preconceptions and a lack of self-awareness can have on the way in which I engage with the world. 
How I perceive the world impacts how I facilitate and guide the collaborative process that is SDPC.  
 
SDPC provided me with a wealth of data, including access to interview participants that 
may not have been available to me otherwise. The data collected from the SDPC sessions included 
notes, in the form of written minutes of the meetings as well as personal reflections on the events 
and dialogues taking place, and photos and flipchart notes created by the participants during the 




As discussed in chapter 2, I use an element of auto-ethnographic writing as part of the 
research design and a method of data collection. While there has been criticism that this form of 
data is narcissistic or self-indulgent (Ettorre, 2017, 359), I used this tool as a way of inspiring 
empathy with the reader, and bringing to the fore subjugated knowledge (Foucault, 1964). Auto-
ethnography has gained traction in the last few years, partly in response to the ethical challenges 
of representing the voices of research participants,  the imbalance of power that can exist between 
the researcher and the researched (Ellits, Adams and Bochner, 2011; Lapadat (2017). Auto-
ethnography addresses these challenges by placing the researcher as a subject, and requiring 
analysis of that position as both researcher and subject (Coffey, 2002). Initially I planned to use 
auto-ethnography extensively throughout the thesis, however, in keeping with the iterative nature 
of the research design, in the end I used it sporadically throughout, and focused the main writing 
on one small chapter highlighting the hidden and silenced narrative of the ‘happy’ drug user. 
Therefore this writing, rather than being auto-ethnographic, is inspired by auto-ethnographic 






Other observational/research action data  
 
In addition to the data collected from SDPC I also observed other spaces which helped me 
build a picture of the narratives within the Scottish Government, and policy actors working within 
and outwith the government departments. 
 
1. Reducing Harm and Drug Related Deaths Committee 
I attended one meeting of this committee as a researcher at the beginning of the data 
collection, however, as a result of the networks I generated while carrying out my research 
I became the ‘lived and living experience’ representative on this group. This presented a 
slight ethical challenge, and in order to circumvent this I chose to report only on the auto-
ethnographic element of this experience, as opposed to some direct quotes I have used from 
the initial meeting. 
 
2. PADS Executive Reference Group - Lived and Living Experience Group 
This was an advisory reference group, put together by the PADS executive committee to 
engage with people who have lived experience of drug users. It was an attempt to include 
non-traditional voices in the policy process and will be explored in more detail in my 
narratives section. I was invited onto this executive reference group as a result of my 
activities within SDPC, and my vocal support of reducing the stigma towards active drug 
users.  
 
3. Scottish Government Substance Misuse Unit 
I held several meetings with the manager of the Substance Misuse Unit on a one to one 
basis, and with other civil servants. While the discussions of the meetings have been held 
in confidence, I have used the themes and views resulting from them in my exploration of 
the narratives in Scottish drug policy communities.  
 
4. Medicinal Cannabis Reform Scotland (MCRS)  
MCRS are a patient led campaign group trying to be involved in discussion around 
cannabis for medical use in Scotland. I became involved as a peer stakeholder 
negotiator/mediator early on in the research, and this involvement became part of research. 
I set up meetings with civil servants, put on events, wrote letters and advised on 
communication.  
 
Below is a table adapted from Dvora Yanow’s little blue book on ‘Conducting Interpretive 
Policy Analysis’ (2015, p.39) that details the different sources and kinds of data I collected “to 






Methods of Accessing 
Data 
Sources of Data Types of Data Yielded 
Participation  Institutional meetings 
Community groups 

















Document analysis Scottish Government reports 
Institutional reports 
Notes on meetings – both 
institutional and community based 









Amount of time spent on each data collected 
Data Time 
12 interviews 11.5 hours of recording – 290 pages of transcript  
12 SDPC sessions 36 hrs of participant observation 
LLEEG events 3 events – 15 hours of participant observation – 5 hours of 
writing and dissemination of events 
MCRS meetings 40+ hours of meetings, phone calls, emails and writing 
Information 
meetings/conversations 
Approximately 10 hours 
Total hours Approximatively 1275 hours  










Data Analysis  
 
“Different data collection methods yield different information and they have to be 
interpreted differently. (Reissman 1993: 55). 
 
My data analysis followed two distinct processes: grounded theory analysis, which led to 
the theoretical development, and narrative analysis. I conducted grounded theory analysis on my 
interview transcripts, which, combined with themes arising from my observation and document 
analysis led to the emergence of master narratives and the development of a critical drug theory. 
From this theoretical framework I chose one pillar – story-telling - and conducted narrative 


















In this section I shall set out how each of these processes came together in a flow 
consistent with an interpretive emergent and iterative research process 
 
Using Grounded Theory Analysis  
 
Grounded theory was first articulated in the ground-breaking book “The Discovery of 
Grounded Theory” (Glaser and Strauss, 1967). Previously there had not been a systematic and 
methodological approach to designing interpretive research studies (Wagenaar, 2015, ch.9). The 
emergence of grounded theory provided “[s]systematic inductive guidelines for collecting and 
analyzing data to build middle-ground theoretical frameworks that explain collected data”. 
(Charmaz, 2000, 509). While purists of grounded theory call for researchers to approach the data 
with an empty mind (Glaser and Strauss, 1967) more recent developments recognise the 





importance of creating a dialogue between the researchers prior knowledge and the data (Charmaz, 
2006; Wagenaar, 2015). As explored in chapter 2, understanding is not something which starts 
when we engage with our data, it includes a combination of the personal journeys we have been 
on and our specific academic and professional training. The challenge when conducting grounded 
theory is how to incorporate that knowledge while allowing for surprises to emerge from that data. 
This is where the initial steps in grounded theory analysis are important. 
 
From the moment I entered into research mode I searched for common themes, picked up 
signals and undertones (and overtones), while at the same time being involved in the development 
of some of the narratives I studied. In keeping with a grounded approach there was a fluidity 
between the themes that I led, and themes that emerged from the data. This is known as pre-
systemic coding (Charmaz, 2006, ch.3; Wagenaar, 2015, ch.9). Pre-systematic coding is an 
interesting time, the process of absorbing, recording, mentally filing and sorting. As I progressed 
through the observation, document analysis and initial interviews, I began to see themes emerge 
from the data which I noted and created memos from (Charmaz, 2006, ch.4).  
 
The next stage in grounded theory analysis is close coding (Charmaz, 2006, ch.3; 
Wagenaar, 2015, ch.9) and I started by going through initial interviews transcripts. Other data I 
collected included field notes, reflections, and documents, which I analysed once I had established 
themes and ideas generated by the close coding of the interview data. These, combined with the 
notes and ideas I had gathered from pre-coding began to illuminate overarching themes, which led 
to two developments: the emergence of master and counter narratives, and the development of a 
critical drug theory (CDT).  
 
I found the process of close coding difficult to begin with for two reasons. Firstly, I was 
hesitant about taking small chunks of data out of context and imposing my own interpretation on 
it. Secondly, as a result of pre-coding I had an idea of themes that were emerging from the data 
and I found it difficult to code without these themes directing my analysis. However,  
 
“although grounded theory analysis is part of a larger, flexible, emergent, 
“improvisational” (Cerwonka & Malkki, 2007) process of inquiry and interpretation, in 
which research design, sampling, data collection and data analysis weave in and out of one 
another, qualitative data analysis represents the moment we test our insights against the 
world” (Wagernaar, 2015, 259). 
 
With this in mind I overcame my hesitation by keeping the codes closer to the text 






“people talk about a chaotic lifestyle, I try to avoid…although I hear people talking about 
it I try to keep away from that because it is so close to talking about peoples lifestyle choice, 
and that’s what people think we are dealing with.” (Senior Policy Officer). 
 
I coded this as “chaotic life is too close to calling it a lifestyle choice”. This was further 
coded to represent “stigma towards drug users” and falls within the “recovery master narrative”. 
This is an active code which highlights how language can impact the way ‘problematic drug users’ 
are viewed: they choose to become problematic and therefore do not deserve social help in 
overcoming that ‘problem’. Recovery is a way of redeeming yourself from this chaotic lifestyle 
choice and showing that you are a valuable member of society, and therefore deserving of help. 
 
By coding line by line, and in some cases incident by incident, I was able to stick close to 
the data and build from the bottom up, as opposed the top down (Charmaz, 2006, ch.3). While I 
was close coding I kept memos of themes and ideas that emerged from the codes. 
The Emergence of Critical Drug Theory  
 
One of the main outputs of grounded theory is theoretical development (Glaser & Strauss, 
1967; Charmaz, 2006; Wagenaar, 2015), yet there is a danger, highlighted by Wagenaar (2015), 
of hiding behind grand theories in order to prevent the messy work of getting to know your data. 
Initially I was hesitant about the development of CDT as I was unsure whether I had conducted 
enough analysis on my transcripts, until I realised that I had been conducting grounded theory 
from the start: my initial hunches, notes, memos, ideas and close coding were all legitimate steps 
in the theoretical development. I shall expand in detail on the development of CDT in chapter 8 
but in brief it developed from a combination of interview data, field notes, observation, prior 
knowledge, and the term being presented to me as encapsulating what I was exploring.  Diagram 







Diagram 4. Analytical Process. Design by Anna Ross  
 
Conducting Narrative Analysis  
 
Using narrative analysis in public policy can be overwhelming as there is such a variety of 
approaches to pick from. Mishler in his book, Models of Narrative Analysis, states that narrative 
is not really a distinct discipline but “a problem-centred area of inquiry” (1995 - quoted in 
Wagenaar, 2015, 216). This is why I initially struggled quite profoundly with trying to understand 
what approach I was using, and what approach fitted the research. In the end I realised that by 
approaching the whole project from a dialogical and interpretive mindset, I was able to use 
different narrative-based tools to analyse aspects of my data and present the narratives in multiple 
forms. 
 
   






Narrative inquiry takes many forms, and for the purposes of my research I use it to 
scrutinise my interview transcripts and the broader reading material to determine (i) the personal 
narratives that stem from the individual, and (ii) the broader symbolic or master narratives that 
appear throughout the interviews, observation, documents and media. It is not about identifying 
an objective truth, but about understanding the meaning and experience of those involved.  
 
My overarching analytical approach was the ‘What’s the Problem Represented to Be?’ 
approach (WPR Approach) (Bacchi, 2009). By subjecting my data to each of the questions in the 
process set out by Bacchi, I teased out the individual and overarching narratives in my data. I also 
incorporated dialogical narrative analysis (DNA) into the process to take into account the dialogic 
nature of the research. For my chapter on historical legacies I used a form of practical storytelling 
(Forester, 1993; Wagenaar, 2015), in addition to DNA, to create a deeper understanding of the 
impact historical events have had on current drug policy narratives. In this section I set out why 
and how I used the different analytical strategies.  
 
As stated, my analysis was not straightforward, and I subjected parts of my data to different 
analytical techniques before settling on a process. Having subjected my initial data to grounded 
theory analysis, and begun the process of developing CDT, which gave me a theoretical framework 
with which to identify my stories and narratives, I then applied two different analysis strategies; 
narrative and WPR.  
 
Doing Dialogical Narrative Analysis 
 
“Dialogical narrative analysis (DNA) understands stories as artful representations of lives; 
stories reshape the past and imaginatively project the future. Stories revise people's sense 
of self, and they situate people in groups” (Frank, 2015, p.2) 
 
The use of dialogical narrative analysis (DNA) is to explore what specific stories say about 
the storyteller, and whether these stories can be merged to find common and/or competing stories. 
Importantly it is an analysis tool that seeks to find the common stories told by multiple voices. It 
takes inspiration from Goffmans ‘presentation of the self’ (Frank, 2015) in the commitment that 
people tell stories about themselves and others that present a character, or ideal that they conform 
to.  
However, there is a tension within DNA between dialogue and analysis. As Bakhtin (1984) 
writes: “the author speaks not about a character, but with him” (63, original emphasis). Bakhtin 
argues that “the truth about a man in the mouths of others, not directed to him dialogically and 
therefore a secondhand truth, becomes a lie degrading and demeaning to him” (59). This is exactly 
how I felt about the stories that my participants told me – we were in dialogue, and it initially felt 
degrading to subject the dialogue to analysis in which I decide what is actually being said. 





shine through, but this is part of who my participant is, and all I can do is reflect on that and 
comment – as opposed to breaking the sentences up and creating meaning where there may have 
been none originally. This was a major hurdle for me to overcome, and in some ways I never have. 
I present the narratives and stories as truthfully as I can, but in the knowledge that it is my 
interpretation that guides the final presentation.  
 
Dialogue is about conversations between multiple voices, and not just the two or more 
voices in the conversations – it is about seeing that stories evolve and are co-created (Frank, 2015, 
3). Bakhtin described this process using two conceptual terms: “polyphony” – when individual 
stories merge together but are separate and aspects of their voices/stories form the plot, genre and 
overarching narrative; and “heteroglossia” – the overarching codes or narratives garnered from 
the many different sources (official documents, emotional expressions, common stories etc) which 
can be applied to guide the plot or genre. This research utilises both conceptual terms: by merging 
individual stories to find the overarching codes and narratives.  
 
The biggest claim to authenticity and professional expertise is that the research has heard 
multiple stories and is therefore able to make the connections and overarching narratives which 
may allude individual stories. However, Frank in his research for The Wounded Storyteller, 
listened to his participants in order to bear witness to their stories. This was not to uncover some 
truth that the storyteller was unable to ascertain for themselves but: “to witness, in the simplest 
sense of gathering voices to give them a more evocative force so that these storytellers could hear 
each other, and so that they could be heard collectively” (Frank, 2015, 4). 
 
This was also my intention. The puzzle which I had identified at the start of this research 
was “why is it that despite the calls from so many around the world, and nationally, those who 
were perceived to be responsible (the policy actors) were still unable or unwilling to pursue more 
radical, but evidence based, reforms?”. I wanted to discover what collective goals and ideals those 
at this level had. As I collected the interviews and observations I began to realise that not only was 
it the marginalised voices of drug consumers that were being ignored, it was also the voices of 
those responsible for policy formation. I therefore sought to witness and collate the stories my 
participants told me so that I could record their anger, pain, joy and frustration, to ultimately create 
an idea of what is common amongst them, and what is different, or distinct.  
 
“Stories need humans in order to be told, and humans need stories in order to represent 
experiences that remain inchoate until they can be given narrative form” (Frank 2010, 5). 
 
Another important element of DNA is there is no ending, no finale to the story (Frank, 
2015). All stories evolve and move, and this is an important tension in DNA – that everything 
changes and there is no ‘end’. Yet in a research report or thesis there needs to be a conclusion of 





constant throughout the research, for example the number of participants, the plot line, the genre 
etc. This allows conclusions to be drawn, yet the story goes on. It can also be dealt with by making 
it explicit that narrative analysis does not have a summary of findings – the dialogic world looks 
at exploring the narratives within the research in order to highlight the common or competing 
aspects of the story, rather than seeking claims of validity or generalisability: “DNA rarely, if ever, 
prescribes responses. It seeks to show what is at stake in a story as a form of response” (Frank, 
2015, 6) 
 
DNA sets the overall tone on how I approached the analytical process, but it is WPR 
analysis that provided the more advanced analytical tools that was needed for in-depth exploration.  
 
Selecting Stories for Analysis  
 
I set out critical drug theory (CDT) in the following chapter, but I used the principles of 
CDT and DNA to select stories based on my phronesis “the practical wisdom gained through 
analytic experience” (Frank, 2015, 11). When collecting data there will be stories which stand out 
and have multiple voices saying the same, or similar things, and the practiced wisdom of the 
researcher will enable these patterns to be identified. For example, during my interview process I 
began to see a pattern emerging, a story that needed to be told about the history of Scottish drug 
policy, and particular events throughout that period seemed to chime with many of my 
respondents. Phronesis also involves making these decisions based on value judgments and this 
relies on ethical grounding. Developing an ethical grounding required me to delve into the meaning 
of my research, as explored in chapter 1. It also involves the hermeneutic spiral - the constant re-
evaluation of the story in light of new understandings. Therefore, narrative analysis is not about 
trying to present something that is the final outcome, it is about creating or crafting a story from 
the narratives that speak to you, and this will be dependent on each individual, and the original 
research questions. I therefore selected data (stories and narratives) that:  
 
1. Answered one or more of the WPR questions, and;  
2. Highlighted the master or counter narratives of drug policy in light of the themes 
generated by my grounded analysis and CDT, and; 
3. Bore witness to the dialogue taking place between both the researcher and the 
participant, and the broader community.  
 
Opening Up for Analysis – Bacchi’s Problematisation Approach  
 
“the primary resources for telling a new story are the stories that are already circulating in 
the setting; again, recognizable character types, plot lines, genre choices and tropes” 





In my research, the character of the ‘problem drug user’ is a constant, so is the intractable 
minister, or the caring practitioner. There are also plot lines that pop up repeatedly, making it 
possible to identify common themes and narratives. Initially I found the process of opening up the 
stories to deeper analysis, particularly my interview data, extremely difficult for the reasons 
outlined above. However, during the initial data collection process and coding I began to see the 
emergence of themes that would fit into the analytical framework outlined in Carol Bacchi’s 
‘What’s the Problem Represented to be’ (WPR) (2009). I saw that by following her framework for 
analysing policy it was likely I would be able to build a case for a critical drug theory using tenets 
articulated in critical race theory (Delgado & Stafancic, 2012; Solorzano & Yosso, 2001). See 
diagram 5 below for a visual aid in how this framework was developed. Furthermore, as I started 
to write up the narratives I began to see how the questions set out by Bacchi could help structure 
the analysis in order to get beneath the narratives I had identified during the DNA process.  
 
The WPR approach has been used to interrogate policy ‘problems’ by a range of 
researchers. For example Lancaster, Duke and Ritter (2015) use it to analyse the recovery discourse 
in Australia, Moore and Fraser (2013) use it to explore the production of the ‘problem’ of addiction 
in treatment services, and Lancaster and Ritter (2017) use it to examine the construction and 
representation of drugs in Australia (also c.f. Farrugia, Seear, & Fraser, 2017; Farrugia, 2016; 
Fraser & Moore, 2011; Lancaster, Seear, & Treloar, 2015; Lancaster, Seear, Treloar & Ritter, 
2017; Lancaster, Treloar, & Ritter, 2017; Ma°nsson & Ekendahl, 2015; Manton & Moore, 2016; 
Seear & Fraser, 2014). 
   
The approach itself is simple: using 6 questions the analyst works through the framework 
with aim of exploring what lies behind the ‘problem’ articulated by the policy. This is highly 
relevant to drug policy, particularly in Scotland where the explicit aim is to reduce the harm 
resulting from problem drug use (Scottish Government, 2015). By using these questions as a guide 
for the (i) coding and analysing the data, and (ii) structuring the thesis chapters, I was able to 
explore the underlying narratives within the communities I have studied, and construct the 








Diagram 5 – The Development of CDT. Design by Anna Ross  
 
The questions, taken from Bacchi (2009) are:  
 
1. What’s the problem represented to be?  
2. What are the presuppositions and assumptions underlying that representation?  
3. How has that representation come about?  
4. What is left unproblematic in this representation? Where are the silences?  
5. What effects (discursive and lived) are produced by this representation?  
6. How can the representation be produced, disseminated and defended, and how can this be 
challenged?  
 
There is a final 7th question which challenges the researcher to apply the WPR approach to 
their own problem representation (Bacchi & Goodwin, 2016). In particular, researchers are 
encouraged to examine their own way of thinking and undertake to “engage in self-
problematization, seeking out possible forms of domination in their own proposals and 
problemitzations.” (40). I shall address these issues in the conclusion where I explore my role in 






The following chapters answer the 6 WPR questions in relation to drug policy in 
Scotland, and the representation of drug use and drug users. Below is a breakdown of which 
questions cover which chapters. 
 
Historical Legacies – Chapters 4 to 6 
 
WPR #1. What’s the problem represented to be?  
WPR #2. What presuppositions underlie this representation?  
WPR #3. How has this representation come about?  
WPR #4. What is left unproblematic, where are the silences? 
 
This historical section explores the development of 'problem drug use’ narratives in 
Scotland in 3 short chapters. It will show that historically policy has focussed on a certain 
demographic as a result of the increase in heroin use leading to the HIV crisis in the mid 1980s, 
and subsequent crisis points since. In doing so it highlights the silences within drug policy, namely 
the use of drugs for pleasure, medicine or therapeutic and spiritual value. 
 
Participation in Drug Policy – Chapter 7 
 
WPR #2. What presuppositions underlie this representation? 
WPR #4. What is left unproblematic, where are the silences? 
WPR #5. What effects - discursive etc are produced by this focus on ‘problem drug use?’  
 
The presupposition that underlies the representation is that drug use is harmful - therefore 
participation in policy is of stakeholders who have experienced this ‘harm’ and are seeking to 
reduce/eliminate it. This chapter will explore what is left unproblematic by showing that the focus 
on 'problem' drug use has resulted in a focus on certain kinds of drug consumption, and a policy 
agenda the match that - recovery. As a result, participation in policy is restricted to certain channels 
where the government feel they can be most effective- ‘problem drug use’ and users.  
 
Developing a Critical Drug Theory - Chapters 8 and 9 
 
WPR #6. How can the representation of the problem be disrupted/questioned/challenged/ 
replaced? 
 
This contributions section consists of 2 chapters setting out the development of critical 
drug theory (CDT), showing how this can help to disrupt and question the representation of the 





and creating master, counter and meta narratives that highlight the different, and at times 




In summary, much like the research design, the methodological process has been iterative 
and non-linear (abductive). I have used multiple methods for both data collection and data analysis, 
and as such have a broad understanding of the different ways in which social research is conducted. 
I have wondered whether this makes me a ‘jack of all trades and a master of none’, however the 
PhD is a place for learning the craft of research, and I feel it is my duty to be honest about the 
messy, difficult and at times confusing process this is. 
 
 The following chapters explore the field using both the WPR questions outlined above and 
the core research questions set out in chapter 2, namely:  
 
• What are the master and counter narratives within Scottish drug policy communities? 
• What are the challenges in engaging different epistemic communities in a participatory 
policy process? 


























The Development of Narratives in Scottish Drug Policy 
 
This part of the thesis explores the development of 'problem' drug use narratives in Scotland 
by exploring the data using four WPR questions:  
 
WPR #1. What’s the problem represented to be?  
WPR #2. What presuppositions underlie this representation? 
WPR #3. How has this representation come about? 
WPR #4. What is left unproblematic, where are the silences? 
 
In doing so it will show that historically, policy has focused on a certain demographics as a 
result of the increase in heroin use leading to the HIV health emergency and subsequent crisis 
points. By exploring the history – the timeline of events – this section develops the understanding 
of the cultural and historical aspects that shaped the representation of the problem. Bacchi calls 
this an exercise in “Foucauldian Archaeology” (Bacchi, 2009, 5), and it is important in 
understanding the problematisation of a policy, and how the master narratives have been developed 
and sustained.  
 
 There are three time periods which arose from the data, in particular the interview data, as 
being important in distinguishing Scottish policy from UK policy, and helped to shape the drug 
policy framework we see today. This part of the thesis will take the reader through these time 
periods using the stories provided by my participants and supported by existing literature and 
documents. The bulk of the data is taken from four interview participants who were heavily 
involved in the drug policy community throughout the time periods. I have chosen their voices 
because they articulate the multiple stories and narratives I came across during my data collection, 
and are representative of the wider narratives present in the analysis of What’s The Problem Is 
Represented To Be, what underlies it, and how it came about.  
 
One note of caution, while I engage in analysis using the WPR approach, I do not subject my 
participants narratives to in-depth critique in this chapter for two reasons. Firstly, I am exploring 
this history through the lens of individual experience to help paint a deeper picture of the impact 
historical legacies have had on current policies and communities. Secondly, much of what my 
participants discuss is not disputed - there was a heroin epidemic and the McClelland Report made 
recommendations and the Scottish Advisory Council on the Misuse of Drugs was set up. It is the 
experience of those involved that I am interested in, and I take inspiration from writers such as 
Margaret Kovach who, in her PhD thesis and following book (Kovach, 2009), uses her interviews 





of creating ‘windows’ into the world I am exploring (Forester, website), moments in time that we 
can look at to better understand the world we are exploring. To this end I aim to develop a 
genealogy of Scottish drug policy that uses both primary and secondary data to tease out important 
historical representations of the drug ‘problem’ in Scotland. Critique of this representation will be 
developed in chapter 9, where I will tell stories based on the narratives discussed here, and provide 
more critical discussion on the issues arising from the narratives.7  
 
This section is divided into three chapters with an introductory section. The introductory 
section will set out what the problem is represented to be in 2019, using government and other 
institutional documents that highlight how the ‘drug problem’ is represented, and answers WPR 
#1. The following three chapters will look at how this problem has come about, what 
presuppositions underlie it, and where the silences are (WPR #2, #3 & #4). I have chosen to start 
from this date for several reasons. Firstly, the time periods emerged from my data as significant in 
the development of Scottish drug policy. Until the late 1970’s there was little in the way of official 
drug strategies specific to Scotland, or indeed the UK (ACMD, 1982; Dorn and South, 1987; the 
Senior Drug Advisor interview participant; Kidd, 2013). The 1971 Act had only recently been 
implemented, and the ‘drug problem’ was confined to a relatively small number of heroin users 
and cannabis smokers (Pearson, 1987; Dorn and South, 1987). Secondly, all my participants whose 
interview transcripts I have used became involved in the drugs field around the late 1970’s and 
early 1980’s. Therefore any genealogy using interview data can only start at the point the interview 
participants enter the scene. Finally, taking this into account it appears appropriate that the 
historical exploration begins at the time drug policy was beginning to become a ‘policy problem’ 
in both the UK and Scotland, according to both the primary and secondary data.  
 
The Representation of the Problem 
 
 In December 2018, the Scottish Government’s Substance Misuse Unit published their 
updated drug and alcohol strategy entitled ‘Rights, Respect and Recovery’. This strategy built on 
the cross-party drug strategy published 10 years earlier entitled ‘The Road to Recovery (2008)’. 
The 2008 document represented the problem in the following way:  
 
“Scotland has a long-standing and serious drug problem. An estimated 52,000 people are 
problem drug users; 40-60,000 children are affected by the drug problem of one or more 
parent; and there were 421 drug-related deaths in 2006. This has a significant impact on 
individuals, families and society – with an estimated economic and social cost of £2.6bn 
per annum” (Road to Recovery, 2008, Executive Summary). 
 
                                                          
7 For a less narrative heavy account of Scottish drug policy during these time periods see Brian Kidd’s Thesis ‘Long 
term outcomes of methadone substitution therapy (OST-M) for opiate dependency’ (2013) which explores this topic 





 It is clear from the 2008 strategy that the focus is very much on a particular construction 
of ‘problem’ drug use. But what is problem drug use? According to the Road to Recovery problem 
drug users are a “category of people who will be experiencing or causing social, psychological, 
physical, medical or legal problems because of their drug use. They are likely to be in touch with 
drug treatment services, although many will not” (Scottish Government, 2008, 12). Furthermore, 
they are likely to be users of opiates and benzodiazepines as opposed to other non-opiate based 
drugs such as 3,4-Methylenedioxymethamphetamine (MDMA), amphetamine and psychedelics 
(Ibid, 1).  
 
 Following on from the 2008 strategy, the 2018 strategy takes the concept of ‘problem drug 
users’, and focuses on the underlying reasons why people may experience such problems:  
 
“There is a growing awareness that those experiencing problematic alcohol and drug use 
are often carrying other burdens such as poverty, inequality and health challenges. This 
means they need to be supported rather than be stigmatised. Treatment services and 
organisations in Scotland are already jointly tackling the harms caused by alcohol and 
drugs and this new strategy reflects that” (Scottish Government, 2018, Rights, Respect and 
Recovery, Executive Summary). 
 
 The institutional representation of the ‘problem’ therefore is for a section of the population 
who use drugs in such a way that it creates social, financial, physical and mental issues for them, 
and society, and that these people often have additional issues stemming from social determinants 
such as poverty, inequality and poor health. So how did this representation come about, and what 







The Heroin Years 
 
 Although distinct from the rest of the UK in many areas such as property law and most criminal 
law, in the 1980s Scotland did not have a devolved government and therefore responses to drug policy 
were set at a UK level, and Scottish specific responses were carried out by the Scottish Office. 
However, in the early 1980s Scotland started to witness a change in drug using habits, leading to an 
increase in heroin use, which in turn led to an increase in blood born viruses such as hepatitis B, C and 
HIV (McKeganey, et al, 2008; RSA, 2008; Scottish Affairs Committee, 1994; Scottish Affairs 
Committee, 2019; Pearson, 1987). This led to a response by Scottish practitioners which broke from 
the UK response, namely harm reduction measures such as needle exchanges and opioid replacement 
therapies (Scottish Home & Health Department, 1986, Stimson, 1987; MacGregor, 2017). The 
following stories explore the changing nature of drug use, and how people, and institutions in Scotland 
responded to this crisis.  
 
 We start off in the early 1980s with Interviewee #6. At the time, this interviewee was a member 
of the Strathclyde Police Drug Squad and witnessed the change from alcohol to heroin use among 
certain communities during this time: 
 
 “…I remember working on some secondment with the drugs squad in the mid-80s, and 
the concentration of heroin use was in Otago Street in the West End of Glasgow. Where 
there used to be flats and they were in rows above each other, that’s where the heroin issue 
was. And your heroin user was your long-haired hippie type, and Neil out of the Young 
Ones8 you know, ‘here come the pigs’, you know the profile of a heroin user that is quite 
different. But then we started seeing people who are well known criminals now dipping 
their toe into the water and stolen cars became serious jail time so they went into drug 
dealing, and then we started seeing the emergence of heroin in the schemes (social housing) 
because people were selling it and making money” (Retired Police Officer).  
 
 What we see here is the experience of a cultural shift in drug taking from one of low level 
‘bohemian’ use to more large scale commercial use. From this extract it appears that the car industry, 
by improving the anti-theft devices on cars, diverted the criminal activity away from car thefts towards 
a more profitable criminal venture in the drugs trade. So, what happened that made heroin such a 
profitable venture? It is evident that the changing nature of crime and responses to crime were in part 
responsible for the increase in drug dealing, yet in order for the drug dealing to be profitable there 
needs to be a market, and something happened in the early to mid-1980s that created the conditions 
for large scale drug use.  
                                                          






The following extract is from interviewee #5, Scottish Justice Minister from 2009-2014, and a criminal 
defence lawyer during the early 1980s: 
 
 “Well I think it was mass unemployment. Mass unemployment, hopelessness, kids were 
hanging around, there was no jobs you know. I mean okay you could say a lot of the ones 
maybe taking drugs were working because they had money, but it was the unemployment 
in the main. It just… it collapsed a whole society… the decent respectable working class 
just imploded you know, dad was depressed, dad was on the drink you know, and it was 
hopelessness, there was no future, you weren’t gonnae get a job, so who cares! I suppose 
it’s that replication, I mean I always remember when I was Justice Secretary that drugs 
offences in Shetland were perceived as different because they’re actually working people.  
And it was the fishing. I mean it was ‘don’t tell me it will kill me because I’m out there and 
I could get swept away’, and actually the heroin problem in Shetland wasn’t coming from 
marginalized housing schemes, it was coming from people who were actually doing 
remarkably well, making money, I mean the trawlers (fishermen). But that was a culture 
there. Other than that, in central Scotland it was poverty and despair. This is the whole 
implosion of society! Your society in the housing schemes just began to disintegrate. You 
know the old men who would have been in charge were denigrated because they were 
shuffling round unemployed, so everything just tumbled down into that. Then of course 
where there’s a market criminal gangs came in and that’s why the Arthur Thompson's 
(notorious Scottish crime boss), who initially disdained drugs and would have nothing to 
do with it, all of a sudden moved in. So for lawyers all of a sudden boof…off it took” 
(Scottish Minister #1). 
 
This experience, and opinion on what was causing the shift towards greater drug use, and in 
particular dependent heroin use, is supported by a large body of research that links neo-liberal 
economic policies of the 1980s to long term poverty and high mortality rates in Scotland (MacGregor, 
2017; Galea et al, 2005; McCartney et al, 2012; Scott-Samuel et al, 2014; Collins et al, 2011; Dorn 
and South, 1987; Minton et al, 2017; Scottish Affairs Committee, 2019; Parkinson et al 2016). In 
particular, recent research has shown that the impact of these policies on vulnerable men such as those 
transitioning from teenage to adulthood, and those who are unemployed or from deprived 
environments, has resulted in a steady increase in drug related deaths (Parkinson et al, 2017; Minton 
et al, 2017). This research built on previous papers exploring Scotland's excessive mortality rates 
compared to the rest of the UK and Western Europe (Parkinson et al, 2016; McCartney et al, 2011) 
and was hailed by many in the field as confirmation of the impact Conservative policies have had on 
the most vulnerable populations. While the policies of de-industrialization impacted the whole of the 
UK, Scotland was disproportionately affected as a result of having a large industry-based economy. 





resulted in mass job losses, and there were no new jobs created. This led to a sense of hopelessness 
and despair amongst the affected communities. 
 
In 2019, while writing my thesis, I worked as a Special Adviser to the Scottish Affairs Select 
Committee for their inquiry into ‘problem drug use in Scotland’. In this role I helped steer the tone of 
the committee inquiry, selected witnesses for evidence, and helped write the report. Many of the topics 
covered in this thesis were evidenced in the report, although I have not included much as it took place 
after the data collection period. However, in relation to the impact of de-industrialisation on Scottish 
communities, one of our witnesses had this to say:  
 
“The area that I was living in was being pulled down. It was an area of urban deprivation. 
There was high unemployment and crime. It seemed that nobody was working. Bear in mind 
that I grew up during the miners’ strike, you know. It was probably a sense of hopelessness 
throughout the area. There was no investment in the area. There was no community centre 
as such. For me looking back, it was a sense of no hope and no sense of purpose […] Just 
that: feeling heartbreak, feeling “what’s the point?” and I coped with that by using 
substances” (witness, Scottish Affairs Select Committee, 2019, p.11). 
 
The following interview participant, a support worker working in a deprived area of Glasgow 
at the time, recalls:  
 
“My own personal simple view would be is in terms of the market. The market had reached 
Glasgow from the South, whatever way, and probably it could be a mixture of the 
experience young people had of alcohol problems, you know maybe made them look 
elsewhere, and then the particular, you know, combined with the view it was subversive, it 
was part of the criminal infrastructure, you know. And I think under Thatcher there was a 
growing dissent and division in the country and em…I think people found it helped kill pain, 
kill worry, that’s probably a lot to do with it, and it was also a cultural thing that people 
shared (Longstanding Government Advisor). 
 
 However, while there is no doubt these policies had an impact, as demonstrated by research 
and my own participants’ experience, the link to current drug related deaths may suit the narrative 
promoted by the Scottish Government. This narrative is that the rise in drug related deaths is a result 
of an aging cohort who became addicted to heroin during the 1980s stemming from UK Conservative 
policies at the time. It is this presupposition that underlies much of the Scottish government responses 
to drug use, and shapes the narrative of how Scotland developed such a large drug problem. Focusing 
on policies from the past diverts attention away from the impact current polices, both from the UK and 
Scottish Government, are having on ‘problematic drug users’ such as reduction in drug treatment 
budgets and failure to implement evidenced harm reduction measures (McAuley et al, 2017). 





the 1980s was predominantly a result of the economic policies, by governments and companies alike 
(c.f. MacGregor, 2017). This changing culture is explored below by a participant who experienced it. 
Here he talks about his experience of purchasing drugs during this changing culture: 
 
Senior Policy Officer: “[A]nd sociologically this as an interesting time, I mean it would 
have been 1982/3/4, or 3/4/5 maybe. So, in the West End of Glasgow in those days the sort 
of middle class drug users, we used to buy cannabis from old bikers, hippies, guys what 
were around the university, or that sort of milieu, they wouldn’t have been matriculated 
students necessarily, but they were around that scene. And, one summer, I would say it was 
the summer of 82/83, in the pubs in the West End of Glasgow, all of a sudden these working 
class guys started selling drugs, and cannabis and amphetamines. And they sold it in a 
completely different way, so they were much more reliable right, you didn’t have to hang 
about waiting for a man kind of thing, hanging about waiting for some older greasy biker, 
muck you about in a kind of patronizing way. It was much more open, I mean this guy was 
about the same age as you, slighter older, he was heavy to hang about with, in fact you 
didn’t hang about with him, you went in, you were a customer, and you walked back out. 
And it was much more open dealing, so I can remember going into a pub and there was a 
guy sitting there with lots of cannabis sitting there on a table, or the bar, he was just dealing 
like he’s opened a shop. And whether that was including the management, or the 
management had been…were scared to do anything about it I dunno, but it was a lot more 
open dealing. 
 Interviewer: Would you link that to de-industrialization and lack of opportunity? The 
beginning the of the drug economy? 
 Senior Policy Officer: And it was that. Some of those guys who were um, culturally they 
looked like football casuals, you know, guys in their late teens, they had a sort of way of 
dressing which was meant to be kind of sharp if you like, and they were kind of in their own 
way kind of clean cut guys, but they had a heaviness about them, and some of those guys 
developed serious substance use problems, some of them will have moved on in life, and I 
suspect some of them, the guys I knew at that time, will be Mr Big from some notorious 
family in a scheme in Glasgow. But that was the very beginning of that and you saw that 
supply chain change entirely and become much more organized, and people had pitches 
and all that, which you know…people will have had them in the past, but it was a very 
different world, and I’m not so sure that we’ve done anything to fully catch up with what’s 
going on there at all.  
 
 Although the interviewee does not directly answer my question on whether the increase and 
change in drug use can be linked to de-industrialisation, he tells us an important story about the 
professionalization of drug dealing, and ergo its’ potential to capitalise on the increase in demand. 
Sociologically this time period is indeed very interesting as we witness a shift from the early concepts 





or hippies, to more ubiquitous, commercially driven drug use and dealing. Interestingly, the fact that 
this new breed of drug dealer stems from the working classes can be linked to change in gang culture 
in the 1980’s, from theft to drug dealing. This move created opportunities for hierarchical structures 
that were being lost as a result of the disintegration of the traditional working class communities. The 
influx of heroin into these communities opened up previously unavailable opportunities for this kind 
of gang culture. It also caused widespread concern and challenges for practitioners in the field and 
significantly changed the way in which institutions reacted to drug use (Buchanan & Wyke, 1987; 
Dorn & South, 1987; MacGregor, 2017), as a participant working as a GP at the time recalls: 
 
 “[t]his is ‘79-’80. And just out of nowhere, extraordinary, with all sorts of stories you 
know, like most of them didn’t know what heroin was. We would ask them are you using 
heroin, and they would say no I’m using smack, and you’d say that’s heroin. They’d say no 
it’s smack, and you’d say well what’s in it, and you know… people were totally uninformed” 
(Senior Drug Advisor).  
 
 There was a lack of knowledge surrounding heroin and its potential for physical dependency 
at this time, by consumers and the medical profession. As a result, the increase in heroin use without 
the harm reduction measures we are familiar with today, such as needle exchanges and opioid 
replacement therapies, combined with a tepid institutional response arguably exacerbated the spread 
of HIV and other blood born viruses, and provided the presuppositions for the narrative of problem 
drug use and drug harm we see today. This Senior Drug Advisor was a GP at the time and helped to 
identify HIV in injecting drug users. He said:  
 
 “You know the electorate were really taken for a ride and there was a lot of damage 
done I think especially in those poor communities, and there was no interest, I mean drug 
clinics were closing down. You know the drug clinics were set up in 1967 across the 
country, 200 drug clinics across the UK, which worked actually quite well to start with. But 
then they stopped working because money ran out, people developed this notion that 
recovery was all about abstinence. I mean the new national guidelines in 1982, said give 
people methadone for two weeks and then stop because they’re better. The Advisory 
Council on the Misuse of Drugs, their treatment and rehabilitation document in 1980, 81/82 
maybe (ACMD, 1982), said there was no medical role in treating, it was all about social 
services, and recovery, the same as the agenda now. But within a very short period of time 
we had an epidemic of hepatitis, and we had people coming in with jaundice, and we started 
this study just taking blood from patients with jaundice and testing them for hepatitis, hep 
B, there is no test for hep C at that time, but we know now there was hep C as well, and we 
know now that HIV was going through that group at the same time... But nobody knew they 
had HIV or hep C, and it wasn’t until 1985 that we got a test for HIV we are able to identify 






In 1985 the narrator and his colleagues discovered that many of their injecting drug users were 
also carriers of the human immunodeficiency virus (HIV). This created a national furore and paved the 
way for harm reduction measures that had previously been dismissed. The Senior Drug Advisor again: 
 
 “well we published in 869 it was published, but the test became available in September 
‘85 and Tom Peter and a few other colleagues in Edinburgh did some testing of people who 
they thought were drug users in casualty in Edinburgh, found some positive HIV tests and 
published that in the Lancet and everybody was shocked and horrified. But we had this 
database, we had a database of about 200 patients. We had stored samples in the lab which 
were taken for the hep B patients so we went to test all the samples, and we found out that 
51% of them were positive. And in fact a lot of them were old samples so possibly even as 
much is 60% or 65% of them were positive for HIV. That was a game changer, I mean that 
was published in the BMJ, and over the next 12 months we had approximately 50 film 
crews, and television companies, and I thought the BBC only had one film crew but you 
know the hundreds of people that came to the door of Muirehouse10 surgery, and phoned 
me up wanted an interview, wanted to meet drug users wanted to talk about HIV, wanted 
to explore all the issues. Everybody. And of course policy people, government people, from 
Westminster because you know drugs is still a reserved power, and then there is no 
devolved Scottish Government, so most of the interest was from Westminster. So there was 
a huge amount of interest, and on the back of that there was research money, you know 
where you get interest like that you get research money.” 
  
 As a result of the publication, Scotland became the focus of attention. As the narrator points 
out Scotland did not have its own department on drug policy, however, despite this it implemented 
measures to counter the harm stemming from injecting drug use by introducing needle exchange and 
methadone programmes, backed by the Scottish Home and Health Department. Interviewee #10 
continued: 
 
  “I mean Scotland was ahead of England because of our problem, and Scotland had 
this committee, MacLelland Committee, Brian McClelland was the Director of the 
Transfusion Service…So Brian McClelland convened this committee and we all sat and 
chatted for a few weeks and decided that we had to give people methadone, and give them 
needles and syringes, and that of course was revolutionary, I mean it wasn’t really - as we 
been doing it already- but it allowed us to do it without any criticism. And all we were doing 
was copying Amsterdam, I mean Amsterdam the previous year had given out 500 sets of 
syringes without any reports of any bad things happening so really we were copying them, 
but we were the first in Britain, and the McClelland Committee was the first committee that 
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actually sanctioned distribution of needles and syringes11. The Dutch had sort of done it as 
part of the Junkie Bond: a group of users who set up their own group and distributed 
needles and syringes and they got criticism, but the Dutch Government couldn’t decide 
what to do, so didn’t prosecute them and didn’t pursue them. The Junkie Bond became quite 
famous across Europe, and everybody suddenly thought ‘you know that they got something 
here, you know they are actually doing some prevention’. So we were copying them and we 
did needles and syringes, and the Lord Advocate eventually said we could do it. And then 
England copied on really off that, the Advisory Council really and the Home Office 
Committee did a report the year after12, which more or less at the same as the McClelland 
report, except with more detail and more national coverage. But Scotland was the first.” 
 
 The importance of this process was that Scotland began to focus on harms stemming from drug 
use as a health problem, and power to do this was given by the Lord Advocate of Scotland. The Lord 
Advocate of Scotland is a constitutional post and provides judgments on whether an action contravenes 
the constitutional arrangements between the UK Government and Scotland. At the time there was no 
devolved Scottish parliament, but aspects of the law had always been separate, and the role of the Lord 
Advocate was to mediate these aspects. As can be seen here, the Lord Advocate made a bold decision 
in the face of a national crisis to allow the provision of drug using paraphernalia (specifically prohibited 
under the Misuse of Drugs Act 1971), although he was backed by the Home Office at the time:  
 
  “[B]ut when HIV came along they [the Home Office] didn’t know what to do, they sort 
of said well this is actually medical stuff, it’s nothing to do with us, it is best placed as 
medical. And they were right, they’re right” (Senior Drug Advisor).  
 
 This is contrasted with a recent Lord Advocates ruling on drug consumption rooms: a proposal 
put forward in 2018 to provide harm reduction for street injecting drug users, in the face of an increase 
in HIV infection for the first time in 20 years. In the recent ruling, the Lord Advocate refused to 
comment on the legality of setting them up, citing it as a public health issue, and therefore not suitable 
for a Lords Advocates reference (SDF, 2017). As can be seen, this is not entirely accurate, and it is 
interesting that over 30 years later Scotland appears to be in a similar position regarding responses to 
drug related harm. I shall explore this in more detail below.  
 
 The Muirhouse practice in which interviewee #10 was working during this time was subject to 
intense scrutiny and a large influx of injecting drug users. There was great debate among practitioners 
about how to respond to the epidemic unfolding which focused on the role of maintenance (harm 
reduction) versus abstinence (Buchanan & Wyke, 1987), and this was compounded by the intense fear 
felt by those working directly with injecting drug users:  
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  “And the police were… it’s hard to remember how worried everybody was, there was 
a real fear about HIV, I mean a real fear. You know people wouldn’t sit next to somebody 
in the bus because they thought they might have HIV, you know one of our drug users spat 
at somebody in Jenners department store, and was taken to court for attempted murder, 
you know because…you know there are all sorts of cases like that. And people were very 
worried about contamination in the blood suddenly became poisonous, you know whereas 
you know we used to take blood samples and slosh blood around into different tubes, and 
you get blood on your hands, you know you put into a tube that was bloodstained and then 
put into a tray in the lab, I would come pick it up, the blood sample would get cracked and 
then the blood on the tray, and it was just quite different. And all of a sudden nobody would 
take the blood samples from drug users, you know nobody wants to touch them, for fear. 
You know people didn’t know to be fair. 
 And then the test came in. So a real turning point study was Gerald Friedland who is 
one of the physicians in the Bronx and he tested everybody he could get hold of who lived 
with somebody who is HIV-positive and found out that none of them are positive, except 
people who had had sex with them or were sharing needles13. And he concluded from this, 
and it wasn’t a terribly big paper, it wasn’t terribly scientific, but it was a breath of fresh 
air, it was just a huge sigh of relief from the profession saying actually maybe it isn’t that 
infectious. So it’s blood to blood, you can spread it sexually you can spread it by needles, 
you can spread it by blood transfusion, and very rarely you could get it by needlestick or 
contamination. But otherwise you’re not going to get it, and all of a sudden it switched of 
the huge anxiety amongst the profession, and to a certain extent amongst the public as it 
filtered through” (Senior Drug Advisor). 
 
 The point of highlighting this fear-based narrative is that it is this fear - of contamination and 
more broadly the drug users themselves - that has been sustained throughout the decades. Despite it 
being known that HIV can only be spread through blood to blood, the image of the sick, dependent 
and dirty drug user has stuck in societies imagination. As one participant said of the time:  
 
 “When I worked in the Citizens Advice Bureau there the guy that I went out with, he 
had whole groups of friends that had died in shooting galleries and you know, he wasn’t 
drug user himself, but he knew whole families, 3 sons had died of heroin related…so…yeah, 
I suppose growing up in Edinburgh in the 80s you had a very strong view of heroin, so I 
think that’s quite interesting, the extent to which that experience probably – not necessarily 
personally but I see that played out through the Road to Recovery” (Senior Civil Servant). 
 
 This image underlies much of the current representation of the problem: that drug users suffer 
harm (and death) as a result of their drug use, and therefore strategies to address this harm are the most 
important focus. This is reflected in a broader public narrative about the harm of drugs, and the 
                                                          





‘problem’ of drug users. There is a view amongst many politicians, and policy makers, that ‘the public’ 
are a homogenous group ‘out there’ that supports punitive approaches to drug policy because of this 
harm narrative. It is felt that any moves to disrupt this focus would result in election defeat and uproar 
from this ‘public’. As one participant, who was in government during the late 1990s, said: “I mean too 
often politics ends up in that place where you do things that are described as tough, and maybe look 
tough, but if they’re ineffective then so what?” (Ex Scottish Minister #1). This constant need to look 
tough and alleviate ‘public’ concern has been a barrier to effective reform. Furthermore, the idea that 
the public consist of one group is misguided. Drug users are ‘the public’, drug users families are ‘the 
public’ policy makers are ‘the public’. This othering of stakeholders away from the ‘general public’ is 
one of the things that continues the narrative of harm.  
 
 This narrative was in the process of being developed in the 1980s, and as interviewee #4 points 
out, was reflected some 20 years later in the Scottish drug strategy. Furthermore, heroin users were 
associated with crime, another deviant activity that influenced the representation of the drug user: 
 
  “[w]ell the 80s was HIV and all these things you know. Theft went through the roof, 
the number of clients you had that were just feeding a drug habit you know. And it escalated 
you know. It would start off just shop lifting and then they’d end up doing house robberies, 
you know house robberies with people in the house” (Ex Scottish Minister #1). 
 
 This quote illustrates the increase in criminal activity that surrounded dependent heroin use in 
the mid 1980’s, and as a result there began an association of drug use with criminal activities such as 
house robbery. This, combined with the kinds of communities many heroin users were, and still come 
from (working class or lower socioeconomic communities) (Pearson, 1987; Milton, 2017), meant that 
despite there being a national crisis, the amount of money needed to invest properly in these services 
was not forthcoming.  
 
 “You know people always say well it must’ve been great and things were easy, and the 
health service, and there was loads of money, but there’s never been loads of money, and 
there’s never been a time when people weren’t stressed and vexed by not having enough 
resources. But mental health has always been bad, it’s always been the bottom of the pile, 
and drug use of course is the bottom of the bottom of the pile, you know - a lot of stigma a 
lot of prejudice, a lot of poor press coverage, you know which we did get. But the press was 
not quite so intrusive, so vicious. I mean I’m glad that they weren’t, you know we did get… 
I mean the Home Office used come round, you know the Drug Inspectorate, and we got to 
know them quite well, and they came round, and they gave us rather sort of cryptic 
warnings, you know about ‘you better be careful we are watching you and we are recording 
your every prescription’. And we so said okay so is that a good or a bad thing [laughter]” 






 The impact of the heroin/HIV epidemic was seismic. In 10 years Scotland went from 
having virtually no institutionally agreed responses to drug harm, to a world leading harm 
reduction program in the form of needle exchanges, opioid replacement therapies and ultimately a 
strategy specifically for Scotland (Scottish Affairs Committee, 1994). This period created the 
conditions for the representation of drug use as a problem, with unacceptable levels of harm 
stemming from use. It dominated the narratives of several key participants in my research and had 
a lasting impact on the way Scotland responded to drug use. Nevertheless, there were constant 
challenges in implementing these initiatives and the intervening years between 1990 and 2008 saw 




This chapter sought explore 4 of the WPR questions using the historical legacies, and told through 
the experience of key actors. What we can see here is that the representation of the problem of 
drugs (as set out in the introduction to this set of chapters) began to develop in more depth during 
the 1980’s. The representation came about as a result of the focus on injecting heroin use and 
resulting HIV/AIDS and blood borne viruses transmission associated with injecting drug use 
(WPR#3). The underlying presupposition developed at this time was that drug use was harmful, 
bad and resulted in death or severe health consequences for both the individual and society at large 
(WPR#2). As a result the problem of drugs started to become represented by poverty stricken 
injecting drug users (the trainspotting generation – WPR#1). Yet missing from all of this is the 
other forms of drug use, the cannabis smoker, the psychedelic traveller, the amphetamine 
associated with the punk scene, and the MDMA user just starting to get going in the UK (WPR#4). 










The Intervening Years: Developing the Narrative of Harm, 
Silencing the Narrative of Pleasure 
 
This chapter charts the intervening years between the end of the ‘heroin epidemic’ and the 
implementation of the Road to Recovery (2008). I was a child during the 1980s, so the stories collected 
from that time are from my interviewees and literature. However, from 1994 onwards I can start to 
input my own auto-ethnographic/reflective accounts of drug use and drug policy, in particular to 
highlight where the silences are in the developing institutional narrative response to drug use. This 
speaks to #4 (where are the silences?) and #5 (what are the effects?) of the WPR approach, as well as 
developing groundwork for critical drug theory by using personal narrative to highlight 
marginalisation. In this chapter I do this by using diary entries and reflection on those years, combined 
with interview and other data relevant to that time. 
 
 The years between the heroin epidemic of the 1980s and the implementation of the Road to 
Recovery in 2008 saw a raft of changes in Scottish drug policy, not least the impact of the devolved 
Scottish Parliament in 1998. Overall, in the policy world, there was a further shift towards treating 
problematic drug use as a health issue over a criminal issue (see the list of reports in appendix) and 
from 2001 there was a strong focus on ‘recovery’ and treatment as a process for addressing drug 
problems (Kidd, 2013, ch.2). However, until 1998 all drugs policy rested with the UK Justice 
Department, and enforcement was a major part of the policy response. Following devolution in 1998, 
public health responses to drug use were devolved to the Scottish Parliament, and enforcement of 
criminal sanctions were carried out by the Scottish police and courts. Legislative changes however 
continued (and continue) to reside with the UK Justice Department. 
 
 Because of this focus on problem drug use, other forms of drug use, and drugs, were largely 
ignored in official policy responses. Yet it is during this period that Scotland saw a huge increase in 
the use of psychostimulant drugs such as MDMA, amphetamine and cannabis, something the Retired 
Police Officer witnessed during his time in the drug squad: 
 
 “I saw the ecstasy market come from absolutely nothing, and it was all about the club 
scene. I had one of the biggest recoveries in Scotland which was 111 MDMA tablets, that 
would have been around 1990, the biggest at that time, when I first went to the Drugs 
Squad, and it (the MDMA) was destined for the hanger 13 scenes down in Ayr (West Coast 
of Scotland). There was a huge rave scene down in Ayr, and that’s where they all went. And 
that’s exactly what they were all doing. They were sourcing eccies (MDMA), taking them 





as a side line. I was in the drugs squad proper until 1994, and I remember latterly 600,000 
ecstasy tablets in a concealment coming in from Belgium and I took them out and they were 
concealed in a van.” 
 
This participant is talking about the burgeoning rave culture in the early 1990’s, where hundreds of 
young people would converge in old warehouses and airfields in the country to listen to loud 
techno/dance music, and consume ecstasy. What he is describing here is the increase in the amount of 
ecstasy in four years: going from just a couple of hundred confiscated during a weekend, to hundreds 
of thousands of tablets being shipped in for consumption. It was during this time that I got involved in 
the rave scene as a result of hanging out with punks who were also into techno/dance music. In the 
following excerpt I reflect on the first time I took an ecstasy tablet:  
 
 “I took ecstasy on New Year 1994 when I had just turned 16. We had found an afterparty in 
the New town (of Edinburgh), an old townhouse rigged with stolen electricity and different dance 
rooms on all floors, it was mental. I had a gram of speed (amphetamine) in my pocket and had taken 
some already that night but when I looked for it at the party it must have 
fallen out my pocket as it was not there. I was with school friends, but 
funnily enough the folk I was with were not into taking drugs, except one. 
Anyway, we are at this party and the guy who had taken us there who was 
lovely said he could get me some pills, seeing as I had lost my speed. So, 
he got us a pill, they were California Sunrises I think, and me and a friend 
shared it. Everyone else went home and me and her stayed. I remember 
sitting in the chill out room having amazing conversations with people, 
feeling light and warm and fluffy and in love with my new experience. At 
the time I didn’t think I was feeling anything, it felt natural, but 
just like the speed experience I remember chatting to a woman 
telling her it was my first time but it didn’t seem to be working 
and she just smiled at me. Finally we made our way home and 
crawled into my single camp bed at 7am, both of us feeling light 
and fluffy and bonded. My ecstasy experience was the beginning 
of a very nice relationship with that drug, I had some very good, 
life affirming times over the next decade.”  
  
Around this time there was a brief institutional focus on this 
kind of drug use, in response to an increase in illegal raves 
taking place in warehouses and empty fields across the country. 
The UK Government’s response was to deter such activity by 
passing the Criminal Justice and Public Order Act 1994. The 
Act was wide ranging, and targeted the traveller communities 
in particular. But it was Part V that those of us involved in the 
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rave scene at the time saw as an act of state repression. It was Section 63(1)(b) that stuck out and made 
it illegal to play certain kinds of music: “music includes sounds wholly or predominantly characterised 
by the emission of a succession of repetitive beats.” The passing of this Act resulted in a massive crack 
down on warehouse parties and illegal raves. My friends and I attended demonstrations and continued 
to go to illegal raves, but the enforcement became heavier, and gradually the music moved to licensed 
clubs and festival venues.  
 
Another of my participants, who remains anonymous for this extract, talks about their 
experience during this time:  
 
 “Well yeah, I think in the sense, as I say, it was all kind of influenced around music so 
like when I was late to mid teens it was kind of indy and stuff like that, and that kind of 
influenced all the other activities, so fashion, drugs, gigs and that sort of stuff, and then 
yeah, then I started going raving and that all changed the scene. And once we were driving, 
we used to go to raves out in the countryside and then like drive home (tentative laughter)… 
[A]nd the all night clubs, they were wicked... Yeah it was like a kind of group mentality. It 
was all fun and everyone looked out for each other… and I think that thing of people looking 
out for each other when you’re raving and stuff and making sure everyone’s alright was 
probably good for me... So yeah, pretty positive.”  
 
Thatcher’s War on Acid House. Source: Vice.com14  
 
                                                          





What we are seeing here is a window into a drug scene that was characterised by people 
experiencing pleasure as a result of their drug use. This is in contrast to the narrative of drug harm that 
was developing as a result of the heroin/HIV epidemic. The thing I find most fascinating when I look 
back at those times is that the people I raved with were from all walks of life, and many of them came 
from communities that were in the grips of heroin use. We connected through our use of illegal drugs, 
and the music that came with it, dancing for six hours till our bodies were soaked in sweat, breaking 
only for water and animated chats with a new best friend when you went to the toilet. After the clubs  
we would return to an after-party and there the conversations and dancing continued. It is during this 
time that my deviant identity was developed. 
 
 As well as the enforcement focus on ecstasy, in 1996 a retired policeman’s daughter, Leah 
Betts, died from drinking too much water while high on ecstasy (The Independent, 1996). The ensuing 
moral panic surrounding her death, fuelled by her father’s grief, resulted in ecstasy and the associated 
clubbing being viewed as harmful. It is around this time that Crew 2000 were working to respond to 
the increase of people using psychoactive drugs, and the differences in strength and purity.  
 
As a clubber using a considerable amount of ecstasy at the time, I noticed the change in quality. 
Until 1998 my personal experience had been that although different brands had different qualities, 
generally speaking you knew what you were getting. California Sunrises were extremely lovey, 
rhubarb and custard were red and yellow, and more speedy, Mitsubishis were full of ketamine, and 
Picture taken 1999 at an afterparty. The police had 
been called because of a noise complaint, and were 
asking us to turn it down. The routine was they 
would wait around until we had turned it down, and 
some folk had left. Often this was a good excuse to 
get rid of anyone who was being a pain in the arse 
or causing trouble. I was into photography and 
asked everyone in the picture if it was okay to 
photograph, although I am not sure how much 
consent my friend was capable of giving! She has 
since ‘soberly’ consented. I thought it was an 
interesting exchange, and showed the tolerance of 
the police towards the ravers during this time. We 
were not travellers, or having a free party, just a 
large party in a small flat in a housing scheme, with 
a massive sound system after a club. 
I was 19 at this time, and my life consisted of 
working in a late night café near Edinburgh 






signalled the death of clubbing to me. They came in around 1999/2000, along with GHB (gamma-




The other thing that killed the vibe was alcopops. Indeed, during an interesting conversation 
with the Senior Drug Advisor we discussed alcopops in the clubbing scene. This extract also shows 
Shaken or stirred. Original poster from Crew 2000. The message is harm reduction – don’t mix your 





how I developed relationships with my interviewees, by being completely honest about my experience, 
sharing my stories, and encouraging them to share their own.  
 
Interviewer: “I was a raver when alcohol pops came in and they were the death of the rave 
scene. You know we used to go clubbing and take maybe one, one and a half ecstasy tablets, 
dance for six hours, nobody drank, we all just sipped water and sat around hugging each 
other and then went back to after parties. And then you know you drink and stuff like that 
when you are coming down. And then they introduced alcopops, because when you are on 
ecstasy you didn’t want beer or something… Maybe some people have cider. But they 
introduced alcopops in the clubs, people started dying, because they were mixing MDMA 
with alcohol, and the effect, the impact it was having was horrible. They weren’t able to 
dance for ages, they just turned into arseholes…” 
Senior Drug Advisor “Well it’s back to what we were saying about alcohol. It was a very 
cynical move by the industry to trap a young generation of people, women in particular, 
but also men into drinking something sweet and not bitter, and apparently not toxic, but 
actually very strong. And it was a cynical ploy to get people addicted to alcohol, and it 
worked very well. You are the generation of young people drinking spirits whereas they 
weren’t drinking spirits before, and then there were cocktails, and this again was a 
conspiracy by the industry, and government colluded with it, they sort of said well this is 
industry, this is revenue. And so you know liver disease started going up, women with 
cirrhosis at the age of 30 suddenly started going up, transplants going up, all sorts of things 
directly related. So alcopops was a disaster.” 
 
The harm here was the encouragement by the alcohol industry to drink sweet alcoholic drinks 
to quench your thirst, as opposed to water. This is not to say that taking illegal drugs such as MDMA 
is harm free, but they are safer and more enjoyable taken in small, pure quantities without the addition 
of (too much) alcohol (Nutt, 2015). But that does not make much money.  
 
Except for the legislative processes used to clamp down on this activity, and the moral panic 
surrounding ecstasy deaths in the late 90s, drug policy largely ignored, and continues to ignore, this 
group of drug consumers. The only area where we are legitimate voices is in the area of harm reduction, 
however, as we will see in chapter 7 even this is limited, and more recent harm reduction initiatives 
such as drug checking in festivals and clubs have not been acted upon. Harm reduction appears to 
predominantly focus on reducing the harm of ‘problem drug use’, as opposed to reducing the harm 
from all drugs use, and as a term/concept it did not feature strongly in the data. It is for this reason I 
do not spend much time on what harm reduction is, or how it is implemented in Scotland.  
 
 This ignoring, or silencing, of certain kinds of drug use speaks to #4 WPR question of ‘where 
the silences are in the representation of the problem’? As we are beginning to see, the main silence is 






 At the same time that psychostimulant drug use was increasing, heroin use continued to 
escalate. The Retired Police Officer again, on his experience of the early 1990’s heroin scene: 
 
 “So, the heroin situation just escalated and escalated and that was when we saw more 
and more initiatives… By the time we got into the 90s I went to CID, the drug squad in 
Berts Street, and then Easter House in the north of Glasgow between ‘85 and ‘90. These 
were really rough areas but there was drug dealing, but the drug dealing was just supplying 
like an undercurrent of drug users, it was still… The main issues were violence and alcohol. 
But behind that they start to set up the drug dealing business because they saw the money 
that could be made. But it was a demand driven market, we lived through Temgesic, (opiate 
based pill). So you saw them identifying that there was money to be made, and the more the 
people that took it the more people that said ‘go on try that’. And the cannabis market 
definitely grew because of shipping availability, and heroin was very much the same, coke 
(cocaine) still never appeared.  
 
 The Retired Police Officer is identifying the growth in criminal gangs using drug dealing as a 
source of income. As he says, it was a demand driven market, people wanted the drugs, so the gangs 
supplied them. As we saw from the 1980s, the demand was a complex mix of situational pressures 
such as the disintegration of communities, lack of employment, and an anti-authoritarian sentiment.  
 
This Senior Policy Officer was working as a support worker at the time:  
 
 “At one time in Glasgow, in Scotland, I’m sure the whole of the UK, we had a whole 
group of people who, they were highly employable, they were just unemployed cos there 
just weren’t any jobs. But in the time that I did that work it became apparent to me there 
was less and less people like that, and there were just more and more people who were 
unemployed and just had huge issues.” 
 
 By the mid 1990’s support services were starting to see people who had over 10 years of social 
deprivation behind them, and little in the way of education and employment. It is around this time the 
authorities realised this ‘problem’ needed more than a few needle exchanges and methadone 
programmes.  
 
The Retired Police Officer again:  
 
 “And then it just started to grow (the amount of heroin use). The police started to look 
at law enforcement being the answer. Going back, Strathclyde Police appointed a Force 
Drugs Coordinator to start to look at engaging with services. Back in 1994 it was Barry 





engaging with NHS, the drug courts, looking at drug related deaths because the drug 
related deaths figures fluctuated, I can’t remember what year it was but there was 51 deaths 
in one year, and we thought okay that’s surprisingly low, no rhyme nor reason.” 
 
 Interviewee #6 was instrumental in setting up inter-agency dialogue around problem drug use. 
In 1994 the different agencies dealing with the fallout of problematic drug use had little interaction. 
The police arrested, the courts passed judgments, social workers dealt with families, and the NHS did 
not know how to deal with it at all.  
 
The following Drug Policy Advisor was a Trainee Psychiatrist in a Glasgow hospital during 
this time, and his view of drug users was common amongst his peers:  
 
 “You know you would see half a dozen injecting drug users wanting treatment every 
night when you’re on call. So it was a very unusual and unpleasant environment. and I have 
to say my view of drug users and managing drug users at that time, if someone had said to 
me you’re going to become an addictions specialist, I would have laughed in your face, it 
was just such a…it felt like you couldn’t offer anything, like you didn’t have anything to 
offer. It was unpleasant, it was just not nice.”  
 
 What we can see here is that it is not just the individuals using substances (in particular heroin) 
that had a sense of hopelessness and despair, but the service providers also felt a sense of hopelessness 
at their inability to respond to the increasing numbers of dependent heroin users. At this time there was 
still a lack of understanding that the cause of such use was largely systemic: that the conditions of the 
communities and lack of social investment was main driver of ‘problem’ drug use. Service providers 
were being inundated with cases they were unable to address at the root cause.  
 
 This started to change in the late 1990s when the Scottish Parliament was set up, and both the 
UK Government and the Scottish Executive began investing in drug policy. This Drug Policy Advisor 
was a policy adviser to the Scottish Government during that time and takes us through this period:  
 
 “And then in 1999 you have a Labour Scottish Parliament Government, and they 
produce a strategy which was, well it almost epitomized the Labour party because it was 
really heavily influenced by the English Labour Party15. Because when the Labour Party 
got into power in Scotland they were very obvious, if you were involved in government, they 
were being worked by London. And drugs was a very big thing for Tony Blair's 
Government. They had a Drugs Czar, a guy called Keith Halliwell, who was a policeman 
with a very very good suit [smiles], but also a bit of a difficult guy. And they drove 
everything by…I mean he was based in the Cabinet Office, so he was based in No 10, so 
                                                          





anything the Scottish Labour Parliament were doing was very heavily influenced by the UK 
Labour Party.  
 So what happened, I mean SACDM16 after the 1999 strategy recognized - or Angus 
McKay17 and his people recognized - that the problem in Scotland was not going to be 
investment, because he’d secured investment (10 million). The problem was going to be 
whether that investment had any impact at all. And the reason for that was a number of 
things. One thing was we had drug action teams (DATS) which were the local area kind of 
planning group, which were funded by the Scottish Government - the Scottish Office, the 
Scottish Parliament and then the Scottish Government - and quite significantly.  
 So Angus McKay started working very hard to change that, to get better membership, 
user involvement, community involvement, much better involvement in the committee, 
because SACDM was just seen as a kind of talking shop and it became a much better thing. 
He also invested in the development of DATS into much better groupings, and that’s 
because DATS had been evaluated externally at great expense and found to be awful: 
ineffective, lots of money for nothing. So he invested in that, and the delivery infrastructure 
was improved. So we had money, which people were going to be ready to spend, and he 
had… Basically all the DATS had the away day meetings, and they had development officer 
people helping them to become, apparently, better committees and better organizations and 
better partnerships.” 
 
 This Drug Policy Advisor is telling us about the institutional changes that took place in order 
to better integrate drug policy (treatment) services, as a result of the growing recognition that the 
problem of injecting drug use was not going to be confined to the 1980s. Money needed to be invested, 
and there needed to be an impact. In 2001 the Scottish Executive published their Drug Action Plan in 
which they stated that the aim (impact) of the plan was to prevent young people from using drugs, 
prevent drug related anti-social behaviour, enable treatment for drug users and to ‘stifle’ the 
availability of drugs’ (p 10-11). The problem, as they saw it, was that drug use resulted in increasing 
criminal activity, had become more accessible to young people, was linked to unemployment and 
homelessness, and prevented people from achieving a fulfilled life (p 3-4). By 2001 therefore, we can 
see that drug use has been firmly rooted in a ‘problematised’ narrative focusing on the harm attributed 
to such use. While there is an understanding that the type of drug use being focused on was a result of 
social inequality and trauma, there is no mention of the other kinds of drug use or using behaviour. 
Furthermore, despite this growing understanding, there was a strong enforcement narrative that drove 
much of the policy. As this Ex Scottish Minister #2 recalls:  
 
 “Well I was a Minister from 1998 to 2001, which was the first few years of Scottish 
Parliament, so is absolutely the beginning. And it was all during the period which Labour 
- who of course was the lead coalition partner then – Labour was… well it was developing 
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its own sort of the Blairite tough on crime tough on the causes of crime. But in my view… 
in my view they kind of lost the plot - just got completely carried away with being tough on 
crime, as opposed to being tough on the causes.” 
 
 Between 1999 and 2003 there was a focus on drugs policy by both the UK Government and 
the Scottish Executive. In 2001 the UK Home Affairs Select Committee announced it would hold an 
inquiry into drug policy. The subsequent report ‘The Government Drugs Policy: is it working?’ (HAC, 
2002), explicitly outlines the focus of drug policy going forward:  
 
 “We believe it is self-evident that by focusing on the relatively small group of problem 
drug users, the Government could have a significant impact on the harm caused by such 
drug us” (para 24). 
 
 “We believe that drugs policy should primarily be addressed to dealing with the 
250,000 problem drug users rather than towards the large numbers whose drug use poses 
no serious threat either to their own well-being or to that of others” (para 38). 
 
 The report goes on to detail what it considers problem drug use to be:  
 
 “Most harm is caused by and to the group of users commonly classed as "problematic". 
These are users who are often dependent on crack cocaine and/or heroin and perhaps other 
drugs, who live extremely chaotic lives with high levels of risk to their health and that of 
others, and are often involved in crime” (para 21). 
 
 We can see here then that the focus on this small cohort of drug consumers is one of the 
underlying presuppositions that has resulted in the representation of drug use as being harmful and 
problematic. It is acknowledged that this cohort are not representative of the larger drug using 
community, and indeed they heard evidence that:  
 
 “Those people who are involved in chronic misuse of drugs are generally damaged and 
it is the underlying causes we need to look at...most drug misuse is a symptom and not a 
cause. The same stuff will go on in those people's lives, abuse, poverty, unresolved 
bereavements, being in care, drug-dependent parents, the same stories come out again and 
again and again, and if you tackle those issues those people will not get into those problems 
in the first place" (para 22). 
 
 The report further states that: “[W]hile around four million people use illicit drugs each year, 
most of those people do not appear to experience harm from their drug use, nor do they cause harm 
to others as a result of their habit” (para 20). Yet despite this, there is no further discussion on the 





cohort of drug users. As a result, the focus of policy is on the harm of drug use, and other experiences 
are silenced and ignored.  
 
 In Scotland, the Scottish Executive turned their attention to this small cohort of problem drug 
users by investing large sums of money in various treatment and enforcement-based policies (Scottish 
Executive, 2001). To address this they set up the Effective Interventions Unit (EIU), “a kind of unit 
within the Drug Policy Unit, whose job was to review the literature, review the evidence, produce 
guidance, produce standards and ensure that services were meeting those standards across Scotland” 
(Drug Policy Advisor). 
 
 The EIU set about producing a series of reports focused on drug treatment (2002, 2002a) and 
integrating care for drug users (2002b). The new money outlined in the 2001 Drug Action Plan was 
starting to be spent, and drug services were beginning to focus on the concept of recovery as a way of 
creating pathways out of drug dependence. Alongside this, the first example of a citizen’s jury on drug 
policy in Scotland was convened by the ‘Glasgow Alliance’ (no longer functioning or available 
online). This event spanned over two years (1999-2001) and findings were fed into Scottish policy 
being developed at the time (Glasgow Alliance, 2001). For example, the report recommended the 
creation of dedicated Drug Courts, and the first one was set up in the autumn of 2001. However, despite 
the flurry of activity surrounding problem drug use, drug related deaths were increasing, and in 2003 
the media began to report on this:  
 
“And what tends to happen in the field is that there is some kind of uproar about something 
and is often about deaths or children dying or something. Something happens. And round 
about 2003/4 there’s a big concern about drug deaths, and so the government decided to 
invest in drug deaths research” (Drug Policy Advisor). 
 
 In 2003 there were 385 drug related deaths, and this topic began to be picked by the media 
(BBC Scotland, 2003a & 2003b). What I found interesting when reviewing this data, and listening to 
my participants recount this time, was how similar the narrative is to the current one. Indeed, the 
narrative of the older problematic drug user who has suffered as a result of social policies enacted 
during the 1980s seems to have started around this time: 
 
 “Users with a long history of drug use are at particular risk because of the long-term 
impact of drugs on their bodies…the figures underline the continuing need to tackle the 
root causes of problem drug use as well as improve the wide range of treatment, service 
and education necessary to minimise harm to drug users” (BBC Scotland, 2003a). 
   
 Sixteen years later and this narrative is firmly embedded in much of the literature and minds 
of the drug policy community. At the time it was a relatively new understanding, in Scottish policy at 





complex problem drug users, there would a reduction in drug use and drug harm (Scottish Exec Drug 
Strategy, 2001). Yet, over the last sixteen years there have been several ‘uproars’ regarding drug 
related harm, and deaths in particular, which have continued to increase (see box 1). 
 
 
Box 1 National Records of Scotland, July 2019 
 
 The Scottish Executive responded to the media furore by commissioning a drug death review 
(SACMD, 2006). Interviewee #2 and his colleagues in SACMD brought a wide range of researchers 
together to review every drug death that took place in Scotland in 2003 and report of their findings, 
with recommendations: 
 
 “And that was interesting because what we did then is basically what people are doing 
now, so it hasn’t moved on. People are doing what I would call a psychological autopsy on 
deaths. So basically they look at a big bunch of people that died, and say look lots of them 
are male, most of them are like this and lots of them are like that, and something must be 
done. And you go well we know that, the question is ‘is there anything we can do that is 
likely to impact, get back to impact again, that can impact on this’. And that would require 
a particular type of research approach, which is actually what we’re doing now (with the 
new Drug Network and Research Scotland)” (Drug Policy Advisor. 
 
 The 2006 SACMD report made a range of recommendations on improving responses to 
overdose, improving and developing existing approaches, targeting those at greatest risk and service 
provision. Their final reports, Reducing Harm Promoting Recover, and Essential Care in 2007, paved 
the way for the Road to Recovery in 2008.  
  
 There are many important moments during these years which are outwith the scope of this 
thesis. The important point to pull from this period is that the reports from the UK Government on 





surrounding political and media attention in 2003, was what initiated the current master narrative that 
runs throughout Scottish drug policy discourse. This narrative is of the individual who has a complex 
history of trauma and uses substances in such a way that it affects the mental, physical, social and 
financial well-being of themselves, and those around them. This narrative describes a small cohort of 
illegal drug users, but is almost the sole focus of drug policy.  
  
 In response to this narrative the Scottish Government focussed on an emerging philosophy of 
recovery, and sought to implement this into Scottish drug policy strategy going forward.  
 
Summary  
  This second chapter in Historical Legacies developed the narrative around what the silences 
are (WPR #4) and continued the analysis around how the representation came about (WPR #3) and 
what presuppositions underlies the representation (WPR#2). As we saw, recreational, social and so 
called non-‘problematic’ drug use received scant attention from policy makers except in the area of 
criminal justice. The reasons why people were using, the spaces they were using in, and the enjoyment 
many got out of using were ignored and in some cases deliberately silenced. This silencing and 
ignoring of certain drug using communities begins to highlight the competing narratives within drug 
policy – that of the recovery agenda versus the human rights/criminal justice agenda.  
 
 The recovery agenda in general seeks to take people who are using drugs and help them 
‘recover’. While this is laudable, and will be explored more below, the underlying premise is that 
people want to stop using drugs, that drug use is bad for you, and that the goal of policy is to help 
people move away from drug using lifestyles. Conversely the human rights/criminal justice agenda 
can be seen as the collective of individuals who use drugs, regularly or not, enjoy their use (usually) 
and are in fact more harmed by the criminal justice systems interventions in their drug use, thn the 
drugs themselves. This narrative will be developed in more detail in chapter 9 where I set out policy 








The Road to Recovery and Beyond  
 
 The Scottish Government’s drug strategy published in 2008 - the Road to Recovery - was 
seminal in that it was a cross party strategy put in place by an SNP minority Government which 
combined both criminal justice interventions and public health approaches under the banner of 
recovery. The concept of recovery in the Strategy was that individuals should be supported through 
their drug use using multiple responses including medical treatment, psychosocial treatment 
(community support, counselling etc.) and broader support in the form of addressing underlying factors 
such as poverty and deprivation (Road to Recovery, 2008, 23). In this way it highlighted the role 
broader societal conditions have on problem drug use, and created a role for the wider community and 
local government in addressing these issues. Problem drug use became a social issue, and recovery 
became a community response.  
  
At the same time that the Scottish Government were working on the strategy, two other 
important documents were being written and published: The Royal Society of Arts, Manufactures and 
Commerce Commission (RSA) report entitled Drugs: Facing Facts’ (2007); and Scotland's Futures 
Forum (SFF) report, Approaches to Alcohol and Drugs in Scotland: A Question of Architecture (2008).  
  
 The RSA Commission published their report in 2007 and were looking at UK wide policy, but 
their Scottish Commissioner was one of my participants, and her informal contact in Scotland was 
another one of my participants. The report’s main objective was “[t]o examine, as an independent 
body, all aspects of the relationship between public policy and the use and abuse of illegal drugs” 
(RSA, 2007:4). Their main finding and recommendation was the scrapping of the Misuse of Drugs Act 
1971 and subsequent legislation, which was to be replaced with a consolidated Misuse of Substances 
Act (RSA, 2008:310). This new Act should encompass all substances (including alcohol and tobacco) 
and should be focused on the harms caused as opposed to drug use per se. Possession and use of drugs 
would effectively be decriminalised, until such use started to cause harm. 
  
 The Scottish Futures Forum (SFF) is the Scottish Parliament’s futures cross party think tank, 
owned in whole by the Scottish Parliament’s corporate body. Its remit is to research and stimulate 
discussion on challenges facing Scotland, and to enable MSPs to have a long term view of how 
decisions made today will impact the future18. Their alcohol and drugs report was published in 2008, 
two weeks after the Road to Recovery, and received a lukewarm reception according to the participants 
involved. It utilised a systems approach which identified seven key areas which they used to explore 
the narrative of drug policy at the time, and how the narrative could be changed over time in order to 
reduce the harm of drugs by 2025 (SFF, 2008: 12).  
                                                          





 It was not until I had interviewed some of the participants involved that I understood how 
closely interlinked these three documents were, and how they constitute two major competing 
narratives emerging from within Scottish drug policy communities: public health-based reform, and 
legislative reform. Public health-based reform policy is based on the current legislative and 
constitutional framework of Scotland. The Road to Recovery represents this reform, with the focus 
being on public health responses such as treatment, education and engagement (all devolved aspects), 
and enforcement via the current legislative framework of the Misuse of Drugs Act 1971 and 
surrounding legislation. Legislative reform on the other hand seeks changes in the legislative and 
constitutional landscape. Furthermore, the narrative of public health-based reform sees problem drug 
use as the main focus of policy, embedding policy responses in a problematised harm narrative (the 
harm paradigm), with criminal justice interventions as a core component. In this narrative, other forms 
of drug use are ignored or silenced because they do not fit the narrative of harm. Legislative reform on 
the other hand recognises that people take drugs for a myriad of reasons, and that the harms stemming 
from drug use are a result of wider societal factors. While still framing the issue around a problematised 
harm narrative, there is recognition that criminal sanctions for drug use are limited in their 
effectiveness, and are based on moral ideology as opposed to evidence of harm (RSA, 2008, 284-300; 
SFF, 2007, 35).  
  
 The years following the implementation of ‘the Strategy’ up until the policy refresh in 2018 
were dominated by the development of the recovery agenda. Outwith Scottish drug policy 
developments there were important shifts in the wider narrative of drug policy, and this section will 
explore how these competing narratives developed and started to merge.  
 
The Road to Recovery - Consensus or Competing Narratives  
 
 The 2008 strategy was billed as a consensus strategy, but the reality was slightly different: 
 
 “The political history of the Road to Recovery is important. So this is a document which 
got through the Parliament by being supported by a minority SNP Government with the 
backing of the Conservatives, who fought through that budget, asked for two concessions 
from the SNP, one of them was on drug policy19. [A]nd within the Road to Recovery, the 
thing that they wanted was ‘towards abstinence…drug free’…so that was the main driver 
behind it. It’s then got cross party support, eventually, no one’s willing to say anything 
against it. I have to say to be fair to the government, the politics and the parliament, the 
last thing you want is a really contentious strategy and for everything to be politicised in 
that party sense. So they managed to maintain a consensus, and they done that by cleverly 
going back to the Parliament setting up an ORT 20 review group to say that methadone 
works in Scotland and all the rest of it, to keep all the parties on board, and they’ve done 
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that very well. But actually, are we really saying that the point with treatment is to achieve 
abstinence, and if we don’t do that we are failing, and if we’re doing that, lets’ do that – it 
wouldn’t be what I would advocate, but this is what’s happened in England where it is more 
clearly a conservative agenda. but in Scotland we’ve fudged the issue around what means 
what, for good reason, because we don’t want to go there” (Senior Policy Advisor). 
  
 In addition to the competing narratives of pragmatic or legislative reform, we are beginning to 
see the emergence of another competing narrative that dogged Scottish drug policy for many years: 
the lack of clarity around what constitutes recovery, and by extension what the actual purpose of the 
policy is: to reduce harm or to encourage individuals to live drug free lives. These narratives intertwine 
with one another, with the pragmatic/legislative narrative becoming more important once the aim of 
Scottish drug policy is made clearer in the 2018 refresh. During this time however, the tension that 
developed as a result of the lack of clarity is what dominated my participants’ stories. This Senior Civil 
Servant was part of the Scottish Government’s Drug Policy Unit at the time: 
 
 “Well I think there was one story, but people viewed recovery very differently. So, 
everyone could talk about the Road to Recovery and the strategy and the consensus around 
it but actually ultimately it looked like consensus, but under the surface there really wasn’t 
consensus.” 
  
 This tactic of creating ambiguity in policy is politically essential in gaining consensus on issues 
which cause diverse opinions (Stone, 2002, ch.6). By gaining collective consent for the concept of 
recovery the Scottish Government were able to implement a policy that would have otherwise been 





 In order to implement ‘the Strategy’, the Scottish Government set up a Delivery Reform Group 
to examine ways in which the policy could be brought into effect (Scottish Government, 2009). The 
Drug Policy Advisor again: 
 
 “…So, Delivery Reform was created, very coherent approach, they invested in things 
like the Recovery Consortium, trying to do new things, and they invested in the Drug 
Strategy Delivery Commission (DSDC). They had closed down SACDM, ‘cause they felt it 
was a talking shop and it wasn't that valuable. 
  I agreed... and they wanted to come up with an independent commission (the DSDC) 
which I thought was really incredibly good news. They said you can get who you want on 
it, you can set it up how you like, you will have your own secretariat who will be employed 





so everything...there’s what is called a Chinese wall - not sure if you are allowed to say 
that - but a wall between you and them, so you do your own stuff, it's independent. So we 
did that. We started working, and that was really interesting and really exciting, and I really 
really thought we are actually gonna make a difference, it's going to be possible to make a 
difference. And we worked very very hard, and did some very good things.” 
 
This Drug Policy Advisor hopefulness that the strategy would deliver the impact the 
community sought was indicative of the narrative of this time. The strategy gave the community a 
position to work from: implementation of essential care based on the concept of recovery so that 
problem drug users can be helped to work towards a drug free, and by extension a fulfilling life. 
Delivery reform had its challenges though: 
 
 “well we were trying to do it collaboratively with stakeholders, with partners, but yes, 
at times I had to do some quite tough things that weren’t very popular because… an 
example would be around the recovery consortium (SRC), which didn’t feel to me when I 
first took over the role (in 2009) that it was really going in the direction that we wanted it 
to. We were looking at community recovery so we had to do some quite tough things around 
that. We did have some really difficult things around the drugs commission (DSDC), and 
part of my role was really more around trying to keep the political consensus around the 
strategy to allow the investment to be made and the work to be done, because it wasn’t 
going to be a short term fix.  
 …And you know, there was some quite difficult conversations about trying to get the 
money out from the health boards and to set up services. Trying to get the…I suppose we 
described it as trying to hardwire the house in a way that made it more likely to deliver 
recovery, and it was quite boring but it was things like how to do you re-train your 
workforce, how do you ensure that you’ve got governance in the community so that 
community planning partnerships care about this. How do we actually have data that shows 
outcomes and improving. It was all of that. And so trying to create that 
environment…[making sure] you’ve got the right kind of delivery mechanism to start 
effecting change. Trying to keep other politicians on side, particularly trying to hold the 
ground around methadone actually, because the evidence base was you know, it was a 
reasonable thing to do, you know, there is clinical evidence around all of that. But … And 
I think the other thing was keeping the money so, you know, spending reviews went through 
in 2010 arguing why Justice money was being spent on these health service” (Drug Policy 
Advisor). 
  
 With delivery reform underway, the independent DSDC set about monitoring its 
implementation and preparing advice for the Minister to take forward. As mentioned by the Senior 
Civil Servant there were some difficulties surrounding the DSDC which they would not elaborate on. 






 Drug Policy Advisor: “But the first year we took lots of evidence on work and we 
presented our first report to the Minister21. The week before I was at a conference the 
Minister was at, and he was asked ‘do you think the Road to Recovery is working’, and he 
said well it's not for me to say whether the Road to Recovery is working, we have a Drugs 
Strategy Commission which is an independent commission who are about to give us their 
first report, and we shall hear from the senior Dr Brian Kidd next week, whether or not we 
are successful’. So I went along and said him ‘not very successful’, and he fell out with me, 
and that was that. And essentially from that day on the DSDC was seen as...difficult because 
we... 
 Interviewer: “So were you making recommendations that were effectively, potentially 
unachievable in the current climate? I mean what was...” 
 Drug Policy Advisor: “No no no, no. We were simply not producing a report that said 
the government is doing really well.” 
 Interviewer: “ahhh...right, okay” 
 Drug Policy Advisor: “And that's the awful thing. Cos I suspect, behind closed doors 
they would say we understand that, we want constructive feedback, which is what they were 
getting. But they actually don't, because what they want is the report...I mean what they say 
to you is 'look, you're independent, you can publish your report saying that if you want, it's 
just that we'll have to defend ourselves'. But I thought we were part of this machinery, our 
job is to try and say to you 'look guys, if you do this we want to input...the evidence base 
says we should be doing that, and you’re not doing that'. And your not doing it because it 
is really hard for central government to influence local delivery, effectively. So we're 
wanting to give you more strength to your arm, to make the things you want to happen, 
happen.” 
 Interviewer: “So is that what led to the dissolution of the DSDC?”  
 Drug Policy Advisor: “Ultimately, ultimately.” 
  
 The 2011 report was not scathing of the Scottish Government, indeed it recognised that there 
had been significant investment and implementation of key actions set out in the 2008 strategy (DSDC, 
2011, 14). The report recommended that the government bring alcohol and drugs under the same team 
(by implication they should be under the health team), that it improves its ‘institutional memory’ (22), 
and overcome barriers to local delivery of national strategies (23). However, the recommendations 
would have required the Minister, and their civil servants, to work harder at making sure local delivery 
was in line with national priorities. This would require further investment in time and money, 
something it appears they were not willing to do.  
  
 While the DSDC may have come across difficulties resulting from political pressure, the 
Scottish Recovery Consortium (SRC) on the other hand went from being initially problematic to a 
                                                          





success story that is still going today. Here the CEO at the time talks about the initial few weeks when 
they took over in 2011: 
 
 “Em, well the great thing about taking something over that’s in a shit storm22 is they’re 
just glad you turn up. And so I was deeply inspired by the Drug Policy Unit.…We created 
new forms, we used conversation cafes, we created the recovery colleges where we 
developed the activists. Me and a mate both on the back of a fag packet after the very first 
conversation café that we attended – first week of my job – we could see there was 
something trying to happen and it needed help now, and we couldn’t wait, so on the back 
of a fag packet – cos I was still smoking obsessively – we wrote up this idea that we called 
the recovery college – let’s do it. And within 6 weeks we had the very first recovery college 
students up and running” (CEO of Drug Charity). 
  
 As you can see, the Road to Recovery initiated a raft of changes that radically altered the way 
in which the Scottish Government engaged with drug policy. There was enthusiasm and hope 
surrounding the initial phase, but this hopefulness began to wane towards the end of the period: 
 
 “Drugs policy is populated by people who have been involved in policy for many years 
and are either entrenched in their views of what drug use is and who the drugs user is – ie 
problematic users – or weary and saddened by the lack of going forward regarding policy” 
(Senior Drug Advisor).  
  
 However, it is important to pick up that the narrative which policy engaged with most was the 
recovery narrative. As we have seen recovery was a concept which enabled cross party support, albeit 
with ambiguity at its heart. The DSDC on the other hand presented the government with challenges 
which they were unable, or unwilling, to take on board at that time.  
 
Missing from all of these policy initiatives is the ‘non-problematic’ drug consumer. The 
strategy is almost silent in regards this kind of drug consumption except to situate it in a problem/harm 
narrative by stating: “[T]he Government is committed to tackling recreational drug use through 
improved education, information and enforcement of the law. Recreational drug use today can become 
problem drug use tomorrow.” (Road to Recovery, 2008, 2). However, in 2009 the Scottish 
Government conducted research into the scale and impact of illicit drug markets in Scotland (Scottish 
Government, 2009a) which found that there was an estimated 199,977 ‘problem drug users’, and 
624,234 so called recreational users (23). The policy therefore only addresses one third of the drug 
using population. Given the data was sourced from two surveys: the Scottish Crime and Victimisation 
Survey, and the Scottish Schools Adolescent Lifestyles and Substance Use Survey, and many of us 
who started our drug using careers in the rave scene of the 1990s will have not participated in either 
of these, it is reasonable to conclude the ‘recreational’ use is indeed higher. It is also reasonable to 
                                                          





assume this as most drug use is illegal so it is difficult to get honest answers and that marginalised 
groups don’t fill out the surveys as you have to be in stable housing or schooling to participate 
  
 While in Scotland policy grappled with how to implement the Road to Recovery, and roll out 
recovery orientated systems of care, large shifts were taking place in regards drug policy governance. 
This is important because the recent changes in narrative evidenced by the 2018 Scottish strategy 
Rights, Respect and Recovery (discussed in the following section) were influenced by these shifts, in 
particular the UK Drug Policy Commission’s wide ranging report on governance.  
 
Shifts in Narrative  
  
 In 2012 the UK Drug Policy Commission (UKDPC) published a report into drug policy 
governance in the UK. The Commission was an independent commission with a mandate to look at 
how far national drug policies were routed in evidence. Essentially they set out to explore whether they 
could identify what a good governance framework is, to examine how drug policy is made, developed, 
implemented and scrutinized.  
 
1. Create a cross-party political forum to progress discussion about future policy, including  
engaging with the public. 
2. Move the political lead from the Home Office (justice led) to the Department of Health. 
3. Ensure drugs strategies are evaluated from the start. 
4. A new independent body should be established to co-ordinate the drug research effort and  
provide analysis. 
5. Develop deliberative methods for engaging with the public around the goals and options for  
drug policy. 
 

























 In 2016 SDPC held a governance workshop presented by Roger Howard, a commissioner on 
the UKDPC commission. He was familiar with Scotland because he had been invited to get involved 
with various advisory groups looking at how to implement the UKDPC recommendations. The 
following is an extract from his presentation: 
 
“When it comes to thinking about the formulation and implementation of governmental 
policy on drugs then Scotland fared better than England. Better insofar better that a lot of 
the policy actors were pretty well rehearsed and engaged in shaping and influencing. This 
may have been a function of size of the country or behaviours, or perhaps the politics of 
devolution. But, I think there was a very obvious attempt to do things like policy analysis 
and logic models, to look at things like effectiveness. In fact the Scottish Government had 
set up its own effectiveness unit. Of course I could have a go at them for doing away with 
it. I’m sure there are rational reasons, but you know it did originally commit itself to try 
and build an evidence base. It also had an implementation scrutiny mechanism involving 
independent experts. For all its faults and limitations - I was a member of it so I know some 
of them – the Scottish Drug Strategy Delivery Commission did provide a bit of architecture 
around drug policy implementation. If you look at Westminster there’s nothing like that, 
there’s nothing that will enable that dialogue between government and other interests to 
really genuinely take place. But we know, landscapes change, events change” (Roger 
Howard, UK Drug Policy Commission, CEO, SDPC Governance Workshop, 2016). 
1. Clear overarching goals 
2. Effective leadership  
3. Good coordination of policy efforts  
4. Policy design with options & evaluation 
5. Development and use of evidence 
6. Implementation resources & flexibility 
7. Accountability and scrutiny mechanisms 
8. Stakeholder engagement   
 
The commission published a range of 
findings setting out what makes good 
governance: 
1. Governance structures were inadequate  
2. There are unclear and contested goals  
3. There is limited evidence of impact 
4. Inability to audit and assess  
effectiveness and value for money 
 
They compared the current UK 
policies with the findings of what 







 Many of us in SDPC were unaware that the UKDPC Commissioners had been involved in 
advising the Scottish Government on how to develop good drug policy governance, so this workshop, 
and acknowledgement of the role being played, was important in understanding how the narrative of 
drug policy was developing. It was apparent from the recent changes in drug policy governance that 
some recommendations had been acted upon, for example in early 2016 the lead for drugs policy in 
Scotland was moved from the Justice Department to the Health Department. At the same time a new 
independent (non-governmental) advisory framework had been set up (Partnership for Action on 
Drugs), which had broadened the remit of policy to include drug harm more generally, and had a strong 
focus on prevention and community solutions. Yet there were many areas that had yet to be addressed, 
and I will start to tighten the focus on one particular area, participation of stakeholders, in order to 
delve deeper into the research contributions.  
  
 During the course of the discussion following the UKDPC presentation there was discussion 
on reform, in particular around greater participation of people who use drugs in policy formation, and 
the decriminalisation of drugs. One participant made a comment along the lines of:  
 
 “I think there is a distinction between the policy opportunity and the political 
opportunity. I think that part of the challenge is that academics/researchers etc. can 
develop as great an evidence base and robustness, and we can come up with this and we 
can collaborate and we can develop, and it can be done quite openly and quite in an 
inclusive way with the government. But until the politicians have a level and degree of 
comfort then the change will not happen. And this presentation is really helpful for policy 
makers because they are in that policy bubble that is trying to set policy change. They are 
doing a lot more around evidence and all these gaps are beginning to get focussed on 
including this issue about citizenship and how they engage with communities, and they’ve 
started that conversation I believe” (anonymised due to Chatham House Rules). 
  
 This comment shows a belief that there is a shift in narrative away from focussing solely on 
treatment options for problem drug use, to a desire to engage with a wider audience in order to address 
drug policy problems. The stumbling blocks are the politicians. While the structure of policy may 
allow for multiple inputs and options for engagement, ultimately it is the civil servants who write the 
recommendations as policy briefs/reports/bills or sign off the cheques, and the minister who rubber 
stamps. It is therefore possible to have a well written policy document, with a range of expertise and 
recommendations, yet little in the way of meaningful engagement on the issues going forward23. For 
example, the desire was laid out in the paper ‘National Research Framework for Problem Drug Use’ 
(Scottish Government, 2015) which called for a wider range of policy stakeholders to be involved in 
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In particular, work has taken place around the area of lived experience engagement – or peer led advocacy as it is 





the policy process (10). The following is an extract of my notes on this discussion which I wrote while 
transcribing the workshop recordings:  
 
 “The conversation has indeed been started but the structure of the conversation is still 
very much dictated to by those that hold the power – the policy makers, the institution that 
is conducting the conversations etc. For example, the LII 324 discussion on ‘seek keep and 
treat’25 was presented as gathering voices, experience, knowledge and views on the new 
strategy, and there was a lot of deeply informative conservations which , if taken on board, 
could alter the way SG implements the strategy –education, trauma, prescribing, criminal 
justice system. However, there was a feeling amongst the group they were there to rubber 
stamp the new approach, that it would not alter the implementation. On a similar note the 
refusal to engage with MCRS to the point of discord shows how the SG are not willing to 
reach too broadly, or deal with issues that may be seen as politically sensitive. They have 
however engaged, to an extent with SDPC, but we are more formal, there is recognition of 
the kind of group/interest we are representing. Someone, in regards BM’s26 attempts to get 
SG policy representation, actually said to me on the phone something along the lines of 
‘there are ways of doing these things and she is not doing that’. They expressed resistance 
because MCRS appeared to be a one women band determined to get the ball rolling, and 
she was, but MCRS ultimately represent thousands of people seeking cannabis as a solution 
to medical problems, who are too scared to put their name to official papers, and the 
government should have reacted better” (Field notes, December, 2016). 
  
 The groups mentioned in this extract will be explored in more depth in the following chapters, 




This section ends where my data collection period starts, 2016. From here on in the focus of 
the thesis will be on the narratives surrounding one aspect of the data, participation of stakeholders 
in drug policy formation. In order to explore this using the WPR approach we needed to develop 
an understanding of the historical legacies and how these helped shape the representation of the 
problem.  
 
This chapter addressed four of the WPR questions:  
1) What’s the problem represented to be? 
The problem in drug policy is represented as the impact that problematic drug use 
has on the well-being of individuals and society. As we saw, in 2001 policy began 
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to explicitly focus on the small cohort of individuals who use opiate based 
substances, and their use is perceived to cause harm to them and their community.  
2) What presuppositions underlie this representation? 
Underlying this representation is the presupposition that drug use causes 
unacceptable levels of harm to the individual and society.  
3) How has this representation come about?  
This representation has developed as a result of an increase in opiate based drug 
use, combined with an increase in poverty and deprivation as a result of the policies 
of the 1980’s. These policies resulted in the devastation of many industrial based 
communities, with job losses and lack of investment in housing etc. At the same 
time other forms of drug use were increasing, but their use was not perceived to 
cause the same amount of harm as dependent opiate use. As a result policy was 
directed towards the smaller, but more harmful, cohort of opiate based drug users.  
4) What is left unproblematic, where are the silences? 
The focus on harmful problem drug use has meant that other forms of drug use have 
been ignored, and at times actively silenced. People who use drugs but do not 
engage with treatment services, or do not use drugs to such as extent that they come 




In addition to answering four of the WPR questions, this chapter also set out to map the 
master and counter narratives in Scottish drug policy communities that have emerged over the last 
40 years. In doing so two narratives come through: one master, and one counter.  
 
The master narrative is: 
Drug use is harmful to the individual and society. Opiate drug use in particular has been 
causing harm in our communities for decades. The roots stem from the 1980’s economic and 
cultural upheaval, and as such we have embedded problematic drug use. This use is linked strongly 
to deprivation, poverty and trauma, but ultimately the individual needs to seek to recover.  
 
There are two aspects to this narrative:  
1) People need help to stop using drugs problematically, and the focus should be on 
encouraging individuals to stop their drug use and enter into recovery. Recovery is 
supported by the government and you will find different services to support you on your 
recovery journey.  
2) That sadly some individuals do not make it to the recovery stage and die from drug related 
illness/disease/use. Our job (the government, policy discussions, service providers and 
the wider community) is to prevent this from happening by focussing on the reasons why 






The counter narrative is:  
Drug use is pleasurable, and harm resulting from such use is often as a result of the criminal 
nature of the drug. Many people use drugs, but these voices are silenced or ignored by the focus 
on ‘problem drug use’.  
 
In summary the 1980s saw an increase in heroin use and increase in deaths from AIDs, 
resulting in the development of the problem/harm narrative. This section of the data focused on 
the development culture of drug use and the problem responsive policy developed as a result of 
the increase in opiate drug use and HIV infections. The narrative of current (2016 onwards) drug 
deaths being a result of the 1980s social policy is in part justified, but it is evident that responses 
from the more recent Scottish administrations have failed to address the overarching barriers to 
more radical solutions. The 1980s also saw the beginning of the debate in Scotland around 
abstinence or harm reduction. 
 
As we progressed through the years the focus moves away from the culture of drug use to 
institutional responses. As a result, the policy narrative becomes more and more focused on 
‘problem’ drug use, as opposed to drug use per se. Policy is explicitly directed towards problem 
drug users and the legacy of drug policy barely touches on so called recreational drug use usually 
associated with drugs such as cannabis and ecstasy. We see that despite an increase in so called 
recreational drug use resulting from the illegal rave scene, the only response is an increase in 
criminal sanctions through the Criminal Justice Act 1994. This silence in the policy arena is 
deafening, particularly to someone who has spent her adult life involved in multiple drug using 
cultures, and identifies as a recreational drug user. 
 
The 2008 Road to Recovery saw a shift towards recovery-based policy responses, and the 
competing narratives of pragmatic versus legislative reform began to become more evident. Over 
the following 10 years policy continues to be dominated by narratives of problem drug use and 
harm stemming from such use. By 2016 it is clear that the policy is solely focused on problem 
drug use as a health problem.  
 
The purpose of this section was to develop the understanding of what the problem is 
represented to be in Scottish drug policy, and how this came about. In doing so it addressed four 
of the WPR questions, and highlighted the emergence of master and counter narratives in Scottish 
drug policy development. As noted in the introduction, 2016 was the beginning of a raft of changes 





















“Calls for “evidence-based policy” and greater community “participation” are often 
heard in the drug policy field. Both movements are in different ways concerned with the 
same questions about how “drug problems” ought to be governed and the place of 
“expertise” and “engagement” in democratic societies. However, these calls rely on the 
assumption that knowledge’s, publics, expertise, and issues of concern are fixed and stable, 
waiting to be addressed or called to action, thus obscuring ontological questions about 
what “participation” (be that lay or expert) may do or produce. There has been limited 
research in the drugs field that has taken “participation” as an object of study in itself and 
through critical examination attempted to open up new possibilities for its remaking” 
(Lancaster et al, 2018, 351). 
 
This chapter goes some way to filling the research gap noted by Lancaster et al by exploring 
my experience of ‘doing’ participation with different drug policy communities, and critically 
analyses this experience using the WPR approach. In order to do this I use three of the six analytical 
questions set out by Bacchi (2009): 
 
4. What is left unproblematic in this representation? Where are the silences? 
5. What effects (discursive and lived) are produced by this representation?  
6. How can the representation be produced, disseminated and defended, and how can this 
be challenged?  
 
In answering these questions this chapter will address a core research question: What are the 
challenges in engaging different epistemic communities in a participatory process? 
 
The first part of this chapter will explore the literature on participation in policy, with a 
particular focus on expertise in drug policy. The second part will introduce my findings on 
participation using three groups that I was involved in: SDPC, LLEEG, MCRS27.  My involvement 
with these groups reflects the different ways in which participation can be enacted, and the extent 
to which this participation may be meaningful. Using myself as the main character in the story, I 
chart how participation can range from being consultative (giving feedback on a set agenda) to 
being influentially involved (setting the agenda). Further, my involvement saw me as an 
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expert/academic (SDPC), a representative of a community (LLEEG) and peer facilitator (MCRS), 
giving insight into different positions within policy groups. All three of these groups gave me an 
insight into how participation between non-institutional stakeholders and the government can be 
negotiated and sustained depending on the position (and ultimately the legitimacy) of the 
stakeholders. The final part analyses the findings of the chapter using Bacchis’ WPR Approach. 
In doing so it develops the core themes of the research, and shows how meaningful participation 
is dependent on the structure and power dynamics of the group in question.  
 
Finally, an important aspect of the following discussions is the concept of meaningful 
engagement. The experience of meaningful engagement is not static: it is dependent on the 
experience of the individual or group, and cannot be fully quantified. Therefore, for each group I 
briefly describe what meaningful engagement meant for them, or at least how I interpreted what it 
meant for them. Because I use myself as a subject, my own perception of what meaningful 
engagement entails is also relevant. The main focus is on the overarching process as opposed to 
analysis of the way in which groups were set up/conducted etc. The three groups are presented 
using a combination of auto-ethnographic narrative, written reports on the meetings, observational 
data, interview data, and documentary evidence. 
 
From ‘Evidence-led Policy’ to Stakeholder Participation 
 
In 2005 the UK Labour Government made a commitment to ‘evidence-led’ policy making, 
and in particular the use of ‘robust’ evidence in drug policy formation (Bennett & Holloway 2010). 
As discussed above in chapter 1, in the years following there has been growing understanding 
about the problems surrounding the concept of evidence, particularly regarding drugs (Stevens, 
2011; MacGregor, 2013; Roberts, 2014; Bennett & Holloway, 2010; Duke & Thom, 2014; Stevens 
& Ritter, 2013; UKDPC, 2012). 
 
While on secondment to a UK drug policy unit, criminologist Alex Stevens observed 
behaviours which highlighted problems with the use of evidence in drug policy formation 
(Stevens, 2011). Stevens found that while there was a high level of commitment to using evidence, 
there was often an ‘over saturation’ of evidence resulting in evidence being cherry picked to suit 
desired outcomes (Stevens, 2011). Furthermore, evidence was not used to challenge the 
conventional structures of power but to maintain the status quo and uphold the government’s 
narrative of ‘totemic toughness’, which downplayed the role inequality and poverty plays in 
‘problematic drug use’ (Stevens, 2011). This narrative highlights the use of evidence that supports 
a way of thinking that is comfortable with the unequal distribution of power and wealth (Stevens, 
2011; Lancaster, 2014). Further, it gives weight to a constructionist viewpoint that, as a result of 
the construction of the drug policy arena, those whose voices are more powerful and fit the 






It is argued therefore that evidence-based policy sets out criteria that is used to maintain a 
power structure that already exists (Stevens, 2011, 2018; MacGregor et al, 2014; Lancaster, 2014, 
Duke and Thom, 2014). This maintenance of dominant structures, through the use of evidence-
based policy, supports the development of a critical drug theory outlined below, by highlighting 
the use of evidence that suppresses the voices and narratives of those less able, or willing to 
conform or engage in institutional policy development. Increasingly forms of evidence used to 
meet this criterion are being challenged as maintaining the status quo of power structures that exist 
within the institutions of policy making (UKDPC, 2012; MacGregor et al, 2014; Lancaster, 2014; 
Lancaster et al, 2015; Stevens, 2018). For example, randomised controlled trials (RCTs) are seen 
as the gold standard of all evidence production, however this form of evidence production does 
not allow for the more inclusive forms of knowledge generation such as consultations, deliberative 
workshops, stakeholder representation, and narrative based evidence (MacGregor et al, 2014; 
Lancaster et al, 2015; Epstein et al, 2014; Duke & Thom, 2014).  
 
Non-professional (lay) participants can help policy makers understand how a proposed 
intervention will work, and give more insight into the social construction of the problem, and its 
goals (Epstein et al 2014, Colebatch, 2009, ch.3). However, it is argued they often lack cultural 
capital that is termed ‘political’ (May, 1992; Epstein, 2014) – the more nuanced understanding of 
the political and structural processes involved in policy formation. Further potential problems 
include co-option, tokenism and other ways in which lay participants (and in particular drug users) 
are involved, but side-lined, which I found to be true in my involvement with non-traditional 
stakeholder groups.  
 
Professionals involved in the formal evidence gathering process are part of a ‘community 
of practice’ that understands how to present their ideas and evidence in order to have the maximum 
impact. The term ‘community of practice’ was first coined by Jean Lave and Etienne Wenger 
(1991), who explored this term in relation to the development of apprenticeships. It is now taken 
to mean the broader social learning and shared sociocultural practices that emerge from specific 
social groups, in this case policy professionals (Nuttall, 2010). 
 
“The prominence of hard data, cost-benefit analysis, and formal premise-argument-
conclusion reasoning thus constitutes an important element of the shared repertoire – a boundary 
object that comes to delineate ‘legitimate’ participation in the development of policy” (Jasanoff, 
1997; Star and Griesemer, 1989; Fiorino, 1990; Epstein, 2014, 248).  
 
Lay participants on the other hand present their evidence using personal and contextualized 
narratives that may include in-depth knowledge about the topic, but because of the way it is 
presented they are not considered impartial, or based on the reasonable assessment of the situation 





ways of persuading policy makers, as McDonough comments in relation to stories versus peer 
reviewed evidence:  
 
“Stories can enable lawmakers to understand a legitimate need for policy change but just 
as readily can lead them to make bad policy decisions. Stories can bring to life drab data 
analyses, helping us to visualize problems and opportunities for change. But stories also 
can lead us down wasteful and dangerous paths and blind us to uncomfortable truths we 
would prefer to ignore, like the fact that there yet is no easy cure for breast cancer” 
(McDonough, 2001, 209). 
 
Drug policy is problematic therefore, because it involves ‘normative and evaluative issues’ 
which are embedded within the individual about how much weight to give to evidence (Roberts, 
2014), and determinants of risk and harms are subject to influence from political and cultural 
narratives (Rolles & Measham, 2011). Stories and narratives are built into the framework of 
deliberation as a result of historical legacies, making it difficult to challenge. It has been argued 
that a way of breaking these structures is to broaden the concept of drug policy expert to include 
previously marginalised voices such as drug user representative groups and drug consumers 
(Glasby & Beresford, 2006; Duke and Thom, 2014; Lancaster et al, 2018; RSA, 2007). 
 
Although the concept of user involvement in drug policy has been around for some time, 
it has only recently gained traction in mainstream institutional settings. For example, Public Health 
England have created a service user led treatment service (Public Health England, 2015), and 
researchers such as Alison Ritter and Kari Lancaster (2013, 2014), Betsy Thom (2014), Dorok 
(2014) and David Nutt (Carhart-Harris & Nutt, 2013) have investigated the opinions of drug users 
to help broaden to concept of policy expert to include drug consumers as stakeholders. In Canada 
there has been greater strides to include those with lived experience in policy development, since 
the release of Nothing About Us Without Us (Canadian HIV/AIDS Legal Network, 2007), 
particularly around harm reduction and injecting drug use. Since then, there have been various 
ways in which ‘peers’ have been engaged in policy development, with the ‘Canadian AIDS 
Society’ even developing an instruction manual entitled ‘Peerology’ (2015), on how to engage 
peers in local policy decision process. Peer engagement has been described as “consulting and 
collaborating with decision makers using a bottom-up approach in order to better address the 
needs of the community (Ti, Tzemis & Buxton, 2012, 47).  
 
Australia has also seen the impact of drug user organisations, with the Australian Injecting 
and Illicit Drug Users League who regularly submit policy recommendations developed within 
their membership community. In Europe there is the European Network of People who Use Drugs 
(EURONPUD), who also attempt to affect policy change and greater involvement in policy 
processes. Indeed, one member of the Scottish peer network was part of EURONPUD, but has 






Furthermore, Scotland’s Road to Recovery (2008) began the discussion around 
engagement in its definition of recovery, stating that “all services and commissioning partners 
must put service users at the heart of their activities” (4). In developing this approach, the updated 
Scottish Strategy ‘Rights, Respect and Recovery’ (2018) calls for greater inclusion of ‘lived and 
living’ experience stakeholders in all aspects of policy formation in Scotland by calling for an: 
 
“[E]vidence informed approach, which appropriately involves academic evidence, the 
voice of lived and living experience, family members, those with professional experience 
and other intelligence on alcohol and drug related harm and recovery” (Scottish 
Government, 2018, 4). 
 
Despite this increase in participation of drug users, there is growing criticism from a 
number of critical scholars on how this participation is enacted, including the ‘problematisation’ 
of evidence-based drug policy (Bacchi, 2017), and the way in which voices are legitimised in the 
process (c.f. Fraser & Moore, 2011; Fraser, Moore, & Keane, 2014; Lancaster, 2014, 2016; 
Lancaster, Seear, Treloar, & Ritter, 2017; Lancaster, Treloar, & Ritter, 2017; Ritter, 2015; 
Valentine, 2009). This growth in critical voices in part led to the development of critical drug 
policy set out in the following chapter, in order to ‘house’ the growing critique. Importantly it 
develops alternative paradigms to the harm narrative, in order to challenge the foundations on 
which most drug policy rests upon.  
 
The following explores my participation with three different groups: SDPC, LLEEG, 
MCRS, all of which had an element of drug user engagement. The SDPC was not explicitly drug 
user led, however many of us involved in the process have used, or currently use illegal drugs. The 
two further groups were explicitly user led, with one focussing on the engagement of those with 
lived and living experience of problem drug use, and the other with people who use cannabis for 
medicinal or therapeutic reasons. I chose these groups because through exploring the different 
journeys of engagement, they highlight the master and counter narratives that run through the 
different communities, and show how different stakeholders are afforded different privileges 
depending on their status. My involvement with these groups generated a considerable amount of 
data, and here I focus on specific experiences during the processes that shed light on the dynamics 
between individual/group narratives, and the institutional narratives that constrain (or empower) 
them. From this I developed a typology of stakeholders with the aim of providing a heuristic to 
explore positionalities and perspectives as mobilised in participatory processes: the professional, 
the sick, the recovered, and the happy.  
 
The reason I developed a typology of stakeholders is that during the analytical process it 
became evident there were different positions afforded to different groups/individuals depending 





between those who had lived experience, and those who were ‘experts’.  However, the deeper I 
went, and the more reflection I conducted on my own engagement, the more it became obvious 
that there were several different layers of legitimacy that impacted how individuals could engage 
at an institutional level. The typology evolved out of this analysis and reflection to become the 
four types of engagement mentioned above, and which I develop below. These statuses, or 
typologies, are not mutually exclusive however: it is possible to be a professional and recovered 
stakeholder for example. However, in most instances I found them to exist on their own, as 
explored below.  
 
The Lived and Living Experience Executive Group (LLEEG):  
The ‘Official’ Way to Engage  
  
 The Lived and Living Experience Executive PADS Group was set up to provide a pathway 
for the voices of people who have ‘lived and living’ (current) experience of ‘problematic drug 
use’. I chose to use this group because I was involved from the beginning, and it highlights the 
challenges and positive outcomes engagement with this group can provide. Furthermore, the group 
was set up by the PADS executive committee to provide a pathway for lived experience 
representatives to attend the executive committee, and is therefore a good example of pathways to 
policy engagement. However since my data collection, two developments have happened. Firstly 
the suggestion by PADS committee members to include representatives from the LLEEG group 
on the executive committee was rejected (private communication with members). This was not 
communicated to the group and shows how disconnected drug policy governance in Scotland can 
be. Secondly, the PADS advisory structure was disbanded in August 2019 to be replaced with a 
Drugs Death Taskforce. Therefore, regardless of whether a representative was chosen or not, their 
involvement would have been short lived28. Despite these developments, my involvement with 
this group helped shape my understanding of how engagement is enacted, and may be conducted 
in Scottish drug policy in the future.  
  
 The development of the term ‘lived and living’ is in interesting one as it shows the 
implementation of what Fleetwood (2016) terms ‘narrative interventions’ during the course of the 
LLEEG journey. Narrative interventions, as described in chapter 2, are a well-developed technique 
in certain disciplines such as education (Fleetwood, 2016; Hochstetler et al., 2010; Presser, 2009). 
However, Fleetwood has argued for its incorporation into criminology in an attempt to change 
harmful discourse, as opposed to the perceived harmful individuals (Fleetwood, 2016, p.188). It is 
argued that such interventions have the possibility of creating harm by imposing the dominant 
discourse onto marginalised populations (Fleetwood, 2016). However, they can also be used to 
empower, by challenging the dominant language and initiating change to reflect the discourse of 
those who are marginalized. Exploration of these interventions in the following pages also 
                                                          





highlights where the silences are/were (WPR #4), the effects of the problems representation (WPR 
#5), and how this representation can be disrupted, questioned, challenged and replaced (WPR #6).  
Meaningful engagement for this group of participants was not uniform, with some seeing the 
setting up of the group itself a form of meaningful engagement, and others seeing the whole thing 
as a charade, with meaningful engagement requiring power at the agenda setting stage (executive 
group/direct links to Ministers).  
 
Are we Lived, or Living?  
 
 The term ‘lived experience’ was initially used to describe someone with experiential 
knowledge of drug treatment and recovery services. During the course of its development, it was 
acknowledged that people who currently use drugs should also be involved in the process, and it 
was expanded. This is an example of a narrative intervention. I was part of the first LLEEG 
meeting that started to ‘disrupt’ this term and my reflections on this specific point were as follows:  
 
 “I found the process very moving – in regards who is the drug user in this narrative it 
is most definitely the reformed user – those who have gone through the recovery process 
and are now ‘clean’. Yet, at the same time there was a recognition that there are voices 
missing from the conversation – that of the living drug user (i.e. those who still use drugs 
and are not interested in stopping). 
 Even with the awareness that the living experience is missing, there seemed to be an 
unwillingness to properly address the fact that we are only focusing on those whose drug 
use appears to have caused a lot of harm, to themselves and their families. When I tried to 
get clarification on whether they mean all drug users I was met with nods of agreement, 
but a silent feeling that I was trying to bang a drum for something that was not worth the 
time (field notes LLEEG, 2017). 
  
 My attempt to get clarification on the exact kind of living experience is reflective of my 
personal agenda. I have found that there is general agreement within the policy community that 
Scottish drug policy is directed towards those that appear to cause the most ‘harm’, and this is 
logical, as I showed in Part 2, Historical Legacies. The issue lies in the fact that drug policy, both 
reserved and devolved, affects all drug users. As a person who has used drugs for decades, and 
interacted with many drug using communities, I have seen and experienced this. My personal 
agenda, this rearing up of my internal sense of injustice, was something I struggled with throughout 
the research process. Personal agendas aside, the extract show us that the discussion began to give 
voice to the previously ignored - those who currently use drugs - and initiated the broader 
conversation of the impact drugs policy has on all drug users.  
  
 The following is an exploration of my engagement in the third LLEEG meeting. This 





establishing a  “network of people who are experts by experience” (Field notes, LLEEG, 2017), 
getting feedback on the draft drug strategy ‘Seek, Keep, and Treat’, and developing pathways for 
involving more people with lived and living experience. I have adapted my own reflections written 
just after the event, combined with official records of the event, and up to date reflection and 
analysis. Many of the quotes are taken from the official report sent out to participants. When I am 
using these quotes, or any part of the official report I shall use the reference LLEEG report, 2018. 
The report is public, but not published online.  
 
Lived Experience Group Number 3 – 25th January 2018 
 
We were introduced to the event and informed we would be looking at all different aspects of 
the addiction/recovery continuum. This made it explicit that the focus was on ‘problem drug use’ 
as opposed to all drug use. The Scottish Government aims for the refresh were to broaden the 
advisory structure to include service users (‘problematic drug users’) in order to provide:  
 
1) Continuous improvement – which involves service user engagement.  
2) Asset-based – looking at the things which are good – not just as what are bad/not working. 
3) Co-produced –mobilising service users to help produce research.  
 
 The event was structured into different sections. The Minister for Health and Sport at the 
time - Aileen Campbell - spoke first, and then left for the day. This was not received well, with 
participants feeling that they were being subject to the same treatment that had been going on for 
years: “[W]here are the outcomes of these meetings being carried forward? “I’ve been coming to 
these sorts of meetings for years and the Minister turns up and then she leaves. Smacks of 
tokenism” (Field notes, LLEEG, 2018). Underlying this is the belief that Ministers are not actually 
interested in the voices of lived and living experience, which sets the tone for the engagement 
going forward.  
  
 In her speech to the group the Minister reiterated the tagline of ‘Seek, Keep and 
Treat’, and how this means the focus is completely on services, but she highlighted that she wanted 
it to be holistic, all encompassing, and trauma informed. She stated that she wanted all policy to 
be underpinned by lived experience input, but she was also looking to be challenged, for the 
boundaries to be pushed. I found this to be at odds with the discussion I had with her prior to the 
speech. I cannot comment on the discussion except to say she appeared to be emphatic that much 
of the drug policy responses were constrained by constitutional elements.  I call this ‘constitutional 
sidestepping’. By acknowledging but ignoring, a form of this tactic is successfully employed to 







We then did an A-Z exercise where people were asked to put comments starting with A 
through to Z on what recovery meant to them. This was another indication that despite remarks to 
the contrary, the group was focused solely on the recovery agenda.  
 
In discussion with people during this aspect of the event it became clear that the focus on 
recovery and addiction silences, or completely ignores, all other forms of drug use, and users. 
There is a focus on addiction (or ‘problem drug use’) because people with addiction present the 
biggest ‘problem’ to society in regards to economic and social impact. Despite the fact that there 
is a recognition of the social conditions and trauma that leads to or exacerbates ‘problematic drug 
use’, the focus is firmly on the drug use of individuals, how can we help ‘them’ stop using drugs. 
 
A comment from the main facilitator highlighted the underlying normative assumptions of 
those in the recovery and institutional organisations: “we asked not just people with lived 
experience but also academics, experts and professionals…” (Field notes, LLEEG 2018,). My 
indignant personal agenda raised its head again. “But I am an academic (burgeoning at least), and 
an ‘expert’, and a professional, as well as a person with lived/living experience. Where do I, and 
all those like me, fit into all of this?” This narrative establishes an epistemic boundary which makes 
lived and living experience, and academic and professional judgement mutually exclusive. By 
creating these distinctions the narratives of ‘us’ and ‘them’ are maintained, and the avenues for 
engagement are constricted to the type of stakeholder you are identified as, or identify with.  
 
Once again, this focus on problem drug use to the exclusion of other forms of drug use 
highlights where the silences are in this engagement. By limiting the possibility of discussion to 
people with lived and living experience of problematic drug use, and further limiting this to 
discussion on treatment provision and how to increase uptake, a large section of the drug using 
population is ignored.  
 
Feedback on the Draft Strategy ‘Seek, Keep, and Treat’ 
 
The main focus of the event was the feedback on the draft strategy document. A member 
of the Substance Misuse Unit (SMU) introduced the strategy, and appealed to the participants to 
look past the title and focus on the content. In doing so, he made it clear that they were already 
aware of the problems associated with the title. The following explores how the strategy was 
introduced to participants, and the reactions to the strategy, with analysis.  
 
The tagline ‘Seek, Keep, and Treat’ came out of the Opioid Replacement Therapy (ORT) 
Rapid Evidence Review by the DSDC (2013), with each word representing a stream identified as 
being important in encouraging uptake of ORT. While the streams identified fitted an 





Treat’ demonstrated a lack of sensitivity or understanding about how that title may come across. 
The following is an exploration of the response.  
 
 The SMU member urged us to look beyond the headline and try to imagine initiatives and 
possibilities that are not immediately obvious. He introduced them as: 
 
1) Seek – finding those people who are not in treatment and supporting them in a 
compassionate way.  
2) Keep – designing services that attracts people and makes them want to stay. 
3) Treat – how do we keep and treat people to help them ‘change’.  
 
The group were asked to comment where we thought lived and living experience sat in this 
process. We were asked to discuss (i) what we thought of the wording and substance of the draft 
strategy, and (ii) what we thought would ‘solve’ ‘problematic drug use’. Here is another example 
of the harm paradigm that drug policy is seen through. In engaging drug users in policy there is an 
unchallenged assumption that their use is a ‘problem’ to be ‘solved’. This paradigm is critiqued 
and challenged using critical drug theory set out below. 
 
It is fair to say that the response from the floor was not enthusiastic. The people in 
attendance expressed great dissatisfaction with the slogan. The (good?) intentions behind it being 
obscured by the language used. Discussion on the wording elicited strong responses:  
 
• “This is inherently stigmatising – would you do the same for obesity/smoking?”  
• “It’s really important the government gets the language right. Stigma starts in policy”. 
• “I think the heading is absolute balls”.  
• “Seek, Keep, Treat. Sounds like a zoological hunt for an endangered species”.  
• “The strong reaction is rooted in fear. There is fear that the professionalised world of 
academics and medics are (re)exerting their power” (LLEEG report, 2018,5; Field notes, 
LLEEG, 2018.) 
 
1) Seek – means you are looking for people with certain characteristics. Yes, it can be said 
there does exist the stereotypical, low income, most likely inter-generational drug or 
alcohol addiction, problems in family and community, often known to services but never 
or rarely engaged, but this demographic forms one example of a range of people 
experiencing so called ‘problematic drug use’, and often they are part of the system already. 
It therefore has the possibility to increase stigma, discrimination and marginalisation. 
 
2) Keep – you are forcing people, or strongly encouraging people into pre-defined models of 
what is believed to be the ‘best’ treatment model. This is despite the assurances that 






3) Treat – too clinical, “operation addiction, sounds like the name of a heat seeking missile” 
(Field notes, LLEEG, 2018). The focus is still on the individual, it is the person using the 
drugs which is the focus of attention, not the context, the institutional and societal 
frameworks.  
 
This fear is not misplaced, as has been born out by the disbanding of the LLEEG group 
and the replacement of an advisory structure that focusses heavily on academic and medical 
interventions (Drug Deaths Taskforce). The use of language was deeply misguided, and showed 
that those developing the policy had little understanding of the impact it would have on those the 
policy is directed towards. Further, participants expressed the fear that:  
 
“[T]he gains of the last few years are being set aside. There was anger in the room. People 
feel disempowered by this. People also saw the model as being a ‘rebrand’ of what is 
currently being offered. What is being offered are not ‘recovery’ services. People feel that 
recovery hasn’t been given a true chance, it hasn’t got started in many places” (LLEEG, 
2018, 5).  
 
The reason people feel this is that practice throughout Scotland is not being carried out 
uniformly. Access to services, how recovery is being implemented, and even what recovery means, 
are still issues in many areas (c.f. Dundee Drug Deaths Commission).  
 
• “Related to this is a feeling that no-one is being held to account, that there is no 
responsibility being taken by services or those with power (whether political or 
purchasing). There is a question that needs to be raised about the hierarchy of evidence 
that gets used to help shape strategy and system redesigns such as these. Who gets 
listened to, and why?” 
• “It explicitly focuses on a certain demographic. BUT, when challenged we are told it 
is about ALL”. 
• “The clinic model has not had and continues to have very limited success. How does 
this wording suggest anything NEW?” 
• “How is this different from the concept of ESSENTIAL CARE in the 2008 strategy?” 
(LLEEG, 2018, 5; Field notes, LLEEG, 2018) 
 
This links in strongly with the research into different types of evidence and the weight 
given to it. There is a belief that robust and strong evidence is based on scientific research 
principles, and that stakeholder input in the form of stories or narrative (as opposed to technical 
reports, scientific research and so on) are considered persuasive arguments that may support policy 





Jasanoff, 1994). For example, an interview participant, who was also one of the main policy 
advisers to the Scottish Government, had this to say about the hierarchy of evidence:  
 
“I mean look up the Cochrane database, they do surveys on analysing the evidence on this 
drug and that drug, this procedure that procedure, you know they’ll do research on… And 
Cochrane databases are hugely informative and hugely useful, in just spelling out what is 
the literature and that’s what it says. So the top of the evidence tree is RCTs, you know 
double-blind trials, but the bottom of the evidence trail is self-reports and opinion, either 
professional opinion or patient opinion. So you know if they were scoring it after 10-and 
they don’t score out of 10- but if they were, 10 out of 10 would be an RCT on the subject, 
one out of 10 would be a patient saying this drug worked and now I feel better and the pain 
went away, and all the way in-between you have different levels of studies. 
  So you know you’ve got observational studies or studies with patient groups, you got 
non-controlled studies, so there are levels of evidence, and all these levels of evidence are 
taken into account. So if you’re studying the effect of a drug on rheumatoid arthritis you 
will go to the database and say where are the RCTs on this, there aren’t any okay, where 
are the observational studies, here it is, quite a good study, you know this is a good study 
from France that shows 300 patients reported positive… So you know you have a level of 
evidence there. But you know you would like an RCT, so people would go on to do in RCT, 
and it is a big investment you know then people would like there to be RCTs, RCTs are 
considered to be important. But for policy, policy doesn’t work like that… [T]hey sort of 
say how much damage is this going to cause me to make this decision” (Senior Drug 
Advisor). 
 
What is interesting about this statement on evidence hierarchy is that in some ways he 
contradicts what those in the LLEEG feel is happening - that the academics and medics are re-
asserting their power. This participant comes from a medical background, and his use of evidence 
is based on that paradigm. Yet his perception is that decisions on drug policy are made on a damage 
limitation basis, as a further quote illustrates:  
 
“I mean Michael Howard said to us (the ACMD) once, you know we said ‘we need to do 
something on cannabis Minister’, and he just laughed said ‘why would I do anything on 
cannabis’, he says ‘how could that possibly help me as Home Secretary to do anything on 
cannabis. You find out it is not harmful is that going to help me? You find it is harmful is 
that going to help me?” (Senior Drug Advisor)  
 
These quotes illustrate that the participants have in fact good reason to be fearful and feel 
dis-empowered as the medico/legal/political paradigm appears to be as strong as it ever was.  There 
were feelings in the group that the LLEEG was just another political exercise to smooth over the 





stakeholders, as per the Scottish Governments commitment. Indeed, during my data collection I 
had begun to wonder whether I should have focused a bit more on evidence, however when I put 
this to an interviewee responsible for evidence and data in health research she replied ‘“well it 
doesn’t exist does it! So, while there is a lot of effort being made to create evidence informed 
alcohol policy, drug policy does not have the same investment” (Senior Civil Servant). 
 
Furthermore, to many people the frustration was that ideas such as this continues to miss 
the point – that ‘addiction’ is a symptom of something else. We can continue to “shift the deck 
chairs on the Titanic” (LLEEG 2018, 5) but what is really needed is something that begins to 
address the reasons why people get ‘addicted’ in the first place: “Why the addiction, why the pain, 
society broken”, and, “most people use substances to cope with underlying issues. Until you find 
out what the true root of the problem is, it’s like a plaster over a gaping wound” (LLEEG, 2018, 
5). 
 
An Example of Narrative Intervention 
 
Overwhelmingly the response to the draft strategy document was a focus on the 
stigmatising impact of the choice of words. Alternative wordings were suggested:  
 
“Find, Choice, Offer, Nurture, Enhance, Support”, “Welcome-Input-Nurture”, and, 
“Options/Choice/Empower” (LLEEG, 2018). 
 
These alternative words show how the participants felt policy should be developed. Using 
words such as “choice, options, empower and nurture” shows the human rights based language 
that we have come to internalise through the focus on such rights: Participants want to be respected, 
to be given choices on how they engage with the system. In response to this criticism the SMU 
changed the title of the strategy to ‘Rights, Respect and Recovery’, and embedded peer 
engagement and participation into many of the key outcomes. The 2018 drug strategy states that 
“all citizens: 
 
• Have the right to health and life - free from the harms of alcohol and drugs; 
• Are treated with dignity and respect; 
• Are fully supported within communities to find their own type of recovery.” 
(Scottish Government, 2018, 4) 
 
Having gone from a medicalised ‘problem’ orientated response with ‘Seek, Keep and 
Treat’, the final strategy document focusses on human rights, dignity, and the role of communities. 
This change in language is an example of a narrative intervention: where the language was changed 
in order to reflect the perception that previous language was harmful to the stakeholders it was 





identified by policy makers as ‘key’ stakeholders express frustration at the lack of perceived 
meaningful engagement. An pillar of critical drug theory would use these stories of frustration and 
develop narratives to challenge, and change the systemic ‘problem’.  
 
 In contrast, my experience of engagement between institutional actors such as the 
government and the police, and users/non-traditional stakeholders within the medicinal cannabis 
movement in Scotland was not so organised, as set out further on. The next group I look at explores 
how ‘professional’ stakeholders can navigate engagement with policy actors.  
 
The Scottish Drugs Policy Conversations (SDPC): The Professional 
Stakeholders 
 
As outlined above, SDPC was set up by co-convener Mike McCarron and myself, and 
initial participants were those who were known to us, and were in some way involved in drug 
policy deliberations in Scotland. However, the groups aims were to go further than just ‘chat’ about 
drug policy, but to have meaningful engagement and input into the formal policymaking process 
(see Appendix 2 for breakdown of conversations). Meaningful engagement and input for SDPC 
meant direct links with the bodies who formulate and implement the policy, through engagement 
of these bodies in the conversations. This meant that in order to us to feel we had provided both 
meaningful engagement and input, members of the government needed to attend (in particular the 
SMU) as well as other institutional bodies such as Police Scotland, NHS Health Scotland, and the 
different 3rd sector groups involved in carrying out drug policy initiatives. Furthermore, we wanted 
to see themes and discussions arising from the conversations being implemented by these 
organisations through language change (such as the commitment to engage more stakeholders, and 
a move away from terms such as ‘addiction’), and a more general focus on the impact of policy, 
as opposed to the impact of drugs. However, because of the structure of SDPC – initially designed 
to be collaborative and have a focus on the quality of the engagement as opposed to outcome 
focussed – the concept of ‘meaningful engagement and input’ was more about personal experience, 
and therefore cannot be quantifiably measured.  
 
This story is about how to become involved in the policy advisory framework without 
being part of that framework. It highlights the ease with which those who are considered 
‘professional’ can access policy makers and the wider advisory community, despite not being part 
of the official framework. Once again I use a mixture of field notes at the time combined with up 
to date reflections to form one narrative, as well as quotes from interviewees and documentary 
analysis.  
 






The first step was to contact the Drug Policy Unit of the Scottish Government (now the 
Substance Misuse Unit - SMU) to make an introduction. It is not easy to get the emails of particular 
civil servants, and I used my networks to find out who I should be contacting. Here is a musing on 
the initial set up process: 
 
“I have had some really good communications with several people I have approached 
about the SDPC. Many people are on the same page, and I realise that this process is going 
to need to be delicately managed, as there are so many different groups and people, ideas 
and motives that in a sense it can’t become too solid in its aim. I think it has to remain a 
relatively ad hoc collaboration but provide a forum whereby different experiences, 
opinions, research and ideas can be shared. This should also include a mechanism to feed 
directly into policy, kind of acting as a third party but maybe not as that term is not a good 
representation” (Reflective diary, 21st April 2015). 
 
I am musing here on the positivity surrounding the initial setting up of SDPC. Many people 
I had engaged with through interviews, participant observation and informal conversations at 
meetings and within the drug policy community, felt that a new way of discussion and 
collaboration on drug policy issues was needed. There was hope that the ‘new landscape’ outlined 
in the Scottish Governments 2015 document could lead to meaningful engagement with non-
traditional policy stakeholders. There was also a desire to include as many voices as possible, in 
the recognition that different perspectives needed to be listened to. We held our first conversation 
on the 18th June 2015 with 20 people attending. 
 
Overview of SDPC 1 
 
“Working within such a process, the inaugural meeting of Scottish Drug Policy 
Conversations served primarily to prepare the ground and build rapport between all 
participants. People attending showed openness and keen interest in being involved with 
an initiative that may help change the way in which drug policy is viewed and talked about 
in Scotland. Much of the conversation was about why people attended; their questions 
about current policy, a concern to engage all stakeholders, and other issues detailed below. 
There was not enough time to focus on systemic issues or discuss the pros and cons of 
current legislation almost fifty years on from the Misuse of Drugs Act 1971. As a result it 
was agreed that the same group should meet again with the aim of reaching a deeper and 
shared understanding to underpin a proposal for the focus, next steps and timeframe of 
SDPC.  
…Conclusion and Next Steps 
There were encouraging signs that Conversation 1 created a safe space to air critical 





The ever-changing complexity, variety of stakeholders, and continuing harms associated 
with drugs indicates drug policy is apt for consideration using PRUDDIE (an engagement 
technique) and keeping in touch with other participative social change technologies being 
tried out in Scotland” (SDPC 1: Record of Discussion, 18th June 2015). 
 
Conversation 1 generated an enthusiastic discussion. The focus on the concept of respectful 
dialogue (see Appendix 3) and even the setup of the room (a circle as opposed to tables and chairs) 
created an environment that encouraged open, yet challenging dialogue. Although at times there 
were competing views, because of the structure and the facilitation in particular, these views were 
discussed in a respectful way. Additionally, on reflection, the timing was important. Scottish drug 
policy was beginning to experience a lot of criticism, and relationships between the different 
stakeholders was often confrontational. Providing this safe space to explore these sensitive issues 
was important, and feedback at the time and since has been that we found a window of opportunity 
to influence policy decisions (Kingdon, 2003). Whether we influenced policy was another matter 
and will be discussed below. One aspect that was not recorded in the official minutes was the 
reasons why people were interested in being involved. Everyone in the room was involved in 
different aspects of drug policy, from academic research, providing front-line services, policy 
making, policing and health. All those who came to this first meeting did so because they were 
frustrated with the pace of change, had an interest in dialogue on the issues, and importantly many 
had some kind of lived experience - either personal use or through friends and family - that made 
them view current drug policy as not working. This is a theme I identified throughout my thesis, 
and beyond. Those who have a personal stake in the outcome of policy, either through friends, 
family, or from engagement in the field for a long time, appear to have more impassioned 
engagement in the process, and usually directed their views towards drug policy reform.  
 
Furthermore this meeting was attended by civil servants from the Scottish Government, 
who participated in the open and honest conversations generated within the group, and between 
the smaller group discussions. This set a tone, at the outset at least, of meaningful engagement: 
participants felt they were in some way involved in the process of policy making at the agenda 
setting stage.  
 
These smaller group conversations highlighted systemic issues surrounding drug policy, 
one of which was that a focus on drug harm meant that those who use drugs without such harm 
were silenced and ignored, and have limited avenues of ‘officially’ contributing to drug policy 
formation:  
 
 “it was expressed by many that the current legislative and policy framework does not 
recognise the multiple ways in which drugs are used. It therefore tends to focus on 
problematic drug use and criminalises those who use recreationally, responsibly and to 





related harm actually means and the social impact of drug use were highlighted as 
problematic.  
While many (not all) participants thought that reformative and even legislative change is 
needed, and indeed with many having been involved in shaping drug policy over the years, 
there appears to be difficulty in influencing policy considerations at a higher level to take 
account of changing attitudes of the public, research findings and shifts in drug policy and 
practice in other countries towards less punitive drug regulation” (SDPC 1, July 2015). 
  
Despite the fact that the room was full of people who held prominent positions in drug 
policy formation, this frustration on the pace of change was almost unanimous. The question that 
bugged my mind was why, despite the frustration at many levels, is there not more movement? An 
interviewee answer may help to clarify:  
 
“[O]f course there is a complex drug problem, with lots of other things, but I think the 
belief in government circles is that we’re quite safe to not do anything, not get too involved, 
and you can quite happily cut back and nobody’s going to complain. So, cynically I think 
there is a view that there is no need to do anything urgently, and despite colleagues and 
other people I know trying to draw attention to it - you know these new guidelines are going 
to draw attention to some of the harms, our own committee shouting about all the harms 
are going on (Drug Related Harm PADS Committee) I think it will have some impact. 
Ministers listen to it but I don’t think they have the statesmanship to sort of say okay we 
need a shift here, we need something new, we need something different. And I don’t think 
we have the money to do it either, you know that’s a problem in a declining economy then 
it’s very hard to find things - you know - to put some things ahead of other things. So saying 
you gonna spend, I don’t know - an extra couple of hundred million on drug use services - 
because that’s what it would take - people are going to say what about the waiting lists for 
hip operations for little ladies” (Senior Drug Advisor).  
 
What is being said here is that despite there being serious concerns from the drug policy 
advisory committee, and the wider drug policy community, about the pace of change, politicians 
do not want to become too involved because services for drug users are not as politically sensitive 
as “hip operations for little old ladies”. The fear of public retribution should money be spent on 
‘wicked issues29’ prevents investment in drug services, and ultimately more deaths. Returning to 
the theme of ‘meaningful engagement and input’ this comment makes it clear that unless drug use 
and drug policy become as salient issue for the ‘general public’, such engagement and input will 
not take place.  
 
                                                          
29 This term was used in private discussion with a minister when asked why the Scottish Government were not more 
vocal about drug policy reform. However, this term developed in the 1970’s as a way of describing policy problems 
that are complex and difficult to deal with using simpler exhaustive solutions (c.f. Rittel, H & Webber, M. 





Overall this inaugural meeting highlighted master narratives that are being explored 
throughout this thesis: the focus on problem drug use as opposed to all drug use, resulting in a 
silencing of narratives that challenge this focus; and the desire to see more meaningful 
participation in drug policy formation which may help to speed up the pace of change, at all levels.  
 
Negotiating ‘Meaningful Engagement’ - Policy Makers 
 
An important element of creating ‘meaningful engagement’ was the involvement of the 
Scottish Government Substance Misuse Unit (SMU - formerly the Scottish Drug Policy Unit) - the 
civil servants responsible for Scottish drug policy.  I had good email communication with members 
of the SMU, and with representatives at our initial conversations. However, our role and position 
within the formal policy process was not clear, and Mike and I were invited for a meeting with the 
Unit Manager (UM) and Division Head (DH) to discuss how SDPC could contribute and 
compliment the formal structure. The following is an excerpt from my notes of the meeting in 
January 2016: 
 
“AR and MM then gave a background on SDPC and thoughts on where this may be leading 
– we felt that SDPC provides an amazing space for people to talk about issues without it 
becoming confrontational. We also saw the possibility for SDPC to collaborate with the 
SMU on an ad hoc basis and this was picked up by the SMU and agreed. When we outlined 
the core problems identified by the group in SDPC 3 we were told that the same problems 
had been identified in a similar exercise carried out internally within the SMU. This helped 
to make us all feel we are singing from the same hymn sheet, as far as problems are 
concerned” (Field note, 2016) 
 
Mike and I were greatly encouraged when we discovered that many of the themes SDPC 
had identified were replicated by the internal exercise at the SMU. Overall the focus was on the 
dynamic between health and criminal justice approaches, and evidence in policy formation. In 
particular, the focus on drug related harm, combined with criminal justice measures, means that 
harms created by drug policy, and those who take drugs without harmful side effects are ignored. 
Listening to those voices helps to de-stigmatise drug use by highlighting how not all drug use is 
harmful, and that drug users do not lack agency. Furthermore criminal sanctions, and a focus on 
the harmful effects of drugs perpetuates stigma towards drug users by (i) criminalising the activity 
and thereby creating criminals, and (ii) perpetuating the narrative that all drugs are harmful. The 
important point is that there appeared to be alignment of narratives between those in SDPC and 
the civil servants responsible for drug policy. This was furthered by the following: 
 
“UM emphasised that the goal within the SMU is to reduce the harms associated with 
problematic drug use and this is important as it highlights the actual goal, as opposed to 





differences lie, and the SMU are constrained in the options open to them. Always a focus 
on problem drug use and associated problems. AR highlighted that part of the discussions 
within the SDPC had raised awareness of the non-problematic drug users, and how these 
represented the majority of drug users. If this is highlighted and is given more coverage it 
then focuses the attention on the real problems being suffered by problematic drug users; 
life history and trauma rather than drug use per se. UM and DH agreed with this.” 
 
This was the first time I had heard what the goal of Scottish drug policy is ‘from the horses 
mouth’ so to speak. While reduction of harms resulting from ‘problem drug’ use is a key goal of 
Scottish drug policy (Scottish Government, 2008, 2015, 2018) there is less clarity on how this 
harm is identified, and whether all forms of drug use are covered by it. Key to this was the 
agreement that the drivers of problematic drug use must be addressed, and this was evident in the 
future 2018 drug strategy Rights, Respect and Recovery (Scottish Government, 2018) (chapter 6 
and 7) which focussed a large portion of the strategy on community recovery and addressing 
underlying problems such as mental health and early life experiences. This exchanged clarified 
that the goal was the small minority of drug users who had multiple problems including drug use 
– the ‘problematic substance users’. Furthermore, it highlighted that it is not only non-institutional 
stakeholders that need to be meaningfully engaged. Participation of civil servants, and the 
involvement of all stakeholders is required in order to create meaningful connections and dialogue. 
The agreement from the SMU that most people use drugs non-problematically, and that by 
focusing on this we can move attention to the reasons people use drugs, as opposed to focusing on 
people who use drugs, was important, and signalled the common counter narrative to ‘problem’ 
drug use that was emerging from this engagement: that the focus on ‘problem’ drug use 
ignores/silences non-problematic drug use.  
 
Other notes of this meeting included:  
 
“The SMU seemed encouraged by the direction the SDPC appears to be going and we then 
discussed exactly where they thought the SDPC could contribute. It was suggested by us 
that we would continue to work as an independent group but could potentially provide an 
advisory role on specific items. It was also suggested, by the SMU, that the SDPC could 
help to smooth the way for certain policies which may receive backlash from the media. 
Although no specific policies were mentioned in this context it was said that when a minister 
starts his/her position s/he is presented with a range of policies by the SMU, which includes 
other possibilities, but until there is clear public support for such initiatives these policies 
recommendations remain under the table.  
In the final part Mike and I clarified that the SMU would encourage the continuation of 
SDPC in whatever role, including challenging the status quo and having a reform agenda. 
We ended with an agreement that a representative from the SMU would always try to come 





process of incorporating the structure of SDPC with a view to becoming a part of the wider 
Scottish drug policy landscape. There was a suggestion that Mike and I meet with the SMU 
quarterly to update and see whether there are areas we can collaborate on.”  
 
This final section shows that the initial engagement with the SMU was productive, and 
there was agreement going forward of both the role of SDPC in providing the more 
challenging/reform agenda style input, and the engagement of the Unit in the meetings. This 
engagement of the Unit provided the first step towards what we had identified we would need to 
provide the perception of meaningful engagement and input. Given how our collaboration actually 
worked, this initial meeting appears to have been more aspirational than was perhaps achievable. 
If I had known about the comings and goings of the independent Drug Strategy and Delivery 
Commission (chapter 6) I may have been more wary. However, here it shows how negotiating 
engagement with policy makers involves reciprocal arrangements. We agreed to help them by 
smoothing the way for potentially controversial initiatives, and they helped us by agreeing to attend 
the meetings and continue the dialogue. This worked for us because it was important that SDPC 
had some formal arrangement with the SMU in order to give a sense of legitimacy and ability to 
enact change. On the other hand it worked for the SMU because it showed they were engaging a 
broader range of stakeholders. We were, in effect, working within the horizontal policy making 
arena (Colebatch, 2009). 
 
The creation of SDPC provides an insight into how non-traditional structures can 
participate in the policy arena, yet we were taken seriously because our participants were viewed 
as ‘legitimate’ and the way in which we engaged was non-confrontational, to be begin with. Our 
participants were pooled from a cross section of stakeholders and included many of the ‘same old 
faces’. Yet there were many non-traditional participants such as the Psychedelic Society of 
Edinburgh, cannabis reform campaigners, criminal justice reform groups, 3rd sector organizations 
that were not currently involved in policy, and a range of academics. This gave us an additional 
appeal: not only were we conducting our conversations using deliberative public engagement 
processes with a focus on respectful dialogue, we had managed to gather a varied mix of 
stakeholders. As the co-convener of SDPC, which was being hosted at the Institute for Governance 
at the University of Edinburgh, and a PhD candidate with professional experience in the public 
sector, I was able to approach senior figures in a range of institutional settings and be taken 
seriously. My own drug using history was not known, and I was therefore considered a neutral 
broker between stakeholders. Generally speaking I had little difficulty accessing policy makers 
and associated advisers, and developed professional relationships with members of the SMU. This 
enabled me to feed back the outcomes of the SDPC, in the hope they would be used to help shape 






The next section explores the deterioration of my relationship with institutional actors as 
my persona of neutral professional/expert became entangled with activist based stakeholder 
persona (the sick and/or happy drug user). 
 
Medicinal Cannabis Reform Scotland (MCRS): The Sick Stakeholders 
 
There are two kinds of ‘sick’ stakeholders: those who are considered sick as a result of 
their addiction and are thus legitimate participants in the policy process, and those who are using 
illegal drugs to treat illnesses as a result of a disease like cancer, epilepsy, fibromyalgia, anxiety 
and so on. This research shows that the latter stakeholders are not considered legitimate by 
institutions such as government or the police, at least not legitimate enough to be involved in policy 
decision making.  
 
This case study follows my engagement in the Medicinal Cannabis Reform Scotland 
(MCRS) campaign, as they attempted to create some form of stakeholder engagement with the 
Scottish Government on cannabis issues. MCRS is a grass roots campaign calling for the ‘Right 
to Choose’ medicinal cannabis to treat illnesses – the concept of individual sovereignty and the 
empowerment of stakeholders to treat themselves in the way they see fit (Appendix 4). I use field 
notes, up to date reflection on the process (as a form of auto-ethnography), and minutes of the 
meetings. For the most part I combine field notes and reflections into one, and present as the 
following narrative. 
 
I became involved with the campaign leader through liking a Facebook page set up to 
support the first meeting held by MCRS at the Scottish Parliament. They had managed to get 
several MSP’s and other interested parties to a meeting to discuss the movement towards a 
medicinal cannabis framework in Scotland, and I was impressed. I contacted them and suggested 
they became involved in SDPC, and she attended the SDPC session on Cannabis (Appendix 2). 
However, it became apparent that the best role for them was running the MCRS group and building 
momentum for that campaign. They set up the first meeting and I helped them set up the subsequent 
ones by connecting them with relevant institutional actors such as the SMU, Police Scotland and 
the Crown Office and Procurator Fiscal Service (COPFS). My role within this process has been to 
provide the academic position, to highlight the legal and practical hurdles that need to be 
overcome, and to provide a link between the different stakeholders involved by chairing the 
meetings using SDPC principles of respectful dialogue. In addition I identify as a cannabis user, 
both therapeutic (I use for helping to sleep and as a topical cream for eczema) and recreational. 
This meant my persona in this process straddled both the professional, the happy and the sick drug 
user.  
 
The campaign is heavily focused on medicinal cannabis, and therefore follows a narrative 





suffers from multiple conditions, the most debilitating being fibromyalgia, and uses cannabis to 
treat them. She works alongside the stalwart mother of an epileptic boy who has been a tireless 
media campaigner, putting pressure on the policy makers from a different angle (Blackstock, 
2019). Lisa’s son has gone from up to 100 epileptic seizures a day to zero in the last year and a 
half since using legally prescribed Dutch cannabis oil. The problem for her and other patients is 
NHS Scotland won’t fund legal cannabis prescriptions, and the Scottish Government, so far, have 
been unwilling to step in to provide guidelines or funding. The sick consumer is popular at the 
moment because it highlights the need to focus on health rather than criminal approaches to drug 
use. Cannabis, as we know, has developed a strong narrative of medical/therapeutic use, and is 
legal in several countries already. Yet there is a blurred line as to what constitutes medicinal or 
recreational, and this is what concerns the Scottish Government, the police and other institutions 
and individuals who see injection of substances for pleasure as wrong or indulgent.  
 
This group engagement highlights one narrative of the ‘sick’ stakeholders: those who have 
illnesses that can be treated using (illegal) drugs. The focus was on dialogue around the policing 
of people who use cannabis for medicinal purposes, de-facto decriminalisation which is within the 
competence of the Scottish institutions needed to implement such a measure: the Scottish 
Government, Police Scotland, and the Crown Office and Procurator Fiscals Service (COPFS). 
Most importantly they wanted dialogue, to feel like their concerns were being listened, to, and 
hopefully acted upon in some way.  While the sick stakeholder is a legitimate participant in the 
‘recovered’ stakeholder narrative as a result of the addiction as a disease model (explained below), 
the sick stakeholder who does not suffer from addiction is not afforded the same privileges.  
 
 
From ‘Notes on MCRS - October 2017 to December 2018’ 
 
The following is data taken from my notes of engagement during this period. I combine 
the notes written during this time with more recent reflection, turning the following section into a 
narrative of engagement.  
 
Initial engagement  
 
One of the main stumbling blocks in moving MCRS forward was getting the SMU, and in 
particular the Unit Manager (UM), to engage with it. I was informed during a private conversation 
with the SMU that cannabis is not an area of importance to either the government, or the police. I 
was also informed that there was concern about the focus. The UM, and by extension the 
government ministers, were wary of being ‘soft’ on cannabis and not highlighting the dangers of 
excessive cannabis use. However, the Scottish Government stated that they were open to the 
implementation of medical cannabis, and there was a suggestion that I use the SDPC as a vehicle 





between BM (the campaign manager), and the various institutional bodies she was contacting. And 
nor should I, but this lack of control, and the passionate and at times aggressive way that BM 
approached institutions, meant I was often on the back foot in regards persuading risk averse civil 
servants to engage. As a result, the following exchange took place. 
 
BM had been trying to engage the Scottish Government for months, but all she received 
was the stock replies stating cannabis is a reserved matter and until this changes the SMU will not 
enter into dialogue with stakeholders – an example of ‘constitutional side-stepping. However, once 
I became involved I contacted the SMU to request attendance, and in response BM received 
communication that someone from the SMU would attend the meeting. This was good news and 
a signal that, as per the motion passed at the SNP conference in November 2016 on implementing 
medicinal cannabis in Scotland, the Scottish Government were taking the stakeholder involvement 
seriously. Yet it also showed that these stakeholders were not being taken seriously until a 
‘legitimate’ stakeholder became involved. In this case I was the ‘legitimate’ stakeholder, and my 
legitimacy had been built up as a result of my previous engagements with the SMU around broader 
drug policy engagement, and my professional/academic persona. In the build up to this meeting I 
had several phone conversations with the UM in which it became apparent that the only reason the 
Unit were considering engagement was because of my involvement as a representative from the 
SDPC.  
However, this changed. The UM declined the invite without saying why, and this decline 
sparked BM to lodge a formal complaint with the Scottish Government, in particular the SMU and 
the then Unit Manager. I found myself scrabbling to provide damage limitation and restore 
relations between the SMU and BM. The complaint was made on the basis that the SMU had a 
duty to engage with cannabis stakeholders, and the refusal to attend the meeting was a dereliction 
of duty. The reason I was given for the refusal to attend was more mundane: the UM was not 
working that day and had a prior commitment. It was argued by BM and MCRS representatives 
that the UM could have delegated attendance to someone in the SMU, as is often the case for 
stakeholder meetings, and I agreed. While the pulling out of attending the meeting may not have 
been intended as a snub, or a deliberate attempt to ‘organise out’ a group of stakeholders, it was 
perceived as such, and therefore the reputational damage was done. I was beginning to understand 
that engagement in the policy processes rests as much on good relations with those responsible for 
the formation of policy (the vertical dimension of policy), as it does on your position within the 
field (the horizontal dimension of policy). 
 
The main complaint from the UM regarding the MCRS was that they did not follow the 
correct protocols in setting the meeting up, and that there was too much emotion and aggressive 
energy being directed at the Scottish Government. This speaks to concept that policy involves 
order “that is, shared understanding about how the various participants will act in particular 
circumstances” (Colebatch, 2009, 116). The meeting had been termed an All Party Parliamentary 





been done. The meeting was being hosted by the Scottish Liberal Democrat Alex Cole-Hamilton’s 
office, and this was another alleged barrier to engagement. I was told that it is unusual for civil 
servants to attend meetings hosted by opposition parties, but I have since learned that this is not 
the case. It was suggested that SDPC become the vehicle through which the collaboration between 
the stakeholders and the government – a suggestion which was reiterated by the NHS Scotland 
rep, who also declined the invitation. This whole scenario highlights the difficulty in creating 
policy engagement outwith the recognised norms of policy making, and the difficulty institutions 
have in extending their vertical dimension of policy development, to incorporate broader 
horizontal ways of engaging.  
 
The other institutional actor that was missing was Police Scotland. The main contact at the 
time had accepted the invitation, however following the formal complaint and the subsequent fall 
out, the invitation was also declined. There was a feeling in the MCRS that the Police Scotland 
and NHS Health had pulled out under pressure from the UM in response to the formal complaint. 
This feeling exacerbated the alienation felt by those in the group, and the feeling that their 
engagement as stakeholders was not considered legitimate by these institutions.  
 
At this stage I was disappointed with the level of engagement by the SMU and Police 
Scotland, given my positive experience of engagement in regards SDPC. Despite this we received 
good media coverage on the various meetings, which raised the profile of the group as a whole 
(Nutt, 2017).  
 
And we try again  
 
One year later a second meeting was set up, with a vastly different outcome. Once again a 
meeting was called in the Scottish Parliament, and a range of stakeholders had been approached. 
BM and I had spent the previous year having one to one meetings with institutional actors, holding 
public meetings, getting sympathetic pieces in the press, and crucially the UM whom the official 
complaint had been made against was off on sick leave and there was a new interim manager in 
place. I had met with him and explained the back story, and his view was the SMU should be 
engaging more with the cannabis community. He responded positively to BM and they began 
direct communication. 
 
The meeting’s aim was to tell the stories of stakeholders who represented a cross section 
of medicinal cannabis users in order to highlight the different ways cannabis is being used, and the 
impact that the lack of regulation and continued criminal sanctions has on these stakeholders. The 
meeting was a success: the SMU responded positively and agreed to start investigating ways to 
help access cannabis based medicines, in addition to creating a more formalised cannabis advisory 





collaboration between the different stakeholders. Both the SMU and Police Scotland responded 
positively:  
 
“Scottish Government: [The UM] took the opportunity to thank the stakeholders for their 
powerful stories, that he was touched by them, and that the Scottish Government were 
committed to working with stakeholders going forward.  
Police Scotland: Police Scotland were also touched by the stories, and respected what the 
stakeholders were saying. They are only human, and as it is becoming more apparent, 
cannabis obviously works for some people. They too are committed to working with 
stakeholders and those responsible for policy implementation to see that we can move 
forward on this issue” (Record of Discussion, MCRS, 18th September 2018). 
 
This use of stories to persuade policy makers of the importance of the issue being discussed 
is not a new tool, and is often very effective (Davidson, 2017; Epstein, 2014; Stone, 2002, ch.6). 
Stories help to create empathy by personalizing what is otherwise a de-personalized policy. Civil 
servants are used to making policy decisions that encompass a variety of stakeholders, and stories 
can be a powerful way of highlighting what different stakeholders feel. For example, during my 
interview with a Senior Civil Servant previously responsible for the SMU, she commented:  
 
“[S]o, you know, I did quite like going to speak to people who were in there – called service 
users but actually just people – I’d like to speak to people and get a sense of what it felt like 
for them, and their perspective, and I did things like the LEAP programme used to do, 
graduation ceremonies for people coming out of that, and I did some of the graduation 
ceremonies, which kind of really brought home to you some of the…you know it wasn’t just 
drugs, it was drugs and alcohol kind of related issues, but the impact it had on families. 
And you know the stories of the individuals that they gave at those graduation ceremonies, 
I mean really I could tell you the whole story because they were just so difficult to hear 
really, the story of their lives, and their families lives, had - I’d be honest - had really been 
destroyed. And you could see it in the pain in their families faces” (Senior Civil Servant). 
 
The result of this interaction was an increased passion to implement the 2008 drug strategy 
properly. What we hoped by telling the stories of those affected by cannabis criminalisation was 
the same. And it worked. Both the Police Scotland reps and the SMU manager left that meeting 
promising to help us move the issue forward. This is not the end of the MCRS story, I am still 
involved as a peer negotiator, and more recently we were instrumental in setting up the Cross Party 
Group on Medical Cannabis in Scotland (Lambrou, 2020a). There have been successes in getting 
prominent figures to the table such as the Chief Medical Officer for Scotland, but so far the actual 









Analysis of Narratives using WPR Approach 
 
We have established in Part Two that the ‘problem’ of drugs is represented to be the 
perceived harms resulting from ‘problematic drug use’ (WPR #1). We have further established 
that ‘problematic drug use’ is the demographic of consumers who experience perceived harms 
such as health harms (HIV/AIDS, BBV’s, and other medical conditions), combined with broader 
societal ‘harms’ such as deprivation, trauma, and mental health issues. As has been shown, the 
presuppositions that underlie this representation (WPR #2) in relation to participation in policy is 
that (i) drug use is harmful therefore (ii) participation in policy is of stakeholders who have 
experienced this harm and are seeking to reduce it (the sick or recovered stakeholder). This 
representation is not unique to Scotland, however, as Part Two shows, in the Scottish context this 
representation came about by a focus on certain demographics resulting from the HIV crisis of the 
1980’s, and subsequent policy responses to an increase in drug related deaths.  
 
The questions this chapter sought to explore in relation to participation in drug policy are 
questions 4, 5 and 6 of the WPR Approach, and we shall take each one in turn.  
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4. What is left unproblematic by this representation, where are the silences? 
 
The focus on 'problem' drug use has resulted in a focus on certain kinds of drug 
consumption, and a policy strategy to match that - recovery. As a result, only certain stakeholder 
views are taken into consideration when participation is being designed at an institutional level, 
and only certain discourse is considered legitimate. As seen above I separated these stakeholder 
engagements into three narratives: the professional, the sick and the recovered stakeholders. A 
further narrative – the happy drug user – emerged from my analysis as being absent from any of 
the engagements. Within these typologies, further analysis of the perceived legitimacy of these 
stakeholders has been done. The legitimacy of the stakeholder determines the level of ‘meaningful 
participation’: the amount of engagement and involvement in the policy process individuals are 
given depending on their perceived legitimacy.  
 
5. What effects – discursive and lived, are produced by this focus on problem drug use?  
 
As a result of policy being focused on drug related harm, participation in policy is restricted 
to certain channels where the government feel they can be most effective. It is evident that they 
feel they can be most effective in addressing the harms stemming from addiction/dependency, and 
participatory processes to engage this affected community are developed along these lines.  
 
This organising in and out of decision making processes is a recognised aspect of policy 
making (Colebatch, 2002, ch.4; Stone, ch.15). Colebatch (2002) comments that: authority, then, 
frames the action, in ways that make it easier for some people, and more difficult for others, to 
take part in the process.”(27). This framing is part of the horizontal and vertical dimensions of 
policy making, as seen in diagram 6 below. The vertical dimension is concerned with the 
authoritative aspects of policymaking – the following of rules and authorized decision-making. It 
shows that in policy decisions there is often a line of legitimate authority, with (in the case of drugs 
policy) a minister as the top decision maker, and the various subordinate civil servants authorised 
to enact decisions. 
 
The horizontal dimension on the other hand, according to Colebatch (2002), views policy 
as “the structuring of action” (23). It shows that policy involves multiple actors, agencies and 
participants that do not have lines of authority, yet are part of the policy process. They bring 
different ideas of what policy is to them, and how these ideas and engagements are enacted from 
the basis of horizontal policy making (Colebatch, 2002, ch.3). It is therefore better to think of 
policy making as a collection of people participating in policy through the different channels 










6.How can the representation of the problem be disrupted/questioned/challenged/replaced? 
 
The main bulk of this is answered in chapter 8; however, we can see from the narrative 
intervention in the LLEEG group that there are areas that can be challenged, even within the 
current institutional frameworks. By challenging the use of language and the involvement of 
different stakeholders, gradually change can happen. This form of challenge can be classed as a 
‘narrative intervention’ (Fleetwood, 2016).  
 
The following sets out in more depth the different types of stakeholders identified by using 
the WPR approach, and levels of meaningful engagement afforded depending on the perceived 
legitimacy by the institutions of the stakeholders. This also highlights the master, counter and 
competing narratives. As discussed above, these typologies emerged from the data as a way to 
make sense of the different levels of legitimacy afforded to stakeholders when engaging in drug 
policy deliberations. However, categories are not fixed in their meanings, and in some ways I have 
simplified these types of stakeholders in order to fit them into my ‘types’. On the otherhand, they 





emerged from the data, and therefore represent an analysis that I saw to be correct, taking into 
account the interpretive nature of this research.  
 
The Recovered/Recovering Drug Users: Legitimate stakeholders and part of the master 
narrative 
 
These users are people who are either in the recovery treatment system, or have recovered 
and are ‘drug free’. People in this community are predominantly in recovery from opiates, alcohol 
and cocaine, although the term covers all behaviours considered to cause dependence30. They are 
the main staple of drug policy engagement and are considered important stakeholders in policy 
development.  
 
The recovery narrative has been part of Scottish drug policy since the 2008 ‘Road to 
Recovery’ strategy, and this has informed much of the participation work going forward. However, 
as one senior civil servant responsible for drug policy at the time (2008) commented:  
 
“I think the other thing that was interesting to me, and hadn’t really been so…[I] hadn’t 
really had to think about it, was the number of people involved in this world that had 
actually been impacted by those issues themselves. So quite a lot of people declaring early 
on to me that they were in recovery and it became like a…it was almost like they were more 
worthy than other people because of their lived experience” (Senior Civil Servant). 
 
I experienced the same when engaging, particularly with the LLEEG group. The legitimate 
drug consumer was one who had stopped using drugs and was now able to present their experience 
to the group. They used their experiences (sometimes from 20 years ago) as their identity within 
the groups, yet challenged those of us who attempted to broaden out the narrative to include 
different kinds of drug users. As we saw, the lived experience expanded to include living 
experience, yet I only came across a handful of people within the group who identified with the 
living element, and those who did were either parents of children currently using drugs 
‘problematically’, or were topping up their legal prescription with street drugs.  
 
Drug user voices have traditionally been absent in policy decisions that affect their lives 
(Storbjork, 2012). They are often “treated as second rate citizens; not as subjects with rights, a 
voice and an identity, but rather as passive recipients or subjects of help or measures of control, 
punishment and discipline” (Anker et al, 2006, 5 – quoted in Storbjork, 2012, 606). As discussed 
above, the development of the LLEEG group was an attempt to address this lack of user 
involvement in policy, and in some respects it was successful. However, while there was a space 
provided for those with lived and living experience to discuss and input into policy, what emerged 
from the analysis of this engagement was that the avenues for agenda setting were still constrained 
                                                          





to an identified stakeholder – the person in recovery. The result is a side-lining of those not in 
‘active recovery’, and the continuation of stigma directed towards people who use drugs.  
 
Stigma is a major theme within the drug policy community, and has become the focus of 
much of the institutional output. The definition being used by the LLEEG is the definition of 
stigma allegedly set out by Goffman “Stigma is the situation of the individual who is disqualified 
from full social acceptance” (Goffman, 1963)31.  
 
The stigmatisation of people who use drugs is common amongst the ‘general public’ as 
well as policy and health settings (c.f. Corrigan et al, 2009, Lloyd, 2013; Radcliff and Stevens, 
2008; Room, 2005, UKDPC, 2010, 2011). A narrative literature review conducted by Lloyd in 
2013 found that: 
 
  “Stigmatizing attitudes towards problem drug users (PDUs) are common among the 
general public and non-specialist professionals. The impact on users is profound and 
represents a significant barrier to recovery. Reasons for this extreme stigmatization include 
negative reactions to injecting and widespread attributions concerning danger and blame” 
(Lloyd, 2013, 85). 
 
However, there is also evidence that there is ‘within-group’ stigma directed to different 
kinds of drug users, where some are considered more ‘problematic’ than others (c.f. Lloyd, 2013; 
Simmonds & Coomber, 2009, Lancaster, 2014). This supports the experience described above, 
where those in recovery were engaged because of their recovery, and those still actively using 
were side-lined.  
 
Stone (2005) notes that every part of society, every rule, policy and form of governance 
identifies people according to their perceivable conduct and circumstances, then sets them into 
categories and determines how they are to be treated (ch.2). Similarly, Colebatch identifies this 
‘organising in/out within policy making as an aspect of how policy formation is conducted (2002, 
ch.3). Individuals and institutions are identified through the policy process as having a stake in the 
development. However, while this may be true for ‘problematic drug users’ as a result of their 
behaviour and engagement with services that highlights their ‘problems’ to those around them, it 
is unclear what impact this has on other drug users, who may only use within a certain social group, 
settings, or in the privacy of their own home and therefore remain ‘undetected’. Do they internalise 
this stigma? And if so do they then set themselves apart without the need for external socially 
imposed stigma, or do they internalise the stigma and reject it? These were questions that ran 
through my head as I engaged in the different policy meetings. The answer for me is I internalised 
the stigma of being a ‘recreational’ drug user (I am weaker, prone to self-indulgence, not a 
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‘responsible adult etc. etc.). However, as a result of having to disclose my various experiences of 
drug use (ranging from problematic to therapeutic), I found myself legitimised in certain contexts 
- the family member of an opiate user, the professional with ‘expert’ knowledge on drug using 
communities, and so on. 
 
As can be seen from the engagement above, this organising in/out of participation in policy 
is not only conducted by ‘gate-keepers’ such as civil servants, but by the very community the 
policy is trying to engage with. However, the side-lining of active drug users is not so clear cut, 
certain active drug users are afforded an element of legitimacy if they are considered ‘sick’. 
 
The Sick Drug Users: Sometimes a legitimate stakeholder 
 
There are two kinds of ‘sick’ stakeholders: those who are considered ‘sick’ as a result of 
their ‘problematic drug use’, and those who are ‘sick’ as a result of a physical or mental condition 
not connected to ‘problematic drug use’. I encountered and engaged with both groups and from 
this developed the understanding of which group was afforded more access, and therefore more 
legitimacy in the policy engagement process.  
 
The sick user in the participation of drug policy is only fully legitimate in one context: the 
engagement of ‘problematic drug users’. In this context the sick user is one who is currently using 
drugs ‘problematically’ and may not want to stop, but needs to be engaged in order to provide 
pathways for recovery when they do want it. In many areas drug dependency is considered a 
disease of the mind, and people with dependencies are considered to have a ‘Drug Use Disorder’ 
(Grant et al, 2016). The narrative goes ‘they are sick and need our help to get better’ (into treatment 
and off drugs). However, despite being a legitimate stakeholder, as seen above, those who are 
currently using drugs (living experience) are largely absent from the policy process (Lancaster & 
Ritter, 2018; Field notes, participant observation). Drug user organisations are often invited to 
‘represent’ these voices, but, [w]hile drug user organization representatives are usually invited to 
sit on committees or participate in policy events (such as roundtables), tokenism is rife (Lancaster 
& Ritter, 2018, 353).  
 
It appears that the stigma directed towards those who are currently using drugs is prevalent 
even within spaces that are designed to promote their engagement. While there are challenges of 
involving people who are using ‘problematically’: for example ‘problem users’ may turn up to 
events under the influence of drugs, or miss events because their life is chaotic and they do not 
remember (all comments given to me as reasons why it was difficult to include living experience 
at various events). However, these behaviours are at the extreme end of drug use, and not 
representative of the majority of drugs users, including so called ‘problem drug users’. The main 
stumbling blocks are issues that can be addressed. For example, Greer et al (2016) conducted a 





providing a supportive environment, equitable participation, capacity building and providing 
opportunities for empowerment, were vital in creating and sustaining drug user involvement. 
Further barriers to participation include lack of payment for attendance (Sandhu, 2017) and 
childcare provision (What Works Scotland, 2017; Blake et al, 2008). 
 
However, in a different context the sick user has even less legitimacy. In the context of 
using cannabis, psychedelics or MDMA, all drugs that have recently been shown to help in various 
physical and mental illnesses 32, users are not engaged with pro-actively, and in many cases 
engagement is made intentionally difficult. My experience of trying to engage policy makers and 
institutions responsible for patient engagement such as the MCRS was difficult when I was 
representing the medicinal cannabis user. Indeed, my involvement with this group, as seen above, 
resulted in my own legitimacy being questioned, and my persona of professional and objective 
policy expert became one of drug user lobbyist. As a result, my ability to access institutional policy 
makers and engagements was reduced. The thing I am still unable to fully comprehend is whether 
this loss of legitimacy was a result of the personal dynamics between the different stakeholders, or 
a broader stigma attached to those who are pushing for engagement on these kinds of drugs. I 
imagine it is a bit of both, and I explore my positionality within the research context in more depth 
in the conclusion.  As discussed above, drug users are subject to labels that once attached, are 
virtually impossible to get rid of. Cannabis is gradually becoming an accepted drug, however, in 
regards legitimacy in the policy process, it appears there is still some way to go. Having said that, 
as I expand on in the conclusion, since I finished my data collection I have continued to be involved 
in this movement, and we are starting to see meaningful engagement from both the politicians and 
the civil servants.  
 
 Despite this, on a wider level, the ‘sick’ drug user, seeking to heal that sickness through 
the use of cannabis, psychedelics, MDMA or Ketamine, is not present at any stage of the Scottish 
policy process, and would not be considered a legitimate stakeholder in the current framing of 
policy engagement. This is the silence. 
 
The Professional Drug User: Sometimes a legitimate stakeholder 
 
The professional drug user is hard to find because of the stigma associated with drug use. 
In general, professionals (and by this I mean individuals who are part of an institutional profession 
such as academia, third sector, public bodies etc, or are in the process of creating a professional 
career) do not disclose drug use because to do so would risk their career development. A good 
illustration of the consequences of drug use being discovered is the following story from one of 
my interviewees: 
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“An incident happened and a doctor overdosed on heroin in this hospital, and it was really 
horrible because it was one of these things where his wife phoned up and said my husband’s 
not come home, does anyone know where he is, that kind of thing, and he was found in a 
toilet. He was alive! And of course, somehow these things always seem to get on the front 
page of the Daily Record you know [laughs] so names, people get named and all that. So 
it was one of these organisational things that happened, ‘oh my god’, you know. And the 
organisation just decided they were gonnae have this guy for breakfast, so they were 
gonnea take him down a very very unpleasant disciplinary route.  
And as the local addictions specialist I was asked to give my opinion with regard to this 
guy. And of course I gave the opinion which was he has a…without going into all the details 
there were many reasons why this had happened, it was all very understandable, it was all 
very explainable. And, when you’re faced with people not being able to perform at work, 
in the NHS, you take them down one of two routes: its’ either a disciplinary route, or it’s a 
- as we would call it- a sick doctor route. I advised we should take him down the sick doctor 
route.  
Wow. Light the torch paper, stand well back. I was in hearings, and it was…so they were 
trying to say you can’t possibly be a doctor and have had a drug problem. So, because 
people can’t…what they were really saying was people can’t not have a drug problem 
anymore, he’s a heroin addict, he’s going to take people’s drugs and use them for 
himself…that monster! So, it was really interesting cause I had to put…you know it was 
one of those, you know, when you’ve got a career, you actually have to go hmmmm, okay, 
I’m gonna step over here now, and you have to go nut (no), this is my position, here’s my 
position” (Drug Policy Advisor). 
 
This story gives us insight into the professional implications of drug use, and the responses 
from the institution. What the narrator is telling us is that the institution was not able to respond in 
a compassionate way, because they did not understand the complexity of drug use. Even with the 
advice of the specialist, they were unable to comprehend how someone could continue to be a 
professional once they have used drugs. While the potential for him to be considered a ‘sick’ doctor 
(legitimate) existed, this was not an option because of the publicity surrounding the case: the fear 
of media scrutiny prevented the advised form of disciplinary action. This highlights the 
institutional oppression and stigma that I expand on in the development of critical drug theory 
below. There was a choice, one of which would not have involved professional ruin for the drug 
user. From this, and many other anecdotes I came across, it has become apparent that there is a 
dichotomy between the professional and the drug user (as seen by the quote in the LLEEG group 
in regards who was invited). It is not possible, in many context, to be both a professional and a 
drug user.  
 
Research surrounding this area supports this. As discussed earlier, there is a growing body 





research is that it strengthens the argument that there is a dichotomy between an ‘expert’ and a 
‘drug user’. It is possible to be an expert with lived experience, for example Duke and Thom (2014) 
note that there ‘has been the call for a broader notion of knowledge - knowledge based policy and 
practice, which includes the experiential knowledge of practitioners and the lived experience of 
service users” (965; c.f. Glasby & Beresford, 2006). Furthermore, Lancaster et al (2018) notes 
that while there is increasing participation within drug policy development, it is limited to certain 
areas such as engagement on health issues (c.f. Bryant et al, 2008; Treloar, Fraser, & valentine, 
2007; Treloar et al, 2011), or treatment decisions. “Rarely are people who use drugs (or, even 
more so, people who deal or supply drugs) seen as legitimate stakeholders in policy discussions” 
(Lancaster et al, 2018, 354). More rarely, if at all, are drug users seen as professional experts.  
 
I experienced this dichotomy, and I believe I have gone some way to challenging it. My 
involvement in the policy process came about through SDPC, and my persona, as mentioned 
above, was one of an academic and professional. However, through the course of the engagements 
I became more vocal about my own drug use, thereby mixing my engagement as a professional 
and a drug user. The first time I informed a member of the Unit that I used drugs I was met with 
that slightly startled flickering eye movement. I could see them processing this information and 
trying to make it match with their previous impression of me. It was a risky move, and I was 
advised against by several peers, but I felt I could not continue to engage and speak about drug 
users as if they were somehow ‘other’ to me. My relationship with the Unit and other institutional 
representatives did not change much initially after my disclosure, but I was still constrained in how 
I could participate, through the avenues described above. I have found that the policy identity that 
is being cultivated as a result of disclosing lived experience, is a ‘lived experience policy expert’, 
both of whom are legitimate in my typology of participation. However, if I start engaging with the 
‘happy drug user’ persona, I am not afforded the same weight in policy discussions.  
 
These stories show that in some contexts the professional drug user is considered a 
legitimate participant, however in general professionals who use drug are not considered legitimate 
stakeholders in the process, or indeed legitimate professionals, in many instances. 
 
The Happy Drug User: Never a legitimate stakeholder, and part of the counter narrative 
 
I use the term flippantly, and to make a point, but the ‘happy drug user’ is the person who 
takes drugs and is happy, or content with their level of drug use, or just not ‘problematic’. The 
happy drug user is hardly seen in drug policy. The idea that someone takes drugs happily, and 
continues to be happy despite drug use, is not spoken about, and those who do are silenced or 
ignored. This silencing is subtle. Because of the focus on harm, all initiatives, meetings, 
engagements and documents come from this paradigm. Discussions on the pleasure of drugs are 
silenced by the focus on harm, and those who challenge this are considered to be indulging in 






This silence is not only notable in institutional drug policy discussions such as the 
government, the police, health etc., but in drug policy research and academia too. Yes, there is 
research into drugs and pleasure, for example in 2008 the esteemed International Journal of Drug 
Policy dedicate an issue to the topic of pleasure, many of the articles I will reference in this thesis. 
However, this is an outlier, a golden nugget for those of us keen explore more the what, why and 
how of incorporating pleasure into decisions within drug policy governance. The silence of 
pleasure discourse within drug policy research has been explored by scholars such as Kane Race 
(2017), who, in arguing that drug policy researchers should be thinking with pleasure when they 
explore the topic, states that despite there being some investigations into pleasure and drug policy: 
 
“Researchers tend to think about pleasure or against it; we analyse, consider, investigate, 
invoke or ignore it. The philosophically inclined may even think of pleasure, or write on it. 
But in each of these scenarios pleasure is kept at arm’s length and the researcher appears 
to remain unmoved - detached observers, objective scientists, conceptual experts, program 
directors, policy advocates, sharp critics - sober judges all, our sovereignty secured by the 
formal conventions of established theory, positivist research, institutional authority” 
(Race, 2017, 245). 
 
By keeping pleasure at arm’s length, researchers disassociate themselves from the research 
subject, even if the researcher has some experience of the pleasure of taking drugs. This tension is 
explored in a paper I have written with several other scholars on the pros and cons of coming out 
about one’s own drug use in drug policy research (Ross et al, 2020). While we do not ‘come out’ 
ourselves, we discuss the reasons why some researchers may, or may not be open about their own 
drug use. An important element of not disclosing drug use, or the pleasure associated with it, is the 
criminality of using drugs (as discussed above) and that, as Moore highlights “writing about 
pleasure does not earn a researcher much in the way of research capital, so it is professionally 
safer to accept the focus on risks and harms” (Moore, 2008, 355).  
 
Other scholars such as Fiona Measham and Karenza Moore have written on the pleasure 
associated with certain drug such as ketamine (Moore and Measham, 2006; Moore and Measham, 
2011), or the persistence of pleasure in the binge drink culture (Measham, 2004). Over the years 
other scholars have noted the absence of pleasure in drug policy research (O’Malley and Valverde, 
2004; Duff, 2008; Bunton & Coveney, 2011; Schnuer, 2013; Ivsins and Yake, 2020). More 
recently Lancaster et al (2017) discuss the role of pleasure in the medicinal cannabis discourse, 
and note that “Silence around pleasure in drug policy is not a neutral absence but rather political 
in its effects, profoundly shaping how drugs (and the people who use them) might be thought 
about” (118). This political silencing of pleasure is encouraged by the liberal ideology that sees 
drug use as a threat to the autonomy of the rational choice human (Moore, 2008, 356; Keane, 2002, 





199. 64) that give ‘promises of pleasure so potent, so alluring, that it tricks the subject in the first 
place, then traps them and finally entombs them (Manderson, 2005, 43). It is evident from this 
brief exploration of the topic therefore, that the role of pleasure in drug policy discussion is largely 
absent, and to include such concepts may threaten the very foundations upon which our current 
liberal based social structures rest upon.  
 
Yet, it is not so much that pleasure or the happy drug user is ignored completely within 
drug policy discussions in Scotland, but the tactic of side-stepping is practiced in order to silence 
the narrative. The concept of the non-problematic drug user is set out in the 2008 drug strategy 
where they define three broad categories: experimenters, regular users, and problem users. It is the 
final category that drug policy appears to focus on. In private discussions of drug use between the 
drug policy communities, it is commonly accepted that the majority of drug users consume drugs 
with minimal harm, and they do so for enjoyment. Yet, this acknowledgment is not acted upon 
once it has been expressed. This sidestepping sits alongside the concept of ‘moral sidestepping’, 
developed by Alex Stevens (2019).  
 
In his 2019 article Stevens examines why it is that despite recommendations from the 
ACMD and other institutional bodies, initiatives that would reduce harm such as drug consumption 
rooms and heroin assisted treatment, are not being implemented. Stevens analysed parliamentary 
documents from 2016-2018 and found that there is a practice of moral sidestepping - that is, the 
acknowledgment of the evidence supporting the initiative (consumption rooms etc) and a side step 
by stating their own moral belief that taking drugs should be strongly condemned. The result is 
inaction, and the implication that to act is morally wrong (in a puritanical Christian way) (Stevens, 
2019). In Scotland the excuse is that criminal sanctions are reserved, this allows the policy makers 
to sidestep the tricky questions, without addressing the issue head on – constitutional side-stepping  
 
While policy makers used tactics such as moral sidestepping and silencing to prevent 
broader discussions of drug use, another important factor for non-engagement of ‘happy drug 
users’ in the policy process is the criminal nature of the activity: “[t]he criminalisation’s of most 
psychoactive drugs smothers the capacity of drug users to play a transparent and influential role” 
(Ryan, 2012). Only those who are considered ‘problematic users’ and therefore excused from their 
drug taking behaviour as a result of their lack of agency (addiction brought on by poverty/mental 
health/trauma, and are unable to stop) are considered to be the legitimate focus of participation, 
and only marginally at this. To suggest that the wider drug using population; the health worker 
that smokes joints, the nursery teacher that takes a bit of cocaine every now and then, the postman 
who goes to annual raves or the artist who indulges in LSD, are every bit as legitimate in the policy 
process as those who have serious problematic drug use, is to suggest that drug use per se is not 
the problem. This was apparent from the SDPC engagements where many participants who had 
used drugs, in the past and currently, did not feel able to openly admit it beyond the safety of a 





but once again many felt unable to put their careers and professional persona on the line. Indeed, 
one professional who is also a regular heroin user commented that if they came out, there was a 
very strong possibility the police would use their phone to get to their dealer. This is a very real 
concern, and one that exists in the medicinal cannabis community too. The campaign leader for 
MCRS openly grows her own cannabis plants for her medicine. The police know because through 
our engagement with the Police she has spoken about it. However, this has left her vulnerable to 
criminal prosecutions should the police decide to use this information to make another ‘drugs bust’.  
 
If policy is to include the wider drug using community, these findings suggest that use of 
drugs should be de-criminalised in order to de stigmatise so that voices that cannot and will not be 
heard feel safe to come forward. Because the dominant narrative surrounding drug use is one of 
totemic toughness (Stevens, 2009), and people who use drug are ‘problems’ to be dealt with, those 
whose livelihoods would be put at risk if they were considered to lack personal control and agency 
will not raise their heads above the parapet. This labelling of people who use drugs is well 
documented (Australian injecting and Illicit Drug Users League, 2011; Lloyd, 2010; UKDPC, 
2010, Link and Phelan, 2001), and the pervasive nature of the stereotyping is not easy to dismiss. 
As the Australian Injecting and Illicit Drug users League found: ‘[t]here are clear and definable 
ways in which we become labelled a drug users in the eyes of the general community […][but] 
there are no actions or activities whereby one can become ‘unlabelled’” (AIVL, 2011, 50). This 
is the fundamental problem facing pubic participation in drug policy making; only those willing 
to take the risk, or who have nothing to lose by ‘coming out’, will be engaged at this stage. These 
drug consumers are invariably already part of the system because they have had to identify (and 
therefore be labelled) as a drug user in order to access medical and social support. The focus on 
harmful drug use masks the widespread use of drugs by a variety of different communities, and 




As a result of policy being focused on drug related harm, participation in policy is restricted 
to certain channels where the government feel they can be most effective. It is evident that they feel 
they can be most effective in addressing the harms stemming from addiction/dependency and 
‘problematic drug use’, and participatory processes to engage this affected community are 
developed along these lines.  
 
Yet, because the dominant narrative surrounding drug use is one of totemic toughness 
(Stevens, 2009) - and people who use drugs are problems to be dealt with as a result of the harm 
stemming from their use - those whose livelihoods would be put at risk if they were considered to 
lack personal control and agency will not raise their heads above the parapet. This is the fundamental 
problem facing meaningful participation in drug policy making; only those willing to take the risk, 





are invariably already part of the system because they have had to identify as a drug user in order 
to access medical and social support. The focus on harmful drug use masks the widespread use of 
drugs by a variety of different communities, and prevents honest dialogue about the impact drug 










A central proposition at the start of this research was that the narratives surrounding drug 
use define the process by which the use of evidence and the participation of stakeholders are 
incorporated into policy making. More specifically, the narratives of drug harm and the 
medico/legal structures which surround problematic drug use mean that evidence and participation 
are focused on a small section of the drug using population, namely problematic drug users. This 
focus is, in part, a result of systemic narratives that have been used to justify policies and practices 
which disproportionately affect those whose ethnicity, social class, gender, religious, ideological 
and political viewpoints do not fit into the dominant narrative (UKDPC, 2010a, Hari, 2015; 
Bancroft, 2009, ch.2; Manderson, 2005; Moore, 2008) .  
 
Chapters 4 to 7 have provided evidence to support this hypothesis, by showing that (i) 
representation of drug use in Scotland developed as a result of concern around the harms of certain 
kinds of drug use, (ii) focus on this harm means that participation within policy is limited to 
advising on medical/public health initiatives such as treatment options, and (iii) those who do not 
fit within this paradigm find it difficult to engage at any level of the policy making process. 
Participation in Scottish drug policy is therefore constrained by the historical legacies and 
institutional narratives that guide policy development. Having developed the argument, this 
chapter explores the last ‘what’s the problem represented to be’ (WPR) question: 
 
6) [H]ow can the representation of the problem be disrupted, questioned, challenged, and 
replaced?  
 
It will also address a core research question:  
 
What is critical drug theory, and how can it help us understand drug policy formation in 
Scotland? 
 
In order to answer this question, I will present the development of a theoretical framework 
I call ‘critical drugs theory’ (CDT).  
 
The first section of this chapter will set out what CDT is, how it emerged from the research 
process, and the four pillars that make up the framework. The second section will discuss the role 





challenging the assumption that all drug use is harmful. In compiling this chapter I used interview 
transcripts, observational data including field notes from SDPC/MCRS and other committees, 
reflection and documentary analysis.  
 
From Racism to Drugs Consumption  
 
The journey to a critical drug theory (CDT) is inspired by critical race theory (CRT), and 
is ultimately grounded in the broader critical theory framework. CRT grew out of the critical legal 
studies movement, defined as “an attempt to understand the oppressive aspects of society in order 
to generate societal and individual transformation” (Tierney, 1993, 4; Crenshaw et al, 1995, 
Delgado and Stefancic, 2017). The aim of CRT is to challenge the foundations of liberal thought 
by linking the outputs such as equality theory, legal reasoning, rationalism and the alleged 
neutrality of law, to broader questions around their historical development and implementation 
(Delgado and Stefancic, 2017, ch.1). It contends that the concept of race is a social construct, and 
that racism is embedded within the framework of most institutional settings, and most modern 
minds. In order to challenge these frameworks it seeks to use minority and marginalised voices 
through the use of storytelling and narratives to highlight the impact racism has had on these 
communities, and to break down the defined social order (Crenshaw et al, 1995; Soloranzo and 
Yosso, 2010). 
 
CRT became distinct from critical legal studies because of a perceived inability to 
incorporate analytical frameworks which take into account race and other social injustices (Yosso 
& Solórzano, 2008). It has now evolved beyond the black white binary and incorporates among 
others feminist critical theory (Rhodes, 1990), Latino critical theory (Soloranzo & Yosso, 2010) 
and Asian critical theory (Delgado, 1995a; Yosso & Solórzano, 2008). Like many other 
marginalised communities, drugs consumers suffer from institutionalised stigma, oppression, 
criminal sanctions and social alienation as a result of their drug use (Scottish Government, 2015, 
2018; UKDPC, 2012). While it could be argued that race/ethnicity is not a lifestyle choice and 
taking drugs is, this lacks depth in understanding why people use drugs. Importantly, while a liberal 
drug theory would argue that drug users shouldn’t be judged because drug taking is not a free 
choice, critical drug theory rejects the terms in which choice is framed and argues that drug users’ 
experiences are legitimate in themselves, much like critical race theory does by rejecting liberal 
critiques of racism. While CDT ultimately stems from the increase in critique of the foundations 










Developing a Critical Drug Theory  
 
Critical race theory is still a developing concept (Delgado 2011) but broadly speaking there 
are five tenets that provide the framework of analysis (Delgado & Stefancic, 2012; Solorzano & 
Yosso, 2010; Yosso & Solórzano, 2008).  
 
The following tenets have been taken from the works of Richard Delgado (1995, 2012), a 
leading figure in the CRT movement, and Soloranzo and Yosso (2001, 2008), also leading figures 
in more recent developments of CRT. It was knowledge of these tenets that made it possible to see 
similar themes arising from my own data, and from that an understanding that such a framework 
could serve to legitimatise critique of the foundations that drug policy rests upon. The development 
of theory, or theorising, is not a straightforward process, and “[t]o theorize well, one needs 
inspiration, and to get inspiration one can proceed in whatever way that leads to something 
interesting – and that means any way (Swedberg, 2012, 6). For myself it was a combination of 
basic knowledge of critical race theory, an in depth understanding of the marginalisation of drug 
users, and inspiration from one of my reviewers in my first year board review, all of which led to 
me begining the development of CDT. The following four pillars have adapted the CRT tenets to 
demonstrate how CDT developed out of them. 
 
The Four Pillars  
 
CRT, as outlined above, is grounded in a critical tradition which challenges the dominant 
liberal narratives, specifically those which maintain the legal and educational institutions 
(Delgado, 1995a). It challenges the dominant narrative that accepts race as a natural order by 
arguing that it is a product of ontological power (Crenshaw et al, 1995). In doing so it seeks to 
create change through action, storytelling and giving voice to those who have been marginalised 
and silenced. This silencing of marginalised voices is not constrained to race however. 
 
Drug use has long been seen as a deviant activity (Becker, 1963; Young, 1971), with those 
using drugs often identifying with a specific cultural scene such as jazz musicians, mods, ravers, 
phsychonauts and so on. Furthermore, it is now well documented that historically drug policy has 
been used to target certain communities or groups of people that appear to threaten the dominant 
social order (Fitzgerald, 2015; Hallam, 2018; Race, 2009). Drug use (and users) can therefore be 
considered a marginalised community, and the following four pillars have been developed to show 






The Social Construction of Drug Use 
Social construction as a term comes with its own problems (see further Lancaster, 2014; 
Wagenaar, 2015, ch.7), however, “it is there for a reason…that reason is to rouse, to incite, to 
raise consciousness. The point of using constructionist talk is to be critical of the status quo.” 
(Wagenaar, 2015, 117). 
Critical Race Theory Critical Drugs Theory 
In the context of CRT it is the historical 
construction of race, and structural 
determinism within legal institutions that 
has most importance. CRT holds that 
historical racism stems from colonialism 
and the use of tools such as land grabs that 
saw large swathes of indigenous peoples 
land being taken over. Colonists needed to 
justify this action by viewing the 
indigenous, or people of colour, as inferior 
and therefore not capable of utilising the 
land effectively. Furthermore, law is 
written at a certain moment in history and 
then, by its very nature of being part of the 
structure and language of that time, can 
only be changed slowly, unless there is a 
radical shift in understanding. This results 
in systemic racism which is very difficult 
to challenge (Delgado & Stafancic, 2001; 
c.f. Kimberley Crenshaw). 
Similarly CDT contends that drug use, drug users 
and drug harm is socially constructed: historically 
and legally. It is well documented that the 
evolution of drug regulation is based on 
temperance ideology, fear of social groups that 
challenge the status quo, and a desire to control 
certain behaviours in society (c.f. Duster, 1979; 
Schnieder & Ingram, 1993, 2005; South, 2002; 
Bancroft, 2009, ch.2-3; Hari, 2015; Bourgius, 
1998; Sarang et al, 2010; Manderson, 1995). 
Similarly, the construction of harm and use is 
based on a certain moral ideology: for example the 
UK Misuse of Drugs Act 1971 (MDA 71) sets out 
the parameters of whether a drug should be added 
by looking at its propensity to be misused to the 
extent that they cause a social problem (MDA 71, 
S.1(2)., emphasis added). This highlights the 
nuance, and ability to construct the narrative 
around these terms depending on the moral and 
ethical viewpoints of the constructors.  
What is meant by misuse and social problem are 
contested, and measurements of harm are arguably 
based on pre-determined ideas of what was 
consider unacceptable behaviour (see further Nutt 
et al, 2007). More recently the UK Government 
have been explicit in their moral ideological stance 
that overrides evidence informed policy making 
(Stevens, 2019). This explicit statement of intent 
highlights the historical power dynamics that still 
exists within all aspects of policy, and is especially 








Challenging the dominant ideology and a commitment to social justice 
Critical Race Theory Critical Drugs Theory 
The challenge to a dominant ideology – 
CRT challenges and refutes the claim that 
educational institutions in particular make 
towards ‘objective, equal opportunity, 
colour blind race neutrality’ etc. In fact 
these claims serve as masks to hide behind 
which, if uncovered, reveal the self-interest 
and power politics of the dominant groups 
in society, namely white, privileged 
(wealthy) men and women. It seeks to 
undermine and challenge the assumptions 







CRT is committed to social justice using 
transformational dialogue, and works to 
transform the power structures which 
maintain dominant and oppressive 
narratives. It recognises that social 
institutions often work in contradictory 
ways – on the one hand maintaining the 
oppression and marginalisation, but on the 
other hand have the potential to empower 
and transform. CRT has involved projects 
which help to raise the level of the literary 
consciousness by ‘naming the 
problem/injury’. 
Similarly, CDT seeks to challenge the dominant 
ideology: that all drug use is bad, and the goal of 
drug policy is to eradicate all drug use and/or abuse 
(UN Political Declaration, 1998; The Scottish 
Government, 2000). This ideology ignores the role 
drug use plays in many cultures such as indigenous 
cultures and other uses that are practiced by people 
today (see further M.A.P.S.; Beckley Foundation). 
Further, it silences discourse on the pleasure of 
taking drugs, the role they can play in social 
cohesion, understanding consciousness, 
recreational activity and stimulation (Carhart-
Harris & Nutt, 2013). By focussing on the harm of 
drugs, it ignores the harm of the legislative 
framework that limits the availability of drugs, by 
criminalising all psychoactive substances (Babor 
et al 2018, ch.5).  
 
CDT is also committed to social justice and 
transformational dialogue. It aims to highlight the 
role social institutions play in reinforcing the 
dominant narrative of drug use and drug users, and 
the continued oppression of those who choose to 
alter their consciousness. Furthermore, it seeks to 
challenge the legislative frameworks that create 
and perpetuate much of the social harm associated 
with drug use, and frames drug use in terms of 
problematic, harmful and criminal.  
An example of this can be seen with the Scottish 
Recovery Consortium (SRC) which, as a 
government funded institution is part of this 
‘institutional power’. However, they are using this 
‘power’ to challenge deep rooted stigma towards 
drug users: The dialogue of stigma is coming from 
the professionals, but also these professionals are 
the ones being charged– through anecdotal 





stories – of enacting stigma (Mental health 
services, NHS, G.P’s, Treatment Services) (field 
notes from LLEEG, 2017 
 
Intersectionality 
The intersection between multiple communities and multiple disciplinary approaches 
Critical Race Theory Critical Drugs Theory 
CRT recognises that racism intersects with 
other marginalised groups in society such 
as women, LGBTQI, disadvantaged and 
people with disabilities. Race therefore is 
one defining characteristic that contributes 
to greater injustices and oppression when 
combined with other marginal 
characteristics.  
Intersectionality is a theoretical 
development that grew out of CRT and is 
now well established (Carbado & 
Roithmayr, 2014). The theory was first 
elaborated by Kimberley Crenshaw (1989, 
1991) where she “exposed and sought to 
dismantle the instantiations of 
marginalization that operated within 
institutionalised discourses that 
legitimized existing power relations (e.g., 
law); and at the same time, she placed into 
sharp relief how discourses of resistance 
(e.g., feminism and antiracism) could 
themselves function as sites that produce 
legitimized marginalization” (Carbado & 





CRT draws on multiple disciplines to 
highlight the impact historical and current 
racism has. By using a variety of 
disciplines, CRT seeks to challenge current 
models of scholarly investigation 
Similarly drug use intersects with all sections of 
society, there is no typical drug user, although 
there are perceptions of what kinds of drug users 
there are. However, when drug use is combined 
with vulnerable or marginalised characteristics 
such as gender, race, sexuality, physical 
disabilities, trauma and mental health issues, there 
is an increased risk of physical, psychological, 
social and institutional harm. Importantly the 
impact of laws surrounding drugs has resulted in 
discrimination against ethnic minorities in the UK 
(Shiner et al, 2013, Release, 2013; Roy, 2011), or 
the policing of crack users in the US, highlighting 
the intersection between race and drug policy.  
However, this intersectionality also exists within 
drug using communities, as Crenshaw highlights 
for CRT. Within these communities there are 
different kinds of users, and those who intersect 
with other marginalized positions such as gender, 
race and poverty, are disproportionately impacted 
by drug policy interventions as result of the 
structure that maintains it - enforcement and 
treatment. In addition stigma towards different 
kinds of drug use, as seen in the discussion of harm 
below, can result in legitimized marginalisation of 
different kinds of drug users, by the drug using or 
drug policy community.  
 
Similarly, CDT seeks to utilise multiple 
disciplines that play a large role in suppressing, but 
also transforming the oppression and stigma 
directed towards (and within) drug users and their 





which evidence is presented in drugs policy 
(Lancaster, 2014; MacGregor, Singleton, & 
Trautmann, 2014; Smith & Joyce, 2012) 
 
Narrative and Counter Narrative 
The centrality of experiential knowledge 
Critical Race Theory Critical Drugs Theory 
CRT recognises that the stories and voices 
of those who have experience are 
important to understanding and analysing 
racial subordination. CRT sees experiential 
knowledge as a strength which can be used 
to inform research and policy decisions by 
widening the concept of evidence to 
include knowledge based on storytelling, 
biographies and narratives.  
Similarly CDT recognises that experiential 
knowledge of drugs and their effects should play a 
role in policy relevant issues such as how harmful 
a drug is, what the social impact of different kinds 
of drug use have, and wider concepts regarding 
principles underlying drug use and regulation. The 
reasons for using drugs are as varied as they are 
diverse, and until the experiences of drug users are 
legitimised their voices will be marginalised and 
silenced.  
 
What is Critical Drug Theory? 
 
The development of CDT stems from the increase in critique surrounding how drug policy 
is made and implemented from scholars such as Schneider and Ingram (1993) Carol Bacchi (2009), 
Alex Stevens (2010), Alison Ritter (2011) and Kari Lancaster (2014), to name a few. These 
critiques have highlighted the issues surrounding how evidence is produced (Lancaster, 2014; 
Stevens & Ritter, 2013), how drugs problems are constructed (Bacchi, 2012, 2016; Schneider and 
Ingram, 1993) and how drug related harm is measured (Rolles & Measham, 2011; Stevens, 2008). 
A common thread running through the most critiques of drug policy is the recognition that policy 
fails to address fundamental questions relating to how and why drug policy is implemented, such 
as: what is evidence informed policy (see further Lancaster and Ritter, 2018; Smith, 2015); what 
is drug related harm, what level is acceptable; and what is problematic drug use? In order to explore 
these questions researchers are required to challenge the very foundations that drug policy rests 
on: that drug use causes unacceptable levels of harm to individuals and society. Indeed, CDT 
would question the very basis of harm as a metric for evaluation, in light of the discussion below 
on the experiential perception of harm. The focus on evidence based, or evidence informed policy 
for example highlights the difficulty in getting under-represented voices into policy discussion 
because of the institutional reliance on certain kinds of evidence.  
 
Critical drug theory is therefore a theoretical framework that uses the paradigm of the four 
pillars outlined above to challenge the assumption that drug use always causes harm, and ergo 





social phenomenon, and the focus on harmful drug use is a result of institutional narratives that 
determine what acceptable social behaviour is. Reiterating the above, CDT contends that the 
narratives of drug harm and the medico/legal structures which surround problematic drug use 
means that evidence and participation are focused on a small section of the drug using population, 
namely ‘problematic’ (harmful) drug users. This focus is a result of systemic narratives that have 
been used to justify policies and practices which disproportionately affect those whose ethnicity, 
social class, gender, religious, ideological and political viewpoints do not fit into the dominant 
narrative. By using aspects of the four pillars to develop research projects or critical analysis, these 
systemic narratives can be countered and challenged.  
 
The four pillars of CDT intersect with one another, but for the purpose of this thesis I am 
focusing on the role that narrative, and more specifically counter and Meta narrative, can play in 
challenging systemic (master) narratives. In order to do this, I will take the master narratives that 
have been identified in the previous chapters and explore how counter narratives, and meta-
narratives (Roe, 1994; Fischer, 2003) can help to disrupt, question, challenge and replace them 
(WPR #6).  
 
The focus on harm is also evident throughout this research, with the harm of drug use - and 
the problems that result - being the main focus of all policy interventions. In order to address this 
underlying assumption we must explore what is meant by drug related harm, and how this 
influences drug policy.  
 
The Role of Harm in Drug Policy  
 
As we have seen, drug policy, in Scotland and beyond, claims to be focused on reducing 
the harm thought to be caused by problematic drug use (Caulkins et al, 2011; Rolles & Measham, 
2011; Scottish Government, 2008, 2015, 2018). While the thesis has explored what problematic 
drug use is, and challenged this, it has not yet addressed what is meant by harm. This section 
explores what is meant by drug related harm, and whether there are valid critiques on the current 
concept.  
 
In discussions of drug related harm there is a tacit agreement between key players within 
the drug policy community what it constitutes – namely harm stemming from ‘problematic drug 
use’. Indicators such as deaths recorded as drug related, hospital admissions, crimes, access to 
treatment services and social service contact are all used in calculations of drug related harm 
(Stevens 2007, 2008; Babor et al, 2018, ch.2-3 ). For example, crime that is recorded as linked to 
drug use is recorded as a drug related harm and used by the UK Government in their Drug Harm 
Index (DHI) (Stevens 2008). All recent research used by the UK Government (Godfrey et al., 
2002; Gordon et al., 2006) and the Home Office’s DHI (MacDonald, Collingwood, & Gordon, 





taken into account when weighting the DHI. There had been an established body of literature that 
purported to show associations between drug use and criminal activity (Gossop et al, 2005; Hall 
et al, 1993, Keen, 2005; MacIntosh, 2007). However, in 2017 a systemic review of the link between 
criminal activity and opiate users found that:  
 
“Available evidence suggests that onset-opiate use accelerates already-existing offending, 
particularly for theft. However, evidence is out of date, with studies characterised by 
heterogeneity and failure to use a matched non-opiate-user comparison group to better-
establish whether onset-opiate use is associated with additional crime” (Hayhurst et al, 
2017, 1). 
  
Others have argued that there are assumptions built into how crime is recorded, among 
other things that often mask underlying subjective decisions on whether the crime was drug related 
or not (Stevens, 2007, 2008). Alex Steven (2008), among others, has highlighted this issue by 
showing that while there may be a correlation between drug use and crime, there has been an 
exaggeration of the link (Stevens, 2008). It is argued that police discretion can result in 
discrimination towards certain groups in society such as drug users: crucially drug users from 
lower socio-economic background, or those from ethnic minorities (Fielding 2005; Reiner 2000; 
Stevens 2008, Release, 2013). As a result of the over representation of these kinds of drug users 
in the criminal justice system, the link between drugs and crime is exaggerated (Stevens, 2008, 
Release, 2013).  
 
Measures of drug related harm encompass drug related crime but also ‘social harm ‘thought 
to be caused by drug use. In Scotland 98% of drug related crime is specifically related to offences 
under the Misuse of Drugs Act 1971 (Scottish Government, 2014), and this narrows the scope for 
subjective interpretation of what constitutes drug related crime, although as seen above there is 
debate on how this data is recorded and reported. Drug related social harm however is prone to 
subjective evaluations of what constitutes a social harm. In Scotland social harm relating to drug 
use encompasses drug related crime, child protection data, and public surveys on the perception 
of drugs (Scottish Government 2014). The latter measurement is extremely problematic; that 
public perception of harm is taken as a measurement of the actual harm caused by a drug. In 
particular, the perception that violent crime is causally related to drug use (Scottish Government, 
2014), as opposed to other important factors such as gang culture, poverty and male violence, 
highlights the disproportionate focus drug use has in regards to social harm. Furthermore, there is 
an argument that much of the crime is a result of the illegal nature of the drugs, creating a market 
governed through violence and intimidation that would not exist within a regulated market (Babor 
et a, 2018, ch.2&5; MacCoun & Reuter, 2010, ch.6). Drug ‘related’ crime is therefore often 






These short examples illustrate that even in areas where there appears to be factual 
evidence, there are multiple layers of meaning written into the concept of drug related harm. While 
the harm stemming from problematic drug use is of real concern, there is increasing evidence to 
show that harms stemming from drugs has more to do with systemic societal issues such as life 
trauma (Mate 2008;), poverty (Carliner, 2015), underlying mental health issues and prohibition 
(Hari 2015), and the criminal framework surrounding drugs (Babor et al, 2018, ch.5) than drug use 
per se.  
 
It is apparent therefore that interpretations of what constitutes drug related harm are 
predominantly governed by concepts of harm which in many instances are a result of shared 
narratives which have entered the lexicon of drug policy. Furthermore, these interpretations are 
guided by moral concepts of how people should act (Stevens, 2019), and the levels of harm 
acceptable within society. The experience of the wider drug using populations are set aside in order 
to focus on a small group within this population. In order to widen the lens of understanding on 
what constitutes drug related harm and pleasure, the experience of all drug users should explored. 
 
Yet in order to do this, the experience of all drug users must be considered valid. However, 
as discussed in the previous chapter, participation in the policy process is governed by the narrative 
of drug harm, and therefore discussion of pleasure or enjoyment in drug use are seen as attempts 
to undermine the goal of drug policy: to prevent the harm resulting from problematic drug use.  
 
Counter Narratives to Harm 
 
One of the major stumbling blocks within the drug policy making process, and indeed all 
processes involving scientific measurements of harm and pleasure, is the role of personal 
experience. Traditional scientific research methods such as randomised controlled trials with 
double blind controls, have had difficulty with the concept of personal experience as a form of 
evidence and therefore tended to ignore instead of explore. However, within drug policy research 
it is increasingly understood that examining the experience of a range of consumers and the impact 
this has on individual understanding of harm and pleasure, allows us to explore differences in 
perception between drug consumers, experts and policy makers, and therefore arguably create 
better policy solutions for society as a whole.  
 
There have been a number of studies which have looked at how people who use drugs think 
about harm and drug policy (Darke & Torok 2013; Lancaster et al. 2013; Lancaster et al. 2014; 
Morgan et al. 2010; Carhart-Harris & Nutt 2013; Lancaster et al. 2015). Much of the literature 
concerning the experience of drug consumers has focused on qualitative research with injecting 
drug users (Lancaster et al, 2013, Lancaster et al, 2015) or secondary data research involving large 
scale surveys/questionnaires ((Carhart-Harris & Nutt 2013; Morgan et al. 2010; Lancaster et al. 





users (McPhee, 2012; Morgan et al 2010), the impact of pleasure on measurements of harm 
(Carhart-Harris & Nutt 2013; Morgan et al. 2010), and the impact of prohibition on levels of drug 
related harm (Rolles & Measham, 2011).  
 
In 2010 Dr Celia Morgan and others set up a study in response to growing interest in the 
concept of a Multi Criteria Decision Analysis (MCDA) developed by David Nutt and others (Nutt 
et al. 2007) and designed to improve the ranking of drug harms. This research created a national 
drug survey to measure not only the perceived harmfulness of certain illicit drugs, but also their 
perceived benefit. Findings from the survey were consistent with previous findings with experts 
regarding the high ranking of harmfulness for drugs such as heroin and cocaine, and the low 
ranking of harm for drugs such as MDMA and cannabis (Morgan et al, 2010).  
 
Similar research conducted with regular illicit poly drug users found that heroin was ranked 
by drug users as one of the most harmful drugs alongside cocaine, and MDMA was rated one of 
the least harmful, supporting Morgan et al’s findings (Carhart-Harris & Nutt, 2013). In the latter 
research, pleasure was also ranked and heroin was found to have a pleasure rating in the middle, 
and MDMA was found to have the most acute pleasure rating (Carhart-Harris & Nutt, 2013). In 
this research respondents were given space to elaborate on why they considered a drug to be 
harmful or beneficial. This allowed qualitative feedback on decisions and importantly findings 
showed that reasons for pleasure/benefit rankings were often based on their therapeutic qualities 
(Carhart-Harris & Nutt, 2013). This most recent research illustrates the importance that more in 
depth analysis into the impact pleasure and benefit has on individual measurements of harm, and 
this is where CDT can elaborate. CDT in particular the use of personal stories and larger combined 
narratives can highlight the context specific perception of pleasure. Much of the research around 
pleasure and harm does not elaborate on what pleasure actually is, or how it is perceived. Because 
of the reliance on traditional scientific methods, even within the qualitative field, pleasure becomes 
a box to measure something with, rather than an experience to understand (Race, 2017). In the 
following chapter I look at narratives around drug use, and I begin to develop a more nuanced 
understanding of the uses of drugs, and the ways in which individuals experience pleasure as a 
result of their social context. This helps those who may not have had that experience, to understand 
why someone would continue to use an illegal substance despite the harm, both physical and 
criminal, that may result.  
 
One of my interviewees, who highlighted the harms resulting from drug use, relates an 
interesting aspect of drug related harm. In this story, the harm from drug use is a physical harm, 
akin to the kind of harm you would get from excessive exercise. Indeed, the storyteller equates 
these harms in order to highlight how our risk/reward decisions are different depending on what 
we view as pleasurable, or important. Another interesting aspect to note in this story is that a 






 Senior Policy Officer: “So ,it’s a bit like having a hobby and you’d say oh I’ve got 
blisters because I bought new running shoes or whatever, you know, I’ve got a sore knee 
because I jog or whatever, two experiences I’ve never had…[laughter]…but you know, 
people in the office say these things, you know these are harms that are to do with a lifestyle 
choice, but they are just part of it. And I had, talking of blisters, I…at one time that summer 
I was using amphetamines heavily, I had huge blisters in my heels, which I had to burst wi 
eh needle… 
 Interviewer: From dancing? 
  Senior Policy Officer: no, no from walking, I used to walk at night, and I used to walk 
in a particular gait because I was so out my face [laughter]. So I couldn’t sleep, and I used 
to walk along Great Western Road in Glasgow, which is a great big long straight road. I 
mean I used to walk miles and miles and miles up the road, and then back down again, and 
past the flat and go past the flat and go, I can’t go in, an then go back to George’s Cross 
and then back out to Anniesland, and it was some big big distances. And I developed these 
huge blisters. And I had a bit of mental health stuff, bit of kind of paranoia, but of kind of 
edginess and stuff like that, which was the stuff I didn’t like about cannabis but I put up 
with with amphetamines. And I had a lot of sleep disturbance, and when I wasn’t using I’d 
problems with my sleep patterns and all the rest of it…eh…and when I look back on it as a 
middle aged person now I used to… I mean I used to think you weren’t really there unless 
you could feel your heart pounding in your back. So I mean it wasn’t just that your heart 
was racing in your chest, but you could actually feel it in your back, so if you leant your 
back up against a wall you can feel it. That was my ‘right aye, that’s me up’ [much laughter] 
I can go to that party or whatever.” 
  
 What is being highlighted in this story is that we accept certain harms if they are associated 
with activities considered to be healthy. So a sprained ankle from jogging, or sore limbs from 
exercise are seen as a legitimate harm, whereas harm accrued from drug use is not. Furthermore, 
the story highlights that when using certain drugs we put up with some harms, because the effects 
(whether pleasurable or not) are worth the resulting harm.  
 
The use of drug for pleasure is often overlooked by a policy focussed on harm, and indeed, 
if policy were to accept that people have a right to use drugs (the human right and cognitive liberty 
argument) then justifications around pleasure become null and void. However, policy is still 
focussed on the overriding harm of drug use, and extracts from one of my interviewees highlights 
this issue about pleasure and policy:  
 
  “recreational drugs, MDMA - ecstasy is the worst drug out there for trying to 
say there is anything bad about it because I look at the people, I have been to T in the Park 
I’ve stood behind Pete Tong, watched 6000 people all under the influence… And they were 





having a really good time, you don’t get pitched battles in the slam tent...that’s the user 
experience, [it] is a really hard drug to stand up and say ‘gonnea no dea tha’ [go and not 
do that] because it enhances the whole experience. And I think ecstasy is an example of a 
drug that actually highlights better than any of the drug why it’s taken and the benefits of 
taking” (Retired Police Officer). 
 
   This participant was attached to the drugs division of Strathclyde Police at the time he is 
talking about, and witnessed the use of ecstasy at large festivals. Here he is talking about the 
pleasure that festival goers experience from taking ecstasy, and the non-violence associated with 
it. ‘You don’t get pitched battles in the slam tent’ is saying that there are no fights associated with 
taking the drug. And he hits on a real issue facing drug policy – how can a policy focussed on harm 
take into account the lack of harm experienced by millions of ecstasy users on a weekly basis33. 
Furthermore, as CDT would highlight, there’s a key distinction between on the one hand saying 
the policy and science fails to take account of harm and pleasure in properly calibrated ways; and 
a more fundamental critique that it is incapable of doing so because it cannot capture the reality of 
why people use drugs in the first place. The following extract is an endorsement of LSD by one of 
my interviewees:  
 
  Senior Policy Officer: Interviewee: “Especially LSD absolutely. I mean I can’t 
understand what it must be like to have never used acid in the sense that it’s so…what it 
gave me was the insight that a different perception that seemed absolutely valid… is 
possible. So a colour can be another colour. And of course that’s what it is to be somebody 
else, to see something in a completely different way. So I just think it makes you so much 
more - I don’t mean in the MDMA sense of empathic - but I think you understand difference 
a lot better when you realise that simply putting chemicals in your brain can make you see 
the world in a different way, for your thought patterns to be different and all the rest of it. 
It’s a huge insight.  
  Interviewer: So just to finalise, when you think of that drug period in your life, 
it’s not a negative time in your life? 
 Senior Policy Officer: no, no. The best things I had in my life, in terms of just pure fun, 
were all drug related.”  
 Interviewer: Right. 
 Senior Policy Officer:  I would recommend drugs to anyone who could use them in that 
way.” 
 
                                                          
33 The crime survey for England and Wales (Home Office, 2016) recorded 492,000 people taking ecstasy. Similar 
statistics do not exist for Scotland, although the 2017/18 Scottish Crime and Justice Survey reported that 7.4% had 
taken drugs in the last year. Given that both surveys reach is limited, it is not unfeasible (in my opinion) to assume 
that a million or more people are using it on any given Saturday night all over the UK, particularly during the 





The important insight to be drawn here is that experience and personal knowledge of a drug 
and drug using cultures appears to influence the perceived harm and pleasure of that drug. For 
example, Darke and Torok’s research showed that regular injecting heroin users rank heroin in the 
same harm category as MDMA (2013), yet regular psychostimulant users rank heroin as 
significantly more harmful, and MDMA as one of the least harmful and most pleasurable drugs 
(Carhart-Harris & Nutt, 2013). If it is assumed that these regular psychostimulant users have little 
experience of heroin use, then Darke and Torock’s research provides support for the argument that 
user experience of a drug can determine how harmful that drug is perceived as being. There are 
complex issues therefore to do with the impact personal experience has on how we measure drug 
related harm, and ergo how we legislate to mitigate the impacts of drug related harm. Arguably 
most legislators are not regular consumers of illicit drugs, or consumers of only one type of drug, 
and therefore their perception of drug harm is guided by master narratives on how harmful drug 
use is.  
 
This exploration of harm is important because it helps to frame the overarching narrative 
within drug policy - that of harm resulting from drug use and how to respond to such harm. Yet, 
as this section, and previous chapters has shown, this harm is often context-specific and involves 
a complex interplay of social, political and historical aspects. 
 
Counter-narrative and Meta-narratives in CRT and CDT  
 
CRT has a long history of using storytelling and narrative to explore how people view race, 
and how people of colour experience racism. It is used to provide a counter narrative to the 
dominant white narrative (Bell, 1987; Delgado, 1995a, 1995b). One reason storytelling is 
important in CRT, and CDT, is that is opens a window onto alternative realities that are not 
available to white people (CRT), or in the case of CDT, those who have no experience of drug use, 
or different kinds of drug use.  
 
Counter-story telling helps to shine a light on historical and current narratives that hide the 
often-brutal role law and institutions play in the suppression of people of colour (CRT), or drug 
users (CDT). Johan Hari’s book ‘Chasing the Scream’ (2015) delved into the personal stories of 
those impacted by the drug laws, giving us stories which emphasize the role that poverty, 
institutional oppression, racism and brutality plays in maintaining the dominant narrative. Through 
personal stories and collective narratives, the hidden can be revealed, and the de-humanisation of 
those considered ‘other’ can be challenged (Smith, 2012; Tyler, 2013). Counter-storytelling in 
CDT not only focuses on the stories of people who use drugs however. Narratives of change and 
the suppression of certain voices exist within all levels of the policy making arena (as does drug 
use), and counter – storytelling can give voice to these stories. Counter storytelling therefore, 





those whose voices are silenced or suppressed, to challenge the dominant narrative and highlight 
evidence which undermines it. 
 
Throughout the thesis I have provided the master narratives in the form of the institutional 
response to the perceived drug problem in Scotland using the WPR Approach. This approach has 
also provided counter narratives - such as the silences and ignored narratives - and critiques to 
illustrate aspects of the findings. In the following chapter I shall tell stories based on the master 
narratives that emerged from the previous chapters, and provide counter narratives from my data. 
In doing so we will begin to see the emergence of meta-narratives: narratives that “offer the analyst 
a way of entering and reframing controversies that can lead to new ways of seeing capable of 
moving the disputants beyond policy implications” (Fischer, 2003, pp.179). My construction of 
meta-narratives follows Roe (1994) by using master and counter narratives to construct a meta-
narrative. However, if I am honest, I found Roe’s approach simplistic and too structural. I also felt 
that while it sought to add value, the policy analyst is still coming to their own conclusion. As 
Fischer points out, these conclusions need the analyst to make quite large normative assumptions, 
yet Roe does not incorporate those normative assumptions into the analysis (2003, ch.8). I too 
struggled to overcome the normative assumptions, and as discussed in chapter 2, in some ways I 
have not overcome them, nor is it ideal that I do. However, I believe I overcome this analytical 
problem by developing many different narratives using the process set out by Fischer (1989; 
2003;2009) in his ‘analytics of good reason’:  
 
“It is through storytelling that people assess social positions in their communities, 
understand the goals and values of different social groups, and internalise social 
conventions. Narrative stories do this by imposing a coherent interpretation on the whirl 
of events and actions that surround us. Threading these sequential components together 
through storylines, narratives place social phenomena in the larger patterns that attribute 
social and political meaning to them. In the process, the storyline is at the same time an 
invitation to moral reasoning” (Fischer, 2003, pp.179). 
 
The meta-narrative is a form of moral reasoning. By developing different narratives, and 
using elements of both the master and counter narrative to construct a meta-narrative, the goal is 
to provide an alternative story that speaks to both the inherent risk in the stories, and underlying 
moral reasoning. The challenge in constructing meta-narrative for drug policy stories is that there 
are some people, both in policy and in the wider public, who believe that the goal of policy is to 
eradicate all drug use. This is technically impossible and, arguably, morally unreasonable, and 
therefore my meta-narratives will not be able to speak to those who are adamant that this goal 
should persist. Instead, these meta-narratives seek to show the reader an alternative outcome that 








CDT is a work in progress and will need to be developed and tested by myself and other 
scholars in order for it to become part of the critical theory landscape. However, it is grounded in 
critical thought with the underlying premise that the foundations of drug policy, national and 
international, are based on ideological reasoning that is often used to suppress and silence those 
who seek to challenge the status quo. Subjecting policies to critical evaluation, such as research 
into the impact drug laws have on individuals and society (as opposed to the impact drug use has), 
should be advocated, along with public engagement on the complexity of drug use, pleasure and 
harm.  
 
The following chapter explores the narrative pillar of CDT. By combing all the individual 
stories, and broader narratives present in my data, I have developed a series of narratives that set 








Exploring the Narratives 
 
This chapter will use fictional narratives, developed from the data and my background 
knowledge to explore two core research questions:  
 
• ‘What are the master and counter narratives within Scottish drug policy communities?’ 
• ‘What are the challenges in engaging different epistemic communities in a participatory 
policy process?’ 
 
In doing so it will address the final core research question by showing that narratives of 
engagement and participation, as well as historical narratives, can provide a counter and meta 
narrative – critique- that has the stability, or certainty needed to provide an alternative course of 
action. The final research question is:  
 
• What is critical drug theory, and how can it help us understand drug policy formation in 
Scotland? 
 
Finally, this section will address #6 of the WPR approach:  
• How can the representation of the problem be disrupted, questioned, challenged and/or 
replaced?  
 
The representation of the problem is the overarching master narrative that encompasses all 
aspects of drug policy, and provides the frame(s) for which drug policy is negotiated and enacted. 
The counter narratives are the competing narratives – stories and narratives that are evident in drug 
policy communities, but remain hidden, silenced or ignored. The Meta narrative is a combination 
of both the master and counter narrative that shows how policy could be enacted to take into 
account the different viewpoints and situations of the policy stakeholders. The following sections 
in this chapter each present three narratives - the master, the counter and the Meta narrative – 
addressing the two key areas that the thesis has explored: historical legacies of drug policy, and 
stakeholder participation in drug policy. It will also link to the development of CDT, by starting 
to provide justification for the development of the theory. As Swedberg (2012) notes ‘creativity is 
primarily what matters when a theory is devised; and scientific logic and rigor is primarily what 
matters in the context of justification’. It is hoped that by presenting these fictional narratives as 
amalgams of the stories present in drug policy, the reader will see the creativity that helped develop 
this theory, and the logic of using narratives to highlight the impact current and potential policy 






As discussed in chapter 2, if there are different narratives around complex policy 
‘problems’, policy makers will fall on ambiguity and harden the master narrative line, because this 
provides security and strength to an issue which is complex and full of risk (Roe, 1993; Stone, 
2002). It has been argued therefore that policy analysts should focus on the structure of the 
narratives, both master and counter, and explore the similarities and differences in order to craft 
an alternative story that deals with the uncertainty and risk inherent in all complex policymaking 
(Roe, 1994, ch.2). Using personal stories to highlight policy narratives (both master and counter) 
allows the researcher to craft Meta narratives that speak to both the policy making community, 
and the wider stakeholder community. In doing so the counter and meta narratives can attempt to 
provide the security, coherence and structure needed to create understanding of these complex 
‘problems’ and provide viable alternatives by providing insight into the different competing 
narratives.  
 
The narratives presented here are an amalgamation of multiple stories and narratives that 
present the representation of the problem, responses to that problem, and counter stories. These 
stories and narratives come from my engagement with the different policy groups, interview data, 
field notes, documentary analysis, informal conversations and my background (or situated) 
knowledge of the field. Further, the characters in the stories are fictional characters developed from 
my data in order to provide the frame for the kinds of drug use considered legitimate (or 
illegitimate) in policy participation: the sick, the recovered, the professional and the happy drug 
user. None of the actions carried out by the characters are representative of any one person, but are 
reflective of the different situations the various stakeholders find themselves in depending on their 
context. I will present the master narrative, and then provide counter and meta-narratives for both 
historical legacies and participation.  
 
Historical Legacies  
 
As seen in part two, the representation of the problem is a result of historical legacies that 
resulted in a focus on drug related harm, specifically HIV/AIDs and other potentially deadly 
outcomes from drug use. From this a master narrative was developed encompassing the kind of 
drug user, and drug use, policy was focussed on. The following stories explore this focus.  
 
Historical Legacies Master Narrative: the representation of the problem 
 
“Barry turned the corner and pulled up his collar against the biting November wind. He 
walked slowly, not really knowing where he was going, just walking, hoping that it may 
provide some answers. Yesterday was his last shift at the yard, and now him, and most of 
his pals were unemployed. It was 1986, his dad had lost his job a year ago, and was now 
drinking himself into an early grave while his mum watched on helplessly. Barry was 





was unemployed, in fact he did not have the capacity to think about it at all. His life had 
not been easy: being a small boy he was a target for the bullies, and his older brother had 
vented a lot of anger on him. Growing up in a poor industrial estate had taken its toll on 
him, and he was not a happy young man. As he was walking his pal Neil came up to him, 
asked him if he wanted to stop by his and try this new stuff a pal had sold him – like hash 
but better. ‘Aye, may as well come up now, just walking around here wearing ma shoes 
out’. The first smoke of the brown sticky stuff that smelt like burnt vanilla made him 
violently sick, and then horrendously itchy. His pal Neil told him to give it another go ‘it 
takes time to get used to it but when you do… 
The second time Barry got it. He well and truly got it. You know when you have found your 
drug of choice, and Barry had found his. When he sank back after his hit he could feel the 
years of tension slip from his shoulders, his body slowly forgetting the memory of bruises, 
pain, shame. Wrapped in a warm fuzzy loving embrace, Barry felt safe for the first time in 
his life. Unfortunately this feeling cost money, and Barry had no work, and no prospect of 
work in the near future. The more he took, the more he wanted, and gradually he forgot 
about ‘career choices’ and spent his days finding ways to get his fix for the night. Fast 
forward 30 years and Barry has been dependent on heroin for three decades, most of which 
has been spent in and out of jail for small crimes, staying in various homeless shelters, 
temporary accommodation. The periods of sobriety or permanent housing never lasted 
long.” 
 
Now, this story has two endings, depending on what is being depicted: recovery or drug 
related deaths.  
 
The recovery ending:  
 
Barry was tired: tired of being homeless, tired of the street life, tired of needing to intoxicate 
himself to just stay alive. At the urgings of his support worker Barry started to attend his 
local NA sessions. In this he heard about the concept of recovery, and began to think about 
his life, all the trauma he had experienced both in his childhood, and as a result of his 
addiction. His G.P. was encouraging him to reduce his methadone script and she had 
offered to put him in contact with his local recovery community. One day Barry made 
contact with the community, and since then it has been a journey of discovering a new 
support system that has helped him become drug free, and able to hold down a tenancy. 
Barry is very happy in fact he is ‘better than well’ 34 
 
 
                                                          
34 A phrase recently coined by the recovery movement to describe how those who have been drug free for a certain period of 






The drug death ending:  
 
One cold November morning Lucy was walking to work past Waverley train station in 
Edinburgh and she noticed a homeless man asleep on the side of the bridge. She felt sad: 
nobody should be out begging in this weather, put a coin in his hat and went to work. On 
her way back from work she noticed that the homeless man had not moved. She made a 
note in her head to check the next day. The next morning she passed him again, and he was 
in the same position as yesterday. She decided to call the police to ask them to check up on 
the man. One hour later she received a phone call from the police to update her: The man 
had been a homeless man named Barry McGowan, age 53, and he had died from what 
looked like a heroin overdose. He was given a paupers burial and his funeral was attended 
by his support worker, and no one else.  
 
Problem drug use began to be a policy ‘problem’ around the mid 1980’s as a result of an 
increase in HIV/AIDS that brought heroin use to the attention of policy makers, particularly in 
Scotland. The narrative that is being presented in 2019 is that, as a result of neo-liberal policies by 
the UK Government which saw the closure of many factories and industries, Scotland suffered a 
long- term decline resulting in high unemployment, poverty, and an aging drug using population 
(MacGregor, 2017; Galea et al, 2005; McCartney et al, 2012; Scott-Samuel et al, 2014; Collins et 
al, 2011; Walsh et al, 2010; Dorn and South, 1987; Minton et al, 2017; Scottish Affairs Committee, 
2019; Parkinson et al 2017). This has led to a community of drug users that are either sick or in 
recovery, and the focus has been on how to encourage these drug users to access recovery based 
treatment. This story has helped to focus responses to perceived drug ‘problems’ by providing a 
stable grounding on where the ‘problem’ has come from, and a how to respond to it: by increasing 
access to treatment and addressing the social aspects such as housing, employment, therapy etc.. 
While these are laudable responses, and will have a positive impact on many ‘problematic drug 
users’ who are seeking such treatment, as discussed this focus hides a much deeper complex 
relationship with drugs in society.  
 
Historical Legacies Counter Narrative: the hidden harm of criminal justice policy 
 
As has been demonstrated, the problem was represented historically as a response to an 
increase in drug use, particularly opiate based drug use. However, there are counter narratives to 
this representation, namely the role the criminal justice had (and has) in creating and/or sustaining 
‘problematic’ drug use.  
 
This story is based on stories I came across throughout my data collection, including 
interviews, but also through my peer group, my work as an expert witness working people who 
were being prosecuted for drug offences, and individuals and families who attended the LLEEG 





it was argued that the focus on harm resulted in an increased criminalisation of drug users outside 
the treatment framework. In the prologue I told the story of my friend from my late teens who 
ended up in jail for drug dealing, and this story incorporates his and many others to highlight the 
impact the criminal justice system has on drug users.  
 
 “Jamie was getting ready for the weekend. Shaz had phoned and her crew were wanting 
about 20 pills and some hash, Gerry was wanting another 20 pills, and his own crew 
probably wanted the same. All in all he reckoned if he got 100 pills that would sort everyone 
out for the weekend and leave some spare in case anyone else wanted any. He called his 
guy Mark – a dude he’d become friends with from buying pills, and was now effectively 
working for. ‘Mark, I’m gonnea need 100 pills and probably an ounce of your solid if you 
got it’. ‘No worries pal, Come down in an hour and I’ll have it sorted’. Jamie started to get 
ready. He stuck on his thumping house music, poured a vodka and coke, and started to wind 
up for the weekend. It was gonnea be a belter! Shaz was having her 21st and had hired a 
massive venue just in Ayreshire, DJ’s an all, and the promise of plenty dancing, chatting 
hugging and all round madness was on the cards. He called a taxi to take him to Mark’s.  
The taxi pulled up at the high rise in Easterhouse, god he hated this place. Bleak, empty, 
and nerve wracking. How many busts, stabbings, beatings had taken place down here? He 
wished Mark was up for meeting at his place in the West End, at least he wouldn’t feel he 
was walking into a warzone just to buy some bloody drugs for the weekend. In and out in 
20 minutes, done and dusted. As he was walking down the road trying to hail a taxi (no 
bloody taxis in this place) a police car pulled over. ‘What you doing pal’ said the policeman 
in the driver’s seat. ‘Just walking, on my way out for the weekend’. The policeman stepped 
out the car. ‘We’ve been informed that drug dealing has been taking place, and a man 
fitting your description was seen leaving the suspected premises, we are now cautioning 
you under section 23 of the Misuse of Drugs Act 1971, for the purpose of a search’.  
Jamie was found with 100 ecstasy tablets and 1 ounce of low grade hashish. He was 
sentenced to 4 years in prison, out in 2.5 years for good behaviour. He was 18 years old, 
with no dependent drug use or recorded mental health problems, when he entered Barlinnie 
Prison. 
Jamie squinted in the late afternoon sun. His mum and dad had come to pick him up from 
the prison but he had deliberately told them the wrong time so he could leave without them. 
He was broken. His body ached from the violations of prison, both from inmates and the 
different drugs he consumed just to survive the pain. But he also had a craving. He craved 
the sweet feeling of heroin as it hit his veins, the blind intoxication as the Valium mixed 
with heroin dissipated all the memories of the last 3 years. He needed more, but he knew 
his parents would not understand.  
He always maintained, to anyone who would listen, that he learnt his lesson at 6 months. 
The following two years were spent undoing this lesson, and his life. John spent the next 15 





and he was found dead in his flat from an overdose of Valium, heroin and alcohol. He was 
33 years old.”  
 
The impact that criminal justice interventions, and in particular prison sentences, have on 
drug users is not part of the master narrative. The use of counter narratives is an aspect of CDT, 
and is used to highlight that the focus of policy ignores the impact of on the wider drug using 
population. By creating a story that is based on the amalgamation of different experience, it can 
provide an insight into the experience of those marginalised by policy. Furthermore, as we saw in 
the social construction and intersectionality discussion, criminal justice sanctions result in 
discriminatory practices against marginalised and vulnerable communities, as well as the general 
drug using population. The fact that criminal sanctions may cause the drug problem policy seeks 
to address is ignored in what I have previously termed ‘constitutional side-stepping’. This term is 
used to describe the response by most government representatives. When asked about criminal 
justice sanctions, or whether there will be policy discussion on criminal justice responses, the 
default response is that legislation is reserved to Westminster, therefore there is no control over its 
implementation. This response is not given when in private discussions, or those governed by 
Chatham House Rules, which gives us insight into the fact that it is a political response, as opposed 
to an actual barrier. There are discussions taking place behind closed doors to look into criminal 
sanctions, including the implementation of initiatives such as de facto decriminalisation, but these 
are not published or available unless you are privy to these conversations, as I was.  
 
Scottish criminal law has always been separate from English criminal law (1707 Act of the 
Union, Article 21)). As discussed in chapter one, public health responses to drug consumption are 
devolved to the Scottish parliament. Within the existing devolved powers Scotland has been 
creative and provides alternative options through the drugs courts (Gallagher et al, 2019), and work 
with young people in preventing problematic drug use (c.f. Crew, Scottish Drugs Forum, and 
Health Scotland, 2019). In addition, the breadth of the sentencing structure allows flexibility: for 
example possession of a class A drug on summary warrant (lesser crime) can be up to 12 months 
imprisonment and/or a £400 fine, on indictment (more serious crime) 7 years imprisonment and/or 
a fine. However, this flexibility in itself is wrought with inconsistencies, and dependent on the 
actions of the prosecutor on deciding summary or indictment, the opinion of the Sheriff or Judge, 
and the character of the defendant. This makes the implementation of national strategies such as 
promotion of health based alternatives to imprisonment very difficult to achieve. Further, 
following the introduction of two pilot schemes in England that sees individuals found with small 
amounts of drugs either let off with a warning, or diverted to a third sector support providers35, it 
is clear that strict interpretations of the MDA 71 are not required. If Scotland chose to be flexible 
                                                          
35 See further Thames Valley Police initiative at https://www.thamesvalley-pcc.gov.uk/police-and-crime-






in its implementation of the Act, there are ways in which low level dealing such as subsistence 
dealing36 and social supply37 could be treated without a prison sentence.  
 
Currently in Scotland, drug offences make up 24% (6233 people) of all recorded crime 
(Scottish Government, 2019a). Of this 16% received a custodial sentence with an average stay of 
2 years. A further 24% received a community sentence, and the bulk of convictions (42%) were a 
financial penalty. There has been limited research to date that looks at what impact interaction with 
the criminal justice system has on drug using patterns (Hayhurst et al., 2017), or the impact that 
criminal justice sanctions have on drug using populations, and most of that is based in North 
America. Generally speaking research focuses on whether interventions increase risky drug use 
such as injecting (for example Strathdee et al, 2015), the impact on HIV prevalence (Altice et al, 
2015), or the racial disparities in the US system (Beckett, 2006; Brunson & Miller). The association 
between drugs and criminal justice interventions often focus on the role drugs play, and whether 
drug use or recidivism increases/decreases after engagement (for example Jennings et al, 2020, 
Babor et al, 2018, ch.11). However, the more nuanced understanding of the relationship between 
drug use and criminal justice interventions is still to be done, and using a CDT framework may 
help to re-focus away from the narrative of drug harm, onto the narrative of policy harm. For 
example, my experience as a support worker showed me the huge impact court fines can have on 
drug dependent individuals. More often than not these individuals have no other income other than 
state benefits, and this income goes to fund their addiction – be it alcohol or illicit drugs. Fines do 
not prevent this, and clients would often be in arrears and threatened with custodial sentences as a 
result. I have witnessed anxiety, panic attacks and extreme drug taking, mental health deterioration, 
life chances ruined and death that resulted directly from the stress of being involved with the 
criminal justice system. While this thesis cannot cover this topic in depth, it is an important area 
that should be explored further in future CDT research. 
 
Contrasted with this, 27% of the Scottish population reported ever using illicit drugs in 
2018/19 (1,429,650), with 7.4% (391,830) reporting that they had used in the last 12 months. The 
most common drug was cannabis (70%) closely followed by illegal prescription drugs (34%), 
cocaine (19%) and ecstasy (13%). Heroin is recorded as being used by 1% of the population, 
remaining stable in comparison to previous years (Scottish crime survey 2018/19). The low 
recorded rate for heroin use may be more reflective of the type of drug user (less likely to engage 
in institutional data collection research), than actual use. What this highlights is that there are a lot 
more people using drugs, than being prosecuted by the courts, and this is supported by previous 
research that estimated there were 3000 cannabis users for every 1 arrest (Nguyen and Reuter, 
2012) and more recently 5,500 users for every arrest (Caulkins et al, 2016).  
 
                                                          
36 This term describes dealing that is undertaken in order to supply the dealer with her own drugs, and no more. 
37 This term describes James’ predicament, being the main contact for several social groups and buying drugs but 





The main reason that the master narrative of problem drug use persists is that it clearly 
illustrates the risk of harm that can result from drug use. The counter narrative provided here shows 
the risk of harm resulting from criminal justice interventions, and develops the rationale for a 
critical drug theory. By using personalised stories to focus attention on the silenced or ignored 
aspects of drug policy, CDT can inspire empathy and compassion towards those experiencing this 
silencing, and thus affect change.  
 
The following narrative is a meta-narrative: a fictional story that seeks a middle ground 
incorporating enough of the main stories to provide consistency, credibility and coherence 
allowing for an alternative viewpoint. It combines John and Barry’s story to explore what may 
have happened if our legal and social relationship to drug use was different: i.e. if we implemented 
drug policy reform as advocated by many drug policy activists and workers. 
 
Historical Legacies Meta Narrative: reducing the harm of drug policy  
 
Barry and Jamie had known each other for years. They had been pals in primary school 
but in high school they had drifted apart. Barry was a small shy boy, and the target of 
bullies. He often came into school with bruises and dirty clothes: no-one really knew who 
his family were except to steer clear from his uncle. Jamie on the other hand sailed through 
high school. He had a supportive family, a good circle of friends, and despite the poverty 
surrounding him, he had aspirations of leaving school and getting a good job. It was 1986 
and the factories were closing down around them. Barry had finished school a year ago, 
and he had just lost his job at the yard. The last year had been hard as he watched his dad 
sink deeper into an alcoholic depression, and the black dog of depression was hanging on 
his own shoulders most days. One day, as he was walking the streets aimlessly, he bumped 
into his pal Neil who asked whether he wanted to come up to his and try some smack. They’d 
had drug education in school, and he’d heard that smack (heroin) was a good painkiller 
but that it was potentially very addictive. He knew he felt shit, he knew he’d like to take 
something to stop himself from feeling like shit, but he didn’t want to get into something he 
would have to rely on for the rest of his life. Knowing all this he said ‘nah, you’re alright. 
How come you into that stuff man?’ ‘Ah pal, said Neil, ‘ken, ah knew it was habit forming 
but aye, it’s just so good, once you try it, it makes you forget absolutely fuckin everything, 
and I mean everything.’ Barry nodded, there was a lot he wanted to forget, but he knew 
Neil had more he needed to forget. ‘Heard you can get a script – pure stuff – from the doc, 
have you thought about that?’ ‘Aye’, said Neil, ‘I’m gonnae start Monday, that and some 
therapy. They say I’ve got childhood trauma shite I need to deal wi.’ ‘Good luck then pal’, 
and Barry was off.  
A little while later Barry bumped into Jamie, his old pal. ‘Hi Barry man, how you doing? 
‘Och, no so bad, no so good either to be honest’, Barry replied. ‘Fancy coming to rave with 





off to get the weekend stash sorted. In his drug education Barry had also learnt that ecstasy 
was not very dependent forming, and the main problem was related to quality and quantity. 
He was curious and needed a boost. ‘Aye alright’ said Barry, ‘could do wi a bit of a blow 
out’. Nice one, said Jamie, ‘meet at mine the back ‘o 8, I’m just heading to Easterhouse to 
pick up.’  
As Jamie left the high rise in Easterhouse he noticed a police car driving past. He hunkered 
down, didn’t want to get noticed. Although technically folk weren’t getting done for 
possession of drugs anymore, he had 100 pills and an ounce oh hash, and he wasn’t sure 
he could swing it with that much on him. The police drove past. They recognised him as a 
regular at the flat. ‘No doubt see him out at the rave tonight eh’, said one of the police. The 
other laughed, ‘aye, giving a huge hug and snog to any polis in the vicinity most likely’. 
The police knew that Mark was dealing ecstasy from his flat. They also knew he imported 
the ecstasy from Holland on a monthly basis. But they also knew that the harm caused from 
this activity was nothing compared to what they were dealing with in and around the local 
pubs, and they would rather have the local teenagers munching on ecstasy in a field, than 
beating up their neighbour down the pub.  
Barry had a fantastic night. He danced and danced and hugged and loved and came away 
with 20 new best pals. Jamie and him started seeing each other as friends, and gradually 
they moved from clubbing and working in bars, to other more ‘professional jobs’. 30 years 
later they have 3 kids between them, and still hook up for the odd pint or smoke. 
Occasionally they enjoy a line of coke together but nothing on the scale of the old days.  
 
I have tempered this story to include only policies that are possible within the current 
structures. It is possible to give comprehensive drugs education that tells young people about the 
enjoyable and negative effects of drug use. It is possible to prescribe heroin to people who have 
become dependent on heroin, and it is possible for the police to implement a non-arrest policy for 
low level drug possession and dealing. Indeed, back in the late 1980’s early 1990’s, police hauls 
of ecstasy were relatively low, and policing of the activity was limited. One of my interviewees 
was a drug squad officer for Strathclyde at the time:  
 
“…[W]e didn’t see it because the people who are taking it and the people who are supplying 
it just didn’t come onto the criminal justice radar. We were busy with car thieves, house 
breakers, serious assault, gang leaders, there was a huge gang culture, I mean part of it 
was just running with the gang and dishing out vicious vicious serious assaults, like 
horrible stabbings and slashing and murders, so we didn’t see drug users. 
…I saw the ecstasy market come from absolutely nothing, and it was all about the club 
scene. I had one of the biggest recoveries in Scotland which was 111 MDMA tablets that 
would have been around 1990, the biggest at that time, when I first went to the Drugs 
Squad. And it was destined for the Hanger 13’s scenes down in Ayre, there was a huge rave 





doing. They were sourcing Eccies (ecstasy), taking them down there, punting them and that 
was like your night out, your drugs, and a bit of business as a side line. I was in the drugs 
squad proper until 1994, and I remember latterly 600,000 ecstasy tablets in a concealment 
coming in from Belgium and I took them out and they were concealed in a van” (Ex Scottish 
Minister #1). 
 
One reading of this meta-narrative is that my own personal bias towards psychoactive drug 
use (as opposed to opiate drug use) is being used to illustrate how different drug using choices can 
impact future life chances, but that was not my intention. While there is a discussion to be had 
outwith this thesis on whether involvement with psychoactive drugs instead of opiates does indeed 
impact life chances, the intention here is to present multiple potential outcomes to the master 
narrative, in order to show how policy could be implemented, with different results.  
 
What we can see with these three narratives (master, counter and meta) is that they all 
speak to different developments of policy, and in particular how policy has, or could be, enacted 
over the years. In this way these stories provide evidence for the development of CDT, by 
highlighting the concepts underpinning drug policy, and how these concepts could be different if 
the underlying premises were challenged, and changed. As Swedberg (2012) notes: 
 
“To do science, according to Pierce, means among other things to challenge existing signs 
and concepts, and to show how these have come into being; how some elements of reality 
have come to be cast as this particular concept rather than as some other concept” (11). 
 
Stakeholder Participation in Drug Policy 
 
   The following narratives are about the kind of drug users considered legitimate (or not 
legitimate) stakeholders in policy participation. The narratives here are made up of numerous 
personal stories I came across during the data collection period: interview data, engagement in the 
policy process through advisory groups and committees, combined with my background 
knowledge of the kinds of drug using communities in question, and the official focus of policy 
taken from documents such as the Road to Recovery (2008). As developed in chapter 7, there are 
different typologies of stakeholders: the sick, the recovered, the professional and happy drug 
consumer. These narratives explore each of the typologies but combine both the sick and recovered 
into one narrative, and the professional and happy into another. The final meta narrative combines 









Participation Master Narrative: The Sick and Recovered Drug User  
   
  This narrative justifies why those with lived and living experience should be part of the 
policy process. The narrative is similar to the representation of the problem (Barry’s story), except 
it is more focused on the recovered/sick person participating in policy advisory.  
 
  Debbie stuck out her hand to hail the cab. The rain was lashing down and she’d 
be damned if she was turning up to the group soaking wet and late. This was her second 
meeting with the Scottish Government PADS committee, and she was nervous. As the taxi 
crawled through the city center, heat on full, wipers sloshing the rain away, she reflected 
on how she’d come so far from the streets of Glasgow.  
  10 years ago she would never have thought, in her wildest dreams, that she 
would be one of what she used to call ‘the grey people’: moving through streets in taxis, 
attending meetings and making a difference! 10 years ago she was living hand to mouth, 
sometimes on the streets, sometimes in hostels, always on drugs. How had she ended up on 
the streets? She’d told the story countless times now, so often that it had become a story 
separate from her in some way.  
  Her early life had been hard. Her mum was a single mum with three kids, dad 
had fucked off when she was 3, couldn’t handle her mum he’d always said, but Debbie now 
knew it was because he couldn’t handle his own drug and alcohol problems, and family life 
was too overwhelming for him. Her mum had tried to cope, but she had her own drug and 
alcohol problems, and a series of abusive relationships with men who also abused Debbie. 
At 13 years old Debbie was removed from her mum because the school found out about her 
mum’s drug problems, and the abuse that Debbie was being subjected to by her mum’s 
boyfriend at the time. She often wondered what would have happened if the school and 
social services had actually supported her family, rather than separate them. But that was 
history. 
  She was 15 when she tried heroin for the first time. She’d used plenty of other 
drugs, alcohol, fags, cannabis and speed. She enjoyed the feeling of getting high, it took 
her away from the immediate situation and pain. When her pal Neil offered her a smoke of 
this black sticky stuff she didn’t think twice. Yes she’d heard of the dangers of heroin, but 
she enjoyed drugs, and didn’t believe the hype. The first time she tried it she didn’t like it. 
It made her vomit and itchy, and she didn’t really get a high. However, Neil told her you 
need to take it a few times before you get the proper effects, so, curious to see what the 
‘proper effects’ were like she did. Neil became her boyfriend, and seven years later and 
she’s living on the streets, surrounded by her drug using community.  
  But here she is now, 17 years later, on her way to an official government 
meeting on drug related harm. The ‘lived and living experience representative for the drug 





  “We’re here pal”. The taxi driver’s interjection breaks her reverie. She hands 
him the cash, asks for a receipt, and jumps out. Deep breath, and relax, ‘I’ve got this’ she 
says to herself.  
She’s early, so she sits down to wait for the government official who will escort her through 
St. Andrews House to the meeting room. Her mind wanders. What’s she doing here, what 
value does she add to these meetings? Sometimes she feels like the token ex drug user in 
recovery, in a room full of professionals, everyone talking about service users and problem 
drug users. Is this her role? To provide them with the user experience? But what is her 
experience?    
10 years ago she started her journey of recovery. She had been in and out of treatment for 
several years, never really engaging with the services because she didn’t feel they had 
anything they could offer except the insistence that she stop using drugs. She didn’t want 
to stop using drugs. She liked the feeling they gave her, loved her drug using pals, and 
couldn’t see how she could ever change the situation she was in. Yes her health was 
suffering, she had been in trouble with the police on many occasions, and experienced some 
horrible situations with so called friends, and had no home. But it was all she knew.  
Then one day she was approached by a support worker from one of the recovery groups. 
They offered to support her getting off the streets and onto a methadone prescription and 
stable housing. It was auspicious timing because she had just lost two of her close friends 
to overdose and contaminated drugs, and her partner Neil had spent a stint in jail for drug 
dealing and assault, and was not due to be released for another few years. She was 
paralyzed with fear about her own life chances. Over the next four years she gradually 
stopped using street drugs and stuck to a prescription. She found support from the local 
recovery cafe and a new community was shown to her. Eventually she went on to complete 
the LEAP recovery programme, an abstinence based programme that supports individuals 
and families through their recovery from drug dependence.  
‘So I guess this is why I am here’ she thought. So I can tell them my experience, and the 
experience of my community and what worked for us. 
 
As we saw in chapter 5, the archetype of the legitimate stakeholder is one who has lived or 
living experience of problematic drug use, in particular opiate and benzodiazepine use. This 
includes family members and significant others who have been impacted by problem drug use. 
The recent commitment to meaningfully engage with this community is to be welcomed (Scottish 
Government, 2018), and I struggled writing the counter/meta narratives because I did not want to 
dismiss the importance of including those most affected by drug related harm in policy decisions. 
Yet, as previously argued, the concept of drug related harm is complex, and while improvements 
in engagement have taken place, there is still dissatisfaction by many with the way that 
participation is being carried out, and the silences and sidestepping in regards any other kinds of 






In this section Debbie’s story is the master narrative: the problematic drug user who has a 
history of trauma and dependency but is on the road to recovery. The counter narrative explores 
the silenced drug user: the person who enjoys using illegal drugs, does not engage with any 
treatments service and has minimal harm stemming from their drug use.  
 
Participation Counter Narrative #1: the professional and happy drug user  
 
In the previous chapter the WPR analysis identified one of the silences within current drug 
policy narratives as being the happy drug user. The challenge for a drug policy that is focussed on 
drug harm is where does this voice fit in?  
 
The following narratives use the characters from our historical legacies narratives. I do this 
in order to bring coherence to the narratives, and so that the final meta narrative can link all four 
characters, Barry, Jamie, Neil, Shaz and Debbie in the meta narrative for participation. The unequal 
gender spread of my characters is reflective of the unequal representation I witnessed during the 
data collection period, however I did not incorporate a specific gender element into the thesis. 
Interestingly, over the 5 years I have been engaged at a policy level this has started to change, as 
more women enter the policy space.  
 
There are 3 narratives in total. The first two narratives are based on the professional, sick 
and happy drug user, one from within an institutional setting, and one from outwith. This is because 
I came across these narratives constantly, and are reflective of the wide range of drug using 
experience in society. The last narrative is based on the ‘sick’ drug user: the perceived ‘problem 
drug user’ who is ‘sick’ and needs help. 
 
Jamie trudged to his desk in St. Andrews House. Monday mornings after a mental weekend 
can be brutal. He didn’t go out much these days, what with the kids and the job and that, 
but it was his pals’ 40th birthday and she had organised a weekend away in the woods with 
the old crew. It was a belter of a weekend, reliving the good old days of dancing, MDMA 
and mushrooms, old skool techno and singing round the fires. Every time he had a weekend 
like that he spent the next few weeks with a heart full of love and reconnections. Back to 
the grind though.  
 He had been working at the Scottish Government as a civil servant for the past 12 years, 
and had recently moved to a new policy team – the Drug Policy Unit. He had seen the post 
come up, and given his personal experience of drug use thought it would be an interesting 
post. However, he was beginning to realise his personal experience was not something he 
could share with colleagues on the team. He’d never been open about his drug use with 
work pals. He smoked a bit of dope at the weekends, and had the odd party each year, but 
his socialising with work colleagues went no further than the annual Christmas bash, and 





to get frustrated that he couldn’t be honest about his experience. Every day he was seeing 
things that contradicted his experience as a drug user. They talked about the rise in cocaine 
use as if that was some kind of phenomena – christ, his social circle had been using that 
stuff for decades, and they were not all posh bankers! And the language, it was all about 
problem this and problem that, and how will we get people off drugs, no recognition that 
most people use drugs because they enjoy them, or are using them to self medicate deeper 
personal or socially constructed issues.  
All the folk he had witnessed slide into so called problem drug use had done so because of 
underlying issues. Barry, his old pal from home, had a stint on the smack, but that was 
because he grew up in a household that was full of violence. Mark, his old dealer, ended 
up hooked on Valium and heroin after he got sent to prison for dealing. Shaz had a stint 
with the coke, but she had always had problems with social anxiety, and she got off it 
without any help. And then there were the usual car crashes, people who just took it too 
far. But overall most of the folk he knew outwith work had used drugs for decades, and 
were none the worse for it. In fact he would argue that using drugs like MDMA and 
mushrooms improved people, made them more open and understanding of the different 
kinds of realities that exist.  
And so here he is, another Monday morning, and a raft of meetings throughout the week 
with a focus on how to increase the lived and living experience of drug users in policy 
making, and he can’t say a god damned word.  
 
The frustration for Jamie is his inability to meaningfully take part in the development of 
policy around his own life experience. Although this is a unique position, there are not many people 
working at the policy unit, it is reflective of the wider frustration felt by many professionals 
working within institutions, and their inability to use their own drug using experience in 
discussions on drug policy or engagement. As discussed above, the criminal nature of the act 
prevents open discussion, in addition to the stigma attached to drug use.  
 
The second narrative is about engagement from outwith an institution, and focusses on the 
gatekeeping that can take place in order to restrict certain voices from being heard at a policy level. 
I introduce a new character here, Catherine, who is from a middle class background, low ACE 
score, and a regular drug user since her early teens. She combines the ‘professional’ and ‘happy’ 
drug user typology, and this fictional character is representative of many non-institutional actors 
attempting to engage in the policy process. This narrative also expands on the story of Shaz, who 
we met earlier as a friend of Jamie’s, and who combines the other ‘sick’ stakeholder – using drugs 









Participation Counter Narrative #2: The professional and sick drug users 
 
Catherine put her head in her hand, and thumped the desk with the other one. What was it 
with these people?! She had been organising this event for weeks and then one wee news 
article where one of the participants criticised the government and the civil servants’ 
response to the drug crisis, and boom, they pull out. The article had also focussed on how 
the government were obsessed with drug harm, and refused to acknowledge the wider drug 
using population, specifically calling out the unit for not allowing engagement on other 
issues such as drug testing in festivals and clubs. It had also talked about the use of drugs 
for medicinal purposes such as cannabis, and using psychedelics to treat opiate 
dependence, which wasn’t that controversial, was it? And what were they afraid of anyway? 
Surely it was better to be round the table even if you didn’t agree with everything that was 
being said?  
She took a deep breath and sighed. It was fucking classic. So many non-institutional 
organisations and people were keen to be involved in policy making, especially at the 
agenda setting stage, but it seemed impossible to get past the gatekeepers. If you weren’t 
singing the song of recovery, or god forbid were challenging the effectiveness of recovery 
for some people, then you were locked out of the conversations. She’d even heard rumours 
that the reason the policy advisory structures had been disbanded was because they were 
too challenging and called for more radical reform such as drug decriminalisation.  
The event that Catherine was organising was a multi-stakeholder event for people who use 
drugs. Shaz, her co-convener was an expert on putting on large events. Catherine had 
known her since their clubbing days in the early 1990’s, and her free parties had always 
been the most well organised of the lot! Now she was a professional events manager and 
they were working together to put an event on that was close to both their hearts.  
Shaz had seen her fair share of drugs. Growing up in the ‘90’s she’d been a regular clubber, 
and in her and 20’s she developed a problem with cocaine. Her ‘problem’ had been she 
just enjoyed it too much. It made her feel invincible, and countered the social anxiety she 
had felt all her life, despite coming from a loving and generally stable home. However, too 
much of a good thing can have devastating impacts, and her mental and financial health 
had suffered. She’d pulled herself back from the brink thanks to good friends and an 
understanding she was taking it too far. Her therapist had said she probably developed the 
anxiety from being over-protected: her mum had always been a ‘nervy’ character. In her 
30’s she was diagnosed with M.S., and after several years of trying different 
pharmaceutical drugs that did more harm than good, in her opinion, she became a regular 
cannabis user. It worked wonders for her, and as a result she had become an active 
campaigner in the reform of cannabis, both for medical and non-medical uses. 
So Catherine and Shaz were collaborating on this event, and it was a big deal. The idea 
behind the event they were organising was to broaden stakeholder engagement in policy 





so that they could feed back the outcomes of the engagement, and hopefully get some 
meaningful participation in policy at a higher level than just ‘consultation’. But, they had 
been warned from an early stage, by all parties, institutional and non-institutional, that 
engaging with the government would result in being let down. They had paid lip service to 
user-led engagement for years, and they weren’t about to change, they said. I guess they 
were right, Catherine thought.  
Initially her engagement with the policy makers had been positive, easy even. There were 
good communications, private chats, meetings and the sense that collaboration was 
developing. But somewhere along the way that had changed. Maybe it was when they 
realised she identified as a drug user, maybe it was when those who she collaborated 
challenged them about their lack of engagement, or maybe it was her links to more radical 
aspects such as calling for drugs such as MDMA and psychedelics to be used in a medical 
setting. Who knows. All she knew was the door was firmly closed, and she had an event in 
two days time with the aim of creating links between the policy makers and stakeholders, 
and one of the parties were not going to be there.  
 
This story is about the experience of non-institutional actors who have tried, and often 
failed, to get their kind of meaningful engagement from policy makers. It shows that when 
exploring the oppression and marginalisation of drug consumers using the narrative arm of CDT, 
other aspects of CDT can become intertwined. For example, while much of the policing and focus 
of institutions is on a demographic of drug users that are part of other marginalised groups by 
poverty, race, mental health, etc., the impact of policies cut through many layers. Given her 
position within the professional world intimated here, there should have been little difficulty with 
her being able to pull in a wide range of stakeholders. However, it is her perception, however ‘real’ 
or not, that she is being prevented from accessing the policy engagement because of transgressions, 
such as being open about drug use, or being critical of the government. The exposure of her as a 
drug user has resulted in her becoming a marginalised person, in this instance at least, and 
highlights how the stigma towards drug users has a chilling effect on meaningful engagement 
regardless of social positioning.  
 
The third counter narrative to participation focuses on the ‘sick’ stakeholder, the person 
with living experience of drug use who is not engaged in treatment, and indeed may never be ready 
for the kind of treatment being offered.38 However, it also encompasses the ‘happy’ stakeholder, 
as the character appears to be content with his drug use, despite it being injecting opiate use, which 
is the focus of the harm narrative. Furthermore, this is the kind of stakeholder that is being 
encouraged to engage in the ‘living experience’ consultations, in order to give the Scottish 
Government, and treatment services a better understanding of barriers to treatment and recovery. 
                                                          
38 Heroin Assisted Treatment, although available to the Scottish Government to implement since the Scotland Act 





This story is slightly longer as it requires an element of setting the context, and apologies in 
advance for the swearing! 
 
Participation Counter Narrative #3: the sick and happy drug user 
 
Neil peeled open one eye and squinted. The sun was blazing through the flimsy curtains, 
hurting his eyes but warming his body. He felt the glow spread from his legs up, the warmth 
of the summer sun slowly penetrating his skin. A cloud covered the sun and his body chilled, 
ah, time for my morning fix he mused. As the kettle boiled, he rolled a joint and started to 
set up his kit39. He only had enough left for today, he would have to go easy on his stash 
‘till his money came tomorrow, he didn’t have the stomach for begging today. As he sipped 
his coffee and started to heat up the spoon his phone rang.  
‘Hullo?’  
‘Neil, it’s Debbie…’ 
Neil paused. Debbie.  
When he had come out of prison he had looked for her on the streets, and local doss houses 
they had been known to frequent over the years, but she had gone. Word was she had 
entered into an abstinence based rehab centre, and not been seen since.  
‘Oh, hi. Long time no see eh. How’d you get ma number?’  
‘Och I bumped into Barry, and he said he’d seen you a few years ago, got your number. I 
know it’s weird me calling, I just felt it was time to reconnect. How you been?’  
‘I’m okay I guess. Got out a few years back, got a job, stayed off the smack, lost the job, 
got back on the smack. You know how it goes. But I’m actually okay. I’ve got a flat, benefits 
paid for, seem to be able to hold it all down. I’m not using like we used to, I like to spread 
it out now, ken, a wee starter in the morning, one mid afternoon and then an evening relax. 
Didn’t get back into our old crowd though. After coming out of prison and getting a job I 
started seeing the world differently. Remember when we used to laugh at the ‘grey people’ 
(both laugh), well now I dinnae think they’re so bad after all. Life catches up with you eh.’ 
‘Yeah, funny, I had that thought this morning on my way to a ‘grey person’ meeting.’  
‘So what you been up to? Heard you went full abstinent, no contact, that sort of thing.’  
‘Yeah, I had too. It was all getting too much, thought I’d end up dead or in prison like 
yourself.’ 
They chat for wee while, catching up, exchanging stories about past lives and friends. Then 
Debbie asks ‘do you ever feel you want to get off the smack and the dope? I mean, you been 
on it so long, do you not wonder what life is like without any kind of drug?’  
Neil laughs. ‘So this is when you start coming over all righteous eh! Am I one of your 
conversion targets? Peer outreach, that kind of shite?’  
‘Och, don’t be like that. No, the opposite in fact. Barry had said you were doing good, got 
your flat, got a wee routine, but still using. I wondered if you wanted to get involved with a 
                                                          





group that’s been set up to get folk with lived and living experience of drug use involved in 
drug policy?’  
Neil was interested. His days were spent roaming Glasgow, attending job seeker 
appointments, getting his wee bags of heroin, and watching Netflix, so he was up for 
something a bit different. And Debbie had said the group were not looking to recruit folk 
into treatment, but get people who are currently using drugs to talk about what works for 
them.  
The meeting was being held in some old council buildings, recently done up, but still with 
an air of fallen grandeur. As he sat at his allocated table with 6 other people he looked 
around the room. Everyone looked so normal! He’d had his morning fix, and smoked a 
joint before walking in, but he still felt anxious. What the fuck was he actually doing here. 
Who were these people?  
‘Welcome everyone’ said the lady at the front. She then proceeded to outline the focus of 
the event. ‘We want your feedback, as people in recovery with lived and living experience 
of problematic substance use, to help us design treatment that works for you. As you know, 
the Scottish Government are committed to including your voices in the design and delivery 
of services that you access. Therefore your views matter.’ 
She waffled on for a few more minutes but Neil had heard enough. Soon as he could he was 
gone. Who the fuck was she to tell him that he had ‘problematic drug use’. He’d never 
managed his drug use better in all his life, and that was no thanks to any of the services 
he’d been put in touch with. All he’d got from them was opinions. Opinions on how he 
should behave, opinions on whether his use should stop, opinions on his life. Nut, he was 
fine on his own thanks. The only way that they could help was to give him his medicine for 
free so he didn’t need to use his benefits to pay for it, or risk jail. But that wasnae gonnae 
happen. He’d heard that Glasgow were starting heroin assisted treatment, but they were 
for folk who had gone through the system, were on the streets, were basically near death’s 
door, and he’ be fucked if he was going to return to that state just to get his stuff for free.  
He felt the anger bubble up inside him. He looked round the table. Everyone staring intently 
at the speaker, nodding in the right places. At some point the lady stopped speaking and 
his group turned to the table and started talking. He’d missed what they were meant to talk 
about. ‘We’re to talk about what matters to us, what would work to help us on our journey 
towards treatment’ said a lady at the table. 
He stared at them. ‘Personally I’d just like to get access to ma heroin from the doc, so I 
don’t need to spend so much money myself, and don’t need to risk the jail every time I pick 
up. That’s what would help me’.  
They stared at him. ‘So you’re not interested in the different treatment options, or have any 
suggestions on how they could be changed to make you feel able to access them?’ asked an 
older man to his left. ‘what about getting off the heroin altogether? I mean surely you’re 
not happy taking it every day? I stopped 7 years ago and it was the best thing that ever 





‘Good for you pal’, said Neil, ‘but nut, I’m perfectly happy with my level of drug use the 
now. I’m not on the streets, I’m not using dirty needles, I got a nice wee flat, I’m perfectly 
happy, until I’m not. It’s the reason I’ve never engaged with any of this shite, because there 
is always the underlying assumption that I am using but I don’t want to. How about I just 
want to continue with what I’m doing the now, is there help and support for that?’  
‘I don’t know how to record this as an outcome, it’s not really related to the treatment 
question’ piped up another person at the table.  
Neil pushed back his chair. ‘’Enjoy yourselves’ he said to the group, ‘I’m off for a smoke 
and then my late-afternoon hit’. He winked at the table and turned and left. Bag ‘o’ shite 
he thought as he left the building.  
He walked slowly along the street, taking long puffs on his joint. The sun was setting and 
deep red and golden streaks poured over the sky like a luxurious bedspread. The birds were 
singing their evening song and life was good. He smiled. If anything that meeting had 
confirmed to him he was happy, but he’d never engage in that government shite again.  
 
The main aim of Scottish drug policy is to reduce the harm from ‘problematic substance 
use’ by encouraging people into treatment. In 2015/16 it was reported that approximately 57,300 
individuals (1.62% of the population) in Scotland were using illegal drugs problematically (NHS 
Scotland, 2019). Contrasted with the statistics that show in 2018/19, 10,757 initial assessments for 
specialist drug treatment were completed (Scottish Drug Misuse Database, 2020), we can see that 
a sizeable amount of ‘problem drug users’ are either not initially engaging, or do not continue to 
engage. This focus on treatment is what prevents many people seeking support for their drug use, 
either because they feel they do not want to stop, or there is a distrust of the institutions spurred 
by the stigma associated with using drugs. As we saw with the LLEEG discussion, many 
participants felt anger at the continued focus on medical solutions to what many of us consider 
social ‘problems’.  
  
Neil’s narrative reflects the feelings of many drug users: that to be involved in any service 
or institutional advisory body, it will be assumed that their drug use is something they wish to stop. 
However, as this counter narrative explores, many drug users are content with their drug use, or at 
least do not regard their use as harmful enough to seek treatment. Furthermore, many people who 
have engaged with the treatment system will do no so again, feeling that they have been treated 
with stigma and had a medical narrative imposed on their drug use (LLEEG insights). Over my 
life, and throughout the data collection period, I met people who had experienced episodes of 
harmful use, but ‘recovered’ without the help of services. Often there is a wariness of engaging 
with institutions that have not been seen as advocates of drug users, and this is reflected in Niel’s 
guarded response to being involved at all. Furthermore, as the narrative highlights, often when 
current drug use is brought within lived and living experience stakeholder groups, there is an 
assumption that it is something one is seeking to stop, but unable to do so. This assumption is 





harmful guided most of the dialogue in the institutional settings I was involved in, and it was not 
until less formal settings such as the SDPC emerged that some people felt able to vocalise their 
opposition to this assumption. In fairness this obstacle has been taken into account in the 2018 
Scottish drug strategy, with an emphasis on people finding ‘their own kind of recovery”’(Scottish 
Government, 2018, 4) in the community. However, a strong feeling from some of the participants 
within the groups I was involved in, was that the focus of participation is so heavily directed 
towards recovery and treatment, it fails to take into account other aspects of drug use, in particular 
the pleasure that most purport to experience when using.  
 
We now turn to the final narrative – the meta narrative of participation. To re-iterate, the 
meta narrative is a fictional story that seeks a middle ground incorporating enough of the master 
and counter narratives to provide consistency, credibility and coherence, allowing for an 
alternative viewpoint. To an extent it is an idealised account of what could happen, and the in 
keeping with the storytelling aspect of this chapter, the narrative explores the different characters 
and their experiences, as opposed to the mechanisms of participation.  
 
Participation Meta Narrative: everyone feels listened to and engaged 
 
In an ideal world all stakeholders feel meaningfully engaged and are able to participate at 
all levels of the policy making cycle. However, as the research shows this is often not the case. 
The background to the following narrative is an event that has been put on by an independent 
stakeholder advocacy group, with the backing of the Scottish Government, to discuss drug policy 
reform. This event is fictional and I use this setting – a large stakeholder engagement event – to 
explore each character and what meaningful participation means to them, and whether it can been 
achieved within these settings.  
 
Because the characters circumstances have, in some instances, altered throughout the 
narratives to reflect different possible outcomes, I clarify which storylines I am using for this 
narrative:  
1. Barry – Violent family, exposed to poverty and drug use early, long term opiate 
dependency and, despite accessing services, he continues to use both prescribed 
methadone, street heroin and cannabis.  
2. Jamie – Supportive and loving family, yet family suffered from high levels of poverty. 
Exposed to drug use at a young age, never had an opiate dependency, didn’t go to jail 
for his drug dealing, but instead used drugs regularly and has worked at the Scottish 
Government for the past 12 years.  
3. Neil –violent and sexually abusive yet financially secure family, Exposed to drug use 
in teens. Opiate dependency for several years but then stopped. Started using heroin 





4. Debbie – Violent and sexually abusive background, history of care, long-term opiate 
dependency, now in abstinence-based recovery and part of the lived and living 
experience advisory structure of the Scottish Government.  
5. Catherine – loving but unstable family, middle class but not financially secure 
background, used illicit drugs since her teens, never developed an opiate or other drug 
dependency but continues to use cannabis, psychedelics and psychoactive drugs from 
time to time.  
6. Shaz – loving, stable and financially secure family. Used cocaine extensively in her 
late teens/early twenties, stopped using in her mid-twenties. Diagnosed with M.E. and 
now vapes cannabis on a daily basis and uses psychedelics for spiritual/therapeutic 
reasons.  
 
Catherine stepped out of the shower, grabbed the towel and scuttled to the bedroom. It was 
extremely early on a cold November morning and the heating hadn’t kicked in yet. 
Nevertheless, she was feeling exhilarated and happy. The first day of the stakeholder event 
entitled ‘Deliberating Drug Policy in Scotland’ had gone smoothly, and today was the first 
day of proper deliberative discussion. She smiled as she remembered Shaz’s ecstatic mood 
last night. ‘We did it’ she had screamed at her down the phone. Shaz had left early, 
childcare emergency, but everything had been coming to a close, and Shaz’s main job had 
been to make sure the event had run smoothly from the beginning. Her mum was looking 
after her son today, so no childcare issues on the horizon.  
Catherine dressed, went downstairs, and made herself a coffee. She resisted the urge for a 
cigarette, for now at least, although she was finding it increasingly difficult to do that at 
the moment. ‘Must be the nerves’ she thought. It had been a long slog getting this together. 
Shaz and she had been lobbying for a deliberative process on drug policy in Scotland for 
years, and there had been many a time that they had almost thrown in the towel. It was 
difficult working with institutional actors and activists: so much tension, anger, 
defensiveness and lack of empathy and understanding of other people’s concerns or needs. 
However, they had been successful in convincing the Scottish Government to give them 
funding to put on a large stakeholder engagement event to set the groundwork for a 
Citizen’s Assembly in the future. It was sad but the reason the government and other 
institutional actors were interested was because of the increase in drug related deaths, and 
the media focus that continuously called out all institutions for not engaging with the public 
better on what they actually want drug policy to look like. ‘I won’t lie’ thought Catherine, 
‘this strategy of media/activism/behind closed door negotiations seems to work’. ‘I may not 
enjoy playing different fiddles, but it gets them to the table, and that, in the end, is what 
matters’. She sighed. ‘Once this is all over I am becoming a gardener I think!’  
As she entered the conference centre the participants were filling up the hall, each had been 
allocated a table mixing up the 120 different stakeholders invited, and there was a soft 





event, and made it clear that any outcomes from this event would be fed directly into the 
development of policy. Catherine knew this meant a lot to those involved, particularly those 
who had been invited as lived and living experience participants, and those who had been 
involved in the drug policy scene for a while. She, along with many others, felt slightly 
cynical about the Minister’s promise, time would tell, but the fact that this was even taking 
place was a huge step, and it was supported by a range of respected institutions. This 
promise by the Minister, and subsequent discussions on how the event would be carried 
out, respectful dialogue commitments, and a couple of presentations from experts, had 
created a hopeful energy amongst the participants, and you could hear it in the room this 
morning.  
Shaz came up to her and whispered in her ear ‘I’m having a total fucking nightmare. My 
mum is really not well and can’t take Euan. He’s going to have to sit in the corner and play 
the ipad as it is too late to get anyone, and it’s a Sunday. Catherine turned to her. ‘This is 
where we messed up. We should have had onsite childcare, why didn’t we think of that 
before? It’s one of the main findings in regards community engagement!’ They looked at 
one another. ‘Next time we will, but for now this is the only thing that has gone wrong, so 
let’s keep it that way. Euan will be chuffed to play all day anyway’, said Shaz. Catherine 
smiled, always the positive one, must be the illegal meds. She chuckled as she glanced 
round the room, her eyes resting on Jamie, her old clubbing pal, and she nodded and smiled 
in his direction. ‘Must chat to him before the day is out’ she reminded herself.  
Jamie looked up. At the front of the room he could see his old clubbing pal about to begin. 
It had been shock to meet her yesterday. They had exchanged emails several times, but her 
second name had changed so didn’t realise it was her. They had known each other through 
mutual friends in the West Coast clubbing scene, she had been Shaz’s pal mainly and they 
spent that time at raves and after parties. It had initially scared him when he saw her, what 
if she outed him about his past drug use? Then he realised that outing him would out her, 
and he relaxed. He caught her eye, she smiled and nodded, he smiled back. He’d make a 
point of getting a chat with her today.  
He looked round his table. There were 9 other people at the table, and he vaguely 
recognised one woman whose name tag said ‘Debbie’. He felt out of place. It’s not that 
everyone here was a drug user, there were also representatives of different organisations, 
and people with lived and living experience. He was here as a rep of the Scottish 
Governments drug policy unit, but he felt odd about it. Why couldn’t’ he use his own 
experiences and opinions here, 12 years a civil servant and this was not the first time he 
had wondered whether he had made the right ‘career’ choice. He glanced round again and 
smiled at his table. The lady he vaguely recognised smiled back.  
Debbie’s stomach churned. She hated these kinds of events, they made her feel nervous and 
small. She didn’t know what to say, everyone seemed to know who they were, had 
‘qualifications’, or at least seemed comfortable in their own skin. It was these kinds of 





edge off… But she couldn’t. She took a deep breath. The Convener has started so she tried 
to focus. Today they would be starting the deliberation on drug policy, and to do that each 
table were to have a conversation about their initial thoughts on drug policy, in light of the 
previous day’s panellists. This was to set the scene, give everyone an opportunity to start 
thinking about this before the other deliberative sessions took place. Debbie looked round 
the table. She vaguely recognised a guy called Jamie, he worked for the Scottish 
Government but she was sure she’d met him years back, not sure where though.
 How many of these people actually had any experience of drugs’ she thought, feeling 
anger rise in her. ‘How can anyone speak with any authority unless they’ve actually 
experienced it’?  
The conversation at the table was becoming animated. Debbie had found her voice, and 
was talking passionately about drug policy and how the focus should be on getting people 
off drugs and into treatment. ‘I know’ she said forcefully’ I’ve been there’. The guy she 
vaguely recognised piped up for what seemed the first time. ‘I totally respect that you have 
your experience, but maybe not everyone wants to stop taking drugs, or is taking drugs to 
such an extent that they need treatment. Maybe some people are more damaged by the fact 
that their drugs are illegal, rather than the drugs themselves’. Debbie stared at him, ‘who 
the fuck was he’ she fumed to herself. 
Jamie gulped. He knew he should have kept his mouth shut, being a government rep an all, 
but the conversation round the table was getting heated, and he felt safe enough to put his 
opinion across without it being attributed to the government. As the words slipped out his 
mouth he saw Debbie stare at him. ‘Oh fuck’ he thought’, ‘now I’ve thrown the cat amongst 
the pigeons.’  
‘And how would you know anything about what drug users want?’ Said Debbie, in a cold 
and angry tone. ‘You work for the government. Worse, you work for the Unit, and they are 
responsible for most of the bloody mess that treatment is in. Why would you say something 
like that? It’s completely irresponsible’.  
Before the facilitator had time to interrupt, Jamie replied ‘because I am a drug user Debbie. 
In fact I have used drugs all my life, and many of my pals have used drugs all their lives, 
and most of them have done pretty well thank you, without the need for government enforced 
treatment’. There, he’d said it, he held his breath, he stomach did flips and his breathing 
became tight in his chest. He felt like the whole room had suddenly gone quiet and everyone 
was looking at him. His face turned a bright red and he waited.  
The facilitator looked at both of them, ready to intervene should they decide to continue the 
confrontation. Debbie suddenly remembered. Of course, how could she forget, Jamie was 
Neil’s friend from school! His face had changed, and he’s put on weight, but she 
remembered him suddenly. It must have been the passion as he spoke, his eyes started 
sparkling, and she remembered nights in the pub laughing and joking with him and Neil. 
‘Oh god, I wish I had remembered sooner, then I wouldn’t have laid into him’. Instead she 





I just get quite passionate, it was a really difficult time for me towards the end, especially 
when Neil ended up in jail, I thought I would die. I’m sorry’.  
Jamie looked at her hard. Neil? He wracked his brain. Oh yeah, Neil, his old school pal. 
Ended up in prison for dealing heroin, to his pals. And then it came flooding back, the more 
he looked at her. Yes, she was Neil’s girlfriend, for years if he remembered right. They had 
often spent time in the pub, in between the bouts of serious addiction that her and Neil had. 
He smiled at her. ‘No worries at all, me too. Let’s get a chat after the event today eh, would 
like to hear how Neil is doing’. No-one seemed to have been too shocked at his drug using 
disclosure: there was a brief discussion on why people used drugs, and some others at the 
table ‘admitted’ to using various drugs over the years. Indeed it seemed to lighten to mood, 
created a feeling of trust between the tables, and set the tone for the whole day. Jamie felt 
a weight lift off his shoulders, a weight he didn’t even know was there. ‘I told folk I used 
drugs, and no-one cared! Wow. I wonder how Neil is doing’, he pondered as he returned 
to the conversation. 
Neil turned on his computer. It was 10am on a Sunday morning, cold and drizzly outside. 
What the fuck was he doing up so early, his inner child shouted at him. It wasn’t so bad 
though, he had his coffee, his joint rolled, and his kit beside him, and instead of watching 
some inane T.V. show he was logging onto a huge online community about to take part in 
the second instalment of deliberating drugs policy in Scotland. It was a topic close to his 
heart, but he usually only got to talk about it with his mates, or on online rants about how 
shit it was in various forums. This time his rants might actually matter! Yesterday had been 
a bit boring, lots of shite about respectful dialogue, how the event will be structured, blah 
blah blah. But he had front row seats, and the video often panned over the participants in 
the hall, so he had an opportunity to see who was also taking part. He’d been surprised, no 
shocked even, to see several old pals there. Debbie had given him the link to take part, so 
he’d known she was involved, but he had no idea that Jamie was a bloody civil servant now, 
and Shaz and Cat were running the fucking show! He couldn’t have made it up himself. 
Life was weird sometimes.  
As he waited to join the video link he sparked up a joint. ‘Aaah’ he thought, this is how 
participation works for me. He clicked ‘join meeting’ but left his video off, for now, no 
reason folk needed to see him indulging in a wee illegal activity. Anyways, it was just Cat 
introducing the morning session. The sound of her voice took him back, all those years ago. 
They were a wee crew for a year or so, he mused, great times indeed. Wonder what 
happened to Barry? He dropped off the radar not long after leaving school, heard he got 
into the smack, but hardly saw him since the first time they took it together except for 
bumping into him a year or so back. Och well, you lose some on the way I guess, he thought, 
as he turned his attention back to the Assembly.  
The community centre in Easterhouse was cold, and as Barry hunched over his cup of hot 
chocolate, the sadness overwhelmed him. He had been mid-sentence talking about whether 





last 30 years had suddenly hit him. The tears slipped from his eyes. ‘I...I…I just wish 
someone had given me that option 30 years ago’ he said in a small cracked voice. ‘I know 
now that the reason I started taking it was I was in a lot of pain, my dad and older brother 
beat the shit out of me regularly, we had no money so I was always hungry, and I was raped 
by my brother’s friend when I was 11, but I never told anyone. I just started using to numb 
the pain. If I’d been given the help then, the last 30 years never needed to happen’. His 
body crumpled. The support worker, Anne, put her arms around him and held him as he 
sobbed. ‘It’s okay Barry, we feel your pain’. The others nodded. ‘I never really thought 
about the legality of my drugs’ said the person to his left. ‘I always just felt I was a bad 
person for doing it, but I had to do it because it was the only thing that gave me peace. I’ve 
seen friends die ‘cos no-one wanted to call an ambulance for fear of the police, and others 
locked up in jail for years for a few bags of heroin. It breaks my heart too to think that all 
that was avoidable. All because some fucking morally driven politicians can’t stomach 
giving people the medicine they need to help survive. Oooh, this conversation is really 
making me political!’  
That drew a laugh, even from Barry. Everyone knew that ‘politics’ was usually off the table 
at these support meetings. However today was different as the organisation was taking part 
in a thing called, Deliberating Drugs Policy in Scotland, and had agreed to get feedback 
on certain questions from their service users. One of the questions was ‘if you were 
prescribed heroin at an optimum dose, do you think you would continue to use street 
drugs?’ The answer, it turns out, was probably not, but it resulted in a lot of discussion and 
ultimately tears, as each person realised their lives could have been a lot different if they 
had been able to get their heroin from a doctor, instead of a dealer.  
As the day drew to a close, Anne came over to Barry and asked if he was okay. ‘Aye’ replied 
Barry, ‘just taking on board everything we’ve discussed. It’s given me a mind to contact 
my old pals from the end of school, I started all this with them but lost touch when I got 
into the smack. I’m still in touch with a couple of them, might give them a call. Thanks by 
the way, its really good to know that our opinions and thoughts will be taken on board. I’ve 
been ‘consulted’ so many times I can’t count, but for some reason this time it felt different. 
I think it was the questions, they weren’t focussed just on treatment, they started us all 
thinking about the actual framework, questioning the very basis that our current policy 
rests on, and I didn’t even know what that meant 2 days ago’. They both laughed.  
Six months later:  
‘No way, you did not, you total loon’!! Catherine roared with laughter, Neil had just told 
them a story from one of their days on the street. Debbie laughed ‘aye he totally did’, and 
they were not happy about it’. ‘Well what about that time you nearly got lifted for dealing 
in Easterhouse Jamie? That was Shaz’z birthday party, your life would have been a very 
different one if that had happened’, said Barry. ‘Yeah, 12 years in jail rather than 12 years 






The six of them had met up at one of the nice café/bars in Glasgow, it had a lovely garden 
outdoors, and they were enjoying the sun and various alcoholic and non-alcoholic 
beverages. It had been Jamie’s idea, get everyone together. He’d been inspired by seeing 
Shaz and Cat at the Stakeholder event, and realising Debbie was Neil’s old girlfriend had 
confirmed to him it was high time they all hooked up for a 20/30 year catch up. It had taken 
awhile. The Citizens’ Assembly had used up a lot of time, Barry had relapsed quite badly 
for a couple of months, and no-one was up for meeting when it was freezing. So they’d set 
a date in May, and here they were.  
‘That event you put on went really well eh’? Neil nodded to Catherine. ‘Yes, so far so good. 
We still have a final meeting, and then the report to be written up, but I imagine it will be 
done by the end of this year. Pretty fast for these kinds of things. Did you feel that you got 
anything out of it seeing as you were doing it online?’ ‘Oh aye’, said Neil, ‘it was great! I 
got to sit in my joggers, smoking joints, having a hit if I needed, taking a shit if I needed, 
and feel like I was contributing to some important policy stuff. So yeah, I’d say compared 
to that meeting Debbie invited me to a few years back it was brilliant’. ‘Sorry about that’ 
said Debbie. ‘Ocht, it’s fine, they learnt their lesson and now have these super birds on the 
case’. Everyone laughed. ‘Yeah, thanks for pushing that’ said Barry’. It really sparked 
some intense chats in our group, but we realised that we felt like criminals all our life 
because of our addiction, and now we are feeling more empowered to challenge everything. 
Not everyone is happy with that though’. They all laughed, they all knew what he meant, 
and they all agreed. ‘Well, it just seems our voices are never heard except when they want 
opinions on how to ‘treat’ us, assuming we all want ‘treated’. I’m just glad we are starting 
to challenge that, and it’s taking place in an official space. So thanks, all of yous’ said 
Barry. Everyone smiled, at Barry and at each other. It had been a difficult 30 years for 
them all, but they were still here, and it made each one of them warm in the heart to know 
that change may be around the corner.   
 
When I first started to develop this narrative, I thought I would be developing a narrative 
about Citizen Assemblies, or other ‘new’ forms of democratic innovations (Smith, 2009). Yet as I 
wrote it the story began to take its own path, and explored the characters involvement, more than 
the setting in which they were in. On reflection I realise that this echoes the content of the research 
much better: the focus was not on how participation was carried out, but whether the participation 
had been meaningful. What the research showed was that meaning depends on many things, and 
is personal to the individual experiencing it. Therefore, despite there being a strong argument that 
innovations in the way public are engaged can improve democratic outcomes, including trust in 
the process (Smith, 2009; Boulianne, 2018), the actual setting for the story was less important, for 
this research, than the dynamics experienced by the characters. That being said, the way in which 
participants are engaged will encourage positive dynamics, and the above narrative reflects the 






The research explored several different ways to engage, but the most successful, in my 
experience, were the early SDPC sessions, and the final session of the LLEEG run by the Scottish 
Recovery Consortium. The narrative above recreates, in essence, aspects of these sessions, 
including the friendships. I have found, as someone involved in ‘drug’ scenes since the mid-
nineties, a kind of comradery, a glint in the eye that recognises a fellow traveller. And they crop 
up everywhere! At the same time, well-convened and facilitated stakeholder groups can engender 
that comradery, there’s an energy in the room when people begin to let go of their professional or 
social personas. When you include the sense of urgency that so many conversations around drug 
policy possess one can leave these events feeling like you can change the world, and the world 
will change! Maybe this is not meaningful engagement for everyone, but for many, the feeling that 
their voice is being heard, and listening to others, is as meaningful as it gets. It also depends on the 
expectation of the participant. The LLEEG participants were expecting their voices to be heard, 
and for us meaningful engagement included having our recommendations taken into account when 
the 2018 Scottish drug strategy was re-drafted. And to be fair, some of them were. But for me, the 
most meaningful aspect of that event was the relationships explored between participants, and the 
topics we looked at. The different engagement tools employed encouraged open and honest 
dialogue, and because with drugs there are usually personal stories involving crime, trauma and 
often death, there was depth to the conversations that left all of us feeling quite humbled. Alongside 
this there was a common anger, or frustration, directed towards the public institutions in regards 
the stigma, discrimination, and criminality that we as drug users have been subject to all our lives. 
 
SDPC on the other hand was never about the outcome: it was a pre-figurative space that 
was developed in order to explore the question on how dialogue across diverse perspectives can 
be encouraged, so that the narrative can change to encompass the diverse views, and not just the 
master narrative. The outcome was to have respectful dialogue and explore drug policy reform. 
But this created frustration for some too. Mike and I steered the group with a focus on deliberative 
engagement, respectful dialogue, and setting the boundaries of the discussion from the beginning. 
As a result most of the conversations we held felt meaningful, to me, and from the feedback I 
received, to a lot of other participants. Much of it was about being able to express your honest 
opinion, without the fear of being shot down. Unfortunately this was not always the case, and we 
lost some participants who felt they could not contribute, but there were times that it worked and 
created that buzz.  
 
Another aspect of this final narrative relates to the concept of ‘horizons’ that I discuss in 
chapter 2. As Waganaar states: “we are always part of the situation we are trying to 
understand…we live and understand in emergent time” (2015, 203). In other words, as we 
experience our reality, shifts in perception result in new understandings, and a new reality. In this 
narrative Jamie’s disclosure of drug use results in no condemnation, something which he was 
expecting. As a result, his structural reality shifts – he realises that his drug use disclosure is not 





not need to hide his drug use anymore. The narrative also shows how his disclosure results in those 
around him expanding their horizon: they ‘admit’ their own drug use, there is a feeling of honesty 
engendered by the disclosure, and this carries on throughout the day. This changing of perception, 
the expanding and fusion of horizons, is common in well facilitated drug policy discussions40, and 
was an important drive behind SDPC and the implementation of respectful dialogue.  
 
Barry and Neil’s engagement in the narrative is used to show how engagement can take 
different forms, and that one form may not suit everyone. For example, Neil does not enjoy large 
groups, he prefers to engage under his own terms, and this should not prevent him from taking 
part. For him online access worked the best, and it is not unreasonable to conclude that many 
people would benefit from this kind of engagement. Similarly Barry was not in a position to be 
attending large stakeholder events, but he did attend his local recovery meeting groups. From my 
own experience these groups can be engaged in order to get feedback on how people who use 
drugs would like to access treatment: barriers to access, reasons for access etc. Rarely are these 
groups asked whether they agree in the criminal justice aspect of drugs, and even more rarely are 
they asked whether they feel their life has been harmed by the criminal justice drug interventions. 
This is something that needs to be developed if participation is to include a wide range of voices, 
as well as challenging the institutional stigma directed towards ‘problem drug users’.  
 
One of the most important points to pull from the Meta narrative is that the way forward in 
regards meaningfully engaging as wide a range of stakeholders in the policy process, is to create a 
safe space for everyone to be honest about their drug use, and views of drug use. This enables one 
to take into account the myriad reasons why people choose to use substances in the first place, and 




This chapter explored the role that fictionalised narratives can have in exploring policy 
‘problems’ by providing context and empathy towards the stakeholders in the policy communities. 
Critical race theory uses personised narratives to highlight the often brutal affect racism has on 
individuals and institutions, and so too in this way CDT can use narrative to expose the harm done 
by policy decisions, and humanise the different stakeholders affected.  
 
Critical drug theory is a work in progress and will need to be developed and tested by 
myself and other scholars in order for it to become part of the critical theory landscape. However, 
critical drug studies exists as an academic area of study, and CDT could form part of this 
knowledge production. CDT is grounded in critical thought, with the underlying premise that the 
foundations of drug policy, national and international, are based on ideological reasoning that is 
                                                          
40 Arguably there is not good facilitation in this narrative, however in my experience this expanding horizon was 





often used to suppress and silence those who seek to challenge the status quo. Subjecting policies 
to critique and critical evaluation, such as research into the impact drug laws have on individuals 
and society (as opposed to the impact drug use has), should be advocated, along with public 
engagement on the complexity of drug use and harm.  
 
The following, and final chapter brings CDT, my WPR analysis and my research questions 
together. It will set out how this thesis has answered the core research questions using the WPR 
Approach. It will also look at recent developments from my case studies to highlight how this 
project has provided avenues of participation for current stakeholders, and suggestions of 
participatory practices that could be implemented in the future, in order to create sustainable and 










The aim of this research was to explore the drug policy communities in Scotland to 
determine what the master and counter narratives were in regards to drug use and drug users, and 
whether it was possible to develop meta narratives that encompassed both, and provide a common 
way forward. Within this, the research explored the role that historical legacies had on the 
development of these narratives, and the impact these narratives have on meaningful engagement 
of stakeholders. In doing so, it uses critical race theory and Bacchi’s WPR approach to explore 
what the ‘problem’ was represented to be, and how the ‘problem’ can be challenged.  
 
I have been working on this thesis for over 6 years now, with periods of fulltime paid 
employment in-between. It has been difficult to maintain the momentum, and this last chapter is 
my sigh of relief! We are experiencing such upheavals in our lives: I am currently writing this after 
10 weeks of lockdown in a house with two wee mental children, and a partner who is just as busy 
and stressed as I am. You will have your own challenges, even if the lockdown has been lifted by 
the time this is read. Life will never be the same, I hope.  
 
It is in that vein of thought that I will not represent the entire thesis in a weighty conclusion. 
Instead, I structure into three parts: the first part sets out the thesis in a brief paragraph; the second 
addresses the core research questions with the findings from each chapter using the WPR 
Approach questions. The final section will reflect on my own journey through this thesis.  Evidence 
is provided for my findings in the previous chapters therefore, sticking with the narrative flow I 
shall only use in text citations when I present something that has not been evidenced before.  
 
 
Doing Drugs Policy: In Brief  
 
This research has shown that the policy world of drugs in Scotland has been constructed in 
a way that generates a field of relationships focussed on working within a harm paradigm resulting 
from ‘problem drug use’. As a result, those who do not fit the ‘problem drug user’ category are 
excluded or ignored, and in some cases deliberately locked out of the policy development process 
through silencing, or ‘constitutional side- stepping’. Running throughout the research is the 
exploration of the relational aspect of policy formation: that ‘access’ to policy formation is based 
on the relationship the stakeholders have with the various ‘gatekeepers’, whether they be 
individuals or institutions. These relationships are built on shared narratives, and these narratives 
can at times diverge and lock those involved into certain responses because of the inability to see 





horizon of the individuals, and by presenting situations that allow individuals to expand their 
horizons, new responses, and narratives can be envisaged. By setting out the master, counter and 
Meta narratives, it is possible to see where the ‘problem’ originates, what the critique of the 
‘problem’ is, and a projection of what alternatives are possible.  
 
Summary of Research Findings  
 
‘What are the master and counter narratives within Scottish drug policy 
communities?’ 
 
This research focused on the historical development of drug policy in Scotland, and how 
this has influenced the different ways in which stakeholders are involved in policy development 
more recently. As a result of the different methods used during data collection master and counter 
narratives emerged. By using narrative to highlight the impact specific knowledge and histories 
have on policy formation, it was hypothesised that there were competing narratives within drug 
policy communities about drug policy reform, informed by the history of public health and 
criminal justice interventions on drug use in Scotland, originating in the HIV/AIDs crisis of the 
1980s. This core research question was designed to explore this hypothesis, to see what the master 
narratives were around the meaning of drug use, drug users, participation and policy reform. A 
further aim was to explore whether there are shared narratives which could enable the different 
drug policy stakeholder communities to work towards an understanding of different concepts of 
drug related harm, and solutions stemming from this.  
 
Master Narratives 
What’s the problem represented to be, what are the presuppositions and assumptions underlying 
that representation, and how has it come about? (WPR #1/2/3) 
 
This was explored in Part Two – Historical Legacies – where it was found that the 
‘problem’ in drug policy is represented as the impact that ‘problematic drug use’ has on the well-
being of individuals and society.  
  
This research showed that the development of the narrative surrounding ‘problem drug use’ 
began in the early 1980’s. During the 1980’s there was a fundamental shift in the way drugs were 
bought, sold and used. Previously drugs such as heroin were used by a small cohort of ‘bohemian’ 
users, however, in the early 1980’s drug dealing started to become more commercial. It is argued 
that a part of the reason for this change was the social upheaval caused by Conservative policies 
at the time, which resulted de-industrialisation affecting many communities. As we saw this 
created a sense of hopelessness amongst young people in the housing schemes of Scotland, and an 
increase in the use of drugs such as heroin as a way of dealing with such hopelessness. This 





drug deaths decades later, has become part of the master narrative governing Scottish responses to 
drug use, and helped to shape the harm paradigm that dominates drug policy today. As a result of 
the increase in heroin use, and the resulting HIV/AIDs epidemic that engulfed the late 1980’s, drug 
users were seen as people who suffer and cause harm as a result of their drug use, and therefore 
strategies to address this harm were seen as the most effective way of addressing this. As drug 
policy developed over the intervening years, the focus tightened, and in 2001 policy explicitly 
focused on ‘problematic drug users’. By 2008 the concept of recovery had become embedded in 
policy responses, with the 2008 Road to Recovery strategy enshrining this in drug policy 
development going forward.  
 
The impact of this narrative of harm on policy development, specifically stakeholder 
involvement in policy development, resulted in a focus on stakeholders who had experienced harm. 
Therefore, as the research shows, participants who have had experience of ‘problem drug use’ or 
are currently experiencing ‘problems’ arising from drug use, are the preferred stakeholders in drug 
policy deliberation. Furthermore, as a result of this harm narrative, or harm paradigm, underlying 
assumptions around drug use are not challenged.  
 
The research shows that the underlying assumptions built into development of drug policy 
deliberations are that: most drug use is harmful; that most individuals would like to stop using 
drugs; that people in general would live more fulfilling lives if they were not using drugs; and that 
drug use does not serve any medical, therapeutic, spiritual or pleasurable purpose outwith the 
formal settings of treatment. As a result, the tensions around drug policy reform tend to focus on 
two kinds of reform – public health based reform, which is within the full capacity of the Scottish 
Government, and legislative, or structural reform, which includes changes in legislation, but also 
changes in policy that shift the focus to decriminalisation of drug use. Changes in legislation are 
not within the competency of the Scottish Parliament, but changes in policing and prosecution 
policy are within the competence of the Scottish institutions responsible.  
 
As seen, public health reform has been taking place over the last 10 years, and significantly 
increased over the data collection period. However, as this research shows, the reform embeds 
responses within a problematized harm narrative, or paradigm, resulting in the silencing of 
different narratives around drug use and drug policy reform.  
 
Counter Narrative 
What is left unproblematic in this representation, where are the silence, and what effects 
(discursive and lived) are produced by this representation? (WPR #4/5) 
This research showed that as a result of the historical focus on injecting opiate use that 
increased the risk of HIV/BBV infections, all other forms of drug use have been ignored or 
silenced. During the 1990’s, when Scotland witnessed an increase in psychostimulant drug use 





to prevent these drug users from gathering and listening to music. Heavy enforcement and criminal 
sanctions were applied, and continue to be applied to this cohort of drug users. Throughout the 
thesis I have presented stories of those affected by this enforcement, and it was shown that the 
harm done to individuals as a result of the criminal justice framework can be the same, if not more 
harmful than the drugs themselves.  
 
What this research has shown is that drug use for pleasure or recreation is not a focus of 
the Scottish Government, and policy deliberations are not concerned or interested in the views of 
those who use drugs for these reasons. The issue with this is that many people go through periods 
of drug use that may be considered ‘problematic’, but often come out of it on their own. The idea 
that there is a class of drug users that are always ‘problematic’, and a class of users that are always 
‘recreational’, is a myth. The othering of ‘recreational’ or ‘non-problematic’ drug users as separate 
from ‘problem drug users’ has resulted in alienation of most drug users from the institutional 
structures. This is compounded by the criminal justice framework that applies sanctions for actions 
that would not be considered harmful to self or others if the drug being taken was legal, preventing 
otherwise law abiding citizens from being open about their drug use, and therefore preventing 
meaningful engagement in drug policy deliberations.  
 
What are the challenges in engaging different epistemic communities in a 
participatory policy process? 
 
Master Narrative  
What’s the problem represented to be, what are the presuppositions and assumptions underlying 
that representation, and how has it come about? (WPR #1/2/3) 
  
This research has shown that the master narrative on stakeholder engagement is of 
consulting with people who have lived or living experience of ‘problematic substance use’. At the 
time of data collection the level of engagement was at the consultative level – through surveys and 
creation of the specific LLEEG to feed into the horizontal dimension of policy development. 
However, as the research has shown, engagement was limited to this group, and even this group 
had a marginal role in policy development, despite the commitments to increasing their presence. 
As the research shows the LLEEG group were part of the Partnership for Action on Drugs advisory 
structure to the Scottish Government, but they were never involved at the agenda setting stage. 
Since the data collection period PADS have been disbanded and a new Drug Deaths Taskforce has 
been set up, with 5 out of the 23 people having explicit lived experience. I have heard through 
private communication that the input from the lived experience groups is limited, and the level of 
frustration still exists. Indeed, a recent comment from someone who works closely with the lived 
and living experience group, and the Scottish Government summed it up: “Getting involved with 
“Gov stuff has a tendency to suck the life out of anyone. So much effort just to feed the inertia” 







What is left unproblematic in this representation, where are the silence, and what effects 
(discursive and lived) are produced by this representation? (WPR #4/5) 
 
A further research question was on the participatory aspect of the research. Initially this 
question was seeking to explore why stakeholders such as drug consumers were not being 
consulted or engaged in drug policy development. This changed due to the Scottish Government 
making a commitment to engage drug consumers (and a broader range of stakeholders) in drug 
policy deliberation. However, the question remained pertinent, with a focus on how meaningful 
that engagement is, thereby highlighting the challenges in participation.  
 
The research has shown that the focus on harmful problem drug use has meant that other 
forms of drug use have been ignored, and at times actively silenced. People who use drugs but do 
not engage with treatment services, or do not use drugs to such an extent that they come to the 
attention of public services, are not the focus of policy. The focus on 'problem' drug use has 
resulted in a focus on certain kinds of drug consumption, and a policy strategy to match that - 
recovery. As a result, only certain stakeholder views are taken into consideration when 
participation is being designed at an institutional level, and only certain discourse is considered 
legitimate. As this thesis proposes, these stakeholders can be separated into four typologies, or 
narratives: the professional, the sick, the recovered and the happy stakeholders.  
 
The legitimacy of the stakeholder determines the level of ‘meaningful participation’: the 
amount of engagement and involvement in the policy process individuals are given depending on 
their perceived legitimacy. Importantly for this research it is aspects of the sick and happy drug 
user that appears to be afforded the least legitimacy, at least in the context on non-opiate based 
drugs (the sick opiate user is considered a legitimate stakeholder under the term ‘living 
experience’).  
 
The way in which institutions, in particular the Scottish Government, avoid meaningful 
engagement with these stakeholders is through what I call ‘constitutional side-stepping’. As 
shown, criminal justice sanctions for drug use resides with the UK Government, therefore any 
legislative changes that would see de jure decriminalisation of drugs can only be enacted by the 
UK Government. Engagement of so called ‘non-problematic drug users’ in the policy process 
therefore is seen as non-essential, if it is considered at all. With the focus of drug policy being on 
the impact of ‘problem drug use’ on individuals and society and a public health response, those 
who are not considered to be presenting a public health ‘problem’, are not considered in the policy 
development at all. This is despite the fact that there are many harm reduction initiatives that would 
not require legislative changes at a UK level, such as drug checking in clubs and festivals, de facto 
decriminalisation or possession of drugs, and involvement of drug users at every level of the policy 





The silencing, or ignoring, of people who use drugs but are not part of the ‘problem’ drug 
paradigm is part of the ‘gatekeeping’ carried out by institutional officials, and prevents a wider 
range of stakeholders from taking part in the policy process. As shown in the thesis, access to 
institutional engagement is determined by the relationships between the gatekeepers and the 
stakeholders. As we saw, my relationship with the Scottish Government gatekeepers changed over 
the course of my involvement. When I presented as a professional representing academic 
involvement I was afforded immediate and swift engagement with policy makers. However, when 
I became involved in more contentious groups such as the MCRS, and as a result had to negotiate 
the different relationships involved, I was slowly locked out of the policy process.  
 
The organising in and out of decision making is a common factor in policy making, as 
shown in chapter 7. As discussed, policy can be viewed as both horizontal and vertical (Colebatch, 
2009). The vertical dimension is concerned with the authoritative aspects of policy making – the 
following of rules and authorized decision making. It shows that in policy decisions there is often 
a line of legitimate authority, with (in the case of drugs policy) a minister as the top decision maker, 
and the various subordinate civil servants authorised to enact the decisions. The horizontal 
dimension on the other hand, according to Colebatch (2009), views policy as “the structuring of 
action” (23). It shows that policy involves multiple actors, agencies and participants that do not 
have lines of authority, yet are part of the policy process. They bring different ideas of what policy 
is to them, and how these ideas and engagements are enacted from the basis of horizontal policy 
making (Colebatch, 2009, ch.3). As argued, it is better to think of policy making as a collection of 
people participating in policy through the different channels available, rather than one single set 
of policy makers as such (Ibid).  
 
However, there is a third dimension, of those side-lined out of the policy making arena 
completely: most people who use drugs (Diagram 7). The stakeholders silently engage if they are 
part of the drug policy dimensions, or exist within the wider policy communities, but never have 
the opportunity to engage in policy development explicitly. Arguably their voices are heard 
through various media campaigns, and tacitly through the unspoken knowledge of many people 
working within drug policy, but at an agenda setting stage their voices are missing. As this research 
shows, the main reason for this is the constitutional argument, and legality. Admitting to a crime, 
especially one which has additional labels attached to it, would be career suicide for many, 
therefore only those who have already internalised the label of drug user will be willing to openly 










This aspect has been one of the most difficult ones for me. At the beginning of the research 
I was unsure whether I would ‘come out’ as a drug user, both during the data collection and in this 
thesis. I was warned by many that coming out about my drug use may risk my professional career, 
and by others that it may not be relevant to the research. However, as I began to develop the 
methodology, create SDPC and start the interviews, I realised I could not pretend that I was 
somehow ‘other’ to those who I was engaging with. I therefore decided to use my experience, of 
both ‘problematic’ and ‘recreational/therapeutic’ drug use as a way to develop both my 
professional and research persona. As has been discussed this resulted in me being involved as a 
lived and living experience representative and gave me access to certain policy environments that 
I would not have had otherwise, but it also at times blurred the lines between researcher with lived 
experience - therefore an advocate - and activist/lobbyist. Traversing these boundaries can be 
tricky, particularly when the issue is about drugs, an area already stigmatised with the label of 
inability to refrain from compulsive behaviour, or high sensations seekers (Palmgreen, 2001). 





Being an advocate for drug consumers, and being open about one’s own drug use, will result, in 
my experience, in any advocacy work being labelled as lobbying.  
 
Furthermore, in regards the dimension of policy making, while the structure of policy 
deliberation may allow for multiple inputs and options for engagement, ultimately it is the civil 
servants who write the recommendations as policy briefs/reports/bills or sign off the cheques, and 
the minister in charge who rubber stamps it with the authority. It is therefore possible to have a 
well written policy document, with a range of expertise and recommendations, yet little in the way 
of meaningful engagement on the issues going forward. As the research has shown, until the 
politicians have a level and degree of comfort then the change will not happen” (anonymised 
participant, SDPC, 2016). 
 
What is critical drug theory, and how can it help us understand drug policy 
formation in Scotland? 
 
How can the representation be challenged? (WPR #6) 
 
“Drugs policy is populated by people who have been involved in policy for many years and 
are either entrenched in their views of what drug use is and who the drugs user is – ie 
problematic users – or weary and saddened by the lack of going forward regarding policy” 
(Senor Drug Advisor).  
 
There is an entrenched sense of ennui amongst the drug policy community in Scotland, 
resulting from years, if not decades, of failed policies and promises. As I write this I feel some 
level of sympathy for those in charge of drug policy, because it is not the fault of any one individual 
per se (although as the research shows, relationships form a major aspect of policy development), 
but an institutional lack of drive to push for greater reform. This lack of drive was a recurring 
theme throughout the research, but the ultimate structure of the thesis means that this theme will 
need to be developed in another paper.  However,  throughout the research period I came across 
this frustration, weariness and sadness that ultimately drug policy will always be focused on 
‘problem drug use’, and drug users will always be viewed as ‘problems’. Within this weariness is 
a critique of the underlying foundations that responses to drug use rests upon – that all drug use 
causes harm. Time and again I came across practitioners who questioned this premise, yet did not 
have the ability to openly challenge it, because of the harm paradigm that drug policy is situated 
within. This, in part, is what spurred the development of critical drug theory (CDT). 
 
The development of CDT is set out in chapter 8, where I showed how the inspiration came 
from critical race theory, and the tenets outlined by CRT scholars. It was argued that the narratives 
of drug harm and the medico/legal structures which surround problematic drug use means that 





problematic drug users. Furthermore, government, legal and education institutions in particular, 
work within the drug harm paradigm carrying out the functions of oppression, by applying laws 
that disproportionately affect marginalised members of society. CDT has therefore been developed 
to provide a framework to legitimately critique the foundations that drug policy rests upon, and 
challenge the legitimacy of current policy responses. The question for this research was can this 
theoretical development help us understand drug policy development in Scotland, and specifically 
the barriers to wider participation, and the underlying narratives that exist within Scottish drug 
policy communities?  
 
The research has shown that drug policy is developed within the narrative of drug harm 
(the harm paradigm). As a result discussions on what is considered harmful drug use, who decides 
what is harmful, what drugs are the most harmful, and who decides whether the harm was caused 
by drugs in the first place, are silenced or ignored. Drug use is the ‘problem’ picked from a range 
of ‘problems’ whenever a ‘problematic’ person is seen to be using drugs: drugs are presumed to 
be causing the harm instead of other factors such as mental health, PTSD, trauma, financial stress, 
the stress of living in this society etc.. Furthermore, drug use is used as a justification for certain 
behaviours as opposed to the epidemic of for example male violence, or poverty etc., and drug 
‘related’ crime is often associated and linked to wider organised crime.  
 
However, as has been shown, this focus on the harm paradigm prevents a large section of 
drug users from engaging with drug policy, and therefore creates a barrier to wider participation. 
The critique of the harm paradigm within drug policy is part of CDT. The four tenets of CDT – 
intersectionality, institutional power, social construction and narrative/counter narrative- allow for 
different perspectives to be taken into account, and this research focused on narrative as a way of 
giving voice to the silenced and marginalised by creating stories that highlight the impact of the 
policy, and develop common responses. In particular, using the CDT framework we can explore 
the role that pleasure and therapeutic use has on individuals, as well as the harm resulting from the 
current criminal justice and public health based responses.  
 
A challenge for policy makers therefore is whether it is possible to move beyond the harm 
paradigm to accommodate different perspectives, and narratives, within the drug policy 
governance process. The aim is not to replace the current master narrative, because it is not a ‘false’ 
narrative, but to move to a place of plurality: where all voices are given a forum. As it currently 
stands official narratives systematically exclude narrative pluralism by only taking into account 
the narratives that fit the Scottish drug policy agenda. There are practical things that could be 
implemented, as discussed in the previous chapters, such as widening the possibility to participate, 
and engaging on drug policy issues through a human rights lens, as opposed to a public health lens. 
This is an area I plan to work on going forward, to develop coherent alternative narratives that may 
help policy makers understand how narrative and participation can improve the engagement of 






Another aspect of CDT which falls within the narrative tenet is the use of language to enact 
change. The research showed in chapter 7 that ‘narrative interventions’ can have the effect of 
creating meaningful dialogue between stakeholders, and challenge the institutionalised stigma that 
persists within drug policy. As we saw, the initial draft of the 2018 Scottish drug strategy was 
entitled ‘Seek, Keep and Treat’. This was met with anger by the LLEEG who viewed it as 
stigmatising and not reflective of what they envisioned drug policy to look like. In response those 
responsible for the language changed the title to ‘Rights, Respect and Recovery’. In doing so they 
demonstrated that there is the possibility of enacting change within the institutional settings, albeit 
limited to language, and addressing the harm done by using stigmatising language.  
 
Finally, chapter 9 took all the of the stories and narratives from both my life, and the 
research, and set out the master, counter and meta narratives to demonstrate how one can develop 
fictionalised narratives that speak to a range of opinions, show an array of different stakeholders, 
and cultivate empathy in the reader towards people’s different experiences. In doing so the research 
highlighted both the harm of ‘problematic drug use’ and the harm of drug policy responses, and 
made suggestions of how both harms can be mitigated. This is probably, in my opinion, the most 
important contribution of the research. Developing empathy towards our fellow citizens is 
paramount if we are committed to equitable policy, and drug policy is an area where empathy from 
those in control of the policy dimension is often lacking. It may be that because most external 
stakeholders (such as third sector, campaign groups, people who use drugs) are so vehemently 
empathic and emotional in their engagement with policy makers, that the response is quite guarded, 
or it may be that because drugs is viewed as a ‘wicked issue’ empathy is not considered 
appropriate. The criminal nature of drug use further alienates drug users’ voices due to the deviant 
nature of their activity. Whatever the reason for the inertia and lack of explicit empathy, by using 
stories, both fictional and biographical, empathy can be developed and the impact of policy can be 
seen from a different angle. If nothing else, this research has shown how personal connection and 
storytelling can highlight alternative policy options that may reduce the harm done to all 
stakeholders in the process.  
 
My Journey through the Thesis 
 
Applying the WPR questions to my own ‘problem’ representation. 
 
As discussed in chapter 3 there is a final seventh question which challenges the researcher 
to apply the WPR approach to their own problem representation (Bacchi & Goodwin, 2016): 
 
“[B]ecause analysts, similar to other people, tend to be located within the “unexamined 
ways of thinking” that underpin policy proposals, it is difficult to “stand back” and 





an undertaking for policy workers/analysts to engage in self-problematization, seeking out 
possible forms of domination in their own proposals and problematizations” (Bacchi & 
Goodwin, 2016, 40). 
 
So, what is my ‘problem’ and how is it represented to me? I have been honest from the 
start about what motivated me to undertake this research, and have incorporated the academically 
developed concept of situated/background knowledge into the research design and writing. 
However, it is incumbent on me to analyse in a bit more depth the way in which I situated the 
‘problem’, in order to see how my thinking may have dominated the way in which I collected and 
analysed the data.  
 
When I started the process of developing this research I had in mind what the ‘problem’ 
was. I have never viewed drug use as a ‘problem’, and always viewed drug policy as the ‘problem’. 
Although throughout my life I have seen friends, acquaintances, and clients suffer as a result of 
their drug use, I have always viewed their ‘problematic drug use’ as a symptom of something 
deeper. Drug use, to me, represents fun, excitement, mind altering, social gatherings, losing myself 
in music, relaxing, escaping and therapy. Because of this, when I have seen someone suffer at the 
same time as using drugs, I have seen the drugs as a way of coping, rather than the suffering 
stemming from the drug use. This is despite being in a relationship with someone dependent on 
heroin, who had no obvious childhood trauma or life trauma he seemed to be escaping from. 
Starting at an early age I have learnt to hide my drug use, and in doing so developed a deviant 
personality, distrustful of authority, especially the police, seeking out alternative groups, and being 
vocally anti-authoritarian. This part of personality reared its head in a surprising way during the 
lockdown of 2020. I found it extremely difficult to ‘obey’ the lockdown rules, because I am so 
used to ignoring rules that I do not think should apply. This is not to say I did not agree with the 
lockdown, but the little Hitler’s and rule lovers anger me, and I found myself breaking the rules in 
little ways just to make sure I was not completely conforming! The point of this is that my 
representation of the ‘problem’ was the ‘problem’ of drug policy. I view drug policy as an 
oppressive framework that seeks to control behaviour that may threaten the dominant social order, 
and have had this view since the age of 15. My experience of police oppression and violence in 
the mid 90’s as a young teenager marred my opinion of the drug laws, despite positive experiences 
later on. For example I had many interactions with police at after parties, most of which were 
friendly and never involved criminal prosecutions. But I have seen friends lose their lives to the 
criminal justice system, contaminated drugs, and lack of support. Therefore, I entered this research 
with a strong representation that drug policy, and its enforcement, was the ‘problem’, and those 
making the policy the creators of that ‘problem’.  
 
Reflecting back on my findings, 6 years after starting, I wonder whether I spent that time 
creating a thesis that merely supports my own ‘problem’ representation! Yet personally I have 





challenged or disrupted, I would say that meaningful engagement is what altered my personal 
‘problem’ representation. When I entered the policy field I had strong views on all things to do 
with drugs. Through the interviews, but in particular through the dialogue created by SDPC I began 
to understand alternative viewpoints. I cultivated a more nuanced response to those who did not 
agree with me, and realised it is better to have respectful dialogue between those who may disagree 
with one another, because this opens the ground for deeper understanding of the concerns that 
many people have. A comment I received several times was along the lines of ‘see Anna, you are 
one of us, but you’re also one of them because you can speak their language.” This comment 
invariably came when I highlighted some technocratic issue, how to word an email that would 
have better effect, or making sure meetings didn’t clash with important political announcements 
etc.. It highlights to me one of the barriers to change in drug policy: that you need to appear a 
certain way in order to access certain policy arenas. But it also highlights that over the years I have 
worked to develop the ability to speak to many different ‘publics’, and represent the voices of the 
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Appendix 1: Lists and Reports  
 
This is by no means a comprehensive list of publications relating to drugs in Scotland, however 
it lists all of the key policy documents and reports produced by organisations involved in policy 
advice at that time, and gives an overview of the direction of travel.  
 
My research methods for these documents were as follows:  
• For Scottish Executive/Scottish Government reports, including those from SACDM and 
the EIU, I used the Scottish Government publications search engine with the key word 
‘drug’, together with each year from 2000 to 2016. I did not include evaluation reports 
(unless key to policy shifts) and other reports detailing specific bits of research. I this did 
to limit scope and to focus on key documents, as opposed to every piece or research 
conducted or commissioned by the Scottish Executive/Government. I also used my own 
knowledge of the documents, and references from Brian Kidds’ thesis (Kidd, 2013).  
• For reports and documents not produced by the Scottish Executive/Government I used 
several research methods. Firstly, I was lucky enough to be handed all of Susan Deacon’s 
notes, including reports and publications, from her time at the RSA, where she was the 
lead Scottish researcher for their report ‘Drugs – facing facts’ (2007). In addition, I 
received input from my co-convener of SDPC, Mike McCarron, who has been embedded 
in the Scottish drug policy landscape since the 1990s and has been a committee member 
of several important reports. He was able to direct me to the more obscure reports such as 
the Glasgow Citizens Jury on Drugs (2001) and Melting the Iceberg of Scotland’s Drug 
and Alcohol Problem (2010). Finally, I used my own knowledge of the drug policy 
landscape and went directly to the publications of 3rd sector organisations involved in 




1994 - McLelland Committee Report 
1994 - Scottish Affairs Committee, First Report. Drug Abuse in Scotland. Vol 1 
1995 - Conservative Drug Strategy Document, Tackling Drugs Together 
1998 - Cabinet Office, Tackling Drugs to Build a Better Britain 
 
Post Devolution  
 
1998 – Drug Courts were set up to specifically deal with drug cases, and Drug Treatment and 
Testing Orders (DTTO’s) were implemented as a way of encouraging those caught with drugs 
to stop using them.  
 






2000 – The Scottish Executive’s Drug Action Plan. A complimentary report to the 1999 
strategy which sets out how Drug Action Teams (DAT’s) will support the strategy, and what the 
Executive will commit to do over the next 10 years.  
 
2000 – The Scottish Crime and Drug Enforcement Agency is set up to tackle serious 
organised crime, including the trafficking, production and sale of illegal drugs. See further: 
http://www.gov.scot/Publications/2004/12/20345/47606  
 
2000 – Inquiry into Drug Misuse and Deprived Communities by the Social Inclusion, 
Housing and Voluntary Sector Committee. Volumes 1 and 2 
 
2000 – Drug Misuse Research in Scotland: the Contribution of Research to Scotland’s 
Drug Misuse Strategy. A report commissioned by SACMD prepared to explore the research 
behind the Scottish drug strategy: Tackling drugs in Scotland.  
 
2000 – Effective Interventions Unit set up. 
 
2001 - Scottish Executive (2001) Getting Our Priorities Right. Policy and practice guidelines 
for working with children and families affected by problem drug use  
 
2001 - Scottish Executive Central Research Unit (2001 ) Arrest referral: a guide to principles 
and 
practice. Retrieved online at: www.scotland.gov.uk/Publications/2002/05/14526/2751 
 
2001 - Glasgow Peoples Jury on Drug – the first example of the use of citizen jury’s to explore 
drug policy in Scotland.  
 
2001 – Report of a Working Group for Piloting a Drug Court in Glasgow. Working group 
set up the Justice Minister Iain Grey to evaluate Drug Courts.  
 
2002 - SACDM: Psychostimulant Working Group Report. Highlighted the need for 
additional services aimed at psychostimulant drug users, hence the increase in funding from 
organisations such as Crew 2000 
 
2002 - Effective Interventions Unit - Drug Treatment Services for young people. ‘A report of 
the findings of a systematic review of published research of treatment and care services for drug 
using young people and a separate literature review of the current statutory framework.’ 
 
2002 – Effective Interventions Unit - Integrated Care for drug users: Principles and 
practice. ‘This document provides the rationale for integrated care, its definitions and concepts 
and the key principles and elements of effective practice drawn from the research evidence.’ 
 
2002 - Effective Interventions Unit: The effectiveness of Treatment for Opiate dependent 





highlighted the need for more psychosocial support, in addition to a focus on detoxification and 
abstinence based treatments. 
 
2003 – Scottish Executive –National Investigation into Drug Related Deaths in Scotland. 
Substance Misuse Research.  
 
2003 – Scottish Executive - Good Practice Guidance for working with Children and Families 
affected by Substance Misuse: Getting our Prioritise Right.    
 
2003 -SACDM - Mind the Gaps. Meeting the needs of people with co-occurring 
substance misuse and mental health problems. Edinburgh: Scottish Executive. 
 
2003 - Scottish Executive's Annual Report on Drug Misuse. Findings from 2002 on how the 
Drug Strategy is progressing. Well according to this report.  
 
2003 – Crime and Criminal Justice Research Programme - Establishing Drug Courts in 
Scotland: Early Experiences of the Pilot Drug Courts in Glasgow and Fife - Research Findings. 
Commissioned by the Scottish Executive to evaluate drug courts.  
 
2003 – Scotland’s Drug Problem – Report of the Conference organised by the Royal Society of 
Edinburgh.  
 
2004 – Scottish Executive - Supporting Safer, Stronger Communities : Scotland's Criminal 
Justice Plan. Chapter 2: Tackling Drugs in Our Community. Puts in a range of measure aimed at 
problem drug users including treatment and community measures.  
 
2004 – The Effective Interventions Unit. Advocacy for Drug Users: A Guide. The Scottish 
Executive. 
 
2004 - Effective Interventions Unit: Reducing the impact of local drug markets: A research 
review. The Scottish Executive.  
 
2004 - Effective Interventions Unit: Examining the injecting practices of injecting drug users 
in Scotland. This is a summary of a report of research into the injecting practices of injecting 
drug users in Glasgow which paved the way for investigations into harm reduction initiatives 
such as drug consumption rooms.  
 
2004 – Drug Outcome Research in Scotland (DORIS). This research conducted by Neil 
McKegeny and others re-ignited the debate around abstinence versus harm reduction as a result 
of finding which appeared to show that rehabilitation and methadone treatment were not 
effective at achieving a drug free life. The repercussions of this study were felt for many years, 







2005 - SACDM Working Groups on Drug Related Deaths – The Scottish Executive 
 
2005 – Scottish Executive - Taking Action to Reduce Scotland’s Drug Related Deaths: The 
Scottish Executive Response to the Scottish Advisory Committee on Drug Misuse Drug-related 
Deaths Working Group, Report and Recommendations 
 
2005 – The Scottish Executive: Substance Misuse Research - National Investigation into 
Drug Related Deaths in Scotland, 2003.  
 
2005 - Effective Interventions Unit. Integrated Care Pathways Guide 9: Single Shared 
Assessment for Drug Users. To assist practitioners, managers and commissioners in reviewing 
the way that they design, record and deliver screening and assessment services to people with 
drug problems. 
 
2006 - Scottish Executive - Mental Health in Scotland. Closing the Gaps – making a difference. 
Edinburgh: Scottish Executive 
 
2006 - saw numerous small evaluation projects on topics such as Know the Score campaigns, 
Lloyds TSB funded project Partnership Drugs Initiative, findings from the Crime and Justice 
Survey, and Drug Courts evaluations. None of these however were key policy publications and 
are therefore not listed here.  
 
2007 – Drugs and Poverty: A literature review. A report produced by the Scottish Drugs 
Forum on behalf of the Scottish Association of Alcohol and Drug Action Teams.  
 
2007 - SACDM Methadone Project Group. Reducing Harm and Promoting Recovery: a report 
on methadone treatment for substance misuse in Scotland. Edinburgh: Scottish Government. 
 
2008 – SACDM - Essential Care: a report on the approach required to maximise opportunity 
for recovery from problem substance use in Scotland. Edinburgh: Scottish Government. 
 
2008 – The Scottish Government - The Road to Recovery: a New Approach to Tackling 
Scotland’s drug Problem.  
 
2008 - Scotland's Futures Forum Approaches to Alcohol & Drugs in Scotland, A Systems 
Mapping Approach to How Scotland Can Reduce the Damage to its Population by Alcohol and 
Drugs by Half by 2025. Available at: http://www.scotlandfutureforum.org/assets/files/report.pdf 
 
2009 – The Scottish Government - Changing Scotland's Relationship with Alcohol: A 
Framework for Action. 
 
2010 – The Scottish Government – Best et al (2010) What is the Recovery Evidence Base? 





2010  - The Scottish Government – Best et al. (2010) Research for Recovery: A Review of the 
Drugs Evidence Base. Available at:  
 
2011 – Scottish Government - Social Work Services and Recovery from Substance Misuse. 
Available at: http://www.scotland.gov.uk/Publications/2011/03/18085806/0 
 
2012 - Scottish Government - Scottish Drugs Strategy Delivery Commission, First Year Report 
and Recommendations to Minister. Available at 
http://www.scotland.gov.uk/Resource/Doc/360000/0121682.pdf 
 
2014 - NHS Health Scotland – Outcomes Framework for Problem Drug Use. Available at: 
http://www.healthscotland.com/documents/24442.aspx Accessed 28/06/2020.  
 




2015 – The Scottish Government – National Framework for Problem Drug Use. Available at: 
https://www.gov.scot/publications/scottish-national-research-framework-problem-drug-use-
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Appendix 2: Summary of SDPC sessions  
 
Below is a brief summary of SDPC themes and discussion, up until the present, 2020. The final SDPC 
session is not part of the data collected, however it is included to demonstrate the sustainability of such 
a process, and is of interest to the research. More in depth reports on each event up until 2018 are 





Inaugural meeting to prepare the ground and build rapport between participants.  
19 people attended 
This session was led by John Sturrock focused on getting to know each other and what we 
felt the key issues in drugs policy.  
 
Overarching themes were: the heterogeneity of drug use and how policy and practice did 
not reflect this; lack of understanding of the law, how it is implemented, the impact it has 
on drug users and recovery, how it is interpreted, who has the power to interpret/change; 
systemic change and what are the barriers to reform, positive change and discussion.  
 
The top 3 key issues that came from the small discussion groups were: 
1. Taking stock of the MDA ’71 –negative and positive impacts and whether it is fit 
for a 21st century Scotland, including the socioeconomic cost of the current policy 
and practice.  
2. Examining existing regulatory frameworks 
3. Combination of several key issues- improving collaboration and communication 
between sectors and communities in order to clarify and better understand the 
impact of drug harm, and drug reform. 
SDPC 2 
Developing a shared understanding of the purpose and focus of SDPC and topics for 
further enquiry 
“Following the successful first session, It was agreed that we should spend the next 3-4 months 
deliberating the various questions with a view to producing a document which would highlight the 
findings. What the actual outcome of this process will be is something we shall discover as we go 
through it. As John said, if we focus on the process the outcome will take care of itself. That being 
said I think it is fair to say many in the room want to be involved in something that will actually 
make a difference, and we can work through these discussions with this in our mind.” 
From the record of discussion. As you will see below the format was not followed, but we found a 








This session had a presentation from Police Scotland on its changes to personal 
possession of cannabis, and a group exercise on problems and issues of Scottish drug 
policy 
The presentation from Police Scotland provided an opportunity for SDPC to participate in 
giving feedback on proposed reform. In general it was felt that this is a valid a good use of 
SDPC time and more collaboration on similar proposals would be welcomed.  
 
The group exercise asked participants to individually identify 3 problems and/or issues 
surrounding Scottish drug policy, and these were stuck onto a wall and put into themes by 
the group as a whole. They highlighted 3 overarching themes: 
1. Criminal justice and policing – including issues around criminalization, stigma, lack 
of clear implementation, harms associated with the system and policing. 
2. Health and society – including issues around stigma and language used towards 
drug users, too much focus on addiction, not reflective of the various ways people 
take drugs, too focused on harm (no acknowledgment of benefit or how harm 
could be reduced within a regulatory framework) and over-emphasis on problem 
drug use.  
3. Research, Evidence and policy – lack of evidence and money for research, no 
acknowledgment of public awareness of drugs, and need more policy put into 
practice.  
 
A final thought exercise highlighted that many in the room were keen for change, were 
appreciative of the space the SDPC provided for non-confrontational communication, and 
hoped that SDPC could continue to provide a space where reform and change were 
discussed, but also provide a place where they could speak freely. It was agreed that next 
session would be a blue sky exercise on Scottish drug policy. 
 
SDPC 4 
Presentations on rights, morality and health 
Although the intention was that this session would be a blue skies exercise on what a 
Scottish drug policy could look like, we (Mike, Anna and Richard) structured this session 
around 3 themes that dominated the undercurrent of all discussions so far: rights (law), 
morality and Health.  
 
Although the session was structured to produce an agenda for change, the presentations 
and discussions they generated took up the full 2 hours. However, the discussions that 
took place were refreshing and most participants enjoyed the format of 3 short 






Because of this, future SDPC’s conversations started to stray from the original structure 
and format that had been agreed during the initial process. 
 
SDPC 5 
Presentation by Beverly Francis of the Substance Misuse Unit 
Beverly Francis of the Scottish Governments Substance Misuse asked if she could present 
an overview of the new policy advisory landscape.  
 
Beverley gave us a general overview of how the new landscape is structured and where 
SDPC could fit in. Discussion highlighted that SDPC could provided an independent 
advisory arm, not constrained by the government agenda.  
 
Beverley stressed that public engagement was key to any reform and that this is an area 
that needed to be looked at. Another area that the Government are keen to get more 
research and advice on is how to reduce stigma. Several people highlighted the role of the 
criminal justice system in producing and maintaining stigma, however this is not an area 
that Government can look at until there is obvious widespread public support. 
 
SDPC 6 & Governance Workshop 
UKDPC workshop on Governance with Roger Howard of the UKDPC during the 
afternoon.  
In the late afternoon/early evening the session was on the the ‘Regulation of Minor 
Offences’. 
SDPC held a daytime workshop with Richard Howard where we looked at the governance 
of drug policy. The content of this workshop is not set out in this document.  
 
In the later session we had feedback form Police Scotland and 2 other participants on the 
regulation of minor offenses. 
1. Athol Aitken of Police Scotland gave feedback on the change to minor offenses 
that resulted in small amounts of cannabis being treated as minor offenses, as 
opposed to be charged as possession. The decision had been taken by the Lord 
Advocate and the police not to extend this policy to all class B and C drugs, largely 
on the basis that implementation would have been difficult and costly.  
2. Vicki Craik of Crew 2000 gave feedback from small user group discussion she had 
had, however her feedback was based on the initial remit which was to gauge 






3.   Iain McPhee gave feedback on this issue highlighting aspects that he had come 
across in his academic research, in particular his knowledge of how such offenses 
are policed from a consumer perspective. 
 
SDPC 7 
Engaging the Public – 3 speakers and group discussion 
Following the successful format in session 4 this conversation focused on public 
(stakeholder and wider public) engagement on drug policy initiatives. Oliver Escobar from 
the University of Edinburgh, and a specialist in deliberative forms of engagement, was 
invited to be our keynote listener, and gave feedback and ideas of ways forward.  
 
Our three speakers were:  
1. Saket Pryadashi –discussed the process of engaging the local and wider 
community regarding drugs consumption rooms in Glasgow. Three lessons were 
taken away from this and the resulting group discussion: 
i. People are not as averse to these initiatives as is commonly thought, and 
the media are not as adversarial as one might expect, in Scotland at least.  
ii. Proper engagement with the local community and businesses at an early 
stage is very important for providing evidence of local support. 
Furthermore, it is not always necessary to engage the public at large, as 
those who are affected are the ones who count when decisions about 
whether to proceed are made.  
iii. The formal process of getting such an initiative agreed involves multiple 
layers of bureaucracy. This can result in longer timescale, and in some 
instances the decision makers not having the time, or sufficient evidence, 
to make the right (in our opinion) decision. Good channels of 
communication are therefore essential, but not always available.  
2. Stephen Malloy – discussed his involvement with the European Forum for People 
who use Drugs, and the initial stages of setting up a Scottish branch.  
3. Mike McCarron – discussed his involvement with the Centre for Human Ecology 
and an event he had put on there.  
Oliver gave his feedback, which highlighted the role that deliberative methods of 
engagement could have in this area. Group discussion focused on how to raise finances 









Andrew Learmonth of the National spoke to the group via Skype and gave us some 
insights into who to engage with the media. The main point highlighted from this evening 
was that the media will only get involved if they think there is a story to it. 
 
Overall the evening was a success but there was a feeling that we had come to the end of 
this style of conversations, and that 2017 should open the possibility of more active 
engagement on issues. 
 
SDPC 9  
Taking Stock and Moving Forward 
This session was chaired by Richard Freeman and John Sturrock facilitated, and helped us 
collate the various ideas we had on moving forward. 21 people attended, which is one of 
the best attended session yet. It was great to see many new faces and this made us 
realise that SDPC has now entered a new era and will change to reflect this. 
 
Overall everyone who came felt positively about the last 9 sessions, although there was 
frustration expressed at how long it took to create consensus and whether this was really 
needed. However, once we had done our group work the last 30 minutes were dedicated 
to setting an agenda for 2017. 
 
SDPC 10 
Who are we, what are we? 
This session took place in Glasgow at the Center for Contemporary Arts. It was attended 
by 20 people and took place during the afternoon, as opposed to the evening.  
 
We spent a good amount of time discussing the vision statement and profile of the group. 
This was done in 4 groups of 5, and then a large group discussion. This process highlighted 
the challenges in getting consensus from such a variety of voices and ideas. the final 
vision statement is to be agreed by the group via email by the end of May.  
 
The second half was a mapping exercise. Participants were asked to come up with 3 
critical questions for Scottish drug policy, taking into account the overarching issues 
identified in conversation 3. The aim of this is to condense the questions into 5-10 critical 
questions which can be used as a toolbox for participants and their affiliated 
organizations to take to the wider community. 
 
SDPC 11 
Cannabis in Scotland 
SDPC 11 was a joint event held by SDPC and Contemporary Drug and Alcohol Studies 
(CDAS) at the University of the West of Scotland which focussed on the regulation of 





by 18 participants of SDPC. 
 
 
The event was structured into 2 sessions. The first session was a presentation by Steve 
Rolles of Transform Drug Policy Foundation (www.tdpf.org.uk) on current international 
movements for the regulation of cannabis, and important policy aims and points to 
consider when designing a cannabis policy (slides attached to the email). 
 
The second session was a presentation by Bernadette McCreadie on her experience of 
interacting with MSPs, and Anna Ross on the potential hurdles and challenges to reform. 
  






1. The regulation of cannabis is a policy option gaining traction internationally and 
Scotland should be prepared to engage with the different models and processes 
involved.  
2. Creating a new narrative on cannabis in Scotland, including challenging the idea 
that we are unable to do it because of the Misuse of Drugs Act 1971. There is 
flexibility and grey legal areas that can be worked through if there is a willingness 
by all those involved to engage with it.  
a. The new narrative must engage different publics in order to raise 
awareness around the impact of the current system of non-regulation on 
cannabis consumers, and potential outcomes of legal regulation.  
b. This may also include analysis on potential revenues such as Hemp 
production, cannabis research in Scottish universities and pharmacies, as 
well as taxable income from different regulatory models.  
c. It must also include the impact of criminal sanctions on consumers 
(physical, psychological and financial), and the financial impact on the 
Scottish Courts and police (see below on policy aims).  
d. Engaging with medical community in regards health benefits such as 
chronic pain, MS, arthritis and other neurological and nervous systems 
disorders which have shown to benefit from cannabis use.  
3. The Expert Working Group on Cannabis in Scotland will take the outcomes of this 
meeting and work on a proposal for implementation. This proposal will be brought 
back to the SDPC group as a provisional draft and we will deliberate its content 
and how to take it forward. This will likely happen towards the end of 2017.  
4. A joint letter asking for drug policy reform, akin to the joint letter handed to 
parties at the General Election 2017 will be drafted by Steve O’Rawe and 














Main Outcomes  
 
There was broad agreement on the following outcomes: 
 
1. PUBLIC ENQUIRY - Call for a public enquiry, commission or citizens assembly into drug 
policy in Scotland involving all stakeholders and requiring mandatory participation from 
identified stakeholders. This reflects Recommendation 66 of the Commission for 
Parliamentary Reform report (2017, p.69) which advocates the use of deliberative 
processes. SDPC will work towards this in the coming months. It was also felt that in order 
to input into the current refresh SDPC should work with the Scottish Government to 
collect submissions from stakeholders currently not engaging in the process.  
 
2. UNIVERSAL INCOME – There was across the board support for the implementation of the 
Universal Income. It is envisaged that the impact of the Universal Income would help 
reduce the financial instability experienced by many problematic drug consumers that 
results from benefit sanctions for missed appointments, inability to access the right 
benefit advise, etc. Furthermore, the Universal Income would help reduce the stigma and 
stress associated with being in receipt of benefits, allowing individuals to access 
employment and voluntary opportunities not currently available. Finally, it shifts the focus 
away from economic need to social need.  
 
3. HARM REDUCTION - Implementation of effective harm reduction, including harm 





reduction initiatives are not adequate. While there are embedded practices such as 
needle exchange and naloxone provision, harm reduction as a policy is not implemented 
across the board. Sub-optimal prescribing, the barriers currently being experienced in 
regards drug consumption rooms, low uptake of heroin assisted treatment, resistance to 




Creating Collaboration – designing the engagement toolkit 
This session was separated into two parts.  
 
The first part introduced new members to the group, and set the boundaries and outlined the 
direction SDPC has been taking. This encouraged an open discussion on drug policy including a 
focus on trauma informed policy, and trauma resulting from policy.  
 
The second section was an engagement activity to develop questions for an engagement toolkit. 
We were seeking questions that would require participants to explore their own thoughts and 
beliefs, which could then prompt wider discussion and knowledge exchange. The outcome of this 
exercise was the development of 5 main questions with sub questions which we all agreed would 
instigate deep discussion, and highlight interesting narratives and storylines.  
 
 
1. Experiential questions 
a. What is your experience of drug use and drug policy? 
b. What impact does drug use and drug policy have on you?  
2. Harm and Benefits 
a. Are there harms caused by drug use?  
b. Are there harms caused by drug policy 
c. Are there good aspects to drug use?  





3. Legality and open questions for prompting 
a. Why are some drugs legal and others illegal? 
b. What is the difference between alcohol and illegal drugs?   
4. Scottish powers 
a. Should Scotland have control of drugs policy?  
b. If so how would we do it differently?  
c. What should we do about cannabis?  
 
SDPC 14 
Drug Consumption Rooms 
This event took place in Glasgow and the discussion centered around the proposal that DCRs are 
an important bridge to moving from a prohibition perspective to a regulation model. The 
hypothesis is that DCRs contain practices that are the ones that underpin a regulation approach.  
 
Therefore it would be a good piece of work to clarify what are key principles involved in DCRs and 
how they would apply in a national policy Scotland-wide. Such principles appear to be: 
• Allowing DCR clients to carry and use drugs is effectively decriminalizing possession 
• Recognition that many people will spend many years and sometimes a lifetime using 
drugs problematically pending good-enough resolution of adverse childhood experiences 
and other life traumas 
• Heroin assisted treatment (HAT) for DCR clients and associated research raise questions 
about wider availability for problematic drug use but also the pros and cons of access by 
people with controlled or unobtrusive use of heroin 
• The importance of DCR drug users building relationships with professionals and leading to 
treatment and other forms of help being taken up pose questions for every community 
drug service and their culture, especially intended and unintended stigmatization. 
• DCR clients will no doubt be mainly older heroin users. The experience of working with 
them in DCRs will have many implications for working with older opiate users generally. 
For example, HAT? 
• DCRs’ non-threatening and completely accepting environment allows clients to be more 
honest about what’s going on in their lives, more ready to open up, increases motivation 
to change, helps identify the best sequence of steps to change, encourages developing a 
wide range of help for flexible response to individual circumstances. Is this the reality of 




Memorial for Kenny Simpson 
Pragmatic Approaches to Policing Drugs – which the changed to Pragmatic Approaches to 
Policing People who use Drugs during Covid 19 
Initially we had organised this as a half day event, with speakers and in-depth discussion on 
policing drugs. However lockdown prevented this, and instead it took place over the internet.  
It was well attended all things considered, and we were still able to separate into small groups 
using the online ‘break out’ facility.  
 





David Strang - former Chief Constable of Dumfries and Galloway, and Lothian and Borders, and 
latterly Chief Inspector of Prisons. David has ostensibly retired now, but is involved with a range of 
organisations, including being chair of the Scottish Association for the Study of Offending. David 
discussed community justice responses to PWD. 
Angus Bancroft - Senior Lecturer in Sociology at the University of Edinburgh. Angus discussed drug 
use and the darknet, and the implication during the current lockdown.  
Kira Weir - Training and Communications Officer at Crew 2000. Crew recently conducted a survey 
to understand how drug use, buying etc. has changed during the outbreak. Kira presented her 
findings of the survey so far, which showed that some drug use had increased and some people 
were finding it difficult to get hold of certain drugs. Well-being and reasons for using drugs were 
also surveyed.  
 
The following discussion in small groups really shone a light on the need for more discussion on 
the legislation surrounding drug use, and the concepts of what a drug user actually is. An 
interesting input from the police was the fact that the majority of their time is spent with 
‘problem drug users’ therefore it is difficult for them to discuss drug use without thinking about 







We will be holding further SDPC sessions in 2020. Our forthcoming sessions will be exploring how we 
would regulate should Scotland get devolved drug powers. Would we replicate the Misuse of Drugs Act 
verbatim, or develop legislation based on levels of harm both of the drug and by/to the individual), as 
suggested by the RSA 2007 report. Ultimately it is hoped that SDPC can continue to provide an 
independent and inclusive space for policy stakeholders to deliberate how Scotland can develop a drug 
policy based on human rights and public health concerns, and provide a strong narrative of change in 






Appendix 3: Respectful Dialogue 
 
SDPC’s Commitment to Respectful Dialogue 
 
With thanks to collaborative Scotland www.collaborativescotland.org.uk 
 
The Scottish Drugs Policy Conversation (SDPC) is a space for people with 
varied viewpoints and different experiences of drugs and drugs policy who wish to 
learn from this diversity, an 
d influence future developments within Scotland. 
SDPC welcomes respectful dialogue and open-minded reflection on options for 
improving Scottish drugs policy by engaging with stakeholders and the wider 
public. 
In order to do this we, the participants, agree to: 
 
• Show respect and courtesy towards all those who are engaged in these 
discussions, whatever views they hold; 
• Acknowledge that there are many differing, deeply held and valid points 
of view; 
• Use language carefully and avoid personal or other remarks which might 
cause unnecessary offence; 
• Listen carefully to all points of view and seek fully to understand what 
concerns and motivates those with differing views from our own; 
• Ask questions for clarification and when we may not understand what 
others are saying or proposing; 
• Express our own views clearly and honestly with transparency about our 
motives and our interests; 
• Respond to questions asked of us with clarity and openness and, whenever 
we can, with credible information;   






Appendix 4: The Right to Choose 
 
 
“THE RIGHT TO CHOOSE” 
 MEDICINAL CANNABIS PROGRAM 
SCOTLAND 
 
Every single person in Scotland is unique and individual, especially when it comes to our health.  
The Right to Choose Medicinal Cannabis Program Scotland will ensure we are all treated as such 
and allow us to play a major role in deciding for ourselves how we want our healthcare to 
proceed.  Right now, we are put onto a conveyor belt and treated with the same protocol as 
everyone else with the same named condition, which usually involves doing what your told and 
taking the drugs your prescribed.  This must stop and patient involvement/participation/choice 
must be implemented.  Thanks to technology people are far more educated on their own 
health issues than ever before and are realising there are more ways other than the 
pharmaceutical protocol.  We demand THE RIGHT TO CHOOSE what we put into our bodies, this 









Consultants/Doctors/Nurses/Healthcare Professionals must all be fully and properly educated 
on the therapeutic/medical benefits of cannabis.  They must be properly educated on the 
differences between synthetic/medical cannabinoids and natural/organic/herbal cannabis. This 
won’t be a difficult thing to do as there has already been so much research already done in 
other countries that are so far advanced to us.  All this information is readily available online for 
anyone to read.  Scotland must now take the lead on this and start considering 
collaborations/information sharing projects between our Universities and research facilities, 
and the Universities and research facilities around the world that already have a head start.  
There’s no point reinventing the wheel.  Consultants/Doctor/ Nurses must be given the 
autonomy to personally research/discuss/recommend/prescribe Cannabinoids for 




When a person becomes unwell and visits their GP, the GP must give their patient the choice to 
be medicated with either traditional pharmaceutical medication, pharmaceutical grade 
cannabis/cannabinoids or natural herbal cannabis.  The patient must then get to decide the 
supplier of their medicine or be given the choice to grow their own cannabis for their own 
needs.  This must include the following: 
 
1. A maximum allowance of 6 flowering cannabis plants at a time 
2. A maximum allowance of 6 vegetative cannabis plants at a time 
3. A maximum allowance of 18 seedlings/cuttings at a time (1,2,3 allow and ensure a 
constant rotation of cannabis growth and supply for more serious health issues) 
4. The freedom to makes oils/edibles/concentrates as a responsible adult (we are more 
likely to die crossing the road yet we don’t see anyone getting banned from doing that) 
5. No THC maximum  
6. No CBD minimum  
7. Access to non-profit/compassion clubs where a patient can safely have up to 7 grams of 
clean and tested herbal cannabis or 1 gram of cannabis oil plus 3.5 grams of herbal 
cannabis or 1 gram of concentrate plus 3.5 grams of herbal cannabis, per day available 
on prescription.  All non-profit compassion clubs must also register and adhere with 
SICA (see below). 
8. Access to education from already experienced cannabis users on how to medicate with 





9. A grant system for everyone who chooses to grow their own plants, to help cover the 
cost of equipment and expenses of this exercise, something that will save the NHS 
millions every year. 
10. Issued with medicinal cannabis card to allow uninterrupted access to all the above. 
11. The guarantee that any person who requires the help of a carer/assistant/family 
member with daily life tasks will not be putting their help at risk of prosecution.  
Carers/assistants/family members must have the same leniency afforded to them, they 
are only doing their job or helping a loved one so should also be free from prosecution. 
POLICING 
Police Scotland must be given the autonomy not to arrest or prosecute any person found in 
compliance with this program.  Police Scotland must be given the proper powers and support 
from all Government departments involved in relation to this.   
Policing of cannabis falls under the Misuse of Drugs Act 1971. Schedule 4 of the Misuse of 
Drugs Act 1971 specifies that the following acts involving a Class B drugs (cannabis) will result in 
6-12 months imprisonment and/or a £400 fine 
1. Cultivation of a cannabis plant  
2. Production or being concerned in the production of a controlled drugs 
3. Supplying, offering to supply, or being concerned in the doing of either 
4. Having possession with intent to supply 
5. Being the occupier, or concerned in the management, of premises and permitting or 
suffering certain activities to take place there. 
Given that under the ‘71 Act possession of cannabis carries a 3 month prison sentence and/or a 
£2,500 fine, yet in Scotland consumers are given a Written Police Warning, and other parts of 
the UK have various ways in which they police possession, the terms of The Act are flexible.  
It is possible that acts set out in 1-5 could be subject to a policy created in collaboration 
between Police Scotland, the Scottish Government and the Crown Office aimed at 
improving/protecting public health and reducing drug related harm.  
A policy which allowed consumers to grow up to a 6 (flexible) plants, join social clubs where 
cannabis can be collective grown and potentially consumed (as in Spain, the Netherlands and 
Belgium), and provide a framework in which the £400 ‘fine’ is applied on a regular basis which 
is strictly regulated potentially would not violate The Act.  
Police Scotland officers and senior members must be fully retrained on how to deal with people 
in these special circumstances and what to do if they come across a particularly vulnerable 
person.  This is not trying to increase the work load of our already over stretched and 
underfunded police service but the opposite.  A program like this will free up a lot of police time 







Scotland must introduce cannabis/hemp to the market in a progressive manner by not allowing 
the monopoly for a multi-billion-pound industry to be handed over to the pharmaceutical 
companies alone.  This is an industry that is big enough for everyone to be involved in so there 
is enough to go around.  Scotland must make it possible for smaller businesses to access this 
market financially by creating a non-medical licensing process.  Particularly to give farmers and 
small businesses the opportunity to grow/trade in cannabis/hemp, the same opportunity as 
multibillion multinational companies who can afford it get.  Companies supplying natural herbal 
food supplements/organic plant products should not have to adhere to the rules of the 
pharmaceutical industry because their products are all completely natural and contain no 
added chemicals.  There must be a full testing and labelling process put in place and all 
companies must adhere to registering with the Scottish Industrial Cannabis Association, who 
will have very strict guidelines that all business must follow.  SICA will commit to liaising with 
the Scottish Government with full disclosure from both ends guaranteed always to ensure it 
runs with as little disruption as possible. 
 
